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Abstract 
 
 
Chiral non-racemic ketones have been shown to be powerful promoters of 
asymmetric induction in epoxidation reactions with alkenes in the presence of 
Oxone®. However, the catalyst structural features are specific for the class of olefins 
used as substrates. Up to date, excellent results have been achieved for trans- and tri-
substituted alkenes, while terminal alkenes still represent one of the most challenging 
areas. Much work needs to be done in developing suitable catalysts to lead to high 
enantioselectivities.  
Previous work in Armstrong’s group identified ketone catalysts based on 
oxabicyclo[3.2.1]octan-3-ones and on the N-carboethoxytropinone skeleton, which 
performed very well in enantioselective epoxidation of trans- substituted olefins (up 
to 93% ee for E-stilbene). This thesis describes the synthesis and the efficiency 
towards alkene epoxidations of novel α,α-disubstituted ketones based on the N-
carboethoxytropinone scaffold. In particular, encouraged by the positive results 
achieved by Shi’s group for terminal alkenes, several spiro-motifs α to the carbonyl 
have been investigated. A slight improvement was observed towards the challenging 
terminal olefins compared to the monosubstituted ketone analogues, whilst very high 
ee were maintained for trans- substituted alkenes. However, to our surprise, only 
minor changes in enantioselectivity were observed from modifications of the steric 
and electronic properties of this spiro-motif in the ketone catalyst. Further axial or 
equatorial α' functionalisation was explored as a possible strategy to increase 
enantioselectivity towards terminal and 1,1-disubstituted alkenes. Indeed, significant 
improvements were achieved in enantioselective epoxidation of styrene (up to 50% 
ee) and α-methyl styrene (up to 39% ee). 
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Chapter 1 
 
 
Introduction 
 
 
1.1  Asymmetric epoxidation 
 
Chiral, non racemic, epoxides are highly versatile intermediates and important 
building blocks for the synthesis of enantiomerically pure complex molecules. 
Asymmetric epoxidation of alkenes provides a very powerful strategy to achieve the 
synthesis of such epoxides as two adjacent oxygen-substituted chiral centres can be 
obtained in a single step.1 The major potential of these small heterocycles as building 
blocks in organic synthesis derives from facile subsequent functionalisation, e.g. 
stereospecific ring opening reaction.2 Several methods based on either transition 
metal catalysts and cooxidant (NaClO, PhIO or tBuOOH) or organic / inorganic 
peracids have been developed in the last 30 years for the synthesis of chiral non-
racemic epoxides.3,4 Good progress has been made for some classes of alkenes and 
high enantioselectivities have been obtained for trans- and cis- olefins, di- and tri-
substituted alkenes.5-9 Recently, electron-poor C=C double bonds, as those in enones, 
have been epoxidised under nucleophilic conditions with good ee.10,11 Conversion of 
certain styrene derivatives into the corresponding epoxides can be achieved with 
moderate to high ee with a few metal catalysts such as iron and manganese 
porphyrins,12 Ru(III),13 and also with organic catalysts.3 However, a useful 
epoxidation method for simple terminal and unfunctionalised alkenes still remains 
elusive. The discovery of asymmetric processes to be applied to prochiral olefins still 
represents a primary research activity and more work is needed to obtain high 
enantioselectivities with certain substitution patterns. 
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1.2  Chiral peracids 
 
Peracids were used for the first time in alkene epoxidation by Prileschajew in 1909.14 
Since then m-chloroperbenzoic acid (m-CPBA) has been often used in oxidation 
processes and, in particular, in epoxidation reactions. Reaction of m-CPBA with 
olefins is stereospecific15a but affords racemic products for the absence of chiral 
elements in the reaction conditions. It was then thought to transfer the chirality from 
the reagent to the epoxide product by the use of chiral peracids. Low levels of 
enantioselectivity were obtained by Henbest and co-workers in epoxidation of 
terminal olefins with (+)-monoperoxycamphoric acid 1 (Figure 1.1), 2.0-4.4% ee for 
styrene according to the solvent used.15b 
The low enantioselectivity might find an explanation in the mechanism of the 
reaction and in the transition state analysis. In fact, the oxygen transfer from the 
peracid to the olefin occurs through a concerted mechanism and the chiral element on 
the peracid is too remote to exert asymmetric induction on the product (Transition 
State A16, Figure 1.1).  
 
CO2H
CO3H
R
R R
R
O
H
O
O
R*
Transition State1
A
 
 
Figure 1.1: (+)-Monoperoxycamphoric acid 1 as an example of a chiral peracid and Transition State 
A in peracid epoxidation reaction. 
 
 
Complex optically active hydroperoxides, synthesised for example from isocyanates, 
nitriles or enolisable carbonyl compounds and hydrogen peroxide gave slightly better 
results (Scheme 1.1)17 but, given the mechanism-based difficulty for the chirality 
transfer, high enantioselectivities are difficult to achieve. 
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Scheme 1.1 
 
 
In 2007, Miller published a study on a catalytic cycle based on aspartate-derived 
peracids. The idea was to develop a carboxyl activation in the presence of an oxidant, 
generally aqueous hydrogen peroxide, to generate the corresponding peracid. Oxygen 
transfer to an olefin would then regenerate the starting acid. The same principle can 
be applied to obtain asymmetric induction by introducing the aspartate residue into a 
peptide sequence as in 2 (Scheme 1.2). That sequence was, in fact, known to adopt a 
β-turn type and induce enantioselectivity in other asymmetric processes. High 
conversion and ee (up to 92%) were obtained for carbamates of general formula 3. 
Studies on the possible modes of asymmetric induction are currently under 
investigation.18 
 
 
R OH
O
DCC, 
DMAP
H2O2
R O
O
OH
R R
R R
O
RCO2H = 
Aspartic acid
O
O
NHX O
O
NHX
O
2 eq DIC, 2.5 eq H2O2
CH2Cl2/H2O , -10 °C
4 - 53 h
up to 92% ee
10 mol% 2, 10 mol% DMAP
N
O
HN
OHN
Ph
OBocHN
HO2C
2
X = Bn, Ar
3 4
 
 
Scheme 1.2  
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1.3  Sharpless asymmetric epoxidation 
 
Great progress has been achieved in metal-catalysed epoxidation. In 1980, Sharpless 
and co-workers reported highly enantioselective epoxidation reactions of allylic 
alcohols. Good yields (> 70%) and excellent enantioselectivity (> 90%) for a wide 
range of allylic alcohols were obtained although the methodology is fundamentally 
restricted as it is efficacious for allylic alcohols only.19 The reactions are typically 
performed in DCM at -20 ºC using tert-butylhydroperoxide as the oxidant, titanium 
iso-propoxide and diethyl tartrate as the stereocontrolling element.20 According to 
which enantiomer of diethyl tartrate is used, epoxidation occurs selectively and 
predictably on one face of the olefin (Scheme 1.3). Confidence in the results obtained 
following these empirical rules makes this methodology useful for assignment of the 
absolute configuration of the resulting epoxides. 
 
R1
R2
R3
OH
(CH3)3COOH, Ti(Oi-Pr)4
DCM, -20 °C
(-)-DET (unnatural)
(+)-DET (natural)
O
R2 R1
R3
OH
70-90% yield
> 90% ee
 
 
Scheme 1.3 
 
 
Diethyl tartrate is essential to create not only a chiral environment but also to 
participate in assembly of the metal alkoxides. It has been found that the tartrate 
ligand can stabilize a variety of structural types and eight different tartrate binding 
modes have been identified.21 The main catalytically active species is assumed to be 
the dimer 5 (Figure 1.2) with two titanium atoms bridged by two tartrate ligands. The 
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allylic alcohol is believed to bind to the axial coordination site while the peroxide 
occupies the opposite face, with the proximal oxygen placed in the axial position and 
the distal oxygen in the equatorial position (Figure 1.2).22 
 
Ti
OR
O
O
O
RO
Ti
O
O
O
O
tBu
E
E
R3
R2 R1
E
O
RO
E = COOR
5
 
 
 
Figure 1.2: Dimeric complex in Sharpless asymmetric epoxidation. 
 
 
The addition of 3 Å molecular sieve to the reaction mixture allows the asymmetric 
epoxidation reactions to proceed with only 5-10% of the titanium-tartrate catalyst. It 
is likely that molecular sieve prevents the deactivation of the catalyst by water.20 
In general, E-allylic alcohols are the best substrates and give high 
enantioselectivities, while some Z-allylic olefins and a few hindered ones tend to 
react slowly and give poor ee. 
Recently, Yamamoto has obtained high enantioselectivity in epoxidation of several 
tri-, trans- and cis-substituted allylic alcohols by replacement of titanium with 
vanadium catalysts and by using a hydroxamic acid as ligand (catalyst 6, Scheme 
1.4).23 Notably, improvements have been achieved by the use of complexes bearing a 
C2 symmetrical ligand. Compared to the traditional Sharpless epoxidation, catalyst 
loading can be lowered to 0.2% and aqueous tert-BuOOH can be used instead of 
anhydrous conditions according to the newly developed protocol (Scheme 1.4).24 
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C6H13
OH
C6H13
OH1 mol% 6
tBuOOH (70% aq)
DCM
O
60%
95% ee
N
N
O
O R
R
O
O
V(OiPr)
6    R = CH(Ph)2
 
 
Scheme 1.4 
 
 
1.4  Transition metal porphyrin complexes in asymmetric epoxidation 
 
Transition metal porphyrin complexes (metalloporphyrins) have received great 
attention as potential catalysts in the asymmetric epoxidation of olefins driven by the 
discovery of Fe(III) porphyrin complexes as models for cytochrome P-450. 
Manganese and iron porphyrins are the most important catalysts in the class as they 
give higher conversion and selectivity compared to other metals, such as 
molybdenum.25 
In 1983, Groves and co-workers reported the first example of asymmetric 
epoxidation of olefins catalysed by an iron porphyrin complex (Fe(TPP)Cl) in the 
presence of iodosylarenes (PhIO) in DCM (porphyrin 7, Figure 1.3).26 
 
N N
R
RR
N N
R
M X
7
R = Ph, M = Fe, X = Cl : Fe(TPP)Cl)
 
Figure 1.3: Groves’ porphyrin. 
 
 
The manganese porphyrin 8 synthesised by Collmann in 1993 (Figure 1.4) is a very 
active system for epoxidation of terminal and cis- olefins (e.g. 88% ee for 1,2-
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dihydronaphthalene with iodosylbenzene as oxidant) but still lacks selectivity toward 
trans- alkenes.27 
 
N
N
N
N
Mn
O
OO
O
H O
O O
O
H
O O
Cl
8
 
 
Figure 1.4: Collmann’ s porphyrin. 
 
 
Further studies in the area allowed the development of the C2 symmetric iron 
porphyrin 9 (Figure 1.5) functionalised with binaphthyl units, that gave extremely 
high enantioselectivity for conjugated and non-conjugated terminal olefins (83% ee, 
95% yield for styrene; > 90% ee, 85% yield for 3,3-dimethylbutene). One of the 
main features of the system is its geometry giving an open cleft for access of the 
olefin with steric hindrance in proximity to the metal centre (Figure 1.5).28 
 
N
N
N
N
Fe
Cl
HN
HN R
R
R =
OMe
MeO
NH
O O
HN
9
 
 
Figure 1.5: Improvements in porphyrin design. 
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Unfortunately, a common limitation of the metalloporphyrins is their instability and 
degradation in the presence of excess of oxidant leading to the destruction of the 
asymmetric environment, and the considerable difficulty in effecting their synthesis.  
 
 
 
1.5  Chiral salen complexes in asymmetric epoxidation 
 
In the early ’90s, Jacobsen29 and Katsuki30, almost simultaneously, reported a salen 
(Mn) mediated asymmetric epoxidation reaction of unfunctionalised olefins. Chiral 
salen complexes are sterically well-defined systems that bear stereogenic centres in 
proximity to the metal site to allow the transfer of the chirality to the olefin during 
the epoxidation process. 
Mn(III) complexes usually give good yield and high enantioselectivity for various 
cis- olefins in the presence of NaOCl as oxidant. 
In the case of the Jacobsen Mn(III) complex with chiral ligand 10, it is believed that 
the alkene approaches the metal-oxo bond from the di-imine bridge site (approach a, 
Scheme 1.5), since all other faces (approaches b, c, d, Scheme 1.5) are hindered by 
bulky substituents. The chiral induction is then produced by the axially-locked 
proton on the di-imine bridge which forces approach of the substrate such that the 
steric interactions with the olefin substituents are minimized (Scheme 1.5). The 
features of these catalysts allow high enantioselectivity for cis- olefins despite the 
fact that some of them might isomerise during the epoxidation process thus leading 
to a mixture of cis- and trans- epoxides. In general, trisubstituted olefins are 
excellent substrates while unsubstituted and trans- substituted alkenes afford low 
enantioselectivity thus limiting the applicability of the methodology (Figure 1.6).6,31  
Very recently, a one-pot enantioselective synthesis for ligand 10 has been reported, 
thus further increasing the potential of Mn(III)-salen methodology for epoxidation.32  
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Scheme 1.5 
 
 
 
RAr n Ph
90-98% ee 93% ee87-94% ee
R
Ar R R
R, R'= alkyl, H
Low ee
BUT
 
 
Figure 1.6: Enantioselectivities with the Jacobsen’s catalyst. 
 
 
Katsuki and co-workers investigated similar catalysts bearing additional stereogenic 
centres at the 3- and 3’- positions of the salen ligand (Figure 1.7). Catalyst 11 gave 
slightly improved enantioselectivity toward certain trans- olefins (50% ee for E-β-
methyl styrene). It is believed that the chirality at the 3- and 3’- positions controls the 
epoxidation of trans- olefins while it does not affect epoxidation of cis- alkenes.31 
 
 
tBu O
N N
H Hax
O
Mn
tBu
tBu
tBu
MePh
H H favoured
a
b
c
d
XX
X
O
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O
Ph Et
Et Ph
Ph Ph
11
3 3'
 
 
Figure 1.7: Katsuki’s catalyst. 
 
 
 
1.6  Metal catalysed asymmetric epoxidation of terminal alkenes with hydrogen 
peroxide 
 
All the methodologies that have been discussed until now require the use of oxidants, 
such as alkyl peroxides or inorganic peracids. Research is now focusing on 
development of protocols making use of greener oxidants, which are highly desirable 
for both the academic and the industrial world. Aqueous hydrogen peroxide is 
gaining lots of attention as it is cheap, highly atom efficient, safer and more 
environmentally friendly, with water being the only by-product.33-37  
Nocera38 and Katsuki39 research groups have recently published successful results for 
catalytic activity and asymmetric efficiency of Mn(III)-salen ligands in the presence 
of H2O2 as alternative co-oxidant to NaOCl. As it has the great advantage of 
generating water as by-product, no need for accurate pH control of the reaction is 
required. 
In 2006 Strukul reported synthesis, catalytic activity and efficiency of Pt(II) 
complexes for asymmetric epoxidation of terminal unfunctionalised alkenes in the 
presence of hydrogen peroxide. Coordination of Pt(II) to chiral diphosphine ligands 
generates a very active catalyst which epoxidises alkyl terminal alkenes, with 
moderate to good yields and ee up to 98% (Scheme 1.6). Although styrene was not 
epoxidised by 12 under the standard reaction conditions, allylbenzene gave 75% ee 
in 79% yield. Catalyst 12 showed a remarkable regioselectivity in epoxidation of 
dienes for the terminal and less substituted double bond, contrary to what is reported 
in the literature for electrophilic epoxidation methods (Scheme 1.6).36 
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R RO
P
Pt
P
Ph
Ph
Ph
Ph
C6F5
OH2
+
TfO-
1eq H2O2, CH2Cl2, -10 °C
2 mol%
12
 
 
 
 
 
Scheme 1.6 
 
 
Enantioselectivity seems to be strongly dependent on steric effects, given the rigidity 
and the steric hindrance generated by the aromatic rings around the active site. The 
mechanism of the epoxidation and the selectivity are not fully understood yet and a 
careful analysis is still underway.36  
 
The titanium(salalen) catalyst 13 (Figure 1.8) reported by Katsuki in 2007, was 
successfully used in asymmetric epoxidation of cis- olefins and of a wide range of 
non-activated and non-branched terminal alkenes in the presence of hydrogen 
peroxide as oxidant. High enantioselectivities were obtained at very low catalyst 
loading, up to 1-3 mol%, and no isomerisation was observed for cis- olefins. 
Epoxidation of dienes occurred regioselectively on the less substituted double bond 
and good ees have been obtained.35 
 Chapter 1 
 
 
24 
N N
O O
Ti
H H
H H
O
Ph Ph
2
13
 
 
R= H    85%,  82%ee
R=Me   85%, 74%ee
R=tBu  19%,  97%ee
72%, 95%ee
R
5
95% regiosel
51%, 82%ee
"O
"
 
 
Figure 1.8: Conversion and enantioselectivity in alkene epoxidation reactions with catalyst 13. 
 
 
 
1.7  Oxaziridines and oxaziridinium salts 
 
Oxaziridines are 3-membered ring heterocycles containing oxygen, nitrogen and 
carbon atoms whose reactivity in oxidation processes is undoubtedly related to the 
strained three-membered ring and to the relatively weak N-O bond (Figure 1.9, A). 
Together with oxaziridinium salts they have been used as organocatalysts in metal 
free epoxidation of alkenes by several groups.  
In 1981, Davis and co-workers reported the first example of epoxidation of an alkene 
by an oxaziridine. Cyclohexene was, in fact, converted into the corresponding 
epoxide in 81% yield by heating in chloroform at 60 °C.40,41  In general, the 
methodology requires a stoichiometric amount of catalyst and only very recently the 
first achiral catalytic oxaziridine-mediated epoxidation has been reported by Du 
Bois.37 
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The same methodology was successfully applied in an asymmetric fashion by the 
introduction of a chiral centre on the oxaziridine (14, Figure 1.9). Modest 
enantioselectivities were obtained for a series of alkenes (Scheme 1.7).42 
 
 
N C
O
R3
R1
R2
R1 = H, Alkyl, Ar, RC(O), RSO2
N C
O
HSO2
Ph
Ph
Ph
CH3
14A
 
 
Figure 1.9: Examples of achiral oxaziridines (A) and chiral oxazirine 14. 
 
 
Ph
R
100 mol% 14
25 °C, CHCl 3, 48 h
Ph
R
O R = H  61% ee   (S)
R = Ph 56% ee  (S,S)
 
 
Scheme 1.7 
 
 
The first oxaziridinium salt-mediated alkene epoxidation was achieved in 1976 by 
Lusinchi.43 The methodology was improved by in situ formation of the oxaziridinium 
species by oxidation with Oxone® of the corresponding iminium salt (Scheme 1.8).44  
 
 
 
 
Scheme 1.8 
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Enantiomerically pure iminium salts, such as 15 (Figure 1.10), gave moderate to 
good yields but generally poor enantioselectivities were obtained, even at 
stoichiometric catalyst loading.45 
 
N+
BF4-
Ph
CH3
15
 
Figure 1.10: Iminium salt developed by Lusinchi. 
 
 
Many research groups have been working on the development of iminium salts as 
catalysts in asymmetric epoxidation of alkenes. Aggarwal and co-workers 
synthesised a binaphthalene-fused azepinium salt catalyst (16, Figure 1.11) which 
gave up to 71% ee in epoxidation of phenyl cyclohexene.46 Our group has reported 
the pyrrolidine-derived exocyclic iminium salt 17 (Figure 1.11), which gave high 
conversion for highly substituted olefins. Unfortunately, chiral versions of 17 
showed either isolation or instability issues and could not be tested under the 
standard conditions.47,48 L-prolinol has been used by Komatsu to synthesise chiral 
iminium salt 18 (Figure 1.11) which, in a monophasic CH3CN / water system, gave 
low to moderate enantioselectivities on certain olefins.49  
 
 
N+ CF3TfO-
N+
BF4-
N+
OH
16 17 18
BF4-
 
 
Figure 1.11: Iminium salts from Aggarwal (16), Armstrong (17) and Komatsu’s groups (18). 
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Better enantioselectivities were obtained by chiral iminium salts generated in situ 
from chiral amines and aldehydes, by performing the reaction under slightly acidic 
conditions to promote dehydration of the aminol. The best results were recorded by 
Yang whereby the use of iminium salt 19 (Figure 1.12) gave E-stilbene oxide in 46% 
ee and 81% yield.50 
 
N+
AcO O
N
H
19
tBu
 
 
Figure 1.12: Yang’s iminium salt. 
 
 
Recently, extensive contribution to the development of enantioselective iminium salt 
catalysed alkene epoxidation has come from the Page group. His newly developed 
catalysts bear the asymmetric element in the exocyclic portion of the iminium salt, 
with the idea of bringing the enantio-controlling element close to the active site and 
thus increasing enantioselectivity.51 While catalyst 20 (Figure 1.13) gave only 
moderate yields and moderate ee (up to 59% ee),52 catalyst 21 (Figure 1.13) still 
maintained modest enantioselectivity but was highly reactive and complete 
conversion of alkenes was obtained after only few minutes (1-10 min) in acetonitrile 
/ water system at 0 °C. The high reactivity makes 21 the most active catalyst up to 
date.53 Catalyst 22 (Figure 1.13) also afforded very good conversion and 
enantioselectivities, 95% ee for 1-phenyl 3,4-dihydronaphthalene.54 
 
 
N+
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Ph
N+
O
O
Ph
BPh4-
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O
O
Ph
20 21 22
BPh4- BPh4-
 
Figure 1.13: Page’s iminium salt catalysts. 
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Standard conditions for iminium salt mediated epoxidations consist of the use of a 
stoichiometric amount of Oxone® as cooxidant, of water as co-solvent and of a base, 
typically sodium carbonate, to prevent the background reaction. However, the 
solvent system limits the temperature to 0 °C. Non-aqueous reaction conditions have 
been recently developed by Page by replacement of Oxone® with TPPP 
(tetraphenylphosphonium monoperoxybisulfate) as a stoichiometric cooxidant. Its 
solubility in organic solvents, such as DCM and acetonitrile, allowed the use of 
organic solvents and thus lower temperatures. Similar or better enantioselectivities to 
the aqueous conditions have been obtained in most of the cases.51 
 
 
1.8  Dioxirane-mediated epoxidation 
 
Recently, chiral dioxiranes have been shown to be a powerful class of oxidants for 
olefin epoxidation, in particular for trans-, cis- and trisubstituted olefins.9,55,56 
Dioxiranes were first suggested by Baeyer and Villiger in 1899 as intermediates 
during peroxide oxidation of menthone into the corresponding lactone.57 However, 
Doering and co-workers subsequently showed that the previously mentioned 
transformation did not occur via dioxiranes as intermediates.58 
The existence of dioxiranes was eventually demonstrated experimentally in 1977 
during gas-phase ozonolysis of ethylene,59 but they started to become synthetically 
important reagents only after their isolation, as a solution in their parent ketones, by 
Murray and co-workers.60 In particular, dilute solutions of dimethyl dioxirane 
(DMDO) can be obtained up to 0.185 M from mild distillation of a vigorously stirred 
solution of acetone and Oxone® (potassium monopersulfate, KHSO5, commercially 
available as the triple salt: 2KHSO5·KHSO4·K2SO4) in aqueous sodium hydrogen 
carbonate at ice-bath temperature. Solutions of DMDO are unstable if kept at room 
temperature as DMDO might decompose into acetone peroxide dimers and trimers 
by homolytic cleavage of the weak O-O bond. However, they can be stored in the 
freezer for several weeks.61 
A different isolation protocol, especially designed for non-volatile parent ketones and 
for obtaining more concentrated solutions (0.2-0.8 M), was described by Murray.62 It 
was based on the “salting out” procedure which involved addition of inorganic salts 
to favour the crossing of both the dioxirane and the parent ketone from the aqueous 
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phase to the organic layer. A multiple extraction procedure into organic solvents such 
as chloroform, dichloromethane or carbon tetrachloride was, instead, suggested by 
Messeguer and co-workers to obtain more concentrated dioxirane solutions (0.25-
0.35M for DMDO solutions).63 
 
 
 
1.8.1  Dioxirane generated in situ 
 
Although isolated solutions of dioxiranes are versatile and mild reagents for a wide 
range of transformations, the isolation can be problematic and not applicable to large 
scale synthesis. In situ dioxirane formation without isolation represents a valuable 
alternative. In 1980 Curci and co-workers showed that epoxidation of alkenes with 
Oxone® was accelerated by the presence of ketones.64 Water soluble olefins were 
treated in an acetone / water one phase system with Oxone®. The pH was fixed at 7.5 
with aqueous potassium hydroxide, presumably to neutralise the sulfuric acid that is 
formed as a by-product. Epoxidation of non-water soluble alkenes was carried out by 
using a benzene / water biphasic system with the addition of a phase transfer catalyst, 
e.g. 18-crown-6, which was thought to transport the nucleophilic oxidant from the 
aqueous phase into the organic layer. Attack of the Caroate anion on the carbonyl a 
(Scheme 1.9) delivers the tetrahedral intermediate b (Scheme 1.9), which is then 
subject to ring closure to form the dioxirane c (Scheme 1.9). Subsequent oxygen 
transfer through a concerted mechanism occurs in the organic phase regenerating the 
starting ketone. In principle, the process could be catalytic in ketone as it is 
regenerated at the end of the process (Scheme 1.9).  
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Scheme 1.9 
 
 
It has been suggested by our group that under biphasic conditions and in the presence 
of Oxone® the dioxirane intermediate is not responsible for the alkene epoxidation. 
18O labelling studies carried out on the epoxidation of cyclohexene by 18O labelled 4-
tert-butylcyclohexanone and Oxone® showed absence of 18O transfer in the epoxide 
product. On the basis of this result, it was suggested that an intermediate similar to b 
(Scheme 1.9) can oxidise the olefin at a faster rate than the ring closure to form the 
dioxirane.65 Afterward, it was also suggested that the attack of the oxidizing agent on 
the ketone only occurred in the aqueous phase.66 According to this mechanism, the 
catalyst must be present in the aqueous phase to react with Oxone®, and then be able 
to return to the organic phase to react with the olefin. Thus it will perform as a 
shuttle between the two phases. This would explain why ketopiperidinium salts 
reported by Denmark and co-workers are more efficient catalysts in alkene 
epoxidation than the corresponding aliphatic ones, under biphasic conditions.67  
 
Two main factors can negatively influence ketone efficiency in dioxirane mediated 
epoxidation: the background epoxidation by Oxone® and the Baeyer-Villiger 
decomposition pathway. Ford and co-workers showed that aqueous Oxone® oxidises 
water-immiscible alkenes at room temperature in the absence of organic solvent 
leading to the racemic epoxide.68 However, under the biphasic conditions, Curci 
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observed negligible contribution of the background epoxidation, probably because of 
the limited contact between Oxone® and the olefin, which prefers, instead, to stay in 
the organic phase.64  
Ketone efficiency can be affected by its propensity to react according to the Baeyer-
Villiger mechanism, thus irreversibly generating the corresponding esters (Scheme 
1.10). In fact, the Criegee intermediate can either undergo ring closure (pathway a, 
Scheme 1.10) or rearrange into ester structures (pathway b, Scheme 1.10).  
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Scheme 1.10 
 
 
In 1979, Edwards and co-workers evaluated the extent of decomposition by the 
Baeyer-Villiger pathway for a series of ketones under a biphasic system (dioxane-
water 1:4, phosphate buffer, pH 7.8, 25 ºC). In the majority of the cases no 
significant decomposition was observed, with the only exception represented by the 
highly strained cyclobutanone.69 It is likely that degradation mainly occurs to release 
the ring strain. 
The same group reported a certain variation in the extent of the decomposition with 
the pH and, in particular, that degradation was more severe at low pH. Hence, a 
careful control of the pH is required during the epoxidation reaction. 
Curci and co-workers demonstrated that isolated solutions of 
methyl(trifluoromethyl)dioxirane 23 were more reactive than DMDO.70 Higher 
reactivity was also observed by Yang and co-workers under acetonitrile / water 
homogeneous in situ conditions (pH 7.4-7.7).71,3 A series of alkenes were epoxidised 
by using a 3:2 acetonitrile-aqueous Na2EDTA solution, Oxone® (10 equivalents of 
KHSO5), sodium hydrogen carbonate (15.5 equivalents) and an excess of 1,1,1-
trifluoroacetone at 0 ºC (Table 1.1).72 In general, very high conversions were 
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obtained and also an electron-poor substrate, such as chalcone, was completely 
converted into its corresponding epoxide after a short period of time. 
 
O
CF3
23
 
 
 
Table 1.1: Examples of olefins epoxidised by methyl(trifluoromethyl)dioxirane generated in situ from 
23.a 
Entry Substrate Time (min) Yield (%) 
1 α-Methyl styrene 15 96 
2 Z-Stilbene 30 99 
3 Chalcone 80 99 
4 
 
120 97 
a
 Reaction conditions: CH3CN / aq. Na2EDTA (0.4 mM) (3:2 v/v), CF3COCH3 (22.3 eq), Oxone® (10 
eq), NaHCO3 (15.5 eq), 0 ºC. 
 
 
 
With the development of the one phase CH3CN / water system, a series of acyclic 
and cyclic ketones were tested by Yang in the epoxidation of E-stilbene to assess 
their catalytic activity.71 The results reported in Table 1.2 clearly show that the 
presence of an electron-withdrawing group α to the carbonyl enhances the reactivity 
(Entries 2 and 3 compared to Entry 1, Table 1.2) while steric hindrance close to the 
active site reduces the activity. 
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Table 1.2: Activities of various ketones in in situ epoxidation of E-stilbene.a 
Entry Substrate Time (min) 
1 Acetone 300 
2 
 
<4 
3 
 
20 
4 
 
18 
5 
 
70 
6 
 
210 
7 
 
15 
8 
 
>720 
a. Reaction conditions: E-stilbene (0.1 mmol), ketone (1.0 mmol), Oxone® (0.5 mmol), NaHCO3 (1.55 
mmol), CH3CN / aq Na2EDTA (0.4 mM), room temperature. 
 
 
The epoxidation protocol developed by Yang represents a much simpler and 
convenient solvent system than the biphasic one suggested by Curci. It offers the 
major advantage of circumventing the different solubility profile of the lipophilic 
substrate and of the water soluble oxidant. 18O labelling studies conducted by 
Denmark demonstrate that, in the monophasic system, dioxiranes are the 
intermediates responsible for the in situ epoxidation reaction.56 
Dioxirane mediated epoxidation is stereospecific, efficient toward both electron-rich 
and electron-poor olefins and occurs under mild conditions. Importantly, direct 
oxidation of the olefin by Oxone® in absence of the ketone is negligible in the 
majority of the cases. However, minor variations in the racemic epoxide formation 
by Oxone® oxidation might depend upon the pH conditions and the electronic 
properties of the substrates. 
Dioxiranes form by addition of peroxomonosulfate anion to the carbonyl group of 
the ketone (Step a, Scheme 1.11) leading to the Criegee intermediate. This 
intermediate is subject to deprotonation (Step b, Scheme 1.11) and loss of the sulfate 
moiety to afford the desired dioxirane (Step c, Scheme 1.11). The dioxirane can then 
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transfer one oxygen to the alkene and regenerate the starting ketone (Step d, Scheme 
1.11). Side reactions can occur depending on the characteristics of the ketone and on 
the reaction conditions used (Steps e, f, g, Scheme 1.11). The control of the pH at 
7.0-7.5 with a bicarbonate buffer is critical in order to neutralise the acidity of 
Oxone® and of HSO4- formed as by-product. At lower pH the deprotonation of the 
Criegee intermediate will be suppressed preventing the dioxirane formation, while at 
higher pH autodecomposition of Oxone® is reported to occur. At high pH, the peroxy 
anion SO52- could also compete with the alkene in the addition to the dioxirane 
destroying the dioxirane and forming molecular oxygen (Step e, Scheme 1.11). Some 
ketones can react with Oxone® via the Baeyer-Villiger pathway (Step f, Scheme 
1.11) leading to the decomposition of the ketone. In this particular case, increase of 
the pH is beneficial as it facilitates the formation of the anion (Step b, Scheme 1.11) 
and subsequently of the dioxirane.55 
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Scheme 1.11 
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1.8.2  Dioxirane asymmetric epoxidation 
 
1.8.2.1  Transition states in asymmetric dioxirane epoxidation 
A reliable model to clearly understand the reaction mode of asymmetric dioxirane-
mediated epoxidation and to predict the configuration of the product would offer a 
great advantage for catalyst design. In epoxidation of olefins, the alkene can 
approach the dioxirane by two extreme transition states (TS): Spiro A (Figure 1.14) 
and Planar B (Figure 1.14). 
 
O
O
R
R
O
O
R
R
Spiro  A
Transition State
Planar  B
Transition State
 
 
Figure 1.14: Spiro and Planar Transition States. 
 
 
Baumstark and co-workers noticed that cis-hexenes were epoxidised by 
dimethyldioxirane up to 9 times faster than trans-hexenes.73,74 On the basis of steric 
effects, the outcome is consistent with a favoured spiro transition state since steric 
factors would equally disfavour planar transition states for both cis- and trans- 
alkenes (Planar Cis and Planar Trans Transition States, Figure 1.15). Conversely, cis- 
olefins develop a less hindered spiro transition state than trans- alkenes (Spiro Cis 
and Spiro Trans Transition States, Figure 1.15) which explains their greater 
reactivity. From this analysis, Baumstark suggested that a spiro transition state can 
be invoked to explain the higher reactivity observed for cis- olefins over trans- 
alkenes with DMDO. 
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Figure 1.15: Spiro and Planar Transition States for cis- and trans- olefins. 
 
 
Computational quantum mechanical studies conducted by Houk support this 
hypothesis and provide theoretical evidence in favour of a spiro transition state.75 
Density functional theory (DFT) calculations on ethylene and DMDO showed that 
both spiro and planar transition states benefit from an orbital interaction between the 
ethylene pi (HOMO) and the O-O σ* (LUMO) (Figure 1.16, a). Preference for the 
Spiro Transition State TS A over Planar TS B (Figure 1.16) is suggested to come 
from a favourable stereoelectronic secondary interaction between the oxygen lone 
pair of the dioxirane (HOMO) and the pi* orbital of the alkene (LUMO) (Figure 
1.16), which is feasible in the spiro transition state but not in the planar one.76,77 
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Figure 1.16: Frontier molecular orbital interactions in transition states epoxidation. 
 
 
When using chiral, non-racemic ketones, considerations based on steric and 
electronic effects would predict that for trans- disubstituted alkenes the spiro and the 
planar transition states lead to opposite configurations in the epoxide product. 
Therefore all the factors that influence the competition of these two transition states 
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would affect the enantioselectivity of the epoxidation process. Electronic and steric 
effects may favour one transition state over the other. Alkenes with conjugated 
groups like phenyl, alkene or alkyne usually give higher enantioselectivity. It is 
believed that conjugation lowers the energy of the olefin pi* orbital and that the spiro 
transition state allows a stronger stabilising secondary interaction with the non-
bonding orbital of the oxygen of the dioxirane.78,79 Alternatively, the same outcome 
can be achieved by raising the energy of the non-bonding orbital of the oxygen of the 
dioxirane with electron-donating groups.80 
Measurements of experimental kinetic 13C isotope effects have been recently carried 
out to study epoxidation reactions of trans- substituted, cis- substituted and terminal 
alkenes.81 They provide experimental evidence for calculated transition state 
structures and offer further support to the computational studies mentioned above 
that have attempted to give an insight in to the origin of enantioselectivity. 
Interestingly, the concept of an “asynchronous” transition state, already postulated on 
the basis of theoretical studies, has been strongly reinforced by this work. In an 
asynchronous transition state there is unequal formation of the two new C-O bonds 
during the oxygen transfer (Asynchronous Spiro TS A, Figure 1.17). An 
unsymmetrical transition structure, in fact, could be slightly favoured since the 
potential energy surface is very soft.82 As the distortion energy for ethylene 
epoxidation by dioxirane is only 2.4 kcal/mol, asymmetric olefins may easily shift 
the synchronous transition state towards an asynchronous structure. With asymmetric 
ethylene derivatives, it has been shown that electron-withdrawing groups increase the 
activation energy for a spiro asynchronous transition state having a longer 
developing substituted C-O bond and a reduced partial positive charge on the 
substituted carbon. Conversely, electron-donating groups decrease the activation 
energy and promote a spiro asynchronous transition state characterised by a longer 
developing substituted C-O bond and an increased partial positive charge on the 
substituted carbon.75 
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Figure 1.17: Asynchronous and Synchronous Spiro Transition States. 
 
 
 
1.8.2.2  Electronics and stereoelectronics in asymmetric dioxirane epoxidation 
transition states 
Preference for one transition state over the other can be highly influenced by the 
stereoelectronic effect of substituents in the α position to the ketone. Quantum 
mechanical calculations on epoxidation of ethene by fluoromethyldioxirane and 2-
fluorocyclohexanone dioxirane predict a remarkable effect of the fluorine substituent 
in lowering the activation energy compared to the non-fluorinated analogues.83 They 
have also suggested a considerable preference for transfer of the dioxirane oxygen 
lying syn to that fluorine atom (4.5 kcal/mol for fluoromethyldioxirane) as 
electrostatic repulsion between the oxygen atom developing the greater partial 
negative charge and the fluorine is thus minimised. For axial 2-fluorocyclohexanone 
dioxirane fluorine inductive activation and electrostatic repulsion minimisation 
translate into a favoured equatorial oxygen attack of the olefin (7.4 kcal/mol) (Figure 
1.18, a).83 This fluorine effect of directing the incoming olefin to react with the 
equatorial oxygen of the dioxirane is called “steering effect”. 
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Figure 1.18: Transfer of the equatorial EXO (a) and axial ENDO (b) oxygen in axial 2-
fluorocyclohexanone dioxirane mediated epoxidations. 
 
 
1.8.2.3  The field effect 
An alternative important electronic effect in dioxirane-mediated epoxidations was 
identified by Yang in 1998. She postulated the electronic effect of non-conjugated 
remote substituents as being significant in modulating the enantioselectivity. Various 
ketones derived from (R)-carvone bearing a quaternary centre at the C2 position and 
different substituents, either electron-withdrawing or electron-donating, at the C8 
position (Figure 1.19), were prepared to be tested in epoxidation reactions with para- 
and meta- substituted E-stilbenes.84 
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Figure 1.19: Substituted cyclohexanone derived ketones analysed by Yang. 
 
The X-ray structure of ketone 24, where X = Cl, suggests that the corresponding 
dioxirane adopts a chair conformation with the chlorine α substituent in the axial 
position. Approach of the olefin would preferentially occur from the less hindered 
equatorial face, through a spiro transition state. The most favoured TS would place 
the olefinic proton in the chlorine region (TS A, Figure 1.20), as the alternative 
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approach is highly disfavoured by the steric interaction between chlorine and the 
phenyl group (TS B, Figure 1.20).  
The enantioselectivity was found to vary with the electronic properties of the olefin 
para-substituent. Electron-rich olefins afforded higher ee than electron-poor alkenes. 
This result was mainly due to the electronic effect of the remote substituent at the C8 
position, as the α-Cl at the C2 position is too close to the dioxirane to sterically 
interact with the olefin para-substituents. However, it might exert a certain electronic 
effect by n-pi-repulsion in TS B (Figure 1.20), thus contributing to increase the ee for 
electron-rich olefins. Molecular models showed that the change in enantioselectivity 
was connected to the polar nature of the C-X bond. It was suggested that the polar 
nature of the C-X bond had a major favourable electrostatic interaction through space 
(the field effect) in the favoured transition state (TS A, Figure 1.20) stabilising the 
developing positive charge on the alkene. A quantitative correlation between the 
field values of the C-X bond, expressed by the F values of substituents X, and ee 
was, in fact, found. The higher enantioselectivities obtained when X had a higher 
donating field effect suggested the presence of a larger δ+ on the alkene in TS A, 
leading to the major enantiomer, than in TS B. Therefore TS A would be more 
energetically favoured by a greater stabilising effect from the remote X substituent.84  
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Figure 1.20: Competing Spiro Transition States for ketone 24.  
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1.8.2.4  Early chiral ketones 
In 1984, Curci reported the first procedure to generate chiral dioxiranes in situ 
starting from chiral ketones (ketones 25 and 26, Figure 1.21) and Oxone® in a 
catalytic manner under biphasic conditions (DCM-H2O) (Scheme 1.12).85 The pH 
was buffered to 7-8 and Bu4NHSO4 was used as a phase transfer catalyst. 
Unfortunately, long reaction times were required and low enantioselectivity was 
achieved (6-13% ee). The low efficiency was attributed to the lack of activating 
substituents in proximity to the carbonyl group hence the background reaction was 
quite significant.  
More reactive ketones were synthesised by introducing a trifluoroacetyl or 
trifluoromethyl group, as in ketones 27 and 28. The electron-withdrawing group was 
expected to activate the carbonyl toward Oxone® nucleophilic attack thus favouring 
the Criegee intermediate formation.86 Slightly better enantioselectivities and 
conversions were obtained (18% ee, 77% yield, 42 h for E-β-methyl styrene with 
28). 
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Figure 1.21: Curci’s chiral ketones. 
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Scheme 1.12 
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The activating effect of fluorine substituent was demonstrated also by Marples and 
co-workers with 1-tetralone and 1-indanone ketone derivatives 29 and 30. Despite 
achieving good conversions only racemic epoxides were obtained.87  
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Figure 1.22: Marples’ fluorinated ketones. 
 
 
1.8.2.5  C2 symmetric ketones 
In 1996, Yang reported an active C2 symmetric ketone (31, Figure 1.23) that gave 
high conversion (70-99%) and good enantioselectivity in the epoxidation of trans- 
and trisubstituted olefins.71 Low ees were recorded, instead, for terminal alkenes 
(18% ee for α-methyl styrene).88 A remote binaphthyl unit was used to induce the 
chirality without increasing steric hindrance close to the catalytic site. Two ester 
groups were introduced, instead, in proximity to the active site to electronically 
activate the carbonyl group and to confer rigidity to the skeleton. It is believed that 
conformationally rigid ketones reduce the number of possible approaches of the 
olefin to the dioxirane resulting in higher ee.71 Of note is the substitution on the 
aromatic portion. An X-ray structure of ketone 31 shows that the H-3 and H-3’ 
positions are very close to the dioxirane so they can sterically interact with the 
approaching olefin. It was shown that an increase in the size of substituents Z on the 
naphthalene unit led to higher enantioselectivities, presumably due to an increased 
steric hindrance around the dioxirane group (32, Figure 1.23). Too bulky 
substituents, however, caused a decrease in the ee, suggesting that an appropriate size 
is required for the optimal activity.89 It was thought that by increasing the steric size 
of Z the spiro transition state would be favoured over the competing planar transition 
state. But excessive hindrance would mean lower reaction rate and thus lower 
enantioselectivity. 
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Figure 1.23: Yang’s ketones. 
 
 
Replacement of the binaphthyl ring with a chiral 6,6’-dinitro-2,2’-diphenyl group 
gave ketone 33 (Figure 1.24) which showed similar enantioselectivities to 31 in 
epoxidation reactions under the same conditions. The finding suggested that the 
binaphthyl moiety is not critical to induce selectivity while the 3 and 3’ positions on 
the phenyl ring are the most sensitive in the enantioselectivity tuning.89 
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Figure 1.24: Yang’s 6,6’-dinitro ketone 33. 
 
 
In a study conducted by Yang on C2 symmetric and conformationally rigid chiral 
ketones, it was suggested that the hydration constant for a ketone catalyst could have 
been a useful parameter to indicate the reactivity to give the corresponding dioxirane. 
The rationale was that addition of both water and Oxone® to the ketone requires 
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rehybridisation of the carbonyl group from sp2 to sp3. However, no clear correlation 
between catalyst efficiency and hydration equilibrium constant was observed.90 
 
In 1997, Song and co-workers replaced the ester groups of 31 with ethers so that the 
carbonyl group was closer to the chiral motif (ketones 34 and 35, Figure 1.25). These 
latest catalysts showed lower reactivity compared to 31 and 32, probably because of 
the weaker electron-withdrawing power of the ether compared to the ester. No 
substantial improvement in enantioselectivity was observed.91 Similar ee as those of 
32 were observed for Adam’s ketones 36 and 37 in epoxidation of trans- and 
trisubstituted olefins.92 
 
 
 
Figure 1.25: Song’s and Adam’s C2 symmetric ketones. 
 
 
In 1999, Denmark and co-workers reported novel and active C2 symmetric chiral 
ketones bearing the chiral motif very close to the ketone functionality.93 Ketone 39 
proved to be enantioselective in the epoxidation of E-β-methyl styrene: 71% ee and 
28% conversion using 0.18 equivalent of ketone (full conversion was observed with 
one equivalent). With the use of stoichiometric amount of catalyst, the ketone 
analogue 38 was less reactive and afforded only 24% conversion.56 The epoxidation 
efficiency of 39 was attributed to the fluorine substitution, in accord with the 
beneficial effect of fluorine substituents on dioxirane activity already observed by 
Mello and Curci.94 They showed, in fact, that trifluoromethyl methyl dioxirane gave 
greater reactivity in oxidative processes than the non-fluorinated analogue. 
Increasing the pH from 7.5 to 10 by addition of potassium carbonate greatly 
enhanced the reactivity of 39. Therefore a catalytic amount of ketone could be used 
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in performing the epoxidation reactions and very high enantioselectivity was 
achieved for trans- olefins (94% ee for E-stilbene).93 
O
X X
X = H 38
X = F 39
 
 
Figure 1.26: Denmark’s ketones. 
 
In 2002, Behar and co-workers reported fluorinated binaphthyl ketones (ketones 40-
44). They were structurally similar to Denmark’s ketones 38 and 39 and afforded 
comparable enantioselectivities (Table 1.3). Within the series, α,α’-difluoroketone 
42 gave the best enantioselectivities, up to 86% ee and complete conversion for E-β-
methyl styrene, at 10 mol% catalyst loading and -15 ºC.95 The absence of methyl 
electron-donating groups in 41-44 is supposed to increase the reactivity compared to 
ketones 38 and 39. 
O
40 = R1, R2, R3, R4 = H 
41 = R1, R3, R4 = H, R2 = F  
42 = R1, R3 = H, R2, R4 = F  
43 = R1, R2, R3 = F, R4 = H
44 = R1, R2, R3, R4 = F
R1 R3R2 R4
 
 
Table 1.3: Epoxidation of E-β-methyl styrene with ketones 40-44.a 
Entry Ketone Time (h) Temp. (ºC) Yield (%) ee (%) 
1 40 4 -15 35 46 (S,S) 
2 41 4 -15 57 80 (S,S) 
3 42 3.5 -15 100 86 (S,S) 
4 43 3.5 -15 100 83 (S,S) 
5 44 10 -15 32 40 (S,S) 
a. Reaction conditions: E-β-methyl styrene (1 eq), ketone (10 mol%), Oxone® (1.36 eq), K2CO3 (5.76 
eq), Bu4NHSO4 (4 mol%), DME aq. 
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1.8.2.6  Chiral oxo ammonium salts 
Denmark and co-workers, during their study on reaction parameters in asymmetric 
epoxidation reactions, identified 4-oxopiperidinium salt 45 as an efficient 
epoxidation catalyst.56,67,96 A key feature of this catalyst is represented by the 
presence of the positively charged ammonium ion which has the double function of 
inductively activating the carbonyl group and thus suppressing the Baeyer-Villiger 
oxidation, and acting as a phase transfer catalyst. The alkyl groups on the nitrogen 
atom can vary the phase transfer ability and then modulate the partitioning of the 
ketone, and of the corresponding dioxirane, between the aqueous and the organic 
phase. If R and R’ are too small, dioxirane will form in the aqueous layer but would 
be too hydrophilic to react with the substrate in the organic phase. Decomposition of 
dioxirane would then occur. Ketone 45 was highly active also in epoxidation 
reactions conducted under the monophasic Yang conditions.56 
Some other chiral non-racemic ammonium salts were investigated in epoxidation 
reactions. Ketones 46 and 47 were less active than 45, probably because of the steric 
hindrance around the active site which prevents formation of the dioxirane and thus 
decreases the enantioselectivity. Only modest enantioselectivities were obtained, 
34% ee for E-β-methyl styrene and 58% ee for phenyl cyclohexene using ketone 
47.56,97 
 
 
 
Figure 1.27: Denmark’s ammonium salt ketones. 
 
 
With the idea to further activate the carbonyl towards nucleophilic attack and then 
increase the reactivity, bis(ammonium) ketones 48 and 49 were synthesised for 
asymmetric epoxidation reactions. Indeed high conversions were obtained with the 
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extra positively charged group but still poor enantioselectivities were recorded, 
possibly due to the high flexibility of the 7 membered ring.56 
 
N+
N+
O
2OTf-
N+N+
O
2OTf-
48 49
 
 
Figure 1.28: Denmark’s bis(ammonium) ketones. 
 
 
A more rigid tropinone ammonium ketone was then evaluated by Denmark. 
Complete conversion of E-β-methyl styrene was achieved with 51 compared to 21% 
conversion with 50, after 5 h. The epoxidation efficiency of 51 was attributed to the 
fluorine substitution. In ketone 51, the bridged atom bearing two methyl groups 
should be able to block one face of the molecule and to control the enantioselective 
oxygen transfer. Unfortunately, the ee observed for E-β-methyl styrene was low 
(35%).56,98 
 
 
 
Figure 1.29: Denmark’s rigid ammonium ketones. 
 
 
Denmark’s 4-oxopiperidium salts and bis(ammonium) ketones are very reactive 
catalysts and achieve complete substrate conversion at 10 mol% catalyst loading but 
do require 10 equivalents of oxidant. It has been shown that 20 eq of Oxone® were 
consumed by 45 in only 5 minutes. A possible explanation of the high Oxone® 
consumption was identified by Yang. The positively charged ammonium ion makes 
the ketone, and then the corresponding dioxirane, highly electrophilic and, at neutral 
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pH, would attract the Oxone® anion causing its non productive decomposition 
(Scheme 1.13).99 
 
 
 
 
Scheme 1.13 
 
 
Increasing the steric hindrance around the positively charged group was expected to 
reduce the oxidant decomposition and, in fact, higher yields in epoxide products 
were obtained. This class of ketones also displayed moderate to high hydration 
constants but at that stage it was not possible to establish a general correlation 
between ketone efficiency and hydration equilibrium constant. 
Alternatively, it was thought that enhanced ketone electrophilicity could be achieved 
by a dipole-dipole repulsion between a heteroatom at the 4 position of substituted 
cyclohexanones and the carbonyl group thus increasing the rate of epoxidation. 
Efficiency did indeed increase as a consequence of the unfavourable field effect from 
cyclohexanone 52 to tetrahydropyran-4-one 53 and sulfone 54 (Figure 1.30). 
Complete conversion was achieved in a short period of time and only 1.5 eq of 
Oxone® was required.99 
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Figure 1.30: Substituted cyclohexanones used in epoxidation reactions. 
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1.8.2.7.  Shi fructose-derivative ketone 
In 1996, Shi and co-workers developed a fructose-derived ketone (57, Scheme 1.14) 
that was highly effective and enantioselective in the epoxidation of a variety of 
olefins, giving the highest enantioselectivities to date for trans- and trisubstituted 
alkenes.100 
Ketone 57 can be easily obtained in two steps from the inexpensive D-fructose 55 
(Scheme 1.14) while the opposite enantiomer can be prepared from the readily 
available L-sorbose 58 following a slightly longer synthetic pathway (Scheme 
1.15).100,101 
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Scheme 1.14: i) Acetone, HClO4, 0 ºC, 53%; ii) PCC, DCM, RT, 93%. 
 
 
 
Scheme 1.15: i) 2,2-Dimethoxypropane, DME, 0.23% SnCl2; ii) MsCl, pyridine, DCM, RT, 41-60% 
from L-sorbose; iii) H2SO4-NaOH-H2SO4 one pot, 85%. 
 
 
Studies conducted at pH 7-8 with ketone 57 using E-stilbene as test substrate showed 
that while the yield of E-stilbene oxide increased with the reaction time, the ee 
decreased. It was suggested that the catalyst decomposed during the reaction and that 
an achiral ketone (possibly acetone), formed as by-product, might unselectively 
catalyse the epoxidation reaction lowering the overall ee. It was proposed that the 
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Baeyer-Villiger oxidation could be responsible for the decomposition of the Criegee 
intermediate, despite the fact that the corresponding lactones had never been isolated, 
possibly due to their hydrolysis under the reaction conditions. An increase in the pH 
(to >10), which was achieved by addition of K2CO3 or KOH, was extremely 
beneficial for the epoxidation process favouring the deprotonation of the Criegee 
intermediate and the subsequent formation of the dioxirane. In the monophasic 
system at pH >10, 0 oC and in the presence of catalytic amount of 
tetrabutylammonium sulfate, 20-30 mol% of catalyst loading allows very high 
conversion and enantioselectivity to be achieved (Table 1.4).101 A systematic pH 
study was carried out using E-β-methyl styrene as a substrate and 20 mol% catalyst 
loading at 0 ºC. A dramatic effect was exerted by pH changes on substrate 
conversion which increased up to 10 fold when higher pH (> 10) was employed. 
Enantioselectivity, instead, remained high (90-92%). Most importantly, at higher pH 
the amount of Oxone® consumed was significantly reduced thus allowing the 
development of a catalytic asymmetric epoxidation process. The beneficial effect of 
higher pH on efficiency is due not only to a reduction of the Baeyer-Villiger 
decomposition pathway but also to an increased nucleophilicity of Oxone® and thus 
an increased reactivity with ketone 57, as suggested by the greater conversion 
obtained with acetone and trifluoroacetone at higher pH. It has been experimentally 
proved that at high pH, within 2 h reaction time, the background reaction by Oxone® 
is negligible.101 Conversely, at pH 7.5 the extent of the background epoxidation is 
generally low but varies with the substrates, with the electron-rich olefins being more 
prone to Oxone® oxidation. 
 
Table 1.4: Epoxidation of various substrates by ketone 57.a 
Entry Alkene ee (%) 
1 E-Stilbene 97 (R,R) 
2 Phenyl cyclohexene 98 (R,R) 
3 E-β-Methyl styrene 92 (R,R) 
4 Styrene 14 (R) 
5 α-Methyl styrene 28 (S) 
6 Ζ-β-Methyl styrene 39 (1R,2S) 
a. Reaction conditions: substrate (1 eq), ketone (0.3 eq), Oxone® (1.38 eq), K2CO3 (5.8 eq), CH3CN-
0.05 M Na2B4O7·10H2O of aq Na2(EDTA)(4x10-4 M) sol (1.5:1 v/v). 
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Further studies were carried out with E-β-methyl styrene for optimisation of the 
reaction conditions (Table 1.5). Within the variety of solvents screened, CH3CN was 
identified as the best single solvent in terms of conversion and enantioselectivity 
(Entry 1, Table 1.5). Even better results were obtained by addition of DMM (1:2 v/v) 
and lowering the temperature to 0 ºC (Entry 9, Table 1.5).101 
 
Table 1.5: Solvents screened for optimisation of E-β-methyl styrene epoxidation with ketone 57.a 
Entry Solvent T (ºC) Conv. Time (min) ee (%) 
1 CH3CN 20 100 20 89 
2 CH3CN 0 96 90 92 
3 DMM 20 36.2 60 91 
4 DMF 20 95 20 86 
5 DME 20 100 20 89 
6 CH3CN / DMM (2:1) 20 100 20 90 
7 CH3CN / DMM (1:1) 20 98 20 91 
8 CH3CN / DMM (1:2) 20 94 20 92 
9 CH3CN / DMM (1:2) 0 88 90 94 
a.Reaction conditions: substrate (1 mmol), ketone (0.3 mmol), Oxone® (1.38 mmol) in a mixture of 15 
ml of organic solvent and 10 ml of 0.05 M Na2B4O7·10H2O of aq Na2(EDTA)(4x10-4 M), pH 10.5 by 
K2CO3 1.0 M. 
 
 
A variety of functional groups were compatible with the basic reaction conditions. 
Hydroxyalkenes were effective substrates with high enantioselectivities obtained for 
homoallylic and bishomoallylic alcohols.102 High ee values were also observed for 
conjugated dienes,78 enynes,79,103 and some silyl enol ethers which gave 
enantiomerically enriched α-hydroxy ketones (Figure 1.31).104,105  
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Figure 1.31: Yield and enantioselectivity obtained in epoxidation reactions with ketone 57. 
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A series of 2,2-disubstituted vinyl silanes were enantioselectively epoxidised by 57. 
Subsequent TBAF desilylation of the epoxysilanes indirectly gave access to 1,1-
disubstituted terminal epoxides with high enantioselectivity.106 However, styrenes 
and cis- olefins still remained very challenging substrates. 
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Scheme 1.16: Epoxidation of vinyl silanes by ketone 57. 
 
 
The major epoxides obtained with ketone 57 from trans- and trisubstituted olefins 
are consistent with a Spiro Transition State (TS A, Figure 1.32), in which 57 adopts a 
chair conformation and the olefin approaches the more accessible equatorial oxygen 
of the dioxirane. However, the low ee obtained for Z-β-methyl styrene suggests that 
the environment cannot differentiate between the methyl and the phenyl group of the 
olefin in the two Spiro Transition States TS C and TS D (Figure 1.32).101 
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Figure 1.32: Competing Spiro and Planar Transition States in epoxidation of trans- and trisubstituted 
olefins and competing Spiro Transition States in epoxidation of Z-β-methyl styrene. 
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According to the spiro transition state model previously described, epoxidation of E-
β-methyl styrene by 57 affords (+)-(R,R) epoxide as major enantiomer, with the 
olefin substituents minimising the steric interactions with the spiro acetonide group 
(cf. Spiro TS A, Figure 1.32).  
Further support to this analysis comes from theoretical calculations which identify a 
minimum energy spiro structure where an olefinic hydrogen is pointing toward the 
hindered spiro acetonide group and the phenyl group is oriented toward Hb (Scheme 
1.17). No steric clash is caused as a consequence of the longer Cα-O bond (Scheme 
1.17).81 
Experimental data show a Cβ isotope effect greater than Cα suggesting an 
asynchronous transition state with a Cβ-O bond more developed (shorter) than Cα-O. 
This is in perfect agreement with the theoretical calculations for the lowest energy 
conformations and prediction of 13C isotopic effects. The consistent agreement of 
experimental kinetic isotopic effects with the predicted values obtained for Cα  and 
Cβ  favourably supports the accuracy of the theoretical calculations used and the 
nature of the enantioselectivity of dioxirane-mediated epoxidation reactions.81  
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Scheme 1.17 
 
 
The versatility of the fructose-derived Shi catalyst 57 is demonstrated by the 
practical application that it has found, both in the academic and the industrial area. In 
2007 it was used in a large scale synthesis of lactone 62 (Figure 1.33), a synthon for 
obtaining dipeptide isosteres of formula 61 (Figure 1.33) for treatment of HIV, as 
aspartyl protease inhibitors,107 and blood pressure, by modulating the rennin 
receptors.108 
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Figure 1.33: Synthetic chiral molecules that can be obtained by epoxidation reaction with ketone 57. 
 
 
Retrosynthetically, synthesis of lactone 62 was envisaged coming from epoxide 65 
which could be obtained by asymmetric epoxidation of alkene 66 (Scheme 1.18). 
The major and desired epoxide was predicted to form through a favoured spiro 
transition state, as observed for similar substrates.109 
 
 
Scheme 1.18 
 
 
Fructose derivative 57 was synthesised on multikilogram scale with some 
improvements compared to the original route. In particular, the acid-catalysed 
ketalisation of D-fructose was successfully achieved by replacing the potentially 
hazardous perchloric acid with p-toluenesulfonic acid, while the last oxidation step 
was conducted with RuCl3·H2O / NaIO4 instead of chromium-based PCC. According 
to the Shi methodology, by adjusting the pH to 10-11 with a slow and simultaneous 
addition of an aqueous solution of Oxone® and KOH to the reaction mixture at low 
temperature (between -5 and 5 ºC), a 30 mol% catalyst loading gave the epoxide 65 
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which immediately cyclised delivering the desired lactone 64 in 63% yield and 88% 
ee. 
The application thus reported highlights some major advantages of the Shi protocol, 
such as the absence of buffer, of EDTA or a phase transfer catalyst in addition to the 
reproducible high enantioselectivity and high yield. Unfortunately, an accurate 
control of the pH and the temperature has to be applied to avoid erosion of the ee due 
to decomposition of the catalyst and to the background reaction. The low water-
solubility of Oxone® and of potassium sulfate forming as by product forces the 
reaction to be conducted at a low concentration, which might suggest that a step 
forward in the optimisation of the reaction conditions might be the replacement of 
Oxone® with hydrogen peroxide.109 
The fructose-derived ketone 57 has been successfully used also for kinetic resolution 
of various 1,3- and 1,6-disubstituted cyclohexenes via dioxirane-mediated 
epoxidation.108 The presence of a stereogenic centre at the allylic position and the 
rigid conformation makes these substrates particularly good for kinetic resolution. 
For example, (±)-1-phenyl-6-(trimethylsiloxy)cyclohexene 67 has been epoxidised 
by 57 in 95% ee in favour of the trans- regioisomer 69 while the starting material 68 
is recovered in 96% ee for the (S) enantiomer (Scheme 1.19).110 
 
 
 
 
Scheme 1.19  
 
 
The configuration of the major enantiomer is believed to arise from a favoured Spiro 
TS (TS A, Figure 1.34) while formation of the opposite epoxide via TS B (Figure 
1.34) is less favoured due to the steric interaction between R and the dioxirane 
oxygen.110 
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Figure 1.34: Competing Spiro Transition States in epoxidation of (±)-1-phenyl-6-(trimethyl 
siloxy)cyclohexene 67 with 57. 
 
 
The highly predictive spiro TS model that characterises the dioxirane-mediated 
epoxidation has permitted desymmetrisation of symmetric bifunctional molecules 
such as cyclohexadienes and subsequent kinetic resolution of the epoxide just formed 
with a second oxidation on the remaining olefin.111 When desymmetrisation and 
kinetic resolution act in a synergistic fashion, enhancement of the enantiomeric 
purity of the monoepoxide is obtained. As reported in Scheme 1.20, in the presence 
of ketone 57, 1,4-dimethylcyclohexa-1,4-diene 70 preferentially reacts through a 
Spiro TS (TS A, Scheme 1.20) generating the major epoxide 71. The minor 
enantiomer 72, coming from a less favoured Planar TS (TS B, Scheme 1.20), will 
react faster through the lowest energetic transition state structure TS C (Scheme 
1.20) thus increasing the enantiomeric purity of the major epoxide 71.111 
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A series of analogues of 57 were reported by Shi in order to investigate the effect of 
ketone structural changes on asymmetric epoxidation. The carbocyclic derivative 74 
(Figure 1.35) gave lower conversion and lower ee than 57 (10% yield, 88% ee after 8 
h for E-stilbene) suggesting that the pyranose oxygen is important for reactivity and 
efficiency.112 
 
 
Reaction conditions: substrate (1 eq), ketone (0.3 eq), Oxone® (2.07 eq), K2CO3 (8.66 eq), DMM-
CH3CN (1:1 v/v) and aq AcOH-K2CO3, 0 ºC. 
 
Figure 1.35: Yields and enantioselectivities for various substrates in epoxidation reactions with 74. 
 
 
 
The pseudo C2 symmetric ketones 75-78 bearing two fused acetonide rings on both 
sides of the carbonyl group efficiently epoxidised electron-deficient olefins and 
styrenes with encouragingly good enantioselectivity (65% ee for styrene, 52% ee for 
α-methyl styrene, Table 1.6). The extra electron-withdrawing group had the 
beneficial effect of increasing the electrophilicity of the carbonyl group, as shown by 
the fact that many derivatives exist in the hydrated forms. However, they were 
unstable under the reaction conditions and decomposed through the Baeyer-Villiger 
reaction.113,114 
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Table 1.6: Epoxidation of various substrates using ketone 78.a 
Entry Alkene Temp. (ºC) Yield (%) ee (%) 
1 E-Stilbene -10 95 90 (R,R) 
2 E-β-Methyl styrene -15 92 75 (R,R) 
3 Styrene -10 90 65 (R) 
4 α-Methyl styrene -10 92 52 (R) 
5 E-Ethyl cinnamate 0 34 86 (2S,3R) 
a. Reaction conditions: substrate (1 eq), ketone (5 or 10 mol%), Oxone® (1.38 eq), K2CO3 (5.8 eq) in 
DME-buffer (1:1 v/v) (aq AcOH- K2CO3) or DME-DMM-buffer (2:1:2 v/v) (aq AcOH- K2CO3). 
 
 
Ketone 79 (Figure 1.36), the acetate analogue of 57, was reported by Shi as a very 
active and enantioselective catalyst for epoxidation of α,β-unsaturated esters. For 
examples, E-ethyl cinnamate was converted into the corresponding epoxide in 73% 
yield and 96% ee. Also trisubstituted α,β-unsaturated esters and conjugated enynes 
were effective substrates in terms of yield and enantioselectivity while poor results 
were obtained for trans- aliphatic α,β-unsaturated esters and cis-cinnamates.115 
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Figure 1.36: Shi’s catalyst 79. 
 
 
1.8.2.8  Shi oxazolidinone catalyst and related ketones 
Previous results have shown that dioxiranes generated in situ from chiral and 
enantiomerically pure ketones represent valuable and useful reagents for asymmetric 
epoxidation of trans- and trisubstituted olefins.9,116 However, dioxirane-mediated 
epoxidation of terminal olefins still remains very challenging. Lots of work has been 
done in the area and many structural changes have been made to chiral ketones to 
probe the effect on enantioselectivity for this class of substrate.  
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In order to investigate the factors influencing stability, efficiency and selectivity of 
ketone 57, the spiro ketal moiety was replaced by Shi with a more electron-
withdrawing oxazolidinone. The group should reduce the possible Baeyer-Villiger 
decomposition pathway and create a suitable environment to sterically and / or 
electronically distinguish different substituents on the olefin, e.g. hydrogen / alkyl 
groups versus a phenyl ring.117 Many N-substituted oxazolidinones have been 
synthesised and very promising results have been obtained for terminal 
olefins.117,118,119 
Ketone 80 was not as efficient as the fructose-derivative 57 towards trans- 
alkenes.117 However, it epoxidised cis- olefins and styrenes with a surprisingly high 
enantioselectivity. Within this latest class of substrates, enantioselectivity varied with 
the substitution on the aromatic group, while aliphatic olefins gave lower ee. 1,1-
Disubstituted terminal olefins still afforded poor results (Figure 1.37).117,118 
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Reaction conditions: substrate (0.5 mmol), ketone (0.075-0.15 mmol), Oxone® (0.89 mmol), K2CO3 
(2.01 mmol), DMM-DME (1:3 v/v) (7.5 ml) and buffer (aq AcOH-K2CO3, pH 8.0), at -10 or 0 ºC. 
 
 
Figure 1.37: Epoxidation results for various substrates with ketone 80. 
 
 
 
A few analogues of 80 were synthesised modifying the N-substituent. The results 
shown in Table 1.7 confirm the selectivity trend observed with ketone 80 and 
highlight the effect exerted by the N-substituent on enantioselectivity.117,119,120 
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Crystal structures of ketones 80 and 82 show that the N-group is far away from the 
active site and lies in the same plane of the oxazolidinone thus suggesting an 
electronic influence rather than steric.120 
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Table 1.7: Asymmetric epoxidation reactions by ketones 80-84.a 
Entry Ketone  
Conv. (ee)b 
 
Conv. (ee)c 
 
Conv. (ee)d 
 
Conv. (ee) 
1 80 100 (79) 100 (87) 100 (77) 100 (23) (S,S) 
2 81 88 (61) 100 (59) 97 (72) 100 (65) (R,R) 
3 82 94 (73) 100 (86) 85 (73) 100 (18) (S,S) 
4 83 100 (69) 100 (79) 100 (73) 100 (29) (S,S) 
5 84 100 (77) 100 (80) 100 (75) 100 (23) (S,S) 
a
 Reaction conditions: olefin (1 eq), ketone (0.15 eq), Oxone® (1.6 eq), solvent DME / DMM, pH 8 
(0.2 M K2CO3-AcOH), Bu4NHSO4, -10 ºC. b (R) configuration of the epoxide. c (1R,2S) configuration 
of the epoxide. d (R,R) configuration of the epoxide. 
 
 
 
The increased enantio-discrimination exerted by ketone 80 for cis- olefins and 
styrenes compared to 57 seems to originate from an electronic attraction between the 
oxazolidinone moiety and the phenyl ring of the olefin.121 The favourable interaction 
was effective in differentiating aromatic and non-aromatic groups in the substrate 
thus leading to high enantiomeric excess. On the basis of the configuration of the 
product epoxide, this hypothesis would explain why Spiro Transition State A (Figure 
1.38, where R1 = H) is favoured over Spiro TS B (Figure 1.38, where R1 = H) for cis- 
alkenes.118,121 For styrenes, instead, the Planar TS C is the major competing 
transition state to the Spiro TS A (Figure 1.38, with R = R1 = H). The low ee 
recorded for α-methyl styrene (30%) could be attributed to the steric destabilisation 
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caused by the group R1 = CH3 in TS A (Figure 1.38, with R = H), which would then 
no longer be the most favoured transition state. Spiro TS B or Planar TS C represent 
the lower energy structures leading to the major enantiomer. In particular, the major 
contribution to the enantioselectivity is offered by Planar TS C where the phenyl 
group still favourably interacts with the oxazolidinone. This hypothesis is reinforced 
by the ee improvement obtained when the methyl group in the substrate is replaced 
by a bulkier isopropyl group, which further disfavours TS A relative to TS C and TS 
B (Figure 1.38).117 
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Figure 1.38: Transition state analysis for epoxidation of cis- olefins and styrenes with ketone 80. 
 
 
 
The model invoked by Shi to explain the remarkable preference for the aromatic 
group of the olefin to be proximal to the oxazolidinone ring of the catalyst in the 
spiro TS considers an attractive interaction, described as dispersion forces and 
dipolar interactions, between the two groups.117 The outcome from epoxidation of 
styrene with the Shi oxazolidinone-derivative 80 can be rationalised by invoking 
asynchronous transition states. Formation of the major enantiomer can be explained 
by considering an asynchronous spiro TS in which there is a reduced steric clash 
between an olefinic hydrogen and the oxazolidinone ring, and a favourable dipolar 
interaction between the partial positive charge on the styrene and the dipole present 
on the oxazolidinone moiety (Scheme 1.21).81 While with symmetrical alkenes the 
asynchronicity is negligible, unsymmetrical olefins favour a certain degree of 
asynchronicity which translates into a longer C-O bond next to the phenyl ring. In 
general, very high enantioselectivity is obtained when a natural asynchronicity is 
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allowed by the catalyst in the TS. Departure from the natural asynchronicity requires 
energy and thus lowers the enantioselectivity.81 
Ph
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Scheme 1.21 
 
 
With the idea of addressing catalyst changes to improve enantioselectivity for 
terminal and cis- olefins, new ketones have been synthesised by replacing the Boc 
group with aromatic N-substituents.117,119,120 N-Aromatic substituted oxazolidinones 
can be easily obtained starting from D-glucose 85 by Amadori rearrangement,122 
ketalisation, oxazolidinone formation and PDC oxidation (Scheme 1.22). 
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Scheme 1.22: i) ArNH2, AcOH, trimethoxymethane; ii) acetone, H2SO4; iii) phosgene, base; iv) PDC. 
 
 
 
Ketones 88-90 afforded lower enantioselectivity toward trans- and trisubstituted 
olefins then 57, but epoxidized cis- and terminal aryl alkenes in a highly 
enantioselective manner (Table 1.8).117,118 
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The epoxidation results obtained with ketones 88-90 and some representative 
substrates (cis-, trisubstituted olefins and styrene) (Table 1.8) suggest that the 
substituent on the oxazolidinone plays an important role in determining the 
enantioselectivity. In common with ketone 80, the X-ray structures of 88 and 89 
show that the substituents on the nitrogen are far from the reactive centre and co-
planar with the oxazolidinone moiety. Once again, this implies that they might 
influence the enantioselectivity through an electronic rather than a steric effect.119 
 
O NO
O
O
O
O
X
X = 4-Me    88
X = 4-OMe 89
X = 4-NO2  90
X = 4-Et      91
 
 
Table 1.8: Asymmetric epoxidation reactions by ketones 88-90.a 
Entry Ketone  
Conv. (ee)b 
 
Conv. (ee)c 
 
Conv. (ee) 
1 88 60 (84) 60 (84) 61 (25) (R,R) 
2 89 56 (80) 71 (83) 53 (26) (R,R) 
3 90 30 (79) 55 (90) 64 (27) (S,S) 
a
 Reaction conditions: olefin (1 eq), ketone (0.15 eq), Oxone® (1.6 eq), solvent DME / DMM, pH 8 
(0.2 M K2CO3-AcOH), Bu4NHSO4, -10 ºC. b (R) configuration of the epoxide. c (1R,2S) configuration 
of the epoxide. 
 
 
 
In order to explain the high enantiomeric excess and the absolute configuration 
obtained from epoxidation of Z-β-methyl styrene (80-93% ee), an attractive 
interaction between the aromatic group of the substrate and the oxazolidinone during 
the developing transition state has been invoked.121 As a consequence of this 
interaction, the aromatic pi system of the olefin prefers to be close to the 
oxazolidinone favouring the Spiro TS A (Figure 1.39) over the Spiro TS B (Figure 
1.39). 
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Figure 1.39: Transition state analysis in epoxidation of cis- olefins and styrenes with ketone 87. 
 
 
 
The beneficial attractive interaction is strengthened by electron-withdrawing groups 
in the para-position on the aromatic substituent of the oxazolidinone: an increase in 
the ee is registered going from the electron-donating Me (83%) to the electron-
withdrawing p-NO2 (90%).120,121 These data may suggest the presence of an 
additional phenyl-phenyl interaction between the N-substituted oxazolidinone of the 
catalyst and the aromatic ring of the substrate. Given the co-planarity of the phenyl 
ring with the oxazolidinone moiety in 88 (at least in the solid state), an “edge-to-
face” interaction might be suggested for the two phenyl rings. It is not completely 
clear the exact nature of this interaction and it might be that not only electrostatic 
forces are involved but also non-bonding (e.g. van der Waals forces) and 
hydrophobic interactions.120 
Further evidence of the dramatic effect of the N-substituents on enantioselectivity 
arises from epoxidation of phenyl cyclohexene. While electron-donating groups 
afford the (R,R) isomer through Spiro TS A (Scheme 1.23), electron-withdrawing 
substituents lead to the opposite enantiomer through Planar TS B (Scheme 1.23). 
Electron-withdrawing groups on the aromatic ring of the alkene through conjugation 
reinforce the attraction with phenyl group of the catalyst in the transition state thus 
further favouring transition state B over A and reversing the enantioselectivity.119 
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Scheme 1.23 
 
 
Interestingly, epoxidation of styrene does not seem to be affected by the nature of the 
para-substituents on the oxazolidinone group (Table 1.9). It might be that not only 
Spiro TS B but also Planar TS C (Figure 1.39) are competing with Spiro TS A 
(Figure 1.39) as a consequence of an enhanced interaction between the aromatic 
group of the olefin with the oxazolidinone in the presence of electron-withdrawing 
groups. As the favourable attraction acts on both Spiro A and Planar C (Figure 1.39), 
no change in the enantioselectivity is recorded. These results suggest that the major 
competing transition state is the Planar C (Figure 1.39).119 
A wider and more detailed analysis of the aromatic substitution patterns in the 
oxazolidinone ring revealed the presence of a certain dependency for styrene 
enantioselectivity from the N-substituents. In general, hydrocarbons gave higher ee 
than halogens and ethers (55-87% ee) (Figure 1.40).123 
 
 
 
Figure 1.40: Asymmetric epoxidation of styrene with N-substituted oxazolidinone ketones 92-94. 
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Variation in enantioselectivity of substituted styrenes was observed with ketone 91 
(Table 1.9). Ortho-substitution seemed to lower the enantioselectivity compared to 
styrene (Entry 2, Table 1.9) possibly because of the steric clash between the 
oxazolidinone and the aromatic substituent thus making Transition State A (Figure 
1.39) less favoured. Only minor differences in ee were observed for the meta- and 
para- substitution even if, in general, electron-withdrawing groups lead to higher 
enantioselectivities than electron-donating substituents as a consequence of a 
stronger secondary orbital interaction in the favoured spiro transition state.123 
 
Table 1.9: Asymmetric epoxidation of styrenes with ketone 91.a 
Entry X
 
Yield (conv.) ee (config.) 
1 X = H 72 (100) 86 (R) 
2 X = 2-F 89 (95) 80 (-) 
3 X = 4-Cl 85 (100) 86 (R) 
4 X = 4-CN 86 (100) 90 (R) 
5 X = 4-CF3 73 (100) 92 (-) 
6 X = 3-Me 87 (100) 90 (-) 
7 X = 3-NO2 77 (100) 88 (-) 
8 X = 3,5-Me 86 (99) 90 (-) 
a
 Reaction conditions: olefin (0.40 mmol), ketone (0.06-0.12 mmol), Oxone® (1.07 mmol), solvent 
DME, K2CO3 (4.23 mmol), Bu4NHSO4 (0.04 mmol), buffer (0.1 M K2CO3-AcOH, pH 9.3) (4.0 ml) at 
a temperature comprised between -10 and -15 ºC. 
 
 
Given the increased interest in environmentally friendly oxidants, studies conducted 
by Shi have shown that ketone 91 still remains a very efficient and enantioselective 
catalyst in the presence of aqueous hydrogen peroxide, as oxidant, and CH3CN 
(Table 1.10). The active species that leads to the formation of the dioxirane seems to 
be the peroxyimidic acid 95 (Scheme 1.24).34  
 
CH3CN H2O2+
NH
OOH
95
 
Scheme 1.24 
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Optimisation of the reaction conditions led to the identification of n-BuOH as the 
best solvent for the new protocol which consists of 3.8 eq of CH3CN, 3.0 eq of H2O2 
in n-BuOH-0.30 M K2CO3 in 0.4 mMol EDTA (1:1 v/v). In general, the 
enantioselectivity obtained according to the newly developed procedure were similar 
to or only slightly lower than the ones obtained with Oxone®. The inferior values 
recorded in some cases might be due to the solvent effect, which is a parameter that 
largely affects the electronic and hydrophobic effects that are highly responsible for 
the asymmetric induction.34 
 
 
Table 1.10: Asymmetric epoxidation of various substrates with ketone 91.a 
Entry Substrate 
Catalyst 
loading (%) Yield (conv.)
 ee (config.) 
1 
 
15 82 (96) 92 (+) 
2 
 
25 93 (100) 83 (-) 
3 
 
10 83 (99) 82 (1R,2S) 
4 Ph Ph
 
25 78 (90) 88 (R,R) 
a
 Reaction conditions: olefin (1.0 mmol), ketone (0.10-0.30 mmol), CH3CN (0.20 ml, 3.8 mmol), n-
BuOH (3.0 ml), aq 0.30 M K2CO3 in 4 x 10-4 M EDTA (3.0 ml), and 30% H2O2 (0.30 ml, 3.0 mmol) at 
0 ºC for 24 h. 
 
 
 
A major advantage with the new reaction conditions is that they require only small 
amounts of solvents and salts, and do not need slow addition of the oxidant. 
Conversely, the high pH = 11.5 might cause ketone decomposition with α 
deprotonation and loss of acetone and thus racemic epoxide formation. The reaction 
conditions might also favour the oxazolidinone hydrolysis caused by the nucleophilic 
addition of the peroxide anion. Both decomposition pathways will impact mostly on 
the enantioselectivity of unreactive olefins while for many substrates the new 
paradigm represents an attractive alternative to the use of Oxone®. 
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In order to probe how structural variations in the ketone skeleton might affect 
enantioselectivity, some minor modifications were introduced by Shi on ketone 80. 
In particular, the electronic influence of certain functionalities on secondary orbital 
interaction and thus their effect on the major competing transition states were 
investigated. Initially, the pyranose oxygen in 80 was replaced by a carbon atom. In 
general, high ee were obtained with 96 for styrenes and cis- olefins and only minor 
differences were observed by variation of the electronic properties of the olefin 
substituents (Figure 1.41). As the X-ray structure of 96 is very similar to 80, the 
effect exerted by the catalyst on enantioselectivity has to be inferred to be more 
electronic than conformational in origin.80 
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Z-Methylstyrene:           100% yield
                                       89% (1R,2S)
1-Phenyl-cyclohexene:  100% yield     
                                       40% (R,R)
96
 
 
Figure 1.41: Asymmetric epoxidation of few substrates with ketone 96. 
 
 
The favoured transition state generating the major enantiomer of styrene oxide might 
be represented by the Spiro TS A (Figure 1.42, R = H), with the phenyl group of the 
olefin favourably interacting with the oxazolidinone and the Boc groups. The minor 
enantiomer should be generated, instead, by Spiro TS B (Figure 1.42, R = H), and 
Planar TS C (Figure 1.42, R = H). The higher ee registered with 96 compared to 80 
(90% νs 79% ee) highlights how structural changes electronically influence the 
asymmetric induction. As a consequence, TS A (Figure 1.42, R = H) is further 
favoured or TS B (Figure 1.42, R = H) and / or TS C (Figure 1.42, R = H) even more 
disfavoured. As previously mentioned, spiro and planar transition states represent 
two extreme situations with the spiro structure energetically favoured over the 
planar. The beneficial effect comes from a secondary orbital interaction due to 
overlap between the HOMO orbital of the oxygen of the dioxirane and the LUMO 
orbital of the alkene. This specific interaction can be strengthened by raising the 
 Chapter 1 
 
 
69 
energy of the HOMO (lone pair) of the dioxirane with electron-donating substituents 
on the catalyst. Replacement of the oxygen atom with a carbon could then highly 
contribute to an increased stabilisation of the spiro transition state by raising the 
energy of the non-bonding orbital of the dioxirane. In the case of styrene, the 
enhanced stability coming from the spiro transition state might favour even further 
Spiro TS A (Figure 1.42, R = H) and Spiro TS B (Figure 1.42, R = H) over Planar TS 
C (Figure 1.42, R = H). As a net result, a reduced amount of minor enantiomer is 
formed through Planar TS C and an increased enantioselectivity is obtained.80  
The very similar ee obtained in epoxidation of Z-methyl styrene (89% vs 87% ee) 
suggests that replacement of the pyranose oxygen with a carbon atom does not 
change the competition between the two Spiro Transition States TS A and TS B 
(Figure 1.42, R = CH3) (which are the only two feasible transition states for cis- 
olefins). For styrene, then, it can be inferred that the structural change particularly 
favours TS A (Figure 1.42, R = H) or consistently disfavours TS C (Figure 1.42, R = 
H).80 
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Figure 1.42: Competing transition states in epoxidation of cis- olefins and of styrene with ketone 96. 
 
 
 
A switch in the absolute configuration of phenyl cyclohexene epoxide was 
determined by the heteroatom replacement. This clearly suggests that the structural 
variation leads to opposite preference for the most favoured transition state compared 
to 80. In particular, the usually energetically disfavoured Planar Transition State TS 
B (Scheme 1.25) becomes the favoured structure.80 
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Scheme 1.25 
 
 
The reported analysis reveals the importance of the right choice for catalyst 
functionalisation. In particular, electron-withdrawing groups electronically increase 
the reactivity of the catalyst towards Oxone® attack but may exert a significant steric 
effect close to the active site and modify the preference for the most favoured spiro 
transition state. Hence, they may have a detrimental effect on enantioselectivity. 
In light of these results, an efficient catalyst for terminal alkenes and styrenes should 
require a remarkable preference of Spiro Transition State A over Spiro TS B and 
Planar TS C (Figure 1.42). 
To further prove the presence of an attractive interaction, the ketal moiety 
responsible for the pseudo C2 symmetry was removed so that the incoming olefin had 
nearly equal possibility to attack both dioxirane oxygens (Figure 1.43). Ketone 98 
afforded good enantioselectivity with 2,2-dimethylstyrene (78% ee) while 97 gave 
extremely poor results (3% ee). This data support the presence of a strong interaction 
between the aromatic group of the olefin and the oxazolidinone ring leading to a 
clear preference for the Spiro TS A over the Spiro B (Figure 1.43).117 
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Figure 1.43: Ketones 97 and 98, and transition state analysis in epoxidation of 2,2-dimethylstyrene 
with ketone 98. 
 
 
 
The different epoxidation results obtained with the fructose-derivative 57 and the 
oxazolidinone 80 in respect of the class of substrates prompted to a careful 
investigation of the role of the spiro ring on stereo-differentiation. A few 
modifications were made at the spiro unit, such as the replacement of an oxygen 
atom with a carbon in 99 and the subsequent removal of the gem-dimethyl group in 
100. Alternatively, the oxazolidinone ring was replaced with a lactone group bearing 
hydrogens or alkyl substituents α to the lactone carbonyl functionality.124 Ketones 
99-102 were tested in epoxidation of trans-, cis-, trisubstituted alkenes and styrene 
(Table 1.11). The simple replacement of an oxygen with a carbon atom in the spiro 
unit did not significantly affect enantioselectivity compared to 57. Removal of the 
gem-dimethyl group caused, instead, a consistent drop in ee for E-β-methyl styrene, 
suggesting that other planar or spiro transition states characterised by reduced steric 
hindrance might be competing with the generally favoured spiro transition state. 
Similar considerations applied to ketones 100, 101 and 102. Previous studies have 
shown the beneficial effect of the oxazolidinone ring on asymmetric epoxidation of 
cis- olefins. These latest results further confirm the trend and also the importance of 
the carbonyl group in developing an attractive interaction with the aromatic ring of 
the substrate in epoxidation of cis- and terminal olefins. The lower ee for 101 and 
102, compared to 80, reiterates the fact that additional non-bonding interactions 
between the olefin phenyl ring and the oxazolidinone N-substituent contribute to 
enhance the enantioselectivity.124 
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The extreme sensitivity of the asymmetric epoxidation process to steric and 
electronic effect is revealed by epoxidation of phenyl cyclohexene whose product 
configuration varies on the bases of the steric hindrance developing in the transition 
states (Table 1.11). 
No significant changes were recorded for styrene, suggesting that beneficial or 
detrimental effect of the changes affect all major competing transition states.124 
 
 
 
 
 
Table 1.11: Asymmetric epoxidation reactions by ketones 99-102.a 
Entry Ketone  
Conv. (ee)b 
 
Conv. (ee)c 
 
Conv. (ee)d 
 
Conv. (ee) 
1 99 48 (38) 86 (33) 69 (95) 92 (95) (R,R) 
2 100 93 (55) 100 (61) 98 (72) 86 (29) (R,R) 
3 101 39 (62) 62 (72) 62 (71) 70 (17) (S,S) 
4 102 99 (64) 100 (81) 88 (76) 85 (85) (R,R) 
a
 Reaction conditions: olefin (0.1 mmol), ketone (0.03 mmol), Oxone® (0.212M, 0.84 mL), solvent 
DME / DMM, pH 9.3 (0.2 M K2CO3-AcOH), K2CO3 (0.892 M, 0.84 mL), 0 ºC. b (R) configuration of 
the epoxide. c (1R,2S) configuration of the epoxide. d (R,R) configuration of the epoxide. 
 
 
 
 
1.8.2.9  Miscellaneous carbonyl compounds in dioxirane-mediated asymmetric 
epoxidation 
Extensive work on α-fluorinated substituted cyclohexanones has been conducted by 
Solladié-Cavallo to probe the effect of fluorine substituents on both reactivity and 
enantioselectivity in ketone-promoted asymmetric epoxidations.125-132 In agreement 
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with quantum mechanical methods which have shown that dioxirane derived from 2-
fluorocyclohexanone bearing an α-fluoro in the axial position is more reactive than 
when the substituent lays equatorially (with a difference in the activation energy of 
the corresponding transition states of 2.5 kcal mol-1),83 Solladié-Cavallo showed that 
ketone 103 with an axial fluorine at the α position was more reactive than the 
equatorial diastereoisomer (ketone 104) (Entries 3 and 4, Table 1.12). Higher 
enantioselectivities were also obtained.130 The replacement of a hydrogen atom of the 
iso-propyl group at the C8 position in 103 by a halogen (ketones 105 and 106) or the 
bis-substitution (ketone 107) dramatically increases the ee for trans- olefins. Up to 
90% ee was obtained for E-stilbene (Table 1.12) and moderated to good ee were 
achieved for cinnamates.125 None of these ketones underwent Baeyer-Villiger 
decomposition and they were recovered almost quantitatively after the reaction. 
 
 
 
 
 
Table 1.12: Asymmetric epoxidation reactions with ketones 103-107.a 
Entry Ketone Alkene Conversion ee (%) 
1 103 E-Stilbene 68 60 (S,S) 
2 104 E-Stilbene 69 18 (R,R) 
3b 103 Methyl 4-OMe cinnamate 99 40 (2R,3S) 
4b 104 Methyl 4-OMe cinnamate 43 6 (2S,3R) 
5 105 E-Stilbene 78 86 (S,S) 
6 106 E-Stilbene 90 90 (S,S) 
7 107 E-Stilbene 95 90 (S,S) 
a. Reaction conditions: pH 8.5-9.0, 0.3 eq of ketone, T = 0 ºC, solvent DME / H2O. b Solvent: dioxane / 
H2O, RT. 
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Tomioka and co-workers reported some chiral ketones characterised by chiral 
heterocycle skeletons containing ketones and electron-withdrawing groups (Figure 
1.44). These functional groups had the double function of activating the ketone 
towards Oxone® attack and creating a steric wall to limit the possible approaches of 
the olefin substrate. Epoxidation of E-stilbene using a stoichiometric amount of 108 
afforded 60% ee (S,S) while 109 gave only 6% ee for the epoxide with the opposite 
configuration (R,R). The C2 symmetric ketone 110 delivered stilbene oxide in 66% 
ee (R,R) and showed the same enantio-facial attack as 109. It was assumed that 
conformational differences between 108 and 109 / 110 were responsible for the 
enantioselectivities.133 
 
 
 
Figure 1.44: Tomioka’s ketone catalysts. 
 
 
Recently Shing has studied asymmetric epoxidation of several classes of alkenes 
(trans-, tri-substituted and terminal olefins) by the use of D-glucose- and arabinose-
derived uloses (Figure 1.45).134,135 In general, low enantioselectivities and low to 
modest conversions were observed with ketones 111 and 112. Furthermore, ketones 
112 and 113 were unstable under the reaction conditions thus accounting for the low 
product yields. However, catalyst 114 displayed good enantioselectivity for E-
stilbene (90% ee). Introduction of an ester group α to the ketone in 115 and 116 
made the catalysts more reactive and more stable to the Baeyer-Villiger 
decomposition. Moderate enantioselectivities were obtained with 115 towards trans- 
and tri-substituted alkenes (67% ee for E-stilbene). Better results in terms of 
conversion and ee were achieved by introduction of additional chiral centres and of 
tbutyl groups in 116 at 10 mol% catalyst loading.136 
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Figure 1.45: Shing’s ketones. 
 
 
In 2003, Zhao and co-workers reported alkene epoxidation studies promoted by 
aldehydes. Although ketone dioxiranes can be easily prepared by oxidation processes 
in the presence of Oxone®, aldehydes are more prone to be oxidised to the 
corresponding acids when reacted with peracids.137,138 However, aldehydes can be 
oxidised in the presence of Oxone® to the corresponding dioxiranes if electronic 
effects disfavour alternative pathways, such as the Baeyer-Villiger transformation or 
oxidation to the corresponding acid. By the use of three equivalents of aldehyde, 118 
consistently gave better ee than 117 in alkene epoxidation reactions and up to 94% ee 
was obtained with E-stilbene. The higher selectivity was attributed to the hydroxyl 
group. Assuming that the oxygen transfer occurs through a spiro transition state, the 
free hydroxyl group would deactivate the pseudo-axial dioxirane oxygen by 
hydrogen bonding thus favouring the attack of the approaching olefin on the pseudo-
equatorial oxygen. Moreover, the hydrogen bond would fix the conformation and 
reduce the number of possible approaches of the substrate (Figure 1.46).139 
Low enantioselectivity was observed for terminal and cis- olefins with 118 (18% ee 
for α-methyl styrene).139 
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Figure 1.46: Aldehydes from Zhao’s group, and Spiro Transition State in asymmetric epoxidation 
with aldehyde 118. 
 
 
 
In 2001, Bartolini and co-workers reported an efficient asymmetric epoxidation 
procedure for cinnamic acids based on bile acids derived ketones. Using ketone 119 
(Figure 1.47), up to 95% ee was obtained for p-methyl cinnamic acid. Studies carried 
out with several analogues suggest that modulation of the enantiocontrol can be 
achieved by specific substitutions at the C(7) and C(12) positions.140,141 
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Figure 1.47: Bile acid derived ketone from Bartolini’s group. 
 
 
 
1.9 Previous Work in the Group 
 
The bicyclo[3.2.1]octanone framework (Figure 1.48), identified by Armstrong’s 
group,142 represents an interesting and flexible skeleton for easy and innovative 
functionalisation. Novel ketones designed for asymmetric epoxidation of trans-
substituted and terminal olefins are thus accessible.  
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Figure 1.48 
 
 
Non racemic axially α-monosubstituted N-carbethoxy-azabicyclo[3.2.1]ocatnone 
derivatives can be prepared starting from the commercially available N-
carbethoxytropinone 120 via desymmetrisation using chiral lithium amide 123 
(Scheme 1.26).142 Subsequent electrophilic quenching of the enantiomerically 
enriched silyl enol ether affords the axially substituted ketones. However, only 
enantiomerically enriched catalysts can usually be obtained and subsequent 
recrystallisations are required to deliver enantiomerically pure ketones. Hence, the 
observed epoxide enantiomeric excess has to be converted into eemax, with the 
assumption of a linear relationship between catalyst ee and product ee (which has 
been proved for ketones 124 and 127).143,144 Axially α-monosubstituted ketones 
generally afford high enantiomeric excess towards trans- substituted alkenes and are 
resilient to Baeyer-Villiger oxidation. 
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Scheme 1.26: i) Chiral base 123, TMSCl, THF, -78→-20 ºC; ii) CH3CN, electrophile, RT. 
 
 
Much work has been done in this area and some main features have been 
identified.142-147 The bridgehead atom (Z, Figure 1.48) plays an important role in 
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determining the activity and selectivity of the catalyst. The greater the polar nature of 
the C-Z bond the higher the enantioselectivity (Entry 1, Table 1.13 for E-stilbene and 
styrene vs Entry 3, Table 1.13 for the same substrates). The more polar C-O bond 
afford, in fact, higher ee compared to the N-bicyclic analogues as a result of a 
positive field effect and of a greater stabilisation of the developing positive charge on 
the olefin in the favoured transition state during the dioxirane-mediated epoxidation 
reaction.145,146 
The electron-withdrawing nature of the α-substituent increases the electrophilicity of 
the ketone, activating it toward attack from Oxone®. The catalyst also becomes more 
stable to possible side reactions, such as the Baeyer-Villiger decomposition. 
Many α-monosubstituted chiral ketones have been synthesised (X = F, Cl, OAc, 
OCOR and Y = H) and axially substituted derivatives represent the best catalysts to 
date in the series.145,146 Although trans- alkenes are excellent substrates, the catalyst 
substitution pattern still gives very low ee for terminal olefins (Table 1.13).143-146 
 
Y
O
X
X = F,      Y = NCO2Et         124
X = OAc, Y = NCO2Et         125
X = F,      Y =O                    126
X = OAc, Y =O                    127
 
Table 1.13: Asymmetric epoxidations with ketones 124-127. 
E-Stilbene Styrene α-Methyl styrene 
Entry Alkene 
Yield (%) eemax(%)c Yield (%) eemax(%)c Yield (%) eemax(%)c 
1 124a,f 88 76 (R,R) 33 29 (R) 80 22 (S)d 
2 125b 100e 86 (R,R) - - - - 
3 126b 88e 86 (R,R) 100e 36 (R) 100e 17 (S) 
4 127b 85e 93 (R,R) 100e 48 (R) 100e 10 (S) 
a
 Reaction conditions: olefin (0.1 mmol), ketone (10 mol%), Oxone® (1.0 mmol KHSO5), NaHCO3 
(1.55 mmol), solvent CH3CN (1.5 ml), aq Na2EDTA (1 ml of 0.4 mM sol), RT. b Olefin (0.1 mmol), 
ketone (20 mol%), Oxone® (1.0 mmol KHSO5), NaHCO3 (1.55 mmol), CH3CN (1.5 ml), aq. 
Na2EDTA (1 ml of 0.4 mmol dm-3 solution). c eemax= 100 x product ee/ketone ee. d Epoxidation carried 
out using ent-124. e Conversion estimated by integration of the crude 1H NMR spectrum.  
f. The following convention for assignment of ketone catalyst nomenclature is used throughout this 
publication: ketone 124 gives the (R,R) configuration for stilbene oxide while ent-124 gives the (S,S) 
stilbene oxide. 
 
 
 Chapter 1 
 
 
79 
The rigid and well-defined conformation of the system offers the advantage of being 
able to predict and rationalise the asymmetric induction. The configuration of the 
epoxide produced by the chiral dioxirane correlates to the mode in which the 
epoxidation process occurs. In general, with substituents occupying the α-position, 
the alkene approaches the dioxirane from the less hindered exo-face through a Spiro 
Transition State A, with the main competing transition state being Planar B (Figure 
1.49).145 
Y X
Spiro A Planar B
O O
Y X
O O
 
 
Figure 1.49 
 
 
The introduction of an additional equatorial substituent leads to α,α-disubstituted 
ketones. Unfortunately, they afford enantiomeric excesses approximately 10% lower 
than the corresponding axially monosubstituted analogues (Entry 3, Table 1.13 vs 
Entries 1, 2 and 3, Table 1.14).148 
 
O
O
X
X = F,    Y = CO2Et             128
X = F,    Y = CH2OCOCH3  129Y
 
 
Table 1.14: Asymmetric epoxidations with ketones 128a and 129.a 
128 129 
Entry Alkene 
Conv.b eemax (%)c Conv.b eemax (%)c 
1 E-Stilbene 92 77 (R,R) 84 68 (R,R) 
2 Styrene 100 14 (R) 100 29 (R) 
3 α-Methyl styrene 100 8 (S) 61 2 (S) 
a
 Reaction conditions: olefin (1 eq), ketone (10 mol%), Oxone® (10 eq KHSO5), NaHCO3 (15.5 eq), 
solvent CH3CN / aq Na2EDTA (0.4 mmol dm-3 sol) (3:2, 25 ml/mmol), 24 h, RT. b Estimated by 
integration of the 1HNMR spectrum of the crude reaction mixture. c Catalysts 128 and 129 were 80% 
ee. For these catalysts the quoted ee is  eemax= 100 x product ee/ketone ee. 
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A small number of α,α’-disubstituted ketones have been synthesised and tested in E-
stilbene asymmetric epoxidation reaction. Dramatic decreases in the 
enantioselectivity have been observed compared to 124 towards this class of 
aromatic trans- substituted alkene, in particular with the cis-α,α’-disubstitution 
pattern on ketone 131 (Entry 2, Table 1.15 vs Entry 1, Table 1.13).147 
 
N
EtO2C
O
130
N
EtO2C
O
131
FF
AcO
OAc
 
 
Table 1.15: Asymmetric epoxidations of E-stilbene with ketones 130 and131.147 
Entry Ketone eemax (%)a 
1 130 61 (R,R) 
2 131 28 (S,S) 
a eemax= 100 x product ee/ketone ee. 
 
 
The two-carbon bridge in the bicyclooctanone skeleton was shown not to be crucial 
to achieve high enantioselectivity. The opening of the bridge at the endo-face (Figure 
1.50) still allows 90% ee for E-stilbene to be achieved (Entry 1, Table 1.16).149 These 
ketones proved to be stable under the reaction conditions and could be employed at 
10 mol% loading. In the absence of the bicyclic structure to prevent the attack from 
the endo-face of the ketone, the high enantioselectivity seems to be induced by the 
axial electronegative α-substituent which steers the olefin to the oxygen of the 
dioxirane lying syn to it. 149 
 
O
O
O OR
O
AcO
AcO
R = alkyl, aryl, naphthyl
R = p-OMe-Ph     ent-132
R = OAc               ent-133
 
 
 
Figure 1.50 
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Table 1.16: Asymmetric epoxidations with ketones ent-132 and ent-133. 
ent-132 ent-133 
Entry Alkene 
Conv. eemax (%)c Conv. eemax (%)c 
1 E-Stilbenea 99 87 (S,S) 100 81 (S,S) 
2 E-Stilbeneb 85 90 (S,S) 17 70 (S,S) 
3 Styrenea 100 36 (S) 99 19 (S) 
4 Styreneb 100 43 (S) 100 25 (S) 
5 α-Methyl styrenea 100 21 (S) 100 9 (S) 
6 α-Methyl styreneb 100 43 (S) 100 30 (S) 
Reaction conditions: a olefin (1 eq), ketone (10 mol%), Oxone® (10 eq KHSO5), NaHCO3 (15.5 eq), 
CH3CN / aq Na2EDTA (0.4 mmol dm-3 sol) (3:2, 25 ml/mmol), 24 h, RT. b Olefin (1 eq), ketone (10 
mol%), Oxone® (10 eq KHSO5), NaHCO3 (15.5 eq), tert-BuOH / aq Na2EDTA (0.4 mmol dm-3 sol) 
(1.2:1, 26 ml/mmol), 24 h, RT. c eemax= 100 x product ee/ketone ee. 
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Aims and Objectives 
 
Dioxirane-mediated epoxidation promoted by ketones is clearly a complementary 
method to the Sharpless asymmetric epoxidation and to other metal-catalysed 
epoxidation methods. It is a rapid, simple, clean and environmentally “friendly” 
process since no toxic metals are involved and the ketones can be recovered and 
recycled. The mild reaction conditions used allow the presence of many functional 
groups making its applicability wide. With the general features influencing 
asymmetric induction understood, it is possible to carefully design the chiral ketone. 
In particular, the chiral element should be close to the reacting centre to allow 
stereochemical interaction between the catalyst and the olefin. The presence of 
electron-withdrawing substituents would activate the carbonyl group toward attack 
from Oxone® thus favouring the dioxirane formation and would reduce possible 
decomposition reactions (e.g. the Baeyer-Villiger reaction). Enantioselectivity might 
be increased by forcing the approach of the olefin to occur preferentially on one face. 
This can be achieved by sterically blocking the other face or introducing a C2 or 
pseudo-C2 symmetry element or by appropriate α-substituents which will create a 
suitable chiral environment and will exert a “steering effect” interacting with the 
functional groups of the olefin. 
Unfortunately, chiral ketones designed to date are specific for particular classes of 
olefins. Further studies would help in the optimisation of the ketone design to 
improve enantioselectivity, efficacy and general applicability. 
The aim of this project was the synthesis of efficient and enantioselective ketone 
catalysts for epoxidation of trans- olefins and, most importantly, for terminal 
alkenes, which are still very challenging substrates.  
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Despite the excellent results achieved by our group with earlier α-substituted 
bicyclo[3.2.1]octanones and by other research groups, there is a strong need for new 
catalysts which provide high enantioselectivities for “problematic” alkene 
substitution patterns such as the 1,1-disubstituted olefins.  
Previous work from Shi’s group (vide supra) has shown that functionalisation of the 
fructose backbone with spiro-substituents can give encouraging ee values with 
terminal alkenes. Therefore we wished to investigate the incorporation of the spiro-
motif into our catalysts.  
Since the bicyclo[3.2.1]octanone scaffolds are constructed using synthetic 
methodologies very different to those of Shi’s carbohydrate-derived systems, we 
especially hoped to be able to access novel spiro-motifs that had not been explored 
before (Figure 2.1). 
 
N
EtO2C
O
X Y
 
 
 
Figure 2.1: Example of α,α-disubstituted ketone functionalised with a spiro motif. 
 
Our next goal was to investigate multiply-substituted ketones with both α positions 
of the carbonyl occupied by substituents (Figure 2.2). These substitution patterns, 
again, would be hard to access from carbohydrate precursors. 
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Figure 2.2: Example of α,α,α’-trisubstituted ketone for alkene epoxidation. 
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Novel N-Carbethoxy-Azabicyclo [3.2.1] 
Octanones Containing an α,α-Fused Ring 
 
 
At the beginning of this project, the synthesis of efficient and enantioselective 
catalysts for epoxidation of trans- substituted and the more challenging terminal 
alkenes was a clear and important objective. 
A way of achieving this aim was to investigate the synthesis of α,α-spirocyclic 
disubstituted ketones (Figure 3.1), a motif which has been shown to give high 
enantioselectivity toward unsubstituted terminal alkenes in the Shi fructose series.117 
 
 
N
O
EtO2C
XO
O X = O,
      NR
 
 
Figure 3.1: Examples of α,α-spirocyclic disubstituted ketones.  
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3.1  Preparation of novel N-carbethoxy [3.2.1] azabicyclic ketones containing an 
α,α-fused cyclic carbonate  
 
Given the well-defined conformation of the bicyclic [3.2.1] backbone, the initial plan 
was to introduce a fused cyclic carbonate unit in the α position of the N-
carbethoxytropinone. This ring would activate the ketone toward attack by Oxone® 
and also give a marked steric bias, completely blocking the endo-face of the 
molecule. In the dioxirane intermediate, the two oxygen atoms would then be 
differentiated with the equatorial one sterically more accessible for the olefin 
approach. The increased hindrance on the α position of the ketone and any additional 
stabilising dipolar interactions between the cyclic carbonate and the aromatic group 
of the olefin should lead to an increased enantioselectivity. 
The new chemistry was initially developed in the tropinone series, given the 
commercial availability of the starting material. Any promising and interesting 
results could then be transferred to the potentially more enantioselective [3.2.1] 
oxabicyclic series. 
In the bicyclo[3.2.1]octanone system, the only previous example of an epoxidation 
catalyst bearing a fused cyclic unit in the α position is the acetonide 134 (Figure 
3.2).143 Unfortunately, it proved to be unstable to the Yang acetonitrile epoxidation 
conditions and underwent Baeyer-Villiger decomposition leading to low epoxidation 
efficiency (13% conversion after 24 hours with 100 mol% of catalyst loading in the 
case of E-stilbene).145 We therefore planned to replace the acetonide unit with the 
carbonate group and assess the stability and efficiency of the new catalyst (Figure 
3.2). 
 
N
EtO2C
O
OO
134
 
 
Figure 3.2: Acetonide catalyst 134 previously synthesised by the group. 
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The first target was to improve the existing synthetic route, previously developed 
within the group,145 to compound 136 (Scheme 3.1). This is a key intermediate for 
further functionalisation, which would ideally be synthesised in a short, high yielding 
and scalable manner. 
 
N
EtO2C
O
N
EtO2C
O136 120
 
 
Scheme 3.1 
 
 
The original synthesis of 136 (Scheme 3.2) consisted of the formation of the silyl 
enol ether 121 by deprotonation of ketone 120, followed by internal quenching with 
pre-mixed Et3N and TMSCl. Siloxycyclopropane 135 was obtained in a modified 
Simmons-Smith fashion with diethyl zinc and diiodomethane, and further reacted in 
an electrophilic ring opening transformation assisted by SnCl4. Subsequent base-
induced dehydrotrichlorostannation in the presence of DMSO delivered 136 in 80% 
yield. Unfortunately the synthesis was quite lengthy, low yielding (33% starting from 
120) and characterised by unstable intermediates, such as 135.143 
 
N
O
N
O Si
N
O Si
N
O
i, ii iii iv,  v
120 121 135 136
EtO2C EtO2C EtO2C EtO2C
 
 
Scheme 3.2: i) LDA, THF, -78 ºC; ii) TMSCl, Et3N, 92% over two steps; iii) ZnEt2, CH2I2, Et2O, RT, 
18 h, 42% from 120; iv) SnCl4, DCM; v) DMSO, DCM, 80% over two steps. 
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The initial alternative approach considered was an aldol condensation150 between 
formaldehyde and the lithium enolate of the N-carbethoxytropinone 137 (Scheme 
3.3). Solid paraformaldehyde did not react and any attempts of obtaining the 
monomeric form either by distillation151 or heating failed to deliver reactive material. 
Therefore a more feasible pathway was investigated. 
 
 
 
N
EtO2C
O
N
EtO2C
O120
OH
O
H H
N
EtO2C
O-137
i
Li+ 138
 
 
Scheme 3.3: i) LDA, THF, -78 ºC. 
 
 
The introduction of the exo-methylene unit on the tropinone was successfully 
achieved in a Mannich fashion (Scheme 3.4).152 N-carbethoxytropinone 120 was 
deprotonated with LiHMDS (1.0 M in THF) at -78 oC and then treated with TMSCl. 
The resulting silyl enol ether 121 was then reacted with a stoichiometric amount of 
Eschenmoser’s salt to give the Mannich base 139 which was then methylated with 
MeI. Elimination of trimethylamine was achieved by heating in the presence of 
NaHCO3. Much work was done to identify these optimal conditions (temperature, 
stoichiometry, concentration, work-up) and now the process gives reproducible 
yields around 60% where the main by-product is the disubstituted compound 141 
(Figure 3.3). 
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Scheme 3.4: i) LiHMDS, THF, -78 ºC; ii) TMSCl, -78 ºC; iii) Eschenmoser’s salt, DMF, RT, 1.5 h; 
iv) MeI, 50 ºC, sealed tube; v) NaHCO3, DMF, 95 ºC, 60-65%. 
 
 
N
EtO2C
O141
 
 
Figure 3.3: Bis-adduct from the Mannich reaction. 
 
 
The course of the reaction was monitored by TLC and Mass Spectrometry (ES+). 
The critical steps appeared to be the quaternisation of the Mannich base (Step iv, 
Scheme 3.4) which required prolonged heating at 50 oC in a sealed tube, and the final 
elimination (Step v, Scheme 3.4) which occurred using a large excess of base and 
high temperature. Lower temperature and shorter reaction time cause incomplete 
conversion and lead to very low yield with the main product being 141 (Figure 3.3).  
The synthetic pathway identified to obtain the targeted racemic ketone (±)-143 is 
shown in Scheme 3.5. Following the chemistry developed by Armstrong’s group,145 
the exocyclic enone was dihydroxylated with a catalytic quantity of K2OsO4·2H2O 
and NMO in acetone / water using quinuclidine as the ligand. The reaction occurred 
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stereoselectively on the less hindered exo-face. Evidence of the stereoselectivity, 
which had previously only been assumed, comes from nOe experiments: the 
exocyclic CH2 gives nOe enhancement with the endo-protons of the two-carbon 
bridge, proving its pseudo-equatorial position (Figure 3.4). The diol 142 was then 
cyclised with triphosgene to yield (±)-143 as a colourless solid.  
 
N
EtO2C
O
N
EtO2C
O
OHHO N
EtO2C
O
OO
O
136 142 (±)-143
i ii
 
 
 
Scheme 3.5: i) K2OsO4·2H2O, quinuclidine, NMO, Acetone / H2O, 86%; ii) triphosgene, pyridine, 
DCM, 60%. 
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Figure 3.4: nOe experiments proving the stereoselectivity of the dihydroxylation reaction. 
 
 
With (±)-143 in hand, its potential catalytic efficiency toward the epoxidation of E-
stilbene was evaluated using the standard Yang one-phase conditions. Ketone (±)-
143 clearly showed good catalytic activity at only 10 mol% loading with the 
epoxidation reaction proceeding almost to completion (86% conversion, estimated 
from the proton NMR spectrum of the crude reaction mixture) in only ½ h. The 
experiment also proved that the catalyst was stable to the reaction conditions, as it 
could be seen intact by inspection of the 1H NMR spectrum of the crude reaction 
mixture. 
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3.2  Evaluation of enantiomerically pure spiro carbonate N-carbethoxy bicyclic 
ketone 
 
As a consequence of the encouraging result from epoxidation of E-stilbene mediated 
by racemic ketone (±)-143, the enantiomerically pure catalyst was targeted. The 
route previously developed by Armstrong’s group leading to enantiomerically 
enriched α-substituted [3.2.1.] bicyclic systems consisted of the desymmetrisation of 
N-carbethoxytropinone using Simpkins’ chiral lithium amide bases153 followed by 
treatment with TMSCl (cf. Scheme 1.26). Unfortunately, in many cases, it did not 
provide complete enantiomeric purity but only gave enantiomeric enrichment. It was 
therefore decided to obtain single enantiomers by separation of the racemic mixture 
using supercritical fluid chromatography (SFC).154  
This separation technique is very closely related to high performance liquid 
chromatography (HPLC) but uses a compressed gas as mobile phase (usually CO2) 
together with a modifier (e.g. methanol). It offers many advantages compared to 
HPLC and can perform very difficult separations. With chiral columns, separation of 
enantiomers and stereo / regio-isomers can be easily achieved.155 The use of SFC 
separations offered the great advantage of being able to rapidly evaluate the potential 
catalytic activity of new ketones which could be initially synthesised as racemates. It 
made the entire investigation process much faster and more efficient. For scale-up 
following promising results, the next step would be the development of an 
asymmetric synthesis. 
This approach was successfully applied to (±)-143 and allowed both enantiomers to 
be isolated with extremely high enantiomeric purity (>99% ee).1 
According to the standard protocol, the two opposite enantiomers ent-143 (first 
eluting enantiomer from chiral separation) and 143 (second eluting enantiomer from 
chiral separation) were assessed in the epoxidation of E-stilbene. The reaction time 
was extended from ½ h to 18 h in order to achieve complete conversion. As 
expected, 143 and ent-143 led to opposite enantiomers of E-stilbene oxide, whose 
                                                          
1
 The following convention for the assignment of monosubstituted ketone catalysts nomenclature 
applies to compounds that have been synthesised as racemates and then separated into single 
enantiomers by chiral chromatography: the ent-series gives the (S,S) stilbene oxide. The absolute 
configuration of 143 and ent-143 is not certain but can be inferred by correlation with the absolute 
configuration of E-stilbene oxide obtained and by assuming that epoxidation reaction occurs through a 
spiro transition state (in analogy with similar [3.2.1] bicyclic ketones). 
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absolute configuration was determined by comparison with the literature data.101 
Very high conversion and enantiomeric excess were reproducibly obtained with 
these catalysts (Table 3.1). 
 
N
EtO2C
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CO2Et
O O
O
O
143 ent-143
 
 
Table 3.1: Epoxidation of E-stilbene catalysed by ketones 143a and ent-143a. 
Entry Catalyst Alkene t (h) Conversion (%)b 
Yield 
(%) 
ee 
(%)c Configuration
c
 
1 143 E-Stilbene 18 100 85 87 (R,R) 
2 ent-143 E-Stilbene 18 100 83 89 (S,S) 
a
 Reaction conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), ketone (10 mol%), NaHCO3 
(1.55 mmol), CH3CN (1.5 ml), aq. Na2EDTA (1 ml of 0.4 mM solution). Work-up A, Chapter 7, 
Section 7.4. b Estimated from the 1H NMR spectrum of the crude reaction mixture. c Product ee and 
configuration determined by chiral HPLC analysis.  
 
 
As the enantiomeric purity of the catalysts 143 and ent-143 was close to 100%, the 
ee measured corresponds to the eemax calculated for some similar ketones (e.g. 125 
and 127, Figure 3.5) which were only obtained in a sub-optimal enantiomerically 
enriched form through asymmetric synthesis.145,146 
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Figure 3.5: Examples of axially monosubstituted ketones from Armstrong’s group. 
 
Ketone 143 afforded comparable ee to the acetoxy analogue 125143 but slightly 
inferior to 127144, which had been the best catalyst identified to date in the 
Armstrong group (Table 3.2). Being aware that oxabicyclo[3.2.1]octanones 
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consistently give higher ee than the tropinone analogues, improvements in terms of 
ee may be achieved by introducing the cyclic carbonate unit in the α-position of the 
oxabicyclic skeleton. 
 
Table 3.2: Epoxidation of E-stilbene catalysed by ketones 143 a,d, 125143 and 127144. 
Entry Catalyst Alkene % catalyst t (h) Conversion (%)b ee (%)
c
 
1 143 E-Stilbene 10 18 100 87 (R,R) 
2 125 E-Stilbene 20 3 100 86 (R,R) 
3 127 E-Stilbene 20 24 85 93 (R,R) 
a
 Reaction conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), NaHCO3 (1.55 mmol), 
CH3CN (1.5 ml), aq. Na2EDTA (1 ml of 0.4 mM solution). b Estimated from the 1H NMR spectrum of 
the crude reaction mixture. c Product ee determined by chiral HPLC analysis. d Work-up A, Chapter 7, 
Section 7.4. 
 
With these very promising results in hand, ketone ent-143 was tested on a range of 
olefins covering a variety of functionalities, including challenging terminal alkenes 
(Table 3.3). Trans- and trisubstituted aromatic olefins generally afforded good ee 
(Entries 1, 4 and 5, Table 3.3) while terminal alkenes (Entries 2 and 3, Table 3.3) 
gave lower enantioselectivities. However, although the value for styrene (46% ee, 
Entry 2, Table 3.3) was modest, it was encouraging when compared to previous 
results from catalysts of this type.145,148 E-Ethyl cinnamate, chosen as an example of 
an electron-poor substrate, reacted slowly in the presence of chiral dioxirane 
affording 55% conversion and 74% ee after 18 hours (Entry 6, Table 3.3). 
 
Table 3.3: Asymmetric epoxidation of various alkenes catalysed by ketone ent-143. 
a
 Reaction conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), ketone (10 mol%), NaHCO3 
(1.55 mmol), CH3CN (1.5 ml), aq. Na2EDTA (1 ml of 0.4 mM solution). b Reaction conditions: alkene 
(0.2 mmol), Oxone® (2.0 mmol KHSO5), ketone (10 mol%), NaHCO3 (3.01 mmol), CH3CN (3 ml), 
aq. Na2EDTA (2 ml of 0.4 mM solution). c Estimated from the 1H NMR spectrum of the crude 
reaction mixture. d Product ee and configuration determined by chiral HPLC analysis. e Work-up A, 
Chapter 7, Section 7.4. f Work-up B, Chapter 7, Section 7.4. 
Entry Catalyst Alkene t (h) 
Conversion 
(%)c 
Yield 
(%) 
ee 
(%)d 
Configurationd 
 
1 ent-143 E-Stilbenea,e 18 100 83 89 (S,S) 
2 ent-143 Styrenea,f 1 100 ND 46 (S) 
3 ent-143 α-Methyl styreneb,f 1 100 30 19 (S) 
4 ent-143 E-β-Methyl styrenea,f 1 100 25 63 (S,S) 
5 ent-143 Phenyl cyclohexenea,f 1 98 63 73 (S,S) 
6 ent-143 E-Ethyl cinnamatea,e 18 55 48 74 (2R,3S) 
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In general, for trans- substituted alkenes the configuration of the major enantiomer is 
assumed to fit with the simple spiro transition state model (TS A, Scheme 3.6). Thus 
the alkene approaches from the less hindered exo-face of the catalyst with the 
hydrogen substituent in the vicinity of the cyclic carbonate region. Therefore, trans- 
and trisubstituted olefins reach high enantioselectivity whilst terminal alkenes give 
lower ee as they can attack the dioxirane with two different spiro transition states (TS 
A and TS E, Scheme 3.7) leading to opposite enantiomers. For trans- substituted 
alkenes, the minor enantiomer could arise from the competing planar transition state 
(TS C, Scheme 3.6), or from attack of the olefin from the “achiral” endo-face (TS D, 
Scheme 3.6).  
 
Scheme 3.6 
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In contrast with many other catalysts in the bicyclo[3.2.1]octanone series,146 
epoxidation of α-methyl styrene with ent-143 delivered the (S) epoxide as the major 
enantiomer. The enantiomeric preference is not large (19% ee) but could be 
explained by invoking a spiro TS, where both the substituents are located away from 
the carbonate group (TS A, Scheme 3.7), or a planar transition state where the methyl 
group is in the proximity of the carbonate ring (TS C, Scheme 3.7). 
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Scheme 3.7 
 
The results obtained from these preliminary experiments suggest that the 
conformational constraint imposed by a cyclic carbonate could be beneficial for 
enantioselectivity of trans- disubstituted and terminal alkenes (styrenes) but that 
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much work still has to be done to improve the enantioselective epoxidation of 
disubstituted terminal olefins.  
With the aim of proving the positive effect on efficiency and enantioselectivity 
caused by the bridgehead heteroatom, the synthesis of oxa [3.2.1] bicyclic ketone 
analogue to 143 was later carried out by another member of the group.156  
In analogy with ketone 143, catalyst 144 was stable to the reaction conditions, since 
it was still seen to be present from the proton NMR spectrum of the crude mixture, 
and showed very high efficiency. As expected, replacement of the carbamate group 
with the oxygen bridgehead delivered a more enantioselective catalyst for trans- 
substituted olefins (E-stilbene, E-β-methyl styrene) and for phenyl cyclohexene but, 
unfortunately, no improvement was recorded for the most challenging substrates like 
styrene and α-methyl styrene (Table 3.4).156 
O
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Table 3.4: Asymmetric epoxidation of various alkenes catalysed by ketones 144156 and ent-143. 
Entry Alkene Catalyst eeobs (%)c eemax (%)
d Configuration d 
1 E-Stilbene 144 62 91 (R,R) 
2  ent-143a,e 89 N/A (S,S) 
3 Styrene 144 28 41 (R) 
4  ent-143a,f 46 N/A (S) 
5 α-Methyl styrene 144 1 <1 (R) 
6  ent-143b,f 19 N/A (S) 
7 E-β-Methyl styrene 144 48 71 (R,R) 
8 
 
ent-143a,f 63 N/A (S,S) 
9 Phenyl cyclohexene 144 55 81 (R,R) 
10  ent-143a,f 73 N/A (S,S) 
11 E-Ethyl cinnamate 144 46 68 (2S,3R) 
12  ent-143a,e 74 N/A (2R,3S) 
a
 Reaction conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), ketone (10 mol%), NaHCO3 
(1.55 mmol), CH3CN (1.5 ml), aq. Na2EDTA (1 ml of 0.4 mM solution). b Reaction conditions: alkene 
(0.2 mmol), Oxone® (2.0 mmol KHSO5), ketone (10 mol%), NaHCO3 (3.01 mmol), CH3CN (3 ml), 
aq. Na2EDTA (2 ml of 0.4 mM solution). c Product ee and configuration determined by chiral HPLC 
analysis. d %, eemax = eeobs x 100/68.  e Work-up A, Chapter 7, Section 7.4. f Work-up B, Chapter 7, 
Section 7.4. 
 Chapter 3 
 
 96
 
3.3  Preparation of novel N-carbethoxy [3.2.1] bicyclic ketones containing an 
α,α-fused oxazolidinone ring 
 
To further investigate the effect of a rigid, cyclic unit in the α position of the 
bicyclo[3.2.1]octanone system and the extent of the beneficial effect due to its 
dipolar interaction with the olefin, new analogues containing an α,α-fused unit were 
targeted. 
Shi and co-workers found that the replacement of the spiro ketal in the fructose 
derivative 57 with an oxazolidinone (catalyst 80) provided very good ee for 
epoxidation of styrenes (Figure 3.6).117 Preliminary studies based on transition state 
analysis and further supported by theoretical calculations suggest that the asymmetric 
induction seems to be due to an electronic interaction between the aromatic group of 
the olefin and the oxazolidinone of the catalyst.118,119 The same effect could be 
beneficial for inducing good enantioselectivity for terminal alkenes and styrenes in 
the tropinone series, so catalysts bearing similar functionalities were our next goals. 
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Figure 3.6: Enantioselective epoxidation catalysts from Shi’s group. 
 
 
 
3.3.1  First synthetic route to racemic N-substituted oxazolidinone catalysts 
 
The main objective of this work was to identify a versatile route leading to ketone 
146 (Scheme 3.8), where R could be an alkyl or an aryl group. The epoxide 145 was 
immediately recognised as a key intermediate. 
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Scheme 3.8 
 
 
Initial efforts focused on direct conversion of previously synthesised enone 136 into 
epoxide 145 (Scheme 3.9) which could then be opened with nitrogen nucleophiles. 
However, this transformation was not successful as mixtures of isomeric epoxides 
were obtained under several epoxidation conditions (Scheme 3.9).157,158 We therefore 
decided to synthesise the epoxide indirectly from diol 142 (Scheme 3.10), which 
could be accessed by dihydroxylation of 136, as previously shown. Selective 
activation of the primary alcohol was achieved by reaction with tosyl chloride. 
Having noticed slight instability of tosylate 147 on silica gel, rapid purification of the 
crude reaction followed by treatment with K2CO3 in EtOH afforded epoxide 145.159  
 
 
 
N
EtO2C
O
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EtO2C
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a) K2CO3, MeOH, H2O2, RT
                    or
b) NaOH, MeOH, H2O2, -20 oC
                    or
c) Triton B, THF,
    Cumylhydroperoxide, -20 oC
mixture of 
isomeric epoxides
 
 
Scheme 3.9 
 
 
Nucleophilic attack of sodium azide on epoxide 145 occurred at the less hindered 
position to give 148 which was then reduced by hydrogenation with Pd/C under 
acidic conditions (Scheme 3.10). The presence of acid was extremely important to 
avoid intermolecular condensation between the carbonyl group and the primary 
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amine. After filtration on Celite and evaporation of the volatiles, simple trituration 
of the residue from diethyl ether afforded 149 as a colourless solid. The 
aminoalcohol 149 was then cyclised with triphosgene in pyridine under standard 
conditions160 but the oxazolidinone moiety, unfortunately, was unstable on silica gel. 
In fact, during purification by flash chromatography (5% MeOH in DCM) many 
degradation products were seen on the TLC plate. 1H NMR analysis confirmed that 
decomposition was occurring.  
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Scheme 3.10: i) p-Toluensulfonyl chloride, Et3N, DMAP, DCM; ii) K2CO3, 69% over two steps; iii) 
NaN3, NH4Cl, acetone / H2O, 98%; iv) 10% Pd/C, H2, 0.1 N HCl, MeOH, quantitative yield; v) 
triphosgene, pyridine, DCM. 
 
 
 
As a consequence of the unexpected reactivity of 150 and of the difficulty in 
handling the intermediates of this synthetic route, an alternative and more versatile 
route was devised (Scheme 3.11). As in the previous synthesis, the new approach 
identified the α,β-unsaturated ketone 136 as starting material. Using Luche 
chemistry,161 the carbonyl group was selectively reduced in the presence of the 
conjugated carbon-carbon double bond with NaBH4 and CeCl3·7H2O.162 At this stage 
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it was not possible to assign the equatorial position of the hydroxyl group, with the 
presence of carbamate rotamers making the proton NMR signals extremely broad 
and difficult to interpret. Changing solvent did not help and only VT experiments 
gave sharper peaks. However, these experiments were still not conclusive. 
Epoxidation of allylic alcohol 151 with m-CPBA occurred in a completely 
stereoselective manner as 152 was obtained as a single stereoisomer. nOe 
experiments proved that the oxygen of the epoxide is pseudo-axial with one proton 
on the epoxide ring giving nOe enhancements with the hydroxyl group and with its 
geminal proton (Figure 3.7, a). (If the oxygen of the epoxide was equatorial, the CH2 
of the 3 membered ring would be in a trans di-axial relationship with the C-H(OH) 
and a nOe would not be seen). Chemically, this outcome is explained by considering 
the stabilisation due to hydrogen bonding between the acidic hydrogen of the alcohol 
and the peracid causing the approach of the oxidant to occur from the exo-face 
(Figure 3.7, b). nOe experiments also allowed stereochemical assignment of the 
equatorial hydroxyl group with both endo-protons of the bridge giving nOes with the 
CH geminal to the hydroxyl group (1,4 di-axial relationship) but not with the OH 
(Figure 3.7, a). 
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Figure 3.7: nOe experiments proving the stereoselectivity in the epoxidation reaction of 151. 
 
 
Epoxide 152 was then opened by nucleophilic addition of a primary amine 
(benzylamine) at the less hindered carbon (Scheme 3.11). The reaction was 
effectively carried out in a sealed tube with a 1:1 stoichiometry of reagents allowing 
purification by use of strong cation exchange resin cartridge. 
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Scheme 3.11: i) NaBH4, CeCl3·7H2O, MeOH, 0 ºC, 95%; ii) m-CPBA, DCM, 0 ºC, 70%; iii) 
benzylamine, EtOH, 80 ºC, quantitative yield. 
 
 
Once again, the regioselectivity of the reaction was confirmed by NMR experiments. 
The proton-carbon correlation over three bonds (HMBC) showed that in 153 
(R=benzyl), the benzylic protons give a cross peak with the CH2 carbon of the amino 
alcohol moiety (Figure 3.8, a). If nucleophilic attack had occurred at the more 
hindered position, the benzylic protons would correlate with the quaternary carbon, 
instead (Figure 3.8, b). 
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Figure 3.8: HMBC experiments proving the regioselectivity in the epoxide opening reaction. 
 
 
Moving toward the end of the sequence, the next step consisted of the cyclisation of 
the secondary amine and the tertiary alcohol with triphosgene,160 with the 
expectation that the 5-membered ring formation would be kinetically favoured over 
the 6-membered ring (Scheme 3.12). 13C NMR analysis showed, however, that 153 
cyclised into a “trans-decalin” structure 155 forming a 6-membered ring between the 
amine and the secondary alcohol. As further evidence, subsequent oxidation with 
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TPAP and NMO gave back unreacted starting material supporting the presence of a 
tertiary alcohol (Scheme 3.12). 
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Scheme 3.12: i) Triphosgene, pyridine, DCM; ii) triphosgene, pyridine, DCM, 60%; iii) TPAP, 
NMO, DCM. 
 
 
 
To circumvent this problem, we devised a new approach for conversion of 153 to 
156, performing the cyclisation/oxidation events in the reverse order. The main 
problem was identifying suitable reaction conditions for the chemoselective 
oxidation of an alcohol in the presence of an amine, avoiding the oxidation at the 
nitrogen. None of the traditional methods was successful: TPAP oxidation returned 
intact starting material, probably because of coordination of Ru to the amino alcohol 
whereas PCC oxidation in acidic conditions, Jones’ oxidation and Dess-Martin 
oxidation gave multiple, unidentified products. A very efficient and mild method to 
perform this particular transformation was eventually found to be the use of IBX 
under acidic conditions (TFA).163 In 153, protonation of the amino group made it 
unreactive toward electrophiles so that IBX could easily oxidise the alcohol to the 
ketone (Scheme 3.13). With 157 in hand, the final step was the previously described 
cyclisation of 157 with triphosgene in pyridine to afford (±)-156. 
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This versatile approach offered the great advantage of reacting the advanced 
intermediate epoxide 152 with different amines close to the end of the process and 
allowed ready access to a wide range of racemic alkyl and aryl substituted 
oxazolidinones (Scheme 3.13). The racemates were then separated into single 
enantiomers by SFC delivering enantiomerically pure catalysts.154 
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Scheme 3.13: i) IBX, TFA, DMSO; ii) triphosgene, pyridine, DCM.  
 
Attempts to use this route to prepare (±)-164 (R = Ph) failed at the IBX oxidation 
step (Scheme 3.14): after only few minutes at room temperature, the reaction mixture 
turned very dark and subsequent analysis indicated a complete degradation of the 
amino diol 162.162,164 As an alternative approach, the Swern oxidation successfully 
afforded 163 (Scheme 3.14) which was then cyclised with triphosgene in the usual 
manner to yield (±)-164. 
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Scheme 3.14: i) (COCl)2, DMSO, Et3N, DCM, 79%. 
153 R=CH2Ph 157 R=CH2Ph 63% (±)-156 R=CH2Ph 70% 
158 R=(S)-CHCH3Ph 159 R=(S)-CHCH3Ph 53%       160 R=(S)-CHCH3Ph 53% 
 
 
 
  
      161 R=(S)-CHCH3Ph 57% 
 
 163 R=Ph NAa (±)-164 R=Ph 66% 
165 R=C(CH3)3 166 R=C(CH3)3 88% (±)-167 R=C(CH3)3 38% 
168 R=CH(CH3)2 169 R=CH(CH3)2 60% (±)-170 R=CH(CH3)2 78% 
171 R=CH3 172 R=CH3 n.i.b (±)-173 R=CH3 34% 
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The developed route is a six step synthesis, from the commercially available N-
carbethoxytropinone, which offers the flexibility to synthesise novel analogues from 
the key intermediate 152 in only three steps by varying the primary amine. It 
successfully delivered a range of alkyl and aryl substituted oxazolidinones whose 
catalytic activity could then be tested toward a wide range of alkenes, after chiral 
separation.  
The route allows the synthesis of racemic ketones although non-racemic catalysts 
could be obtained by desymmetrisation of the starting tropinone using, for example, 
Simpkins’ chiral bases.165 
Although we now had a successful route to the desired ketone family, we decided to 
look at further refinements to the synthesis that would allow more rapid and efficient 
access to the most promising catalysts. 
 
 
3.3.2  Improvement in the synthetic route 
 
In order to investigate an even more reliable synthetic approach for this interesting 
class of ketones suitable for obtaining large amount of material, a new route was 
designed. In particular, the purpose was to overcome the IBX oxidation step which 
required freshly prepared reagent. The new route (Scheme 3.15) consisted of the 
opening of the epoxide 152 with methylamine and subsequent reaction of the 
secondary amine 171 with Boc anhydride. After transformation of the basic nitrogen 
into a carbamate group, it was possible to perform a Swern oxidation on 174 to 
deliver the corresponding ketone 175 in high yield. Removal of the Boc group with 
4.0 M HCl in dioxane followed by cyclisation of intermediate 176 with CDI, Et3N in 
THF166 afforded the racemic ketone whose analytical data fully corresponded to 
those obtained in the previously described methodology. 
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Scheme 3.15: i) NH2CH3, EtOH, 70 °C; ii) Boc2O, DCM, Et3N, 67% over 2 steps; iii) oxalyl chloride, 
DMSO, Et3N, 80%; iv) HCl 4.0 M in dioxane; v) Et3N, CDI, THF, 71% over two steps. 
 
 
 
The new synthetic route, despite addition of two extra steps, offered the big 
advantage of easily affording gram quantities of racemic material using 
commercially available reagents without the need for any special storage conditions. 
The additional steps did not require extra isolations and the new route gave highly 
reproducible results for ketone (±)-173, which was targeted for test reactions.  
 
 
 
3.3.3  Attempted chemical resolution and desymmetrisation 
 
In order to find an alternative to chiral chromatography to resolve the tropinone 
skeleton or a close intermediate, a few attempts were made to investigate new 
strategies. 
Initially, it was thought that a useful alternative might have come from reaction of a 
racemic substrate such as 151 or 152 with a chiral auxiliary to generate a mixture of 
two diastereoisomers, which would then be separated by column chromatography. 
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Subsequent cleavage of the chiral auxiliary would yield single enantiomers of the 
starting material. Three different commercially available enantiomerically pure acid 
chlorides / sulfonyl chlorides were chosen (Figure 3.9) and a small amount of each 
one was reacted with two different hydroxyl compounds, according to the reaction 
conditions reported in Schemes 3.16 and 3.17.  
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Figure 3.9: Commercially available chiral auxiliaries. 
 
In this preliminary work, the aim was to achieve TLC separation of the two 
diastereoisomers formed after treatment of the racemic starting material with the 
chiral auxiliary. Unfortunately, no separation was observed with 151 (Scheme 3.16) 
while 152 decomposed in several TLC spots after overnight stirring at room 
temperature (Scheme 3.17). 
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Scheme 3.16: i) Chiral auxiliary, DMAP (cat), pyridine, DCM. 
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Scheme 3.17: i) Chiral auxiliary, DMAP (cat), pyridine, DCM. 
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Alternatively, asymmetric aminomethylation reported by Córdova167 would offer a 
valuable method to achieve desymmetrisation of our starting N-carbethoxytropinone. 
Reaction between aqueous formaldehyde and 120 in a 1:1 ratio and aniline was 
carried out at room temperature (Scheme 3.18). After prolonged stirring, UPLC 
analysis of the crude reaction mixture showed only a minor peak with the desired 
mass while the major product corresponded to an adduct with higher molecular 
weight, whose structure has not been identified (probably a bis-adduct). 
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Scheme 3.18 
 
 
Unsatisfactory results were obtained for the L-proline catalysed aldol asymmetric 
condensation (Scheme 3.19). Literature procedures168 report the use of large excess 
of ketone compared to formaldehyde, which is not optimal for our conditions. Using 
a 2:1 ratio of 120 and aqueous formaldehyde mainly starting material was observed 
by UPLC analysis of the crude reaction mixture and, once again, a product with 
higher molecular weight, possibly a bis-adduct, was present. 
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Scheme 3.19 
 
 
Despite unsuccessful preliminary data, wider and deeper investigation into new 
chemical resolution and desymmetrisation methodologies is highly recommended to 
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have access to enantiomerically pure ketones without relying on chiral 
chromatography. 
 
 
3.4  Efficiency and enantioselectivity of N-substituted oxazolidinone catalysts in 
asymmetric epoxidation of alkenes 
 
The benzyl-substituted (±)-156 was the first catalyst used to test the idea that 
introduction of a bulky aromatic substituent on the oxazolidinone would allow us to 
investigate: a) any aromatic-aromatic interaction between that substituent and the 
olefin; b) the possibility of an electronic interaction between the oxazolidinone and 
the aromatic moiety of the olefin.  
N
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Figure 3.10: N-benzyl substituted ketone (±)-156. 
 
This hypothesis was initially suggested by Shi and co-workers to explain the 
extremely high ee obtained with catalyst 80 (Figure 3.6) towards cis- and terminal 
aryl alkenes.117,118 
With (±)-156 in hand, the first objective was to check its stability and its catalytic 
activity. Using the standard epoxidation conditions, E-stilbene was reacted with 
Oxone® at 10 mol% catalyst loading for 2 hours. By 1H NMR analysis, (±)-156 
appeared to be stable under the reaction conditions but, unfortunately, it showed a 
much lower turnover than (±)-143. In fact, conversion of starting material into 
racemic epoxide corresponded to just 45%. This may be due to the size of the 
substituent on the oxazolidinone and to its free rotation that makes substrate access to 
the catalytic site much more difficult. 
Despite the modest catalytic activity of the racemate, (±)-156 was separated into 
single enantiomers by SFC, and ent-156 (first eluting enantiomer from chiral 
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separation, > 99% enantiomeric purity) was used to screen the standard range of 
olefins in the epoxidation reactions (Table 3.5). Given the low reactivity, reaction 
times were prolonged to 15-24 hours and catalyst loading increased from 10% to 
20%. In the case of E-stilbene (Entries 1 and 2 Table 3.5), neither of these alterations 
to the reaction parameters gave a substantial increase in the conversion. As expected, 
no effect was noted on the ee which, in both cases, remained equal to 82%. Given the 
lack of any beneficial effect from the higher catalyst loading, we chose to carry out 
the remaining experiments using the original standard conditions. In general, ent-156 
showed lower turnover and slightly lower enantioselectivity compared to ent-143 
with the trisubstituted phenyl cyclohexene (51% vs 73% ee, Entry 6, Table 3.5) and 
the trans- substituted E-β-methyl styrene (45% vs 63% ee, Entry 5, Table 3.5). 
These initial results suggested the absence of any significant, advantageous 
interaction between the olefin and the oxazolidinone relative to the carbonate group 
in 143. Also the benzyl substituent did not seem to play any particular role in the 
enantioselectivity of the epoxidation process.  
N
CO2Et
O
N O
O
ent-156
 
Table 3.5: Asymmetric epoxidation of various alkenes catalysed by ketone ent-156. 
a
 Reaction conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), NaHCO3 (1.55 mmol), 
CH3CN (1.5 ml), aq. Na2EDTA (1 ml of 0.4 mM solution). Work-up A, Chapter 7, Section 7.4.  b 
Reaction conditions: alkene (0.2 mmol), Oxone® (2.0 mmol KHSO5), NaHCO3 (3.01 mmol), CH3CN 
(3 ml), aq. Na2EDTA (2 ml of 0.4 mM solution). Work-up A, Chapter 7, Section 7.4.  c Estimated from 
the 1H NMR spectrum of the crude reaction mixture. d Product ee and configuration determined by 
chiral HPLC analysis.  
 
Entry Catalyst Alkene % 
catalyst 
t 
(h) 
Conv.c 
(%) 
Yield 
(%) 
eed 
(%) 
Configu 
rationd 
1 ent-156 E-Stilbenea 10 24 37 17 82 (S,S) 
2 ent-156 E-Stilbenea 20 18 50 50 82 (S,S) 
3 ent-156 Styreneb 10 24 89 68 43 (S) 
4 ent-156 α-Methyl styreneb 10 18 81 49 6 (S) 
5 ent-156 E-β-Methyl styreneb 10 15 83 69 45 (S,S) 
6 ent-156 Phenyl cyclohexeneb 10 15 100 58 51 (S,S) 
7 ent-156 E-Ethyl cinnamatea 10 15 20 17 61  (2R,3S) 
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Driven by the idea of introducing more directionality in the steric interaction 
between the approaching olefin and the exo-face of the catalyst, one of the benzylic 
protons in (±)-156 was replaced with a methyl group. The targeted compounds (160 
and 161) were prepared by reacting epoxide 152 with (S)-(-)-α-methyl benzylamine.  
The introduction of a defined stereocentre offered two advantages: a) giving 
diastereoisomers as final compounds that could be separated by simple flash 
chromatography; b) allowing the determination of the absolute configuration of the 
molecule by correlation of the known stereocentre with the unknown ones in an X-
ray structure. 
One of the two diastereoisomers was crystallised from diethyl ether to give needles 
suitable for X-ray crystallographic analysis. As shown in Figure 3.11, the compound 
crystallised with two independent conformations in the asymmetric unit and clearly 
showed that the compound corresponded to 160. 
 
 
 
 
 
Figure 3.11: X-ray structures of 160 which crystallised with to independent conformations in the unit 
cell. 
 
 
In the solid state, ketone 160 reaches its minimum energy conformation with the 
benzylic proton eclipsing the carbonyl group of the oxazolidinone and the methyl 
group pointing toward the exo-face of the molecule. The phenyl group, instead, is 
placed far away from the catalytic site of the molecule. Being aware that the 
conformation of the molecule in solution might be different from the one in the solid 
state, we decided to check the catalytic activity of 160 and its enantioselectivity 
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toward asymmetric epoxidation of different alkenes in order to correlate the results 
with some structural features of the molecule. 
Table 3.6 shows the results of asymmetric epoxidation reactions using 160 and the 
standard series of olefins. Ketone 160, as expected, was stable under the reaction 
conditions and behaved in a similar manner to 156 in terms of turnover. In particular, 
conversions of E-stilbene (Entry 1, Table 3.6) and of E-ethyl cinnamate (Entry 6, 
Table 3.6) were modest (52% and 28% respectively). The low reactivity did not have 
a negative effect in terms of enantioselectivity with the ee measured for these two 
substrates, being comparable to ent-143’s (87% vs 89% and 73% vs 74%). The most 
positive result is related to the epoxidation of styrene (Entry 2, Table 3.6): 55% ee 
which translates into 10% ee increase compared to ent-143. Unfortunately, still no 
improvement was observed for the epoxidation of α-methyl styrene (Entry 3, Table 
3.6). 
Rationalising the results reported above, the presence of a bulky aromatic substituent 
on the oxazolidinone seems to play a negative role in terms of catalyst reactivity, 
decreasing the catalyst turnover compared to the carbonate series. A feasible 
explanation could be that the increased hindrance around the catalytic site makes the 
approach of the olefin more difficult and that the nitrogen is less electron-
withdrawing than the oxygen atom. No substantial influence on the enantioselectivity 
has been observed. Instead, the replacement of a hydrogen atom with a methyl group 
at the benzylic position slightly improves the enantioselectivity, in particular toward 
styrene. 
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Table 3.6: Asymmetric epoxidation of various alkenes catalysed by ketone 160. 
a
 Reaction conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), ketone (10 mol%), NaHCO3 
(1.55 mmol), CH3CN (1.5 ml), aq. Na2EDTA (1 ml of 0.4 mM solution). b Reaction conditions: alkene 
(0.2 mmol), Oxone® (2.0 mmol KHSO5), ketone (10 mol%), NaHCO3 (3.01 mmol), CH3CN (3 ml), 
aq. Na2EDTA (2 ml of 0.4 mmol dm-3 solution). c Estimated from the 1H NMR spectrum of the crude 
reaction mixture. d Product ee and configuration determined by chiral HPLC analysis. e Work-up A, 
Chapter 7, Section 7.4. . f Work-up B, Chapter 7, Section 7.4. 
 
 
 
In order to investigate further the effect of the substituents on the oxazolidinone, 
diastereoisomer 161 was screened at 10 mol% loading under the standard conditions 
with two key alkenes: E-stilbene and styrene (Table 3.7). Surprisingly, in both cases, 
the measured ee were much lower than for 160: 20% and 28% less, respectively. 
Also the conversion drastically decreased possibly as a consequence of the hindrance 
of the aromatic group which - if 161’s conformational preferences are similar to 
those of 160 - now may point more toward the catalytic site. 
N
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Table 3.7: Asymmetric epoxidation of E-stilbene and styrene catalysed by ketone 161. 
a
 Reaction conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), ketone (10 mol%), NaHCO3 
(1.55 mmol), CH3CN (1.5 ml), aq. Na2EDTA (1 ml of 0.4 mM solution). Work-up B, Chapter 7, 
Section 7.4. b Reaction conditions: alkene (0.2 mmol), Oxone® (2.0 mmol KHSO5), ketone (10 mol%), 
NaHCO3 (3.01 mmol), CH3CN (3 ml), aq. Na2EDTA (2 ml of 0.4 mM solution). Work-up B, Chapter 
7, Section 7.4. c Estimated from the 1H NMR spectrum of the crude reaction mixture. d Product ee and 
configuration determined by chiral HPLC analysis. 
Entry Catalyst Alkene t (h) Conversion
c
 
(%) 
Yield 
(%) 
ee 
(%)d 
Configu
rationd 
1 160 E-Stilbenea,f 12 52 50 87 (R,R) 
2 160 Styreneb,f 12 94 66 55 (R) 
3 160 α-Methyl styreneb,e 24 69 67 13 (R) 
4 160 E-β-Methyl styreneb,e 18 85 70 57 (R,R) 
5 160 Phenyl cyclohexeneb,e 18 100 69 64 (R,R) 
6 160 E-Ethyl cinnamatea,e 18 28 21 73 (2S,3R) 
Entry Catalyst Alkene t (h) Conversion
c
 
(%) 
Yield 
(%) 
eed 
(%) 
Configura
tiond 
1 161 E-Stilbenea 12 24 20 69 (S,S) 
2 161 Styreneb 12 63 40 27 (S) 
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We next sought to reduce the rotation of the N-substituent by the direct linkage of the 
aromatic ring to the oxazolidinone (Figure 3.12).  
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Figure 3.12: Ketone catalyst (±)-164. 
 
 
The removal of the free rotation would decrease the hindrance in proximity of the 
active site and maximize a potential pi-pi interaction between the alkene and the 
catalyst. This extremely important electronic interaction has been invoked by Shi for 
the directly analogous catalysts 88 and 90 (Figure 3.13). They behave particularly 
well toward the epoxidation of cis- and terminal olefins but no examples are reported 
for the epoxidation of trans- substituted alkenes with either 88 or 90.119 
 
O
O O
NO
O
O
X
88 X = Me
90 X = NO2
 
 
Figure 3.13: N-Aromatic substituted oxazolidinone catalysts from Shi’s group. 
 
 
Chiral ketones ent-164 (first eluting enantiomer from chiral separation, 99% ee) and 
164 (second eluting enantiomer from chiral separation, 97% ee) were reacted under 
the same reaction conditions used for previous catalysts (Table 3.8). Once again, the 
absolute configuration of 164 and ent-164 is not certain but assumed by correlation 
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with the absolute configuration of E-stilbene oxide obtained by epoxidation reaction 
occurring through a spiro transition state with similar [3.2.1] bicyclic ketones. 
As expected, removal of steric hindrance from the proximity of the active site 
improved catalyst turnover. In general, higher conversions and also higher ees were 
obtained compared to 160 (Table 3.8). Epoxidation of E-stilbene using opposite 
enantiomers (Entries 1 and 2, Table 3.8) demonstrated the good reproducibility of the 
reaction in terms of conversion and ee. The ee was very similar to the highest one 
obtained with 143. A very encouraging 59% ee (Entry 3, Table 3.8) was measured 
for styrene. A step forward was also made for epoxidation of E-ethyl cinnamate: 
40% conversion and 82% ee (Entry 7, Table 3.8). But unfortunately, still no 
improvement was registered for α-methyl styrene (Entry 4, Table 3.8).  
 
 
Table 3.8: Asymmetric epoxidation of various alkenes catalysed by ketones 164 and ent-164.  
Entry Catalyst Alkene t (h) 
Con 
versionc 
(%) 
Yield (%) ee (%)d 
Configura 
tiond 
1 164 E-Stilbenea,f 12 76 74 87 (R,R) 
2 ent-164 E-Stilbenea,f 12 69 68 88 (S,S) 
3 ent-164 Styreneb,e 24 93 29 59 (S) 
4 ent-164 α-Methyl styreneb,e 24 97 52 12 (S) 
5 ent-164 Ε−β-Methyl styreneb,e 18 96 90 64 (S,S) 
6 ent-164 Phenyl cyclohexeneb,e 18 100 86 58 (S,S) 
7 ent-164 E-Ethyl cinnamateb,e 18 40 35 82 (2R,3S) 
a
 Reaction conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), ketone (10 mol%), NaHCO3 
(1.55 mmol), CH3CN (1.5 ml), aq. Na2EDTA (1 ml of 0.4 mM solution). ). b Reaction conditions: 
alkene (0.2 mmol), Oxone® (2.0 mmol KHSO5), ketone (10 mol%), NaHCO3 (3.01 mmol), CH3CN (3 
ml), aq. Na2EDTA (2 ml of 0.4 mM solution). c Estimated from the 1H NMR spectrum of the crude 
reaction mixture. d Product ee and configuration determined by chiral HPLC analysis. e Work-up A, 
Chapter 7, Section 7.4. f Work-up B, Chapter 7, Section 7.4 
 
 
 
In order to check whether improvement in the ee might be due to an aromatic 
interaction between the catalyst and the olefin, the phenyl ring was replaced with a 
tbutyl group (catalyst (±)-167, Figure 3.14). A drop in enantioselectivity might be 
expected. 
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Figure 3.14: Ketone catalyst (±)-167. 
 
 
In epoxidation reactions with ent-167 (first eluting enantiomer from chiral 
separation, > 99% ee) the ee for E-stilbene (Entry 1, Table 3.9) and for styrene 
(Entry 2, Table 3.9) were similar to ent-156 while α-methyl styrene (Entry 3, Table 
3.9) gave only a disappointing 16% ee.  
In conclusion, an N-aromatic substituted oxazolidinone is not crucial for improving 
enantioselectivity in epoxidation of trans- substituted and terminal alkenes. 
Particular attention has to be paid to the choice of the substituent, in order to avoid 
excess hindrance around the catalytic site. 
N
CO2Et
O
N O
O
ent-167
 
 
Table 3.9: Asymmetric epoxidation of various alkenes catalysed by ketone ent-167. 
a
 Reaction conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), ketone (10 mol%), NaHCO3 
(1.55 mmol), CH3CN (1.5 ml), aq. Na2EDTA (1 ml of 0.4 mM solution). Work-up A, Chapter 7, 
Section 7.4. b Reaction conditions: alkene (0.2 mmol), Oxone® (2.0 mmol KHSO5), ketone (10 mol%), 
NaHCO3 (3.01 mmol), CH3CN (3 ml), aq. Na2EDTA (2 ml of 0.4 mM solution). Work-up A, Chapter 
7, Section 7.4.  c Estimated from the 1H NMR spectrum of the crude reaction mixture. d Product ee and 
configuration determined by chiral HPLC analysis. 
 
 
Entry Catalyst Alkene t (h) Conversion
c
 
(%) 
Yield 
(%) ee (%)
d
 
Configu
rationd 
1 ent-167 E-Stilbenea 18 41 41 79 (S,S) 
2 ent-167 Styreneb 18 >30 8 43 (S) 
3 ent-167 α-Methyl styreneb 18 55 45 16 (S) 
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Of note from Table 3.9 is the extremely low conversion for all the series of alkenes.  
Aiming to gain back high catalytic turnover, the tbutyl group was replaced with the 
smaller iso-propyl substituent to give (±)-170. As expected, all epoxidation reactions 
carried out with 170 (first eluting enantiomer from chiral separation, > 99% 
enantiomeric purity) were quicker and went almost to completion in 18 h. No major 
differences in the ee were noted compared to previous catalysts, suggesting that no 
significant pi-pi interaction between the aromatic group of the olefin and the catalyst 
is occurring. Good enantioselectivity was observed for trans- substituted olefins 
(Entries 1, 4 and 5, Table 3.10), modest for styrene (Entry 2, Table 3.10) and very 
poor for disubstituted terminal alkenes (Entry 3, Table 3.10). 
 
N
EtO2C
O
NO
O
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Table 3.10: Asymmetric epoxidation of various alkenes catalysed by ketone 170. 
a
 Reaction conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), ketone (10 mol%), NaHCO3 
(1.55 mmol), CH3CN (1.5 ml), aq. Na2EDTA (1 ml of 0.4 mM solution). Work-up B, Chapter 7, 
Section 7.4. b Reaction conditions: alkene (0.2 mmol), Oxone® (2.0 mmol KHSO5), ketone (10 
mol%), NaHCO3 (3.01 mmol), CH3CN (3 ml), aq. Na2EDTA (2 ml of 0.4 mM solution). Work-up B, 
Chapter 7, Section 7.4. c Estimated from the 1H NMR spectrum of the crude reaction mixture. d 
Product ee and configuration determined by chiral HPLC analysis.  
 
 
Figure 3.15 shows the X-ray structure of (±)-170. In the solid state, the proton of the 
iso-propyl group is seen to be eclipsing the carbonyl of the oxazolidinone leading to 
a less hindered catalytic site than (±)-167. This reduced hindrance around the active 
site may allow the higher turnover noted in epoxidation reactions.  
Entry Catalyste Alkene t(h) Conversionc Yield ee 
(%)d 
Configu 
rationd 
1 170 E-Stilbenea 18 90 90 87 (R,R) 
2 170 Styreneb 18 88 35 54 (R) 
3 170 α-Methyl styreneb 18 100 27 15 (R) 
4 170 E−β-Methyl styreneb 18 95 53 62 (R,R) 
5 170 Phenyl cyclohexeneb 1 95 54 71 (R,R) 
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Figure 3.15: X-ray structure of (±)-170. 
 
Further decreasing the size of the substituent on the oxazolidinone would therefore 
be expected to lead to even higher reactivity. This hypothesis was tested reacting 173 
(first eluting enantiomer from chiral separation, > 99% ee, Figure 3.16) with the 
standard series of alkenes. 
 
N
EtO2C
O
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Figure 3.16: Ketone catalyst 173. 
 
 
 
173 performed extremely well with most of the substrates (Table 3.11). In particular, 
E-stilbene (Entry 1, Table 3.11) was epoxidised with 91.5% enantiomeric excess. 
The opposite enantiomer ent-173 (second eluting enantiomer from chiral separation, 
> 99% ee) reacted with E-stilbene giving highly reproducible results in terms of ee 
and conversion (Entry 2, Table 3.11). Electron-poor olefins such as E-ethyl 
cinnamate (Entry 7, Table 3.11) showed good ee, despite the low conversion. Other 
trans- substituted (Entry 5, Table 3.11) and trisubstituted (Entry 6, Table 3.11) 
alkenes afforded high ee. Modest results for styrene (Entry 2, Table 3.11) and still 
poorer performance towards α-methyl styrene were however obtained. 
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Table 3.11: Asymmetric epoxidation of various alkenes catalysed by ketones 173 and ent-173. 
Entry Catalyst Alkene t 
(h) 
Conversionc 
(%) 
Yield 
(%) 
ee 
(%)d 
Configura 
tiond 
1 ent-173 E-Stilbenea,f 12 86.5 85 91.5 (S,S) 
2 173 E-Stilbenea,f 12 87 85 91.5 (R,R) 
3 173 Styreneb,f 12 100 79 58 (R) 
4 173 α-Methyl styreneb,e 12 100 90 17 (R) 
5 173 E-β-Methyl styreneb,e 18 100 71 73.5 (R,R) 
6 173 Phenyl cyclohexeneb,e 18 100 65 74 (R,R) 
7 173 E-Ethyl cinnamateb,e 18 44 41 80 (2S,3R) 
a
 Reaction conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), ketone (10 mol%), NaHCO3 
(1.55 mmol), CH3CN (1.5 ml), aq. Na2EDTA (1 ml of 0.4 mM solution). b Reaction conditions: alkene 
(0.2 mmol), Oxone® (2.0 mmol KHSO5), ketone (10 mol%), NaHCO3 (3.01 mmol), CH3CN (3 ml), 
aq. Na2EDTA (2 ml of 0.4 mM solution). c Estimated from the 1H NMR spectrum of the crude 
reaction mixture. d Product ee and configuration determined by chiral HPLC analysis. e Work-up A, 
Chapter 7, Section 7.4. f Work-up B, Chapter 7, Section 7.4.  
 
 
173 is the most active and enantioselective ketone in the oxazolidinone substituted 
series. The small methyl group appears to reach the right compromise between high 
turnover and high enantioselectivity. The ee compares well with the ones obtained 
with 127, the axially monosubstituted acetoxy oxabicycle. Prior to this work, 127 had 
been the best catalyst in the bicyclic [3.2.1] octanone series (Table 3.12). Very high 
enantioselectivity has been achieved for trans- substituted alkenes and a slight 
improvement has been obtained for both monosubstituted and disubstituted terminal 
alkenes.  
 
Table 3.12: Asymmetric epoxidation of various alkenes catalysed by ketones 173 and 127144. 
 
Alkene Catalyst (10%) ee (%) 
Catalyst 
(20%) eemax(%)
c 
E-Stilbene 173a,e 91.5 (R,R) 127a 93 (R,R) 
Styrene 173b,e 58 (R) 127a 48 (R) 
α-Methyl styrene 173b,d 17 (R) 127a 10(S) 
Ε−β-Methyl styrene 173b,d 73.5 (R,R) 127a 70 (R,R) 
Phenyl cyclohexene 173b,d 74 (R,R) 127a 82 (R,R) 
a
 Reaction conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), NaHCO3 (1.55 mmol), 
CH3CN (1.5 ml), aq. Na2EDTA (1 ml of 0.4 mM solution). b Reaction conditions: alkene (0.2 mmol), 
Oxone® (2.0 mmol KHSO5), NaHCO3 (3.01 mmol), CH3CN (3 ml), aq. Na2EDTA (2 ml of 0.4 mM 
solution. c eemax= 100 x product ee/ketone ee. d Work-up A, Chapter 7, Section 7.4. e Work-up B, 
Chapter 7, Section 7.4.  
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3.5  Investigation of the effect of the spiro unit in N-carbethoxy bicyclic ketones 
on asymmetric epoxidation reactions 
 
To further investigate the nature of the possible interaction between the aromatic ring 
of the olefin and the α-substituent of the catalyst, it was thought that the geometry 
and the dipolar properties of the catalyst could be modified by replacing the carbonyl 
group with a sulfate or a sulfamidate motif (Figure 3.17). If the enantioselectivity is 
driven by such dipole-dipole and / or dispersion interactions, a change in the overall 
dipole might translate into a weaker interaction between a sulfate / sulfamidate group 
and the aromatic ring of the substrate and then into lower enantio-discrimination. 
Alternatively, a stronger interaction would be advantageous in order to get better 
discrimination between aromatic and aliphatic substituents in epoxidation substrates. 
 
N
EtO2C
O
X
SO
O
O X = O,       
X = NCH3
 
 
Figure 3.17: Examples of ketones bearing a sulfate and sulfamidate motif. 
 
Following our standard strategy, modifications to the bicyclic system were 
performed on racemic starting materials to access both enantiomers of the final 
product after chiral chromatographic separation.169 
 
 
 
3.5.1  Attempted synthesis of a cyclic sulfate unit 
 
Replacement of the oxazolidinone carbonyl group with a sulfate moiety was initially 
performed on racemic diol 142 which was cyclised with thionyl chloride in DCM 
and pyridine,170 according to Scheme 3.20. A mixture of diastereomeric cyclic 
sulfites was obtained and further oxidised with RuCl3·hydrate and NaIO4,171 as 
proved by proton NMR and mass spectrometry analysis (m/z 306) (Scheme 3.20). 
The product (±)-185 was highly unstable and rapidly decomposed. The outcome was 
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not completely unexpected as cyclic sulfates are very good leaving groups which can 
be easily attacked by nucleophiles. Nucleophilic attack at carbon of the sulfate 
moiety in (±)-185 might then have caused the opening of the spiro ring followed by 
possible degradation of the bicyclic scaffold. 
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Scheme 3.20: i) SOCl2, pyridine, DCM, 79%; ii) RuCl3xH2O, NaIO4, CH3CN, H2O. 
 
 
 
 
3.5.2  Synthesis and assessment of the catalytic activity of the cyclic sulfamidate N-
carbethoxy bicyclic ketone  
 
Since cyclic sulfamidates are generally more stable than cyclic sulfates, the 
chemistry previously described was repeated starting from the racemic amino alcohol 
172, whose synthesis was described earlier (vide supra). Cyclisation of the amino 
alcohol with thionyl chloride afforded a mixture of diastereoisomers that was easily 
oxidised with RuCl3·hydrate and NaIO4.172 The desired compound (±)-187 was 
delivered in a moderate yield, 55% (Scheme 3.21).  
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Scheme 3.21: i) SOCl2, pyridine, DCM, 54%; ii) RuCl3xH2O, NaIO4, CH3CN, H2O, 55%. 
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With racemic ketone (±)-187 in hand, its catalytic activity was tested in the 
epoxidation of E-stilbene under the standard homogeneous Yang conditions. 
After 18 h and 10 mol% catalyst loading, only 57% conversion was observed by 
analysis of the proton NMR spectrum of the crude reaction mixture, with no 
evidence of catalyst in the NMR spectrum or in the aqueous phase after aqueous 
work-up. 
Despite a lower efficiency compared to (±)-173 (which afforded 87% conversion for 
E-stilbene after 12 h at 10 mol% catalytic loading), it was still interesting to examine 
the effect on the enantioselectivity in epoxidation reactions caused by replacing the 
oxazolidinone carboxyl group with a bulkier and more electron-withdrawing 
sulfamidate, since this represents a completely novel modification. First attempts of 
separating racemic (±)-187 into single enantiomers were performed by SFC using 
Chiralpak AD-H as column and ethanol with 0.1% of a solution of 10% 
isopropylamine in ethanol as modifier at 35 °C and 100 bar. Unfortunately, the 
conditions used and, possibly, the presence of the primary amine in the mobile phase 
caused decomposition of the catalyst. Slightly modified separation conditions (chiral 
chromatography performed with n-hexane/iso-propanol as mobile phase without any 
basic amine) gave clean separation of the racemic mixture into single enantiomers. 
Both enantiomers were obtained with very high enantiomeric purity, > 99% ee. Each 
enantiomer (ent-187 being the first eluting enantiomer from chiral separation and 
187 being the second eluting enantiomer from chiral separation) was tested in the 
epoxidation of E-stilbene. Surprisingly, high conversion was observed (95%) after 
only 8 h in both cases with only 10 mol% catalyst loading (Entries 1 and 2, Table 
3.13). The increased efficiency of single enantiomers, compared to the racemate, 
may possibly be explained by a slightly different level of purity of the batches used. 
As expected, opposite enantioselectivities were achieved. 187 and ent-187 were 
found to be highly efficient and also enantioselective catalysts for the epoxidation of 
E-stilbene, affording an enantiomeric excess close to 90%. As observed for the 
racemic catalyst, no trace of the starting ketone was observed in the proton NMR 
spectrum of the crude reaction mixture but no specific decomposition products could 
be identified. The high conversion and enantiomeric data recorded suggest that the 
catalyst degradation must occur at a slower rate than the desired epoxidation process. 
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Table 3.13: Epoxidation of E-stilbene catalysed by ketones 187a, ent-187a and 173a. 
Entry Catalyst Alkene t (h) Conversion (%)b ee (%)c Configurationc 
1 187 E-Stilbene 8 95 87 (R,R) 
2 ent-187 E-Stilbene 8 95 89 (S,S) 
3 173 E-Stilbene 12 87 91.5 (R,R) 
 a
 Reaction conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), ketone (10 mol%), NaHCO3 
(1.55 mmol), CH3CN (1.5 ml), aq. Na2EDTA (1 ml of 0.4 mM solution). Work-up B, Chapter 7, 
Section 7.4. b Estimated from the 1H NMR spectrum of the crude reaction mixture. c Product ee 
determined by chiral HPLC analysis. 
 
 
Unfortunately, while the results with sulfamidate 187 were good, they were not 
substantially different from those with 173.  
In order to further investigate whether the sulfamidate group had a significant 
positive or negative effect in influencing the enantioselectivity under the monophasic 
epoxidation Yang conditions, olefins bearing both an aromatic and an alkyl group 
were analysed. In particular, α-methyl styrene, E-β-methyl styrene and styrene were 
selected. High conversions ranging from 70 to 90% were observed at 10 mol% 
catalyst loading within 8 hours (Table 3.14). Consistently slightly lower 
enantioselectivities compared to 173 were noticed for all kind of alkenes: terminal 
alkenes (Entries 1 and 2, Table 3.14, 30 and 31% vs 58% ee for 173; and Entry 3, 
Table 3.14, 13% vs 17% ee) and trans- substituted alkenes (Entry 4, Table 3.14, 66% 
vs 73.5% ee). 
 
 
Table 3.14: Asymmetric epoxidation of various alkenes catalysed by ketones 187a and ent-187a. 
Entry Catalyst Alkene t (h) Conversion (%)b 
ee 
(%)c Configuration
c 
1 ent-187 Styrene 8 95 30  (S) 
2 187 Styrene 8 71 31  (R) 
3 187 α-Methyl styrene 8 71 13  (R) 
4 ent-187 E-β-Methyl styrene 8 97 66  (S,S) 
a
 Reaction conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), ketone (10 mol%), NaHCO3 
(1.55 mmol), CH3CN (1.5 ml), aq. Na2EDTA (1 ml of 0.4 mM solution). Work-up B, Chapter 7, 
Section 7.4. b Estimated from the 1H NMR spectrum of the crude reaction mixture.c Product ee and 
configuration determined by chiral HPLC analysis. 
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The last two olefins to be analysed with 187 and ent-187 under the standard 
epoxidation conditions were the trisubstituted phenyl cyclohexene and the electron-
poor olefin E-ethyl cinnamate. They afforded very similar results to those obtained 
with 173 at 10 mol% catalyst loading. Reasonably high enantioselectivity was 
confirmed for E-ethyl cinnamate (81% ee vs 80% for 173) despite the extremely low 
conversion, 17% by analysis of the proton NMR of the crude reaction mixture. 
 
Table 3.15: Asymmetric epoxidation of various alkenes catalysed by ketones 187a and ent-187a. 
Entry Catalyst Alkene t (h) Conversion (%)b 
ee 
(%)c Configuration
c 
1 187 Phenyl cyclohexene 8 65 69  (R,R) 
2 ent-187 E-Ethyl cinnamate 18 17 81  (2R, 3S) 
a
 Reaction conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), ketone (10 mol%), NaHCO3 
(1.55 mmol), CH3CN (1.5 ml), aq. Na2EDTA (1 ml of 0.4 mM solution). Work-up B, Chapter 7, 
Section 7.4. b Estimated from the 1H NMR spectrum of the crude reaction mixture. c Product ee and 
configuration determined by chiral HPLC analysis. 
 
 
 
The results thus obtained show that the replacement of the carbonyl group in 173 
with a sulfonyl group does not dramatically improve nor diminish the 
enantioselectivity towards epoxidation of either trans- substituted or terminal 
alkenes, despite the change in the overall dipole moment of the molecule and in the 
increased steric hindrance at the sulfamidate moiety. Still very low enantio-
discrimination is recorded for the challenging terminal alkenes indicating that several 
competing TS structures are close in energy.  
 
 
3.5.3  Preparation and assessment of the catalytic activity of the spiro lactone N-
carbethoxy bicyclic ketone 
 
Given that a spiro group in the α position to the carbonyl may be beneficial for 
inducing enantioselectivity, it was considered interesting to replace the lone pair on 
the nitrogen of the oxazolidinone and / or of the oxygen of the carbonate rings with a 
tetrahedral carbon atom (Scheme 3.22). The structural change would allow more 
control over the directionality of the steric interaction between the approaching olefin 
and the exo-face of the catalyst. The introduction of a spiro lactone motif α to the 
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carbonyl group would then help to better understand whether that specific portion of 
the molecule is important for inducing enantioselectivity and if steric factors in that 
region of space are crucial for enantio-recognition. 
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Scheme 3.22 
 
 
Once again, the target ketones were to be prepared in racemic form while single 
enantiomers were obtained by chiral chromatographic separation.169 
A summary of the anticipated route to this class of ketones is shown below (Scheme 
3.23). It was envisaged that epoxide opening would be achieved from 152 by 
reaction with diethyl malonate and NaOEt in ethanol. Once the opening of the 
epoxide and intramolecular cyclisation steps had occurred, heating in the presence of 
NaCl should lead decarboxylation of the di-carbonyl intermediate. Finally, oxidation 
of the secondary alcohol 189 would deliver the target ketone. 
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Scheme 3.23 
 
 
Initial attempts focused on reactions with the unprotected epoxy alcohol 152, as this 
type of reaction is precedented in the literature173 and would provide the shortest 
route. As shown in Scheme 3.24, when treating diethyl malonate with NaOEt in 
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EtOH and then adding the substrate 152,174,175 complete consumption of the starting 
material was observed but a mixture of products formed. Chromatographic 
purification was attempted but none of them could be isolated in adequate purity to 
be fully characterised. Mass spectrometric analysis showed a significant peak at m/z 
= 342, which could correspond to the desired product 188, but also additional peaks 
at m/z = 270 and at m/z = 274. Separate sets of impure fractions were independently 
reacted in the subsequent decarboxylation step in the presence of NaCl, DMSO and 
H2O. At this stage separation of each of the products was achieved.  
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Scheme 3.24: i) NaOEt, EtOH, diethyl malonate, RT→80 ºC; ii) NaCl, DMSO, H2O, 150 °C. 
 
 
The undesired compound with m/z = 274 was isolated in 10% yield (over 2 steps) 
and identified as 191. This result suggested incomplete deprotonation of diethyl 
malonate from NaOEt and that the nucleophilic base was prone to react to some 
extent with epoxide 152. Peak at m/z = 342 converted into a peak at m/z = 270 during 
the decarboxylation step, as proved by disappearance of the molecular ion of the 
parent ketone and by the increased intensity of the UV trace corresponding to peak at 
m/z = 270 from the HPLC analysis. This mass would correspond to possible products 
189 and 192, and, at this stage, it was not possible to assess the correct structure. 
Once the opening of the epoxide had occurred two possible products might have 
formed. Cyclisation, in fact, might occur on the tertiary hydroxyl group delivering 
the five membered ring lactone 189 or on the secondary alcohol leading to a “trans 
decalin” system 192 (Figure 3.18).  
Only the subsequent oxidation step confirmed the correct structure of the product 
189 (Scheme 3.28, vide infra).  
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Figure 3.18: Two possible products from cyclisation of diethyl malonate. 
 
 
The overall poor yield (13% for 189) and the presence of the identified by-product 
prompted us to examine the epoxide opening on a substrate in which the hydroxyl 
had been protected, so as to ensure that the subsequent cyclisation could occur only 
on the tertiary alcohol. This required a protecting group that was stable under basic 
conditions and also to forced and prolonged heating. The first choice was the PMB 
group. 
Epoxide 152 was reacted with NaH at 0 oC to allow deprotonation of the hydroxyl 
group to occur, and then PMBCl was added. Unfortunately only a low conversion of 
the starting material to product was observed and just 6% yield of the desired 
material 193 was isolated (Scheme 3.25). 
N
EtO2C
OH
O
152
N
EtO2C
O
O
193
O
i
 
 
Scheme 3.25: i) NaH, PMBCl, THF, 0 ºC →RT, 6%. 
 
 
 
After further failed attempts to introduce either a TBDMS or a MOM group, the 
TMS protecting group was selected. Treatment of epoxy-alcohol 152 with Et3N and 
TMSOTf at low temperature delivered 194 in quantitative yield which could be 
isolated and characterised after column chromatography on silica gel or, more 
conveniently, used in the following step as crude material (Scheme 3.26). 
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Scheme 3.26: i) Et3N, TMSOTf, DCM, -78 ºC→-30 ºC, quantitative. 
 
 
 
The synthetic route for obtaining 189 was further improved by carrying out 
deprotonation of diethyl malonate with a non-nucleophilic base such as NaH in THF 
at 0 °C before addition of the epoxide 152. The mixture was warmed slowly to room 
temperature before heating to reflux temperature to allow the cyclisation reaction to 
occur. UPLC analysis showed that the TMS group was partially unstable to the 
prolonged heating and a mixture of 188 and 195 was obtained as crude material. 
When this was submitted to column chromatography, only 188 was recovered as a 
consequence of the lability of the TMS group to the acidity of the silica. The isolated 
product consisted of a 2:1 mixture of diastereoisomers at the chiral centre α to the 
lactone carboxyl group. In order to reduce the number of isolations, the crude 
mixture of 188 and 195 was taken directly through the decarboxylation reaction 
which was performed according to the Krapcho methodology176 (Scheme 3.27). 
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Scheme 3.27: i) NaH, diethyl malonate, THF; ii) NaCl, DMSO, H2O, 150 °C, 35% over two steps. 
 
 
Finally the secondary alcohol 189 was oxidised to the ketone, with the most 
reproducible results being obtained with TPAP and NMO in DCM (Scheme 3.28). 
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Scheme 3.28: i) TPAP, NMO, DCM, 55%. 
 
 
 
According to the synthetic route just described, ketone (±)-190 was easily obtained in 
only four steps and two isolations starting from epoxide 152 with an overall yield of 
19%.  
With racemic (±)-190 in hand, its efficiency was initially checked towards 
epoxidation of E-stilbene. Very high conversion (80%) was observed after 8 h and 
10% catalyst loading. Trace amounts of catalyst (±)-190 were observed in the NMR 
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spectrum of the crude reaction mixture but it was not recovered, given the small 
amount used in the reaction. 
N
EtO2C
O
O
O(±)-190
 
Figure 3.19: Ketone catalyst (±)-190. 
 
As a consequence of this positive result, the racemic mixture was submitted to chiral 
HPLC separation and single enantiomers were obtained in very high enantiomeric 
purity (> 99% ee). 
Since the test reaction with (±)-190 was incomplete after 8 hours, it was decided to 
extend the reaction time to 24 hours when using single enantiomers ent-190 (first 
eluting enantiomer from chiral separation) and 190 (second eluting enantiomer from 
chiral separation). Once again, enantiomers 190 and ent-190 led to epoxides with 
opposite configuration. 190 delivered the (R,R) enantiomer with 90% ee (Entry 1, 
Table 3.16) while ent-190  gave the (S,S) enantiomer with 89.5% ee (Entry 2, Table 
3.16). Again, these were remarkably similar to those obtained with the oxazolidinone 
173.  
From the results thus obtained, it is clear that, despite steric and electronic changes to 
one of the portions of the molecule closest to the catalytic site, little effect on 
enantioselectivity has been recorded compared to the N-methyl oxazolidinone 173 or 
the sulfamidate ent-187 (Entries 3 and 4, Table 3.16). 
 
 
Table 3.16: Asymmetric epoxidation of E-stilbene catalysed by ketones 190a, ent-190a, 173a and ent-
187a. 
Entry Catalyst Alkene t (h) Conversion (%)b ee (%)c Configurationc 
1 190 E-Stilbene 24 95 90  (R,R) 
2 ent-190 E-Stilbene 24 100 89.5  (S,S) 
3 173 E-Stilbene 12 87 91.5  (R,R) 
4 ent-187 E-Stilbene 8 95 89  (S,S) 
a
 Reaction conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), ketone (10 mol%), NaHCO3 
(1.55 mmol), CH3CN (1.5 ml), aq. Na2EDTA (1 ml of 0.4 mM solution). Work-up B, Chapter 7, 
Section 7.4. b Estimated from the 1H NMR spectrum of the crude reaction mixture. c Product ee and 
configuration determined by chiral HPLC analysis. 
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Moving from trans- substituted to terminal alkenes, e. g. styrene and α-methyl 
styrene, only minor changes were observed in enantioselectivity compared to the 
other two α,α-disubstituted ketones 173 and ent-187. Only moderate enantiomeric 
excess was obtained for styrene, 50% ee (Entry 1, Table 3.17), and low enantio-
discrimination for α-methyl styrene, 13% ee (Entry 2, Table 3.17). Epoxidation of 
other trans- substituted olefins such as E-β-methyl styrene or the electron-deficient 
E-ethyl cinnamate confirmed the previous analysis (Entries 3 and 4, Table 3.17). The 
only exception is represented by the trisubstituted phenyl cyclohexene which 
afforded a significantly lower enantiomeric excess with respect to 173 and 187 
(Entry 5, Table 3.17, 45% ee vs 74% ee and 69% ee, respectively).  
 
 
Table 3.17: Asymmetric epoxidation of various alkenes catalysed by ketones 190 a and ent-190 a.  
Entry Catalyst Alkene t (h) Conversion (%)c ee (%)
d Configurationd 
1 ent-190 Styrene 18 100 50  (S) 
2 190 α-Methyl styrene 8 81 13  (R) 
3 ent-190 E-β-Methyl styrene 8 100 67  (S,S) 
4 ent-190 E-Ethyl cinnamate 18 23 78  (2R,3S) 
5 190 Phenyl cyclohexene 8 88 45  (R,R) 
a
 Reaction conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), ketone (10 mol%), NaHCO3 
(1.55 mmol), CH3CN (1.5 ml), aq. Na2EDTA (1 ml of 0.4 mM solution). Work-up B, Chapter 7, 
Section 7.4. b Estimated from the 1H NMR spectrum of the crude reaction mixture. c Product ee and 
configuration determined by chiral HPLC analysis. 
 
In contrast with Shi oxazolidinone catalyst 80 (Figure 3.20), the phenyl cyclohexene 
epoxide absolute configuration obtained with 190 is consistent with a favoured spiro 
transition state. The lower ee might come from a competing planar transition state 
which has been shown to become predominant for analogous ketones, reversing 
completely the enantioselectivity. 
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Figure 3.20: Enantioselectivities obtained in epoxidation reaction of phenyl cyclohexene with ketones 
57, 80, 101 and 102. 
 
From analysis of the results just reported, it is possible to conclude that none of the 
changes made to the spiro ring in the N-carbethoxytropinone series have significantly 
improved or impaired enantioselectivity of epoxidation of either trans- or terminal 
alkenes. The steric and electronic modifications, the overall dipole moment of the 
molecule and the increased steric hindrance at the catalytic site might have not been 
significant enough to exert an altered preference for a specific mode of reaction of 
the dioxirane with the approaching olefin (Figure 3.21). This suggests that no major 
change in the interaction with the spiro unit is occurring in the TS leading to the 
predominant enantiomer during epoxidation reaction. 
 
 
 
 
Figure 3.21: Ketones (±)-173, (±)-187 , (±)-190 in their minimum energetic calculated with Chem 3D 
pro MM2 minimisation. 
 
 
These results suggested also that considerably different modifications to the N-
carbethoxytropinone scaffold would be required to obtain significant improvements 
in epoxidation of the challenging terminal alkenes and such new catalyst motifs were 
therefore targeted in the next phase of the study.  
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α,α’-Disubstituted Ketones 
 
 
4.1  Previous work in the group 
 
With the idea of extensively investigating novel substitution patterns on the 
azabicyclo[3.2.1]octan-3-one framework, α,α’-disubstituted ketones were targeted.  
Work by previous members of the group had mainly focused on the synthesis and 
evaluation of trans-α,α’-disubstituted ketones (Figure 4.1).147 The introduction of an 
extra pseudo-equatorial group to the axially monosubstituted chiral ketones was 
intended to reduce the possibility of an olefin approaching from the achiral endo-face 
and thus increasing the enantioselectivity. Since the system achieves a “pseudo C2” 
symmetry, both axial and equatorial oxygen transfer in the dioxirane would be 
expected to lead to the same major epoxide enantiomer. 
 
N
EtO2C
Y
O
Z
 
Figure 4.1: Example of trans-α-α’-disubstituted ketone. 
 
Unfortunately, these expectations were not met as lower enantioselectivity compared 
to axially monosubstituted ketone was obtained for epoxidation of E-stilbene (Table 
4.1). A possible explanation comes from computational studies83 which suggest that 
the presence of the equatorial acetoxy group in 130 makes the transition state highly 
asynchronous, with the developing C-O bond closer to the equatorial substituent 
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much shorter than the other. The other end of the olefin is then pulled away from the 
stereocontrolling axial substituent thus decreasing its effect on enantioselectivity.148 
 
Y
O
F
X
      124    X = H,        Y = NCO2Et  
      130    X = OAc,    Y = NCO2Et
Y
O
XF
ent-196   X = OAc     Y = O
 
 
Table 4.1: Epoxidation of E-stilbene with ketones 124147, 130147 and ent-196148. 
Ketone Product ee (%)b Catalyst loading 
124a 76 (R,R) 10 
130a 61 (R,R) 5 
ent-196a 64 (S,S) 10 
 a
 Reaction conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), NaHCO3 (1.55 mmol), 
CH3CN (1.5 ml), aq. Na2EDTA (1 ml of 0.4 mM solution). b eemax calculated from eeobserved measured 
by chiral HPLC. 
 
 
Within the class of α,α’-disubstituted ketones, the racemic α-fluoro-α’-bromo-N-
carbethoxytropinone (±)-198, previously synthesised in the Armstrong group,177 is 
the first example of a cis-α,α’-diaxial-dihalogen derivative.  
 
N
O
F
EtO2C
Br
(±)-198
 
Figure 4.2: Ketone catalyst (±)-198. 
 
 
After finding that (±)-198 showed good efficiency in epoxidation of E-stilbene (95% 
yield after 1.5 h using 20% catalyst loading), the enantiomerically enriched form ent-
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1981 (95% ee) was obtained by the group. It was synthesised following the standard 
strategy of desymmetrisation of the racemic parent ketone 120 with the chiral base 
(R,S,S,R)-1,2-diphenyl-N,N’-bis-(1-phenyl-ethyl)-ethane-1,2-diamine 199 to form 
enantiomerically enriched silyl enol ether ent-121. Proceeding according to Scheme 
4.1, intermediate ent-121 was reacted with SelectfluorTM before electrophilic 
quenching of the kinetic silyl enol ether with bromine.177 At this stage the cis relative 
stereochemistry was only assumed on the basis of the usual reactivity of the system, 
with the electrophilic bromine attacking the less hindered exo-face.  
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Scheme 4.1: i) Chiral amine, TMSCl, THF; ii) Selecfluor™, CH3CN; iii) LDA, TMSCl, THF; iv) 
bromine, CCl4. 
 
 
Ketone ent-198 showed high reactivity towards E-stilbene: complete conversion of 
the starting material into the desired epoxide was observed after only 1.5 hours at 
20% catalyst loading. 80% Enantiomeric excess was measured for the product in 
favour of the (S,S) enantiomer. Very interestingly, the absolute configuration of the 
major enantiomer corresponded to the same one obtained with the mono-fluoro 
precursor ent-124, suggesting a different mode of approach of the olefin to the 
                                                 
1
 The nomenclature of the α, α’-disubstituted ketone ent-198 comes from the fact that it has been 
obtained by further functionalisation of enantiomerically pure ent-124. 
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dioxirane. In fact, while fluoroketone ent-124 reacts with E-stilbene generating the 
major enantiomer through a simple spiro TS (TS A, Scheme 4.2), ketone ent-198 is 
likely to preferentially react via a planar TS (TS B, Scheme 4.2) to give the (S,S) 
enantiomer. The spiro approach (TS C, Scheme 4.2) would be expected to be highly 
disfavoured by a steric clash between the bromine atom and the phenyl group. 
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Scheme 4.2 
 
 
This intriguing preliminary result clearly represented a promising starting point for 
investigation of cis-α-α’-diaxially disubstituted ketones, with ent-198 being one of 
the few examples of a catalyst from the [3.2.1] bicyclic series believed to be 
preferentially reacting via a planar transition state. The geometrical constraint 
imposed by the two axial substituents would be particularly advantageous for 1,1-
disubstituted alkenes by reducing the number of possible approaches to the ketone. It 
would also sterically force the preferential attack of the olefin towards a planar 
transition state. Since the two pseudo-axial substituents completely hinder the top 
exo-face of the catalyst, the spiro transition state would be disfavoured. Steric 
repulsion would likely become more significant than the stabilising interaction of the 
oxygen lone pair with the pi* orbital of the olefin, and the alkene would be forced to 
react through a planar transition state (Figure 4.3, a). The differing steric and 
electronic properties of the axial substituents of the catalyst (Y and Z, Figure 4.3, a) 
as well as of the groups R1 and R2 of the olefin would make the planar TS highly 
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asynchronous (Figure 4.3, b). Asynchronicity would then differentiate the interaction 
of the two olefinic hydrogens and the Z and Y groups, strongly contributing to favour 
one epoxide enantiomer over the other. However, the enhanced steric hindrance 
might make the reaction occur on the endo-face generating racemic epoxide. 
With the background of the earlier results in hand, resynthesis of enantiomerically 
pure 198 was targeted in order to test our hypothesis in epoxidation of 1,1-
disubstituted alkenes. 
 
 
 
Figure 4.3: a) Example of cis-α,α’-disubstituted ketone; b) Favoured Asynchronous Planar Transition 
State between 1,1-disubstituted alkenes and cis-α,α’-disubstituted ketones. 
 
 
 
4.2  Synthesis of racemic α-fluoro-α’-bromo ketone (±)-198 
 
To further investigate the effect of a second α’-pseudo-axial substituent on 
epoxidation of terminal and “unsubstituted” alkenes, the resynthesis of this 
interesting enantiomerically pure catalyst 198 was necessary. 
The first approach to rapidly access to both enantiomers of (±)-198 in high 
enantiomeric purity would consist of initital synthesis of racemic (±)-198 in a similar 
way to the one already identified (Scheme 4.1). Chiral separation of racemic (±)-198 
by SFC or chiral chromatography would deliver pure enantiomers to be tested and 
thus provide material to permit further evaluation of the reactivity of the catalyst. 
According to the earlier procedure, N-carbethoxytropinone was functionalised first 
with a fluoro pseudo-axial substituent in the α position (Scheme 4.3). 
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Scheme 4.3: i) LiHMDS 1.0 M in THF, THF, TMSOTf, -78 °C; ii) SelectfluorTM, CH3CN. 
 
 
 
Enolisation of (±)-124 leading to the less substituted silyl enol ether was achieved 
using Et3N as base, TMSOTf as electrophile in DCM, at 0 °C. Preliminary studies 
carried out in the group on mono-halo derivatives177 had shown that different sets of 
conditions (TMSOTf/Et3N/RT or TMSCl/LDA/-78 °C) lead to the same, less 
substituted, silyl enol ether. A possible explanation of this regioselectivity could be 
that, despite the presence of an α-electron-withdrawing halogen, the highly acidic 
geminal proton in the pseudo-equatorial position is extremely inaccessible due to the 
particular geometry of the system. Stereoelectronically, the proton being removed 
must be axial to allow overlap with the carbonyl orbitals. Hence, the equatorial 
proton next to fluorine is much more difficult to remove. 
The silyl enol ether (±)-197 was then quenched using NBS as electrophile (Scheme 
4.4), which gave a slightly higher yield compared to the earlier route which had used 
bromine (32% versus 21% yield). 
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Scheme 4.4: i) TMSOTf, Et3N, DCM, 0 °C, ii) NBS, THF, 32% over two steps. 
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The racemic ketone (±)-198 was delivered as a colourless solid which could be 
crystallised from a cyclohexane/ethyl acetate mixture. The needles thus obtained 
crystallised with a monoclinic lattice and were suitable for single crystal X-ray 
structure determination (Figure 4.4). This proved the pseudo-axial position of both 
the fluorine and the bromine atoms, which had been previously assessed by NMR 
analysis only. nOe experiments, in fact, showed that the proton geminal to the 
bromine atom gave cross peaks with the two endo-protons of the carbon bridge. This 
outcome serves as proof of its pseudo-equatorial position (Scheme 4.4). 
 
 
 
Figure 4.4: X-ray structure of ketone (±)-198. 
 
 
Ketone (±)-198 was submitted to preparative chiral chromatography to separate the 
racemic mixture into single enantiomers. When performing the chiral separation 
(Column Chiralcel OD-H, Mobile phase n-hexane/iso-propanol 85/15% v/v) four 
peaks appeared instead of the expected two. The drift in the baseline of the UV trace 
between the two sets of peaks and a CD analysis clearly suggested the presence of an 
equilibrium between a pair of enantiomers and some other related species, which 
appeared to be enantiomers of each other (Figure 4.5).  
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Figure 4.5: Chiral HPLC trace and CD trace of ketone (±)-198. 
 
 
A small amount of each main peak (peak 1, peak 2, peak 3 and peak 4 from Figure 
4.5) was isolated by chiral chromatography and further analysed by standard 
techniques. All the four species showed the same molecular weight by mass 
spectrometry analysis, while proton NMR spectra showed peak 1 and peak 2 to be 
one pair of enantiomers, and peak 3 and peak 4 the other. 
Interestingly, the analytical HPLC traces (Figure 4.6) showed that peak 1 and 2 
(Figure 4.6, traces a and b) represented the most stable forms of the two possible 
ones as peak 3 and peak 4 rapidly interconverted into their isomers, peak 1 and peak 
2 respectively (Figure 4.6, traces c and d). 
Comparison of the NMR spectra obtained for peaks 3 and 4 (Figure 4.6, c and d) 
with the spectrum of the crystalline racemic compound (±)-198 confirmed the 
configuration with both halogens in the pseudo-axial position as the less stable form. 
It is reasonable to assume a partial epimerisation of one of the chiral centres bearing 
the heteroatom, with the halogen moving from the pseudo-axial to the pseudo-
equatorial position (Scheme 4.5). It is likely that epimerisation occurs at the carbon 
bearing the bromine group as no sign of partial epimerisation has been previously 
observed by the group for the α-monosubstituted fluoro N-carbethoxytropinone 
124.145 
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Scheme 4.5 
 
 
However, it is difficult to rationalise a different behaviour on chiral HPLC between 
opposite enantiomers, peak 1 and peak 2, with only the latter peak appearing to form 
a new species, which also had a very similar retention time. Since the enantiomers 
(peak 1 and peak 2) cannot interconvert, and given that opposite enantiomers behave 
differently in a chiral environment, it is possible that the new species may result from 
a different rate of hydration or of enolisation, in particular in the presence of a protic 
polar solvent such as iso-propanol. The new peak with a retention time of 7.417 
minutes appearing in trace b (Figure 4.6), could be the product of enolisation or of 
hydrolysis deriving from the parent peak 2. It could also be that peak 1 might behave 
in the same way generating a species co-eluting with the main peak at Rt = 7.449 
minutes. 
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c) 
d) 
 
 
Figure 4.6: a) Chiral HPLC trace and 1H NMR spectrum for peak 1; b) Chiral HPLC trace and 1H 
NMR spectrum for peak 2; c) Chiral HPLC trace and 1H NMR spectrum for peak 3; d) Chiral HPLC 
trace and 1H NMR spectrum for peak 4. 
 
a) 
b)
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On a small scale, chiral separation of racemic (±)-198 allowed identification of each 
peak. However, the same separation would have not been feasible on a large scale as 
a consequence of the interconversion process. With these data in hand, it was clear 
that catalyst 198 could not been obtained diastereomerically pure by chiral separation 
starting from racemic (±)-198. In addition, the data suggest that the catalyst used in 
the earlier studies may have not been stable to the epoxidation reaction conditions 
and epimerisation could have occurred. 
 
 
4.3  Bromination of enantiomerically pure α-fluoro ketone 
 
In an attempt to find a robust and reliable way to gain access to the target, it was 
decided to reverse the order of events and to perform the bromination step on the 
enantiomerically pure α-fluoro N-carbethoxytropinone 124 or ent-124 obtained after 
chiral chromatographic separation of the corresponding racemic mixture.  
A new batch of racemic α-fluoro-N-carbethoxytropinone (±)-124 was prepared 
according to the literature procedures.145 It was then submitted to semi preparative 
chiral chromatography to obtain single enantiomers. No instability under the HPLC 
conditions (Column Chiralpak AD-H, Mobile phase n-hexane/ethanol 75/25% v/v) 
was observed, which is consistent with the idea that epimerisation in (±)-198 might 
occur at the carbon bearing the pseudo-axial bromine atom, as previously suggested. 
 
 
Figure 4.7: HPLC traces for racemic (±)-124 and for single enantiomers with the corresponding CD 
traces. The splitting of the CD signal for enantiomer 2 is due to saturation of the detector. 
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Enantiomerically pure α-fluoro N-carbethoxytropinone (+)-ethyl-(1R,2R,5S)-2-
fluoro-3-oxo-8-azabicyclo[3.2.1]octane-8-carboxylate 124 (first eluting enantiomer 
from chiral chromatography) was then further functionalised with an α’-pseudo-axial 
bromine substituent according to the procedure previously described. 1982 was 
delivered as a pale yellow oil, with all the analytical data in agreement with those for 
the racemic compound. The enantiomeric purity could not be assessed by chiral 
HPLC analysis due to the epimerisation and it was assumed on the basis of the 
enantiomeric purity of the fluoro-ketone precursor 124 (99% ee). 
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Scheme 4.6: i) TMSOTf, Et3N, DCM, 0 °C, ii) NBS, THF, 32% over two steps. 
 
 
Interestingly, 19F NMR studies performed at variable temperatures showed that at 
room temperature ketone 198 exists as a mixture of 2 species, possibly 2 rotamers. 
Two broad peaks, which at room temperature appear as doublets with chemical shift 
of -169 and -170 ppm (Figure 4.8, b), were converted into a sharp doublet of 
doublets with coupling constants of 46.5 and 9.5 Hz, by increasing the temperature to 
80 °C (Figure 4.8, a).  
 
                                                 
2
 The nomenclature of the α, α’-disubstituted ketone 198 comes from the fact that it has been obtained 
by further functionalisation of enantiomerically pure 124. 
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a) 19F NMR, DMSO, 80 °C, 282 MHz 
     J1 = 46.5 Hz 
     J2 = 9.6 Hz 
 
 
b) 19F NMR, DMSO, 25 °C, 282 MHz 
 
 
 
 
Figure 4.8: a) 19F NMR spectrum of ketone 198 run in DMSO at 80 °C; b) 19F NMR spectrum of 
ketone 198 in DMSO at 25 °C. 
 
 
 
Unfortunately, but not surprisingly, ketone 198 was not stable at room temperature 
for a prolonged period of time. The colour of the oil turned from pale yellow to 
brown and also the proton NMR spectrum, recorded after two months standing at 
RT, showed epimerisation. A new set of signals, in fact, were observed between 5.2 
and 4.5 ppm and between 2.25 and 1.25 ppm (Figure 4.9, spectra a and b) which 
could be assigned to the isomeric compound obtained from chiral separation, peak 1 
or peak 2. 
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Figure 4.9: a) 1H NMR spectrum of ketone 198 run in DMSO after 2 months; b) Original 1H NMR 
spectrum of ketone 198 run in DMSO.  
 
 
 
4.4  Epoxidation of various substrates 
 
 
N F
EtO2C
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Figure 4.10: Ketone catalyst 198. 
 
 
Despite its instability with regards to epimerisation over a period of time, 
enantiomerically pure ketone 198 was tested under the standard homogeneous Yang 
conditions towards epoxidation of trans-substituted (e.g. E-β-methyl styrene and E-
ethyl cinnamate) and terminal alkenes (e.g. styrene and α-methyl styrene) (Table 
4.2). 
No remaining catalyst was observed by NMR spectroscopy in any reactions carried 
out with 198, although no catalyst degradation products were identified in the 
organic phase. In general, 198 showed high turnover in epoxidation of electron-rich 
a) Spectrum after 2 months 
b) Original spectrum 
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olefins, with complete conversion always being observed after a period of time 
varying from 6 to 18 hours. Any degradation of the ketone must occur at a slower 
rate than the epoxidation reaction thus influencing only to a small extent both 
reactivity and enantioselectivity. However, electron-poor alkenes, and in particular 
E-ethyl cinnamate, registered a very poor conversion, only 17% after 24 hours (Entry 
6, Table 4.2).  
For consistency, E-stilbene was used as a term of comparison for enantioselectivity. 
With 10% catalyst loading and after 6 hours, E-stilbene was completely converted 
into the corresponding epoxide and 67% enantiomeric excess was recorded in favour 
of the (R,R) enantiomer (Entry 2, Table 4.2). The lower enantioselectivity obtained 
for the same substrate with the opposite enantiomer by the Armstrong group177 
(Entry 1, Table 4.2), might be due to slightly different reaction conditions used (20% 
instead of 10% catalyst loading and shorter reaction time, 1.5 hour instead 6 hours). 
Moreover, a different amount of epimerisation could influence to some extent the 
enantioselectivity. 
 
 
Table 4.2: Asymmetric epoxidation of various alkenes catalysed by ketones 198a and ent-198a. 
Entry Catalyst Alkene % catalyst t (h) Conversion (%)b ee (%) 
1 ent-198 E-Stilbene 20 1.5 95 80 (S,S)c 
2 198 E-Stilbene 10 6 100 67 (R,R)d 
3 198 Styrene 10 6 100 42 (R)d 
4 198 α-Methyl styrene 10 18 100 40 (R)d 
5 198 E−β-Methyl styrene 10 6 100 54 (R,R)d 
6 198 E-Ethyl cinnamate 10 24 17 61 (2S,3R)d 
a
 Reaction conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), NaHCO3 (1.55 mmol), CH3CN 
(1.5 ml), aq. Na2EDTA (1 ml of 0.4 mM solution). Work-up B, Chapter 7, Section 7.4. b Estimated 
from the 1H NMR spectrum of the crude reaction mixture. c eemax calculated from eeobserved measured by 
chiral HPLC. d Product ee and configuration determined by chiral HPLC analysis. 
 
 
 
Comparison of enantioselectivities towards epoxidation of trans-substituted alkenes 
(Table 4.3) obtained with 198 and the mono-fluoro substituted catalysts 124 and ent-
124 suggests that 198 consistently gives lower enantioselectivities than the 
monosubstituted precursor (124 and ent-124). The difference varies with the nature 
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of the olefin: it is negligible for E-ethyl cinnamate (3% ee difference, Entry 3, Table 
4.3) while it becomes more significant for E-β-methyl styrene (16% ee difference, 
Entry 2, Table 4.3).  
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Table 4.3: Asymmetric epoxidation of various alkenes catalysed by ketones 198a, 124145 and  
ent-124145. 
Entry Alkene Catalyst 
(10%) 
ee (%)b Catalyst 
(10%) 
eemax(%)c 
1 E-Stilbene 198 67 (R,R) 124 76 (R,R) 
2 E−β-Methyl styrene 198 40 (R,R) ent-124 56 (S,S) 
3 E-Ethyl cinnamate 198 61 (2S,3R) ent-124 64 (2R,3S) 
a
 Reaction conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), NaHCO3 (1.55 mmol), CH3CN 
(1.5 ml), aq. Na2EDTA (1 ml of 0.4 mM solution). Work-up B, Chapter 7, Section 7.4. b Product ee 
and configuration determined by chiral HPLC analysis. c eemax calculated from eeobserved measured by 
chiral HPLC, eemax= 100 x product ee/ketone ee. 
 
 
As previously observed, 198 and 124 afforded the same major epoxide when trans-
substituted alkenes were used as substrates (Entry 1, Table 4.3). To explain the 
absolute configuration of the major enantiomer obtained with ketone 198 and E-
stilbene, if a spiro transition state is operating as in the case of 124, the phenyl group 
should be placed close to the bromine atom, which would be very unlikely (TS C and 
D, Scheme 4.7). Thus a planar transition state where the phenyl ring is placed in the 
fluorine region might be favoured (TS A and B, Scheme 4.7). Spiro transition states 
with the phenyl group of the olefin in the fluorine region (TS E and F, Scheme 4.8) 
will compete in generating the minor enantiomer.  
A minor decrease in enantioselectivity has been observed for 198 compared to 124 
throughout the series of trans-substituted alkenes (Entries 1, 2 and 3, Table 4.3). This 
suggests that the introduction of the bromine substituent slightly reduces the 
difference in energy between TSs leading to the major and the minor enantiomer. It 
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could be that the extra axial substituent does not significantly influence the 
preference for TSs C and D vs TS E and F (Scheme 4.7), or that planar TSs A and B 
(Scheme 4.7) are now preferred. 
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Scheme 4.8 
 
Pleasingly, the α-α’-disubstitution pattern of 198 improved the enantioselectivity 
towards epoxidation of terminal alkenes compared to fluoro-ketone ent-124. 12% ee 
increase was recorded for styrene with enantioselectivity moving from 30% with ent-
124 to 42% with 198 (Entry 1, Table 4.4). An even more significant improvement 
was observed for α-methyl styrene with the enantioselectivity reaching a value of 
40%, the highest within the N-carbethoxytropinone[3.2.1]bicyclic series under the 
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monophasic Yang conditions (Entry 2, Table 4.4).  
 
Table 4.4: Asymmetric epoxidation of various alkenes catalysed by ketones 198a and ent-124145. 
Entry Alkene Catalyst (10%) ee (%)b Catalyst (10%) eemax(%)c 
1 Styrene 198 42 (R) ent-124 30 (R) 
2 α-Methyl styrene 198 40 (R) ent-124 22 (S) 
a
 Reaction conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), NaHCO3 (1.55 mmol), CH3CN 
(1.5 ml), aq. Na2EDTA (1 ml of 0.4 mM solution). Work-up B, Chapter 7, Section 7.4. b Product ee 
and configuration determined by chiral HPLC analysis. c eemax calculated from eeobserved measured by 
chiral HPLC, eemax= 100 x product ee/ketone ee. 
 
 
(R)-Methyl-2-phenyloxirane could be generated through a planar TS (planar TS B, 
Scheme 4.9) where the steric hindrance is minimised, since both the alkyl and the 
aryl substituents are placed away from the pseudo-axial halogens. However, equally 
planar TS D (Scheme 4.9) might compete to give the (S) epoxide. More importantly, 
the spiro TS A (Scheme 4.9) might significantly contribute to enhance the 
enantioselectivity for the (R) epoxide as the presence of the methyl group in the 
fluorine region might be tolerated. Spiro TS A would be definitely preferred to spiro 
TS C (Scheme 4.9) as the phenyl ring is too bulky to stay close to the fluorine atom 
and could increase the destabilisation by n-pi steric repulsion.  
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Analysis of the results coming from epoxidation of several trans-substituted and 
terminal alkenes with the disubstituted ketone 198 shows that the presence of two 
pseudo-axial electron-withdrawing groups in the α and α’ position is beneficial for 
improving enantioselectivity towards the challenging terminal olefins.  
The outcome cannot be simply explained on the basis of steric interactions, despite 
their importance being crucial. A combined effect of steric and electronic factors 
related to the substituents on the catalyst needs to be taken into consideration to give 
a rationale of the most favoured transition state and of the competing ones. 
Theoretical and computational studies might be envisaged to evaluate and quantify 
the influence of the electronegative pseudo-axial substituents on the secondary 
orbital interaction, which primarily affects the competition between spiro and planar 
transition states, and then enantioselectivity. 
Unfortunately, ketone 198 is subject to epimerisation at the carbon bearing the 
bromine group. This effect could negatively influence the overall enantioselectivity. 
A possible way for avoiding this behaviour could the presence of a quaternary centre 
in the α position of the ketone, thus removing the acidic proton geminal to the 
bromine atom. A new class of potentially very interesting ketones derived from the 
N-substituted oxazolidinone catalysts could then be envisaged, generating a new 
class of α,α,α’-trisubstituted ketones. 
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α,α,α’-Trisubstituted Ketones 
 
 
Beneficial features for designing efficient and stable ketones in epoxidation reactions 
include the introduction of electron-withdrawing substituents to activate the carbonyl 
group toward attack from Oxone® and reduce possible decomposition reactions (e.g. 
the Baeyer-Villiger reaction) and the presence of quaternary centres α to the 
carbonyl to exclude the possibility of any potential epimerisation of the chiral centre. 
As described in the previous Chapter, a step forward in the optimisation of the 
catalyst design for epoxidation of terminal and 1,1-disubstituted olefins came in the 
introduction of an α’-pseudo-axial substituent starting from α−monosubstituted N-
carbethoxytropinones. In order to limit the potential epimerisation, a further 
improvement was envisaged to come with the replacement of one of the pseudo-axial 
substituents with a spiro group, such as a cyclic carbonate unit or an N-substituted 
oxazolidinone ring, whose synthesis has been previously described and which 
showed a beneficial effect on enantioselectivity (Figure 5.1).  
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Figure 5.1: Improvement in catalyst design represented by α,α,α’-trisubstituted ketones. 
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This new substitution pattern would allow understanding of the steric and electronic 
effect of the pseudo-axial electron-withdrawing group in the α’ position. A range of 
electron-withdrawing substituents with different electronic properties and steric 
hindrance would be selected and then the corresponding ketones prepared in 
enantiomerically pure form. The purpose would be to identify the optimal 
substitution pattern leading to high efficiency and catalytic activity. Most 
importantly, this would allow assessment of the effect on epoxidation when three of 
the four quadrants of the catalyst are sterically hindered. When the α’ group, Z, lies 
axial, our hypothesis predicted unhindered and thus favoured spiro TSs limited to 
terminal unsubstituted olefins (TS A and B, Figure 5.2), unless unexpected 
secondary interactions were to favour other spiro/planar transition states. In isomeric 
catalysts with the Z group equatorial, electrostatic interactions would play a major 
role compared to the steric ones. Accessible spiro transition states can be drawn for 
substituted terminal alkenes, with the stereo-discrimination being determined by 
different interaction of Z with R1 and R2 (TS C, Figure 5.2). 
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Figure 5.2: Possible spiro transition states between an α,α,α’-trisubstituted ketone and terminal 
olefins. 
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5.1  Synthesis of pseudo-axially and pseudo-equatorially α’-substituted N-
carbethoxy[3.2.1]bicyclooctanones containing an α,α-fused cyclic unit 
 
 
5.1.1  α’-Pseudo-axial fluorination of the carbonate bicyclic ketone 
 
Our first synthetic attempts to obtain α,α,α’-trisubstituted ketones were focused on 
the introduction of a fluorine atom in the α’ position of racemic (±)-143, since the 
cyclic carbonate unit is easily synthesised from commercially available N-
carbethoxytropinone 120 in only three steps. Single enantiomers of the final product 
would then be obtained after chiral separation of the racemic compound. This 
approach would rapidly permit evaluation of the feasibility of the synthetic strategy 
and also of the catalytic activity of both enantiomers. Alternatively, α’-
functionalisation could be performed on α-substituted enantiomerically pure 
material, thus allowing a rapid assessment of the effect of structural changes on the 
epoxidation reaction. 
The route to the desired target was envisaged to consist of the synthesis of racemic 
silyl enol ether (±)-200 from (±)-143 followed by electrophilic quenching with 
SelectfluorTM. The first attempts to synthesise (±)-200 with a strong base (LiHMDS 
or LDA, THF, TMSCl, -78 °C) failed as only starting material was recovered. The 
base used might have been too hindered or the electrophile not reactive enough for 
trapping the enolate thus formed. Et3N, TMSOTf, DCM, 0 °C conditions, instead, 
successfully allowed access to the target compound (±)-200 (Scheme 5.1).  
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Scheme 5.1: i) TMSOTf, Et3N, DCM, 0 °C, quantitative. 
 
As previously reported on unsubstituted azabicyclic ketones,145 fluorination of (±)-
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200 with SelectfluorTM was expected to deliver the α’-pseudo-axial fluoro derivative, 
with best results previously having been obtained using 2.0 eq of electrophilic 
reagent. Analogous behaviour was observed for (±)-200, with the only difference that 
ketone functionality in the product was found to exist solely in the hydrated form and 
not as a carbonyl group (Scheme 5.2). Two sharp singlets in the proton NMR 
spectrum run in DMSO indicated the presence of two acidic protons, which could be 
assigned as the two hydroxyl groups. After D2O addition they disappeared, 
confirming their acidic nature. The rigid skeleton and the presence of the carbamate 
group caused rotamers at room temperature, which were evident by broadening of 
the NMR signals. NMR experiments run at elevated temperature sharpened up the 
broad peaks as the interconversion between the two rotamers became fast on the 
NMR timescale. The most diagnostic signals separated only partially and a coupling 
constant of ~ 3 Hz between Ha and Hb could be measured, but with some difficulty. 
This J value confirmed the pseudo-axial position of the fluoro substituent. 
Unfortunately, degradation was observed after heating a sample of (±)-201 to 90 °C, 
with many unidentified peaks appearing in the proton NMR spectrum. Fragmentation 
of the carbonate ring with loss of a CO2 molecule is a possible explanation for this 
limited stability at high temperature. 
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Scheme 5.2: i) Selectfluor™, CH3CN, 59%. 
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5.1.2  α’-Pseudo-axial fluorination of the N-methyl substituted oxazolidinone 
bicyclic ketone 
 
Analogous α’ functionalisation was attempted with the N-substituted oxazolidinone 
aza-bicyclic ketone, which should be intrinsically less prone to decomposition. 
Catalyst ent-2021 was prepared starting from enantiomerically pure ent-173 
according to the previously described reaction conditions, as reported in Scheme 5.3. 
It showed a similar reactivity to (±)-201 with only the hydrated form present 
(Scheme 5.3). All the analytical data supported this specific structure: absence of a 
peak at ~ 1780 cm-1 in the IR spectrum, molecular ion with m/z 319 and absence of 
the carbonyl peak at ~ 200 ppm in the 13C NMR spectrum. 
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Scheme 5.3: i) Et3N, TMSOTf, DCM, 0 °C; ii) SelectfluorTM, CH3CN, 31% over two steps. 
 
 
In analogy with (±)-201, the proton NMR spectrum recorded in DMSO at room 
temperature (Figure 5.3, a) showed two acidic protons with a chemical shift of 6.64 
and 6.13 ppm. They proved the presence of the two hydroxyl groups belonging to the 
hydrated form of the carbonyl functionality. The two exchangeable protons, in fact, 
disappeared after addition of deuteriated water (Figure 5.3, b). Once again, high 
temperature NMR experiments were required to increase the rate of equilibration 
between rotamers and achieve better definition of the signal splitting. In particular, 
the doublet of doublets system of the proton adjacent to the fluorine was resolved 
and allowed a geminal coupling constant JF-H = 47 Hz and a JHeq-Heq = 3 Hz to be 
                                                 
1
 The nomenclature ent-202 comes from the fact that the catalyst has been obtained by further 
functionalisation of enantiomeric pure ent-173. The same convention applies to other α , α ,α’-
trisubstituted oxazolidinone catalysts such as ent-204 or ent-205 and ent-206 obtained after chiral 
separation. 
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calculated. This latter value for the proton-proton coupling constant proved the axial 
position of the fluorine atom, as a bigger value would be expected for an axial-
equatorial coupling (~ 5 Hz).149 Fluorine NMR spectra run at room temperature 
highlighted the presence of two sets of signals, each one represented by a doublet of 
doublets (Figure 5.4, b). On heating to 90 °C, they collapsed into a single pattern of 
signals (Figure 5.4, d), with coupling constants of 47 Hz (JF-Hgem) and 9.6 Hz (JFax-
Heq) (Scheme 5.3). Unfortunately and contrary to expectations, upon heating to high 
temperature even for a limited period of time, partial decomposition of the molecule 
was observed as new patterns of signals started to appear in both proton and fluorine 
NMR spectra. 
 
 
 
 
 
b)1H NMR, DMSO + D2O 
a)1H NMR, DMSO 
 
Figure 5.3: Proton NMR spectra of ketone hydrate ent-202: a) prior to addition of D2O, d) after D2O 
addition. 
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a)1H NMR, DMSO, 25 °C 
c)1H NMR, DMSO, 90 °C 
b)19F NMR, DMSO, 25 °C 
d)19F NMR, DMSO, 90 °C 
 
Figure 5.4: a and b)1H NMR and 19F NMR spectra of ketone hydrate ent-202 at 25 °C; c and d)1H 
NMR and 19F NMR spectra of ketone ent-202 at 90 °C. 
 
 
The structure and absolute configuration of catalyst ent-202 were unambiguously 
assigned by X-ray analysis. The crystal structure of α’-fluoro ketone ent-202 shows 
the axial disposition of the fluorine atom, the two hydroxyl groups of the hydrated 
form of the ketone and the carbamate group lying orthogonal to the six-membered 
ring in a chair conformation. 
 
 
Figure 5.5: X-ray structure for ketone hydrate ent-202. 
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5.1.3  α’-Pseudo-equatorial chlorination of the N-methyl substituted oxazolidinone 
bicyclic ketone 
 
Using the chemistry just described, further investigation of alternative axial and 
equatorial α’-substituents characterised by different electronegativity properties from 
fluorine, e.g. chlorine and bromine, could be achieved in a straightforward fashion.  
Once again, the shortest and most feasible synthetic route to access to α’-
halogenated α,α-disubstituted ketones consisted of the electrophilic quenching of 
racemic or enantiomerically pure silyl enol ether ent-203. Separation of the racemic 
product into single enantiomers, when racemic silyl enol ether was used, was then 
required. 
The first interesting comparison in terms of reactivity and enantioselectivity was 
between the small and very strongly electronegative fluorine atom and the larger and 
less electron-withdrawing chlorine. Synthesis of catalyst ent-204 was therefore 
targeted. 
As reported in Scheme 5.4, enantiomerically pure silyl enol ether ent-203 was 
prepared according to the standard procedure (Et3N, TMSOTf, DCM, 0 °C) from 
enantiomerically pure ent-173 (ee > 99%). This was reacted at -78 °C with sulfuryl 
chloride and then slowly warmed to room temperature (Scheme 5.4).178 Two major 
products formed from the reaction in nearly equal amounts but only the less polar 
compound could be isolated in high purity (39% yield). The more polar isomer, 
possibly the axial epimer, could not be obtained in adequate purity to be fully 
characterised and used in the epoxidation reaction. 
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Scheme 5.4: i) Sulfuryl chloride, DCM, from -78 ºC to RT, 39%. 
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An equatorial position for the chlorine substituent in ent-204 was initially assumed 
as a consequence of the absence of NOESY cross peak between Ha and Hb (Figure 
5.6). The structure was subsequently confirmed by X-ray analysis (Figure 5.7). 
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Figure 5.6: Ketone ent-204 with highlighted Ha and Hb not giving cross peak in the NOESY NMR 
experiment. 
 
 
It is interesting to notice how, in analogy with ent-202, the structure minimises its 
energy in the crystalline form with the carbamate group lying in a plane nearly 
perpendicular to the plane of the 6 membered chair and the carbonyl group pointing 
toward the chlorine region and away from the oxazolidinone face. Most importantly, 
since the material was enantiomerically pure, the presence of a heavy atom allowed 
confirmation of the absolute configuration. Chlorination of ent-173 had led to the (-)-
(1S,2S,4S,5R) stereochemistry. 
 
 
 
Figure 5.7: X-ray structure obtained from monoclinic, colourless needles of ketone ent-204. 
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In contrast to ent-202, no sign of hydration of the carbonyl group was noticed. The 
bigger and less electron-withdrawing equatorial substituent thus led to a different 
behaviour to the axial fluoro analogue. A different reactivity in epoxidation reactions 
was also expected.  
 
 
5.1.4  α’-Bromination of the N-methyl substituted bicyclic ketone 
 
To cover a wide range of electronegativity and Van der Waals radii, the α’-bromo-
derivative was also synthesised. Following an analogous procedure, the bromine 
substituent was introduced by electrophilic quenching of racemic silyl enol ether (±)-
203 with NBS, according to Scheme 5.5.179 Two products with the same molecular 
weight, but different retention time by UPLC analysis, were formed in the reaction. 
The less polar compound was identified as (±)-205 with the bromine atom in the 
equatorial position, while in contrast to the chloro derivative, the stereoisomer (±)-
206 bearing the heteroatom in the axial position could be easily separated by column 
chromatography, being considerably more polar. 
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Scheme 5.5: i) NBS, THF, 39% yield for (±)-205 and 25% yield for (±)-206. 
 
 
The assignment of the stereochemistry was based on NMR analysis, with proton Ha 
(Figure 5.8) giving NOESY cross peak with Hb when the heteroatom is in the axial 
position (ketone (±)-206) but not when it is equatorial (ketone (±)-205). 
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Figure 5.8: Ha and Hb giving NOESY cross peak in ketone (±)-206. 
 
 
A racemic mixture of each stereoisomer was submitted to chiral chromatography 
(Figure 5.9, a: analytical chromatographic trace for (±)-205; b: analytical 
chromatographic trace for (±)-206). Two different chromatographic systems 
(column/mobile phase) were used to achieve separation into single enantiomers. It is 
important to notice that while the equatorial isomer was stable under 
chromatographic conditions, the axial one appeared not to be stable. It underwent 
partial epimerisation with the halogen substituent moving from the axial position to 
the more stable equatorial one. In fact, small quantities of enantiomerically pure 205 
and ent-205 were isolated after preparative chromatographic analysis of (±)-206.  
 
 
 
Figure 5.9: a) Chromatographic trace on chiral stationary phase of the pseudo-equatorial bromide 
(±)-205; b) Chromatographic trace of the pseudo-axial bromide (±)-206. 
 
 
A sample of enantiopure ent-206 crystallised as colourless needles in an 
orthorhombic lattice from a cyclohexane/ethyl acetate mixture. The X-ray structure 
not only confirmed the axial position of the α’-heteroatom but also allowed the 
assignment of the absolute configuration. The first eluting peak from chiral 
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chromatography was identified as the (-)-(1S,2S,4R,5R)-bromo derivative. It is worth 
noting how, in the solid state, the minimum energy conformation is one in which the 
bridgehead atom assumes an enhanced pyramidal geometry and the carbonyl group 
of the carbamate points away from the axial bromine substituent (Figure 5.10). 
 
 
 
 
Figure 5.10: X-ray structure of ketone ent-206. 
 
 
With these data in hands, it was possible to conclude that halogens characterised by 
different electronegativity and steric demand conferred diverse properties in the 
products. The small and electron-withdrawing fluorine atom, in an axial geometrical 
disposition, favours hydration of the ketone group, while softer and bigger 
heteroatoms prefer an equatorial position and leave the carbonyl group in its ketonic 
form. 
 
 
5.1.5  Alternative attempts at α’ functionalisation 
 
To further differentiate the α’-substituent and to probe a wider range of electron-
withdrawing groups, it was thought that a hydroxyl group α’ to the carbonyl would 
be a useful intermediate that could be converted into more complex functionalities 
like carboxylic esters (Scheme 5.6). 
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Scheme 5.6 
 
 
Initial attempts to α’-hydroxylate ketone 173 were carried out following a literature 
procedure for unsubstituted N-carbethoxytropinone, which employed hypervalent 
iodine chemistry.145,180 Ketone 173 was reacted according to Scheme 5.7 with a 
strong base (KOH) in methanol with iodosobenzene diacetate. Instead of obtaining 
the desired α’-hydroxyl derivative, the hemiketal species 209 formed. The structure 
was assigned on the basis of NMR analysis, with the methoxy protons giving only 
one cross peak, with the quaternary hemiketal carbon at ~ 85 ppm in the HMBC 
spectrum. 
Hydrolysis of 209 under acidic conditions was attempted using either 0.1 M HCl in 
THF or TFA in DCM (Scheme 5.7). However, in both cases, degradation of 209 was 
observed with many spots appearing on the TLC plate. Opening of the bicyclic 
system might have occurred but no major decomposition products could be isolated 
and characterised. 
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Scheme 5.7: i) KOH, MeOH, PhI(OAc)2, 30%; ii) HCl 0.1 M in THF or TFA in DCM. 
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Additional attempts, run in parallel with the previously described strategy, consisted 
of the direct introduction of the hydroxyl group starting from racemic silyl enol ether 
(±)-203 (Scheme 5.8). Reaction of (±)-203 with m-CPBA181 hydrolysed the silyl enol 
ether and gave back the starting ketone (±)-173 while treatment with freshly distilled 
~ 0.1 M dimethyl dioxirane in acetone182,183 yielded an unknown compound that 
rapidly decomposed. 
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Scheme 5.8: i) m-CPBA, DCM; ii) dimethyl dioxirane ~0.1 M in acetone, DCM. 
 
 
A different approach would allow direct functionalisation of (±)-164 with an α’-
acetoxy group. Treatment of one equivalent of ketone (±)-164 with O-acetyl-N-
methylhydroxylamine hydrochloride 213, which was prepared according to a 
literature procedure as reported in Scheme 5.9,184 should have delivered the 
acetylated compound (±)-217. Unfortunately no reaction was observed either at room 
temperature or heating to 70 °C after a prolonged period of time.  
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Scheme 5.9: i) (Boc)2O, K2CO3, THF / H2O, RT; ii) CH3COCl, Et3N, DMAP, DCM; iii) 4.0 M HCl 
in dioxane, RT. 
 
 
It might be that the amine 213 adds to the carbonyl group to form the iminium ion 
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(±)-214 and that this evolves into the corresponding enamine (±)-215 which then 
cannot transfer the acetate group due to the steric hindrance and geometrical 
constraints of the system. Hydrolysis would then return the starting ketone. 
Alternatively, ketone (±)-164 may simply be too sterically encumbered to allow the 
addition of the amine 213 (Scheme 5.10). 
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Scheme 5.10: Mechanism of transformation of ketone (±)-164 into the acetylated derivative (±)-217. 
 
 
No reaction was observed either upon treating (±)-164 with nitrosobenzene in the 
presence of a catalytic amount of L-proline (Scheme 5.11).185 
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Scheme 5.11  
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Given the difficulties encountered in the synthesis of the α’-oxygenated analogues, 
the investigation was limited to the successfully synthesised axially and equatorially 
halogenated ketones in order to evaluate these new features aimed to improve 
catalyst design for dioxirane mediated epoxidation. 
 
 
 
5.2  Evaluation of the effect of pseudo-axial and pseudo-equatorial α’-electron-
withdrawing substituents in asymmetric epoxidation 
 
 
5.2.1  Evaluation of the pseudo-axial fluoro substitution 
 
Studies conducted on 4-tert-butyl-2-fluorocyclohexanones have shown that 
equatorially substituted fluoroketones give better conversion than the corresponding 
axial isomers which, instead, tend to form stable hydrates.56,98 This behaviour may 
influence their efficiency, despite the fact that Yang has reported the absence of a 
clear correlation between the hydration constant and catalytic activity.90 On the 
contrary, previous work in the group has shown that bicyclo[3.2.1]octanones bearing 
an axial α-acetoxy substituent are more reactive than the corresponding isomers with 
an equatorial α-acetoxy group.145 These results are confirmed by computational 
studies83 which suggest that axial-fluoro ketones are more reactive than the 
equatorial ones in the epoxidation step. However, 4-tert-butyl-2-
fluorocyclohexanones also undergo Baeyer-Villiger decomposition, as a major 
degradation pathway. This occurs at different rates for the two isomers, with the axial 
isomer being more prone to the decomposition process. The different behaviour 
could offer a plausible explanation for the overall reduced efficiency of the axially 
substituted ketones. However, the fluorine effect is not limited to increasing the 
reactivity of the dioxirane but is also involved in asymmetric induction.  
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Figure 5.11: Ketone catalyst ent-202. 
 
 
Ketone ent-202 clearly shared some of the features just described, in that it formed a 
stable hydrate. High reactivity was plausible but its stability under the reaction 
conditions was uncertain. We decided to react it under the standard Yang epoxidation 
conditions using 10% catalyst loading. Low enantioselectivity was expected for 
trans- substituted olefins, since the ketone substitution pattern was especially 
designed for improving enantioselectivity of terminal alkenes. In fact, trans- alkenes 
would have to place one substituent next to an axial group in a spiro TS. Hence 
planar TSs might be favoured for those substrates, thus leading to lower 
enantioselectivities. In line with our expectations, 59% ee was obtained in 
epoxidation of E-stilbene after 18 h (Entry 1, Table 5.1) in favour of the (S,S) 
enantiomer. The configuration of the product was consistent with the major 
enantiomer being generated through an asynchronous spiro TS (TS A, Scheme 5.12) 
due to F-Ph repulsion or alternatively with an asynchronous planar TS (TS B, 
Scheme 5.12) where electrostatic attraction between fluorine and the acidic olefinic 
proton may shift the aromatic ring away from a steric clash with the oxazolidinone. 
The minor enantiomer would likely arise mainly from a planar TS (TS C, Scheme 
5.12) made highly asynchronous by n-pi repulsion between the halogen and the 
phenyl group.  
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Scheme 5.12 
 
 
Surprisingly only 75% conversion was registered. No residual amount of catalyst 
was recovered from the organic phase after work-up, suggesting its degradation into 
water-soluble fragments. Qualitatively, these observations suggest that catalyst 
decomposition occurs at quite a fast rate but not as fast as that of the epoxidation 
process. The approach of the olefin to the highly substituted dioxirane may be 
relatively slow, allowing secondary reactions to compete with the desired one. 
 
 
Table 5.1: Asymmetric epoxidation of various alkenes catalysed by ketone ent-202a. 
Entry Catalyst Alkene t (h) Conversion (%)b ee (%)c 
1 ent-202 E-Stilbene 18 75 59 (S,S) 
2 ent-202 Styrene 18 95 39 (S) 
3 ent-202 α-Methyl styrene 5 100 4 (S) 
a
 Reaction conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), ketone (10 mol%), NaHCO3 
(1.55 mmol), CH3CN (1.5 ml), aq. Na2EDTA (1 ml of 0.4 mM solution). Work-up B, Chapter 7, 
Section 7.4. b Estimated from the 1H NMR spectrum of the crude reaction mixture. c Product ee and 
configuration determined by chiral HPLC analysis. 
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Turning attention to terminal alkenes, nearly complete conversion was recorded for 
styrene (95%) but only a moderate 39% ee was obtained in favour of the (S) epoxide 
(Entry 2, Table 5.1). No improvement was achieved compared to 173 (cf. 58% ee) by 
the presence of the extra axial substituent.  
A spiro TS (TS A, Scheme 5.13) may be responsible for generating the observed 
major enantiomer, with both the fluorine and the oxazolidinone regions occupied by 
olefin hydrogens. A certain preference is exerted by the phenyl group to sit on the 
oxazolidinone side, in analogy to Shi’s oxazolidinone “attractive interaction”. The 
minor isomer could be obtained from a favoured and unhindered spiro TS (TS C, 
Scheme 5.13) or from a higher energy planar TS (TS D, Scheme 5.13). On the basis 
of these results, the extra axial substituent decreases the energy difference between 
TSs leading to opposite enantiomers with a net result of loss of enantioselectivity, 
compared to the simple oxazolidinone derivative 173. 
 
 
 
 
 
Scheme 5.13 
 
 
Disappointing results were obtained for epoxidation of α-methyl styrene. Complete 
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conversion was observed after only 5 hours using 10% catalyst loading but nearly 
racemic material was recovered. Compared to 173 (cf. 17% ee), a decrease in 
enantioselectivity was recorded. If planar TSs (A and C, Scheme 5.14) generate 
opposite enantiomers, no discrimination is applied by the ketone substituents towards 
the alkyl and the aryl groups of the alkene. It is possible to think that asynchronicity, 
generated by attraction of the acidic olefinic hydrogen to fluorine, causes loss of 
control from the oxazolidinone stereocontrol element with an increased distance 
between this unit and both Ph and CH3. Alternatively, the steric hindrance around the 
catalytic site might favour the approach of the substrate on the achiral endo-face. 
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Scheme 5.14 
 
 
A qualitative analysis of epoxidation results run with key substrates has shown a 
detrimental effect caused by an extra axial fluoro substituent on enantioselectivity. 
The specific reasons for the decreased enantio-discrimination for both trans-
substituted and terminal alkenes are unclear and might be connected to the peculiar 
steric and electronic characteristics of fluorine. Noteworthy is the opposite 
enantioselectivity obtained with ent-173 and ent-202 in comparison to 198, implying 
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a different preference for the favoured transition state caused by the synergistic effect 
of the fluorine and bromine atoms in the axial position (Scheme 5.15). Correlation 
between the absolute configuration of the ketones (ent-173, ent-202 and 1982) and 
the configurations of the product epoxides suggests that the oxazolidinone is the 
major stereocontrolling element over fluorine and that fluorine is dominant over 
bromine. Deeper understanding of steric effects and electronic properties of 
substituents in proximity of the catalytic site might offer great advantages in 
improving the catalyst design. 
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Scheme 5.15 
 
 
5.2.2 Evaluation of the pseudo-axial bromo substitution  
 
Replacement of the fluorine substituent with a bigger and less electronegative 
heteroatom allowed further investigation of the importance of the steric and 
electronic properties of the α’-substituent on asymmetric epoxidation. 
The standard set of alkenes was submitted to the Yang reaction conditions with 
ketone 206 (94% ee after chiral chromatographic separation). In general, high 
conversion was obtained within the entire series of substrates. No trace amount of 
catalyst was observed in the proton NMR spectrum of the crude reaction mixture nor 
                                                 
2
 The nomenclature of the α, α’-disubstituted ketone 198 comes from the fact that it has been obtained 
by further functionalisation of enantiomerically pure 124. 
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recovered after work-up. In analogy with fluoroketone ent-202, the increased 
reactivity due to the extra axial substituent had a negative effect in making the 
catalyst more prone to decomposition processes thus potentially compromising the 
overall efficiency. Reasonably high enantioselectivity was observed for E-stilbene 
(Entry 1, Table 5.2) while moderate or low ee values were obtained for terminal 
alkenes (Entries 3 and 4, Table 5.2). 
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Table 5.2: Asymmetric epoxidation of various alkenes catalysed by ketones 206 a and ent-206 a. 
Entry Catalyst Alkene t (h) Conversion (%)b ee (%)c 
1 206e E-Stilbene 6 90 83 (R,R) 
2 ent-206d E-Stilbene 24 80 75 (S,S) 
3 206e Styrene 6 100 19 (R) 
4 206e α-Methyl styrene 18 100 33 (R) 
a
 Reaction conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), ketone (10 mol%), NaHCO3 
(1.55 mmol), CH3CN (1.5 ml), aq. Na2EDTA (1 ml of 0.4 mM solution). Work-up B, Chapter 7, 
Section 7.4. b Estimated from the 1H NMR spectrum of the crude reaction mixture. c Product ee and 
configuration determined by chiral HPLC analysis. d First eluting enantiomer from chiral 
chromatography, 94% ee. e Second eluting enantiomer from chiral chromatography, 93% ee. 
 
 
A completely different trend in enantioselectivities was observed compared to the 
fluoroketone analogue ent-202. It is important to stress that interpretation of the data 
for 206 is made even more difficult by the epimerisation process occurring at the 
bromine-bearing carbon, as previously noted by chiral HPLC analysis during its 
synthesis. A different diastereomeric purity for 206 and ent-206 and thus an unequal 
amount of the corresponding epimers would explain the variability in epoxidation of 
E-stilbene using opposite enantiomers (Entries 1 and 2, Table 5.2).  
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Table 5.3: Asymmetric epoxidation of various alkenes catalysed by ketones 206 a and ent-202 a. 
Entry Alkene Catalyst ee (%)b Catalyst ee (%)b 
1 E-Stilbene 206 83 (R,R) ent-202 59 (S,S) 
2 Styrene 206 19 (R) ent-202 39 (S) 
3 α-Methyl styrene 206 33 (R) ent-202 4 (S) 
a
 Reaction conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), ketone (10 mol%), NaHCO3 
(1.55 mmol), CH3CN (1.5 ml), aq. Na2EDTA (1 ml of 0.4 mM solution. Work-up B, Chapter 7, 
Section 7.4. b Product ee and configuration determined by chiral HPLC analysis. 
 
It is very difficult to find a rationale for the results obtained with 206 compared to 
ent-202. The higher ee recorded for E-stilbene epoxidation using 206 suggests that 
the energy difference between TSs leading to opposite enantiomers has increased. It 
may be that the transition state generating the (R,R) isomer is more favoured than for 
ent-202 or that the transition state forming the minor enantiomer is more 
disfavoured. With the assumption that the phenyl ring is too hindered to sit in the 
oxazolidinone region either in a planar and in a spiro transition state, the competing 
transition states will be represented by a favoured asynchronous spiro TS (TS A, 
Scheme 5.16) and a disfavoured planar TS (TS B, Scheme 5.16). In both cases the 
repulsion between the axial halogen and the phenyl will make the transition states 
highly asynchronous. The marked bias for the (R,R) enantiomer suggests that no 
significant attack occurs from the achiral endo-face, which implies that the more 
favoured TS can be easily achieved. 
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The same analysis can be applied to other trans- substituted olefins, such as E-β-
methyl styrene and E-ethyl cinnamate (Entries 1 and 3, Table 5.4) and to phenyl 
cyclohexene (Entry 2, Table 5.4). 
 
 
Table 5.4: Asymmetric epoxidation of various alkenes catalysed by ketone 206a. 
Entry Catalyst Alkene % catalyst t (h) Conversion (%)b ee (%)c 
1 206 Ε−β-Methyl styrene 10 6 100 65.7 (R,R) 
2 206 Phenyl cyclohexene 10 18 100 72 (R,R) 
3 206 E-Ethyl cinnamate 10 24 23 77 (2S, 3R) 
a
 Reaction conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), NaHCO3 (1.55 mmol), CH3CN 
(1.5 ml), aq. Na2EDTA (1 ml of 0.4 mM solution). Work-up B, Chapter 7, Section 7.4. b Estimated 
from the 1H NMR spectrum of the crude reaction mixture. c Product ee and configuration determined 
by chiral HPLC analysis. 
 
 
Quite surprisingly, enantioselectivity for styrene dropped from 39% for ent-202 to 
19% ee with 206 (Entry 2, Table 5.3). It might be that, if a spiro transition state is 
favoured over the planar, the natural asynchronicity of the TS pulls the acidic proton 
of the olefin in TSA (Scheme 5.17) away from the “big” bromine to minimise 
repulsive interactions, resulting in a clash between the oxazolidinone and the phenyl 
ring. 
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Enantio-discrimination in the epoxidation of α-methyl styrene increased from 4% ee 
with ent-202 to 33% ee with 206 by simple replacement of fluorine with bromine. 
Since only planar TSs can be easily drawn avoiding steric clash between the axial 
substituents on the catalyst and the groups in the olefin, the preferred structure 
allocates the bulkier aromatic ring away from the more crowded face of the catalyst 
(TS A, Scheme 5.18).  
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Scheme 5.18 
 
 
A qualitative analysis of the effect of α’-pseudo-axial substituent on 
enantioselectivity in epoxidation reaction has highlighted the extreme sensitivity of 
the system to steric and, most importantly, to electronic properties of the heteroatom 
employed. Significant changes in enantioselectivity can be achieved.  
 
 
5.2.3  Evaluation of the halogen pseudo-equatorial substitution 
 
Given the previously observed variation in properties of the different halogen-
substituted analogues and the additional benefit of having access to both axial and 
equatorial isomers, this novel series of ketones offered significant hope of providing 
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an improved catalyst. 
The effect of the steric and electronic properties of a pseudo-equatorial substituent on 
catalyst activity remained to be explored. The “pseudo C2” symmetry would have 
made the system more similar to the Shi oxazolidinone catalyst 80, thus it was 
particularly interesting to test this new substitution pattern on terminal olefins. 
Three main characteristics differentiate the chloro- ent-204 and the bromo- 2053 
equatorial derivatives (Figure 5.12) from the axial-fluoro ent-202: the geometrical 
disposition of the α’-substituent, its electronegativity property and its size. All these 
factors should be taken into consideration when analysing the behaviour of the 
equatorially substituted ketones compared to ent-202. Mechanistically, a precise 
correlation between absolute configuration of the catalyst ent-204, proved by X-ray 
crystallographic analysis, and absolute configuration of the epoxide could be 
assessed and accurate hypothesis of the most likely TS could be suggested. 
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Figure 5.12: Ketone catalysts ent-204 and 205. 
 
 
Trans- and trisubstituted alkenes (E-stilbene, E-β-methyl styrene, E-ethyl cinnamate 
and phenyl cyclohexene) were initially tested to assess efficiency and 
enantioselectivity of ent-204, 205 and ent-205 (Table 5.5). Using the standard 
homogeneous Yang conditions and 10% catalyst loading, all reactions showed 
complete conversion of the starting materials into the desired products within 18 h. 
High efficiency was then confirmed for both ketone catalysts. Very good and 
absolutely comparable enantioselectivities were obtained for the entire series of 
substrates. No difference seemed to be determined by the steric and electronic nature 
                                                 
3
 Ketone catalysts 205 and ent-205 were obtained by chiral chromatographic separation being ent-205 
the first eluting enantiomer, > 99% ee and 205 the second eluting enantiomer, > 99.5% ee. 
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of the pseudo-equatorial substituent.  
 
 
Table 5.5: Asymmetric epoxidation of various alkenes catalysed by ketones ent-204 a, 205 a and  
ent-205 a. 
Entry Alkene Catalyst ee (%)c Catalyst ee (%)c 
1 E-Stilbene ent-204 91 (S,S)b 205 90 (R,R)b 
2 E−β-Methyl styrene ent-204 71.6 (S,S)b 205 71 (R,R)b 
3 E-Ethyl cinnamate ent-204 80 (2R,3S)d 205 80 (2S,3R)b 
4 Phenyl cyclohexene ent-204 78 (S,S)b ent-205 80 (S,S)b 
a
 Reaction conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), ketone (10 mol%), NaHCO3 
(1.55 mmol), CH3CN (1.5 ml), aq. Na2EDTA (1 ml of 0.4 mM solution), 18 h. Work-up B, Chapter 7, 
Section 7.4. b Conversion 100%, estimated from the 1H NMR spectrum of the crude reaction mixture. c 
Product ee and configuration determined by chiral HPLC analysis. d 83% isolated yield. 
 
 
 
Ent-204 reacted with E-stilbene (Entry 1, Table 5.5) yielding the major (S,S) 
enantiomer in 91% ee while 205 afforded the opposite isomer in 90% ee. These data 
perfectly match the ones obtained with 173 (Entry 1, Table 5.6): very similar 
enantioselectivity and slightly higher conversion for 205 (100% vs 87%). Most 
importantly, the same configuration for (S,S)-stilbene oxide was obtained with both 
205 and 173. This particular result proves that the N-methyl oxazolidinone is the 
major stereo-controlling element in the molecule 205, with the preference for the 
(S,S) enantiomer remaining constant through the series of olefins analysed. No 
significant improvement for epoxidation of E−β-methyl styrene was recorded with 
205 compared to 173 (Entry 2, Table 5.6, 71% vs 73.5% ee), nor for phenyl 
cyclohexene (Entry 4, Table 5.6, 80% vs 74% ee) or E-ethyl cinnamate (Entry 3, 
Table 5.6, 80% vs 80% ee). However, for the first time complete conversion of an 
electron-deficient alkene, such as E-ethyl cinnamate, into the corresponding epoxide 
was obtained with ent-204 (Entry 3, Table 5.5).  
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Table 5.6: Asymmetric epoxidation of various alkenes catalysed by ketones 205 a, ent-205 a and 173a. 
Entry Alkene Catalyst ee (%)c Catalyst ee (%)c 
1 E-Stilbene 205 90 (R,R)b 173 91.5 (R,R)d 
2 E−β-Methyl styrene 205 71 (R,R)b 173 73.5 (R,R)b 
3 E-Ethyl cinnamate 205 80 (2S,3R)b 173 80 (2S,3R)e 
4 Phenyl cyclohexene ent-205 80 (S,S)b 173 74 (R,R)b 
a
 Reaction conditions: alkene (0.1 mmol), Oxone® (1.0 mmol KHSO5), ketone (10 mol%), NaHCO3 
(1.55 mmol), CH3CN (1.5 ml), aq. Na2EDTA (1 ml of 0.4 mM solution), 18 h. Work-up B, Chapter 7, 
Section 7.4. b Conversion 100%, estimated from the 1H NMR spectrum of the crude reaction mixture. c 
Product ee and configuration determined by chiral HPLC analysis. d Conversion 87%, estimated from 
the 1H NMR spectrum of the crude reaction mixture. e Conversion 44%, estimated from the 1H NMR 
spectrum of the crude reaction mixture. 
 
 
The major (R,R) enantiomer observed in epoxidation of E-stilbene with 205 might 
come from a spiro TS (spiro TS A, Scheme 5.19) where the phenyl group is located 
in the bromine region. The pseudo-equatorial substituent at the α’-position does not 
seem to cause steric hindrance or destabilise the phenyl group by n-pi repulsion. In 
fact, it does not cause any detrimental effect on enantioselectivity compared to 173. 
The major source of the (S,S) isomer may result from a planar TS (TS B, Scheme 
5.19). 
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In summary, a spiro TS model can be invoked to explain the major enantiomer in 
epoxidations catalysed by ketones 204 and 205. The similarity of the results for these 
two ketones indicates little interaction of the olefin substituents with the pseudo-
equatorial group of the ketone. 
An enhanced enantio-differentiation was expected, instead, for terminal alkenes, 
since the number of possible approaches to the active site of the catalyst was thought 
to be limited by the additional presence of the pseudo-equatorial substituent.  
Unfortunately, these expectations were not fully satisfied (Table 5.7). In fact, with 
the enantioselectivity constantly favouring the (R) enantiomer, a slight decrease in 
enantiomeric excess of styrene oxide was observed with 205 compared to 173 (50% 
vs 58% ee, Entry 1, Table 5.7). Moving from styrene to α-methyl styrene, an 
encouraging 39% ee was registered with 205 (Entry 2, Table 5.7). The result was a 
substantial step forward compared to the unsubstituted N-methyl oxazolidinone 173, 
which gave a poor 17% ee. It was particularly encouraging given that it was obtained 
at room temperature and without optimisation of reaction conditions such as solvent, 
temperature or pH. Although the ee value still remains reasonably low, the 
modification to the catalyst seemed to have a beneficial effect toward this most 
challenging class of alkenes.  
As observed for trans- alkenes, enantioselectivity of terminal olefins does not seem 
to be influenced by the nature of the pseudo-equatorial heteroatom. Results reported 
in Table 5.7 for ketones ent-204 and 205 are, in fact, extremely similar. 
 
 
Table 5.7: Asymmetric epoxidation of various alkenes catalysed by ketones ent-204 a and 205a. 
Entry Catalyst Alkene ee (%)c Catalyst Alkene ee (%)c 
1 ent-204 Styrene b 50 (S) 205 Styrene b 50 (R) 
2 ent-204 α-Methyl styrene b 37 (S) 205 α-Methyl styrene b 39 (R) 
a
 Reaction conditions: alkene (0.1 mmol), ketone (10 mol%), Oxone® (1.0 mmol KHSO5), NaHCO3 
(1.55 mmol), CH3CN (1.5 ml), aq. Na2EDTA (1 ml of 0.4 mM solution), 18 h. Work-up B, Chapter 7, 
Section 7.4. b Conversion 100%, estimated from the 1H NMR spectrum of the crude reaction mixture. c 
Product ee and configuration determined by chiral HPLC analysis. 
 
 
 
Because an encouraging level of enantioselectivity had been obtained for epoxidation 
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of α-methyl styrene using 205, we decided to examine a wider range of terminal 
alkenes. A comparison between the enantiomeric excess obtained with single 
enantiomers 205 / ent-205 and 173 for styrene and few disubstituted terminal alkenes 
is shown in Table 5.8. The analysis aimed to rationalise the effect of the pseudo-
equatorial substituent for this specific class of alkenes with increasing the steric size 
of the alkyl group. In particular, it was interesting to test how sensitive the catalyst is 
to steric demand of the olefin and how asynchronicity would act to minimise the 
possible repulsive interactions. Due to the absence of literature data for a direct 
comparison, it was not possible to assign for certain the absolute configuration of the 
product epoxides obtained from 222. These missing data limit conclusions in some 
cases. 
 
219 220 221 222
 
 
Figure 5.13: Terminal alkenes submitted to epoxidation reactions. 
 
 
Within the series of terminal olefins, the α,α,α’-trisubstituted ketone 205 achieved 
the highest enantioselectivity with styrene, 50% ee (Entry 1, Table 5.8). A constant 
decrease in ee was observed by increasing the steric demand at the terminal end of 
the alkene. Enantioselectivity moved from 50% ee for styrene to 39% ee for α-
methyl styrene (Entry 2, Table 5.8). A value of 32% ee was recorded for α-ethyl 
styrene (Entry 3, Table 5.8) while a more dramatic drop was observed for the 
branched iso-propyl derivative (19% ee, Entry 4, Table 5.8). By comparison, a very 
different profile was obtained with N-methyl oxazolidinone 173 (Entries 1-4, Table 
5.8). 
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Table 5.8: Asymmetric epoxidation of terminal alkenes catalysed by ketones 205a, ent-205a and 173a. 
Entry Alkene Catalyst  Conversionc ee (%)d Catalyst  Conversionc ee
 
(%)d 
1 Styrene 205 100 50 (R) 173 100 58 (R)b 
2 
α-Methyl 
styrene 
205 100 39 (R) 173 100 17 (R) 
3 
α-Ethyl 
styrene 
ent-205 100 32 (S) 173 100 21 (R) 
4 
α-iPropyl 
styrene 
ent-205 100 19 (Peak 2)e 173 100 27 (Peak 1)e 
a
 Reaction conditions: alkene (0.1 mmol), ketone (10 mol%), Oxone® (1.0 mmol KHSO5), NaHCO3 
(1.55 mmol), CH3CN (1.5 ml), aq. Na2EDTA (1 ml of 0.4 mM solution), 18 h. Work-up B, Chapter 7, 
Section 7.4. b Reaction time 12 h. c Estimated from the 1H NMR spectrum of the crude reaction 
mixture. d Product ee and configuration determined by chiral HPLC analysis. e Absolute configuration 
not determined. 
 
 
A plausible explanation might come from TS analysis. Scheme 5.20 shows all 
possible spiro and planar transition states for terminal alkenes and 205. 
When R is hydrogen, six different TSs can be drawn. It is likely that spiro TSs are 
favoured over the planar ones so that the competing structures might be TSs C, D 
and E (Scheme 5.20). The major enantiomer might derive preferentially from TS C 
or TS E (Scheme 5.20), which could be characterised by a different degree of 
asynchronicity to minimise any possible repulsion. 
When R is an alkyl group, the enantioselectivity data recorded in Table 5.8 suggest 
that, if the major enantiomer comes predominantly from TS E (Scheme 5.20), then 
the larger the R group, the more this TS is disfavoured. 
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Ketone 173 appeared to give a different trend in enantioselectivity to 205 / ent-205. 
However, the analysis is based upon only 3 data points of low ee values; 
consequently it is not possible to draw a firm conclusion. The error in the ee 
measurement might mask any subtle difference in enantioselectivity for the two 
ketones. Spiro TSs A and B (Scheme 5.21) might be responsible for the outcome 
with a possible asynchronous TS where TS B (Scheme 5.21) becomes less favoured 
as the size of the alkyl group increases.  
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Scheme 5.21 
 
 
Exploration of different substitution patterns within the N-carbethoxy-azabicyclo 
[3.2.1]octanone series has led to the identification of ketones 205 and ent-204. They 
represent the most efficient and enantioselective catalysts of this family in alkene 
epoxidations to date. While maintaining very good enantioselectivity for trans-
substituted olefins (similar to the catalyst precursor 173), the presence of the extra 
pseudo-equatorial heteroatom slightly improves enantio-discrimination for the still 
challenging terminal alkenes.  
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Conclusions and Future Work 
 
Encouraged by the very positive results obtained by Shi with the oxazolidinone 
catalyst 80 in epoxidation of terminal olefins, one of the main objectives of this 
thesis was the synthesis and evaluation of α,α-disubstituted ketones bearing a spiro 
unit in the N-carbethoxytropinone series. 
Enone 136 was envisaged as a key intermediate in the synthesis of this class of 
ketones and a scalable and highly reproducible procedure to provide 136 has been 
identified (Scheme 6.1). 
 
N
EtO2C
O
N
EtO2C
O
136120
i - v
 
Scheme 6.1: i) LiHMDS, THF, -78 ºC; ii) TMSCl, -78 ºC; iii) Eschenmoser’s salt, DMF, RT, 1.5 h; 
iv) MeI, 50 ºC, sealed tube; v) NaHCO3, DMF, 95 ºC, 60-65%. 
 
 
Enone 136 gave access to a wide range of spirocyclic groups: carbonate (±)-143, N-
substituted oxazolidinone (±)-173, sulfamidate (±)-187 and lactone (±)-190 which 
have been tested under the monophasic pH 7.5 Yang conditions. 
In general, the novel spiro substituted ketones delivered excellent enantioselectivities 
for trans- substituted olefins (comparable to or better than the non-spirocyclic 
monosubstituted ketones tested earlier in the group). Slight improvements were 
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achieved for styrene (59% ee obtained with ent-164 vs 48% ee with 127) while still 
quite low enantioselectivities were recorded for α-methyl styrene oxide (6-19% ee). 
 
N
EtO2C
O136
N
EtO2C
O
X
YO
X = O,        Y = CO   (±)-143
X = NCH3,  Y = CO  (±)-173
X = NPh,    Y = CO  (±)-164
X = NCH3,  Y = SO2 (±)-187
X = CH2,     Y = CO  (±)-190
 
Scheme 6.2 
 
Contrary to our aspirations, the N-substituted oxazolidinone derivatives did not 
display a dramatic increase in the ee for styrene epoxidation, as had been described 
by Shi for his carbohydrate scaffold. The size of the N-substituent did seem to play 
an important role in the ketone activity, however. Excessive steric hindrance around 
the catalytic site was detrimental for catalyst turnover as well as for 
enantioselectivity. Variation in the steric and electronic properties of the spiro unit 
did not lead to drastic modification in the enantio-discrimination. These results 
prompted us to investigate alternative structural modifications to induce higher 
selectivity in asymmetric dioxirane-mediated epoxidation reactions. Equatorially and 
axially α’-substituted α,α-spiro functionalised ketones were therefore targeted. 
Further functionalisation of the previously synthesised α,α-spiro ketones gave access 
to several analogues (Figure 6.1).  
 
N
CO2Et
O
N O
O
X
N
CO2Et
O
N O
O
Y
X = F   ent-202
X = Br  ent-206
Y = Cl   ent-204
Y = Br   ent-205
 
Figure 6.1: Examples of axially α’-substituted α,α-spiro ketones and of equatorially α’-substituted 
α,α-spiro ketones. 
 
The axial α’ substituent caused a definite improvement in enantioselectivity for 
epoxidation of 1,1-disubstituted olefins, such as α-methyl styrene. This was 
explained by reaction via a favored planar transition state. However, the steric 
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hindrance disfavoured the approach of trans-olefins and, in fact, lower ee was 
recorded compared to the corresponding α,α-spiro ketones. The α’ equatorial 
substituent did not modify the preference for the spiro transition state and very high 
enantioselectivities were maintained for trans- alkenes while a significant 
improvement was observed for α-methyl styrene (39% ee). 
A wide investigation into catalyst design focused on the optimisation of 
enantioselectivity for the challenging terminal and 1,1-disubstituted olefins has 
successfully lead to identify very promising N-carbethoxy-azabicyclo[3.2.1] 
octanone catalysts. The appropriate choice of the substituents, designed to increase 
the reactivity of the ketone toward the olefin attack and to create a suitable 
environment for enantio-recognition, allowed the catalysts to achieve high turnover, 
excellent enantioselectivity for trans- substituted olefins and moderate enantio-
discrimination for terminal alkenes (Table 5.9).  
 
Table 6.1: Highest enantioselectivities obtained for various alkenes with aza-bicyclo[3.2.1]octanone 
ketone catalysts. 
Entry Alkene ee (%)c Conversion(%)d Catalyst 
1 E-Stilbenea 91.5 (R,R) 87 173 
2 E−β-Methyl styreneb 73.5 (R,R) 100 173 
3 E-Ethyl cinnamateb 82 (2R,3S) 40 ent-164 
4 E-Ethyl cinnamatea 82 (2R,3S) 100e ent-204 
5 Phenyl cyclohexenea 80 (S,S) 100 ent-205 
6 Styreneb 59 (S) 99 ent-164 
7 α-Methyl styrenea 40 (R) 100 198 
8 α-Methyl styrenea 39 (R) 100 205 
a
 Reaction conditions: alkene (0.1 mmol), ketone (10 mol%), Oxone® (1.0 mmol KHSO5), NaHCO3 
(1.55 mmol), CH3CN (1.5 ml), aq. Na2EDTA (1 ml of 0.4 mM solution). b Reaction conditions: alkene 
(0.2 mmol), ketone (10 mol%), Oxone® (2.0 mmol KHSO5), NaHCO3 (3.01 mmol), CH3CN (3 ml), 
aq. Na2EDTA (2 ml of 0.4 mM solution). c Product ee and configuration determined by chiral HPLC 
analysis. d Conversion 100%, estimated from the 1H NMR spectrum of the crude reaction mixture. e 
83% isolated yield. 
 
 
Given these encouraging results, optimisation of reaction conditions in terms of pH, 
solvent and temperature are highly recommended. In particular, if hydrophobic and 
dipolar interactions are involved in the enantio-recognition, solvents such as tBuOH 
which might increase pi- pi interactions between the substrate substituent and the α 
substituents of the ketone should be used.  
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Minor improvements in enantioselectivity are expected moving from the N-
carbethoxytropinone to the oxabicyclo[3.2.1]octan-3-one skeleton, as a consequence 
of the through-space stabilising electrostatic interactions between the bridgehead 
atom and the substrate in the favoured transition state. The modification we have 
developed in the N-bicyclic series could be therefore successfully applied to the oxa-
bicyclic backbone. 
Many novel substitution patterns have been explored in the N-carbethoxytropinone 
series targeting the improvement of enantioselectivity towards terminal alkenes. 
Unfortunately, this ambitious objective has not been successfully achieved yet in the 
organocatalytic Oxone™-mediated epoxidation. Completely new catalyst designs 
may be required for this class of olefins, with further refinements aimed at increasing 
the preference for the favoured transition state and reducing the possibility of 
reaction via alternative transition states.  
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Chapter 7 
 
 
Experimental Procedures 
 
7.1 General details 
 
All reactions requiring dry or inert conditions were conducted in oven-dried 
equipment under an atmosphere of nitrogen. Syringes and needles were oven-dried. 
Anhydrous THF, DMF, Et2O and MeOH were purchased from Aldrich Chemical Co. 
All commercially reagents were used without further purification. Flash 
chromatography was performed on silica gel Merck Kieselgel (230-400) mesh or on 
Varian Mega Be-Si pre-packed cartridges or on pre-packed Biotage silica cartridges. 
In a number of preparations, purification was performed using either Biotage manual 
flash chromatography (Flash+) or automatic flash chromatography (Horizon, SP1) 
systems. All these instruments work with Biotage Silica cartridges. 
SPE-SCX cartridges are ion exchange solid phase extraction columns supplied by 
Varian. The eluent used with SPE-SCX cartridges is methanol followed by 2 M 
ammonia solution in methanol. 
In a number of preparations, the following abbreviation was used in the text: dried 
refers to a solution dried over anhydrous sodium sulfate (when organic solvents as 
diethyl ether or ethyl acetate are used) or by phase separator cartridge (when DCM is 
used). Phase separation cartridges were supplied by Whatman (PTFE, 5 µM pore 
size). 
Thin layer chromatography (TLC) was carried out on Merck 5×10 cm plates with 
silica gel 60 F254 as sorbant. Visualisation of reaction components was achieved with 
UV lamp (254 nm) and with ceric ammonium nitrate or potassium permanganate 
stains. Preparative thin layer chromatography was carried out using 20×20 cm silica 
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gel GF tapered plates supplied by Analtech Inc, Newark. IR spectra were recorded on 
a Perkin-Elmer FT-IR spectrometer, Spectrum 1000 or on Nicolet FT-IR Magna 760 
spectrometer. 
Samples were run as thin films (produced by the evaporation of chloroform or DCM) 
on aluminium oxide plates or on nujol. Absorption maxima are reported in 
wavenumber (cm-1). 
1H and 13C NMR spectra were recorded in CDCl3 unless stated otherwise on either a 
Bruker spectrometer at 500, 400 or 360 MHz, or on Varian instruments at 300, 400 
or 500 MHz. Chemical shifts are reported in parts per million (δ) downfield from 
tetramethylsilane as internal standard and coupling constants are quoted in Hertz 
(Hz). Splitting patterns are abbreviated as follows: singlet (s), doublet (d), triplet (t), 
quartet (q), multiplet (m), broad (br) and combinations of the above. The NMR 
spectra were recorded at a temperature ranging from 25 to 90ºC.  
Mass spectra were recorded using a HP1100 flow inject system (50:50 1% formic 
acid-H2O:CH3CN) into an electrospray source of a Waters ZMD2000 or on a 4 II 
triple quadrupole Mass Spectrometer (Micromass UK) or on a Agilent MSD 1100 
Mass Spectrometer, operating in ES (+) and ES (-) ionization mode. Accurate mass 
was recorded using a HP1100 flow injection into an electrospray source of a Waters 
Q-Tof micro or a Waters LCT Premier mass spectrometer equipped with a Z-spray 
source and coupled to a Waters UPLC (Ultra Performance Liquid Chromatography). 
Leucine Enkephalin was used as external standard and infused with a reference 
probe. Optical rotations were recorded on a Perkin-Elmer Polarimeter 241, with a 
path length of 5 cm or on a Optical-Activity AA-5 Polarimeter with a path length of 
5 cm, in chloroform or methanol. [α]D values are given in 10-1 deg cm2 g-1. 
Concentrations (c) are given in grams per 100 cm3. Melting points were obtained 
using a Buchi melting point B-540 hot stage apparatus or a Gallenkamp melting 
point apparatus and are quoted as uncorrected. 
Separation of racemic ketones into single enantiomers were performed using 
Supercritical Fluid Chromatography (Chiralpak IA, Chiralpak AS or AS-H, 
Chiralpak AD-H column) on a Berger Minigram system with UV/VIS detector at 
220 nm using CO2/methanol as mobile phase. Alternatively, they were performed by 
chiral chromatography (Chiralpak AS-H, ACE C8, Chiralpak AD-H or Chiralcel OJ-
H column) on an Agilent HP1100 system with UV/VIS detector at 254 or 220 nm 
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using iso-propanol/n-hexane or methanol/n-hexane as eluent; retention times are 
quoted in minutes. 
Enantiomeric excesses (ee) were determined by chiral HPLC HP 1100 (Chiralpak 
AS, Chiralcel OD or Chiralcel OJ-H column) on an Agilent HP1100 system with 
UV/VIS detector at 254 or 220 nm using iso-propanol/n-hexane or methanol/n-
hexane as eluent; retention times are quoted in minutes. 
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7.2 NMR nomenclature 
 
The nomenclature used for the NMR assignment in the following section is reported 
below. 
 
N
OH3CH2CO
Y
X
O
O
H
H
Hendo
Hexo
Hexo
H H
Hax
Heq
Hendo
Quoted as NCHC
Quoted as NCHCH2CO
Quoted as CCH2Y
Quoted as CHCHax/eqCO
Quoted as OCH2CH3
Quoted as 
CHCH2exo/endoCH2exo/endoCH
or
CHCH2exo/endoCH2exo/endoCHCH2
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7.3 Experimental details for ketone synthesis 
 
Synthesis of (1R*,5S*)-ethyl 2-methylene-3-oxo-8-azabicyclo[3.2.1]octane-8-
carboxylate (±)-136 
 
 
N
EtO2C
O
N
EtO2C
O
1) LiHMDS, THF, -78 oC
2) TMSCl
3) CH2=N+Me2I-, DMF, RT
4) MeI
5) NaHCO3, 95 oC
136120
 
 
 
Under a nitrogen atmosphere, LiHMDS 1.0 M in THF (83 ml, 0.08 mol) was added 
dropwise to a stirred solution of ethyl 3-oxo-8-azabicyclo[3.2.1]octane-8-carboxylate 
120 (15.0 g, 0.08 mol) in THF (150 ml) cooled at -78 oC. After stirring at -78 oC for 
30 minutes, Me3SiCl (14.4 ml, 0.11 mol) was added, and stirring was continued for 
½ hour. The reaction mixture was quenched with a saturated solution of NH4Cl (50 
ml) at 0 oC; then the organic layer was diluted with EtOAc (100 ml) and extracted 
with EtOAc (3× 20 ml). The combined organics were washed with a saturated 
solution of NaHCO3 (50 ml), dried over MgSO4 and concentrated. The crude silyl 
enol ether intermediate was dissolved in DMF (150 ml), under a nitrogen 
atmosphere, and Eschenmoser’s salt (15.4 g, 0.08 mol) was added. The reaction 
mixture was stirred at room temperature for 1.5 hour and then MeI (23 ml, 0.38 mol) 
was added. After stirring at 50 oC overnight in a sealed tube, NaHCO3 (47.0 g, 0.56 
mol) was added and the reaction mixture diluted with DMF (100 ml). It was heated to 
95 oC overnight and then cooled to room temperature, diluted with EtOAc (100 ml), 
washed with H2O (50 ml), extracted with EtOAc (3× 30 ml) and separated. The 
combined organics were dried over MgSO4 and concentrated. The residue was 
purified by flash chromatography over silica gel eluting with 25% EtOAc in n-
hexane to give (±)-136 as a colourless oil (10.1 g, 63%); νmax/cm-1 (CHCl3): 2977, 
1693, 1622, 1410, 1380, 1106, 946, 768; 1H NMR δH (ppm) (CDCl3, 500 MHz): 5.91 
(1 H, s, C=CH2), 5.24 (1 H, br s, C=CH2), 4.91 (1 H, br s, NCHC), 4.57 (1 H, br s, 
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NCHCH2CO), 4.18-4.14 (2 H, q, J = 7.1 Hz, OCH2CH3), 2.78 (1 H, br s, 
CHCH2axCO), 2.46 (1 H, d, J = 18.0 Hz, CHCH2eqCO), 2.29-2.17 (2 H, m, 
CHCH2exoCH2exoCH), 1.80-1.68 (2 H, m, CHCH2endoCH2endoCH), 1.26 (3 H, t, J = 7.1 
Hz, OCH2CH3); 13C NMR δc (ppm) (CDCl3, 91 MHz): 198.5 (C, C=Oketone), 154.0 
(C, C=Ocarbamate), 146.8 (C, C=CH2), 119.6 (CH2, C=CH2), 61.8 (CH2, OCH2CH3), 
58.6 (CH, NCHC), 52.8 (CH, NCHCH2CO), 47.9 (CH2, CHCH2CO), 31.4 (CH2, 
CHCH2CH2CH), 29.5 (CH2, CHCH2CH2CH), 15.0 (CH3, OCH2CH3); m/z (ES+) 210 
([M+H]+, 100%); m/z (ES+) found: [M+H]+, 210,1138. C11H16NO3 requires: 
[M+H]+, 210.1130. 
 
 
 
Synthesis of (1R*,2S*,5S*)-ethyl 2-hydroxy-2-(hydroxymethyl)-3-oxo-8-
azabicyclo[3.2.1]octane-8-carboxylate (±)-142 
 
 
N
EtO2C
O
N
EtO2C
O
K2OsO4•2H2O,
Quinuclidine,
NMO,
Acetone/H2O
136 142
OHHO
 
 
 
To a stirred suspension of K2OsO4·2H2O (5.2 mg, 0.01 mmol), quinuclidine (7.8 mg, 
0.07 mmol) and N-methylmorpholine-N-oxide (336 mg, 2.87 mmol) in H2O (0.64 
ml) a solution of enone (±)-136 (300 mg, 1.40 mmol) in acetone (3.36 ml) was 
added. The reaction mixture was stirred vigorously at room temperature for 3 days, 
then solid sodium metabisulfite (~1.5 g) was added and vigorous stirring was 
continued for a further hour. The reaction mixture was diluted with DCM (10 ml). 
The solid was removed by filtration through a pad of Celite™ and washed with 
DCM (20 ml). The combined filtrate and washings were dried and evaporated to 
dryness and the residue purified by flash chromatography on silica gel eluting with 
3% MeOH in DCM to give (±)-142 as a pale yellow oil (300 mg, 86%); νmax/cm-1 
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(CHCl3): 3526, 3410, 2978, 1726, 1676, 1115, 1068; 1H NMR δH (ppm) (CDCl3, 500 
MHz): 4.61 (1 H, br s, NCHCH2CO), 4.50 (1 H, br s, NCHC), 4.22 (2 H, m, 
OCH2CH3), 4.06 (1 H, dd, J = 18.5 and 5.5 Hz, CCH2OH), 3.56-3.54 (1 H, m, 
CCH2OH), 3.15 (1 H, d, J = 20.6 Hz, CHCH2axCO), 2.41 (1 H, br s, COH), 2.22 (1 
H, d, J = 20.6 Hz, CHCH2eqCO), 2.05-2.00 (2 H, m, CHCH2exoCH2exoCH), 1.64 (1 H, 
br s, CH2OH), 1.61-1.57 (2 H, m, CHCH2endoCH2endoCH), 1.31 (3 H, m, OCH2CH3); 
13C NMR δc (ppm) (CDCl3, 91 MHz): 208.4 (C, C=Oketone), 155.7 (C, C=Ocarbamate), 
80.0 (C, CCH2OH), 62.9 (CH2, CCH2OH), 62.2 (CH2, OCH2CH3), 59.4 (CH, 
NCHC), 54.1 (CH, NCHCH2CO), 46.4 (CH2, CHCH2CO), 28.3 (CH2, 
CHCH2CH2CHCH2), 23.9 (CH2, CHCH2CH2CHCH2), 15.0 (CH3, OCH2CH3); m/z 
(ES+) 244 ([M+H]+, 100%); m/z (ES+) found: [M+H]+, 244.1189. C11H18NO5 
requires: [M+H]+, 244.1185. 
 
 
 
Synthesis of (1R*,2S*,5S*)-ethyl 2',3-dioxo-8-2',3-dioxo-8H-spiro[8-
azabicyclo[3.2.1]octane-2,4'-[1,3]dioxolane]-8-carboxylate (±)-143, (1R,2S,5S)-(+)-
ethyl 2',3-dioxo-8-2',3-dioxo-8H-spiro[8-azabicyclo[3.2.1]octane-2,4'-
[1,3]dioxolane]-8-carboxylate 143 and (1S,2R,5R)-(-)-ethyl 2',3-dioxo-8-2',3-dioxo-
8H-spiro[8-azabicyclo[3.2.1]octane-2,4'-[1,3]dioxolane]-8-carboxylate ent-143 
 
 
N
EtO2C
O
N
EtO2C
O
Triphosgene,
Pyridine,
DCMOH
OH OO
O
142 (±)-143
 
 
 
To a stirred solution of diol (±)-142 (150 mg, 6.15 mmol) and pyridine (0.5 ml, 6.15 
mmol) in DCM (3 ml) a solution of triphosgene (0.182 mg, 6.15 mmol) in DCM (0.4 
ml) was added at 0 oC under a nitrogen atmosphere. The mixture was stirred between 
0 oC and room temperature for 8 hours. It was then quenched with H2O (2 ml). The 
organic phase was diluted with DCM (20 ml), separated, dried over MgSO4 and 
 Chapter 7 
 
 194
concentrated. The residue was purified by flash chromatography on silica gel eluting 
with 50% EtOAc in n-hexane to give (±)-143 as a colourless solid (100 mg, 60%); 
m.p.: 113.4-114.3 oC; νmax/cm-1 (CHCl3): 1806, 1692, 1426, 1335, 1047; 1H NMR δH 
(ppm) (CDCl3, 500 MHz): 5.04-4.99 (1 H, m, CCH2O), 4.85-4.64 (2 H, m, NCHC 
and NCHCH2CO), 4.27-4.18 (2 H, m, OCH2CH3), 4.00 (1 H, d, J = 8.8 Hz, CCH2O), 
3.15-3.01 (1 H, br m, CHCH2axCO), 2.52 (1 H, dd, J = 15.2 and 2.2 Hz, 
CHCH2eqCO), 2.16-2.08 (2 H, m, CHCH2exoCH2exoCH), 1.63-1.61 (1 H, m, 
CHCH2endoCH2endoCHCH2), 1.33-1.24 (4 H, m, OCH2CH3 and 
CHCH2endoCH2endoCHCH2); 13C NMR δc (ppm) (CDCl3, 91 MHz): 199.6 (C, 
C=Oketone), 154.4 (C, C=Ocarbamate), 152.6 (C, C=Ocarbonate), 85.2 (C, CCH2O), 65.8 
(CH2, CCH2O), 62.4 (CH2, OCH2CH3), 59.4 (CH, NCHC), 54.0 (CH, NCHCH2CO), 
47.1 (CH2, CHCH2CO), 27.9 (CH2, CHCH2CH2CHCH2), 23.8 (CH2, 
CHCH2CH2CHCH2), 14.9 (CH3, OCH2CH3); m/z (ES+) 270 ([M+H]+, 100%); m/z 
(ES+) found: [M+H]+, 270.0976. C12H16NO6 requires: [M+H]+, 270.0978. 
 
The racemic compound was then separated into single enantiomers by SFC 
(Chiralpak AD-H column, 220 nm, 90/10 CO2/iso-propanol, 10 ml/min, 35 oC, 
Outlet P=100 bar): 
ent-143: enantiomer 1, Rt = 5.20 min, m.p.: 126.5-128.1 oC; [α]D20 -25.2 (c 1, 
CHCl3); 99% enantiomeric excess, colourless solid. 
143: enantiomer 2, Rt = 6.35 min, m.p.: 116.1-120.2 oC; [α]D20 +21.0 (c 0.3, CHCl3); 
97% enantiomeric excess, colourless solid. 
Absolute configuration of the catalyst assumed by correlation with optical rotation of 
E-stilbene oxide obtained from epoxidation reaction that is assumed to occur through 
a spiro transition state. 
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Synthesis of (1R*,2S*,5S*)-ethyl 3-oxo-8H–spiro-[8-azabicyclo[3.2.1]octane-2,2'-
oxirane]-8-carboxylate (±)-145 
 
N
EtO2C
O
OHHO
N
EtO2C
O
OHO S O
O
N
EtO2C
O
O
p-Toluensulfonyl 
chloride,
Et3N, DMAP, DCM K2CO3, EtOH
142 145147
 
 
To a stirred solution of diol (±)-142 (580 mg, 2.39 mmol) in DCM (15 ml), Et3N (0.5 
ml, 3.58 mmol) was added followed by 4-(dimethylamino)pyridine (catalytic 
amount) and p-toluensulfonylchloride (0.68 g, 3.58 mmol) under a nitrogen 
atmosphere. The mixture was stirred at room temperature overnight. It was then 
diluted with DCM (20 ml), washed with H2O (20 ml) and then the aqueous layer 
extracted with further DCM (3×20 ml). The combined organics were dried over 
MgSO4 and concentrated to dryness. The residue was purified by flash 
chromatography on silica gel eluting with 3% MeOH in DCM to give (±)-147 as a 
colourless oil that was taken immediately through the next step. It was dissolved in 
EtOH (10 ml) and K2CO3 (280 mg, 2.03 mmol) was added. The mixture was stirred 
at room temperature for 48 hours. The solvent was then evaporated under reduced 
pressure and the residue dissolved in EtOAc (20 ml), washed with H2O (20 ml), 
dried over MgSO4 and concentrated in vacuo. The residue was purified by flash 
chromatography on silica gel eluting with 3% MeOH in DCM to give (±)-145 as a 
colourless oil (370 mg, 69%); ν max/cm-1 (CHCl3): 2978, 2360, 2340, 1694, 1416, 
1108, 913, 744; 1H NMR δH (ppm) (CDCl3, 500 MHz): 4.73 (1 H, br s, 
NCHCH2CO), 4.22-4.18 (3 H, m, NCHC and OCH2CH3), 3.49 (1 H, dd, J = 5.5 and 
1.5 Hz, CCH2O), 2.92-2.89 (1 H, br d, CHCH2axCO), 2.74 (1 H, d, J = 5.5 Hz, 
CCH2O), 2.51 (1 H, d, J = 17.8 Hz, CHCH2eqCO), 2.24-2.17 (2 H, m, 
CHCH2exoCH2exoCH), 1.88-1.84 (1 H, m, CHCH2endoCH2endoCHCH2), 1.73-1.69 (1 H, 
m, CHCH2endoCH2endoCHCH2), 1.32 (3 H, t, J = 7.1 Hz, OCH2CH3); 13C NMR δc 
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(ppm) (CDCl3, 91 MHz): 205.0 (C, C=Oketone), 154.5 (C, C=Ocarbamate), 62.1 (CH2, 
OCH2CH3 and C, CCH2O), 58.5 (CH, NCHC), 52.8 (CH, NCHCH2CO), 49.8 (CH2, 
CCH2O), 48.1 (CH2, CHCH2CO), 29.0 (CH2, CHCH2CH2CHCH2), 27.5 (CH2, 
CHCH2CH2CHCH2), 15.0 (CH3, OCH2CH3); m/z (ES+) 226 ([M+H]+, 100%); m/z 
(ES+) found: [M+H]+, 226.1078. C11H16NO4 requires: [M+H]+, 226.1079. 
 
 
 
Synthesis of (1R*,2R*,5S*)-ethyl 2-(azidomethyl)-2-hydroxy-3-oxo-8-
azabicyclo[3.2.1]octane-8-carboxylate (±)-148 
 
 
N
EtO2C
O
O N
EtO2C
O
N3
OHNH4Cl, NaN3,
Acetone/H2O
145 148
 
 
 
To a stirred solution of epoxide (±)-145 (150 mg, 0.67 mmol) in a mixture acetone (4 
ml)/ H2O (1 ml) NH4Cl (107 mg, 2.0 mmol) and NaN3 (108 mg, 1.67 mmol) were 
added. The mixture was stirred at reflux temperature overnight. It was then 
concentrated, diluted with EtOAc (10 ml), washed with H2O (3×20 ml), dried over 
MgSO4 and concentrated. The residue was purified by flash chromatography on 
silica gel eluting with 50% EtOAc in n-hexane to give (±)-148 as a colourless oil 
(175 mg, 98%); νmax/cm-1 (CHCl3): 3396, 2982, 2093, 1694; 1H NMR δH (ppm) 
(CDCl3, 500 MHz): 4.60 (2 H, br s, NCHCH2CO and NCHC), 4.20 (2 H, q, J = 7.1 
Hz, OCH2CH3), 3.94-3.82 (1 H, br s, COH), 3.80 (1 H, d, J = 13.5 Hz, CCH2N3), 
3.34 (1 H, d, J = 13.5 Hz, CCH2N3), 3.13 (1 H, dd, J = 14.7 and 4.3 Hz, 
CHCH2axCO), 2.23 (1 H, d, J = 14.7 Hz, CHCH2eqCO), 2.06-2.01 (2 H, m, 
CHCH2exoCH2exoCH), 1.60-1.50 (2 H, m, CHCH2endoCH2endoCH), 1.26 (3 H, t, J = 7.1 
Hz, OCH2CH3); 13C NMR δc (ppm) (CDCl3, 91 MHz,): 205.9 (C, C=Oketone), 155.9 
(C, C=Ocarbamate), 80.5 (C, CCH2N3), 62.4 (CH2, OCH2CH3), 59.7 (CH, NCHC), 54.4 
(CH, NCHCH2CO), 52.8 (CH2, CCH2N3), 46.1 (CH2, CHCH2CO), 28.2 (CH2
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CHCH2CH2CH), 24.1 (CH2, CHCH2CH2CH ), 15.0 (CH3, OCH2CH3); m/z (ES+) 
269 ([M+H]+, 100%); m/z (ES+) found: [M+H]+, 269.1265. C11H17N4O4 requires: 
[M+H]+, 269.1250. 
 
 
Synthesis of (1R*,2R*,5S*)-ethyl 2-(aminomethyl)-2-hydroxy-3-oxo-8-
azabicyclo[3.2.1]octane-8-carboxylate hydrochloride (±)-149 
 
 
N
EtO2C
O
N3
OH N
EtO2C
O
NH2 HCl
OHMeOH, HCl,
H2, Pd/C 10%w
148 149
 
 
 
Azide (±)-148 (150 mg, 0.56 mmol) was dissolved in EtOH (15 ml); 2.0 M HCl 
(0.42 ml, 0.84 mmol) was added followed by 10% w Pd/C (catalytic amount). The 
mixture was stirred at room temperature under a balloon of nitrogen for 1.5 h. The 
mixture was then filtered through a pad of Celite™ and was washed with further 
EtOH (20 ml). The filtrate was concentrated under reduced pressure. Trituration of 
the residue with diethyl ether afforded (±)-149 as a pale yellow solid (155 mg, 
quantitative yield); νmax/cm-1 (CHCl3): 2980, 1686, 1451, 1033; 1H NMR δH (ppm) 
(CD3OD, 500 MHz): 4.63 (1 H, br s, NCHCH2CO), 4.45 (1 H, d, J = 7.0 Hz, 
NCHC), 4.24-4.18 (2 H, m, OCH2CH3), 3.41 (1 H, d, J = 13.5 Hz, CCH2NH2), 3.13 
(1 H, dd, J = 14.5 and 3.2 Hz, CHCH2CO), 2.98 (1 H, d, J = 13.5 Hz, CCH2NH2), 
2.29 (1 H, dd, J = 14.5 and 1.5 Hz, CHCH2CO), 2.07-2.00 (2 H, m, 
CHCH2exoCH2exoCH), 1.63-1.57 (2 H, m, CHCH2endoCH2endoCH), 1.32-1.24 (3 H, m, 
OCH2CH3); 13C NMR δc (ppm) (CD3OD, 91 MHz): 208.4 (C, C=Oketone), 157.2 (C, 
C=Ocarbamate), 79.0 (C, CCH2NH2), 63.7 (CH2, OCH2CH3), 61.9 (CH, NCHC), 55.9 
(CH, NCHCH2CO), 47.1 (CH2, CHCH2CO), 43.2 (CH2, CCH2NH2), 29.6 (CH2, 
CHCH2CH2CH), 25.5 (CH2, CHCH2CH2CH), 15.8 (CH3, OCH2CH3); m/z (ES+) 243 
([M+H]+, 60%); m/z (ES+) found: [M+H]+, 243.1339. C11H19N2O4 requires: 
[M+H]+, 243.1345. 
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Synthesis of (1R*,3S*,5S*)-ethyl 3-hydroxy-2-methylene-8-azabicyclo[3.2.1]octane-
8-carboxylate (±)-151 
 
 
N
EtO2C
O
N
EtO2C
OH
NaBH4, CeCl3·7H2O
MeOH
136 151
 
 
 
CeCl3·7H2O (7.8 g, 0.02 mol) was added to a solution of enone (±)-136 (4.0 g, 0.02 
mol) in MeOH (30 ml). The mixture was cooled to 0 oC and then NaBH4 (0.79 g, 
0.02 mol) was added portionwise. After stirring at 0 oC for 1 hour, the mixture was 
quenched with water (3 ml). The organic solvent was evaporated in vacuo and the 
residue diluted with EtOAc (30 ml), washed with 0.1 M HCl (10 ml), brine (10 ml), 
dried over MgSO4 and concentrated. It was then purified by flash chromatography on 
silica gel eluting with 50% EtOAc in n-hexane and then with 5% MeOH in DCM to 
yield (±)-151 as a colourless oil (3.8 g, 95%); νmax/cm-1 (CHCl3): 3518, 1697, 908; 1H 
NMR δH (ppm) (DMSO-d6, 500 MHz): 4.92 (1 H, d, J = 6.5 Hz, OH), 4.90-4.89 (1 
H, m, C=CH2), 4.80 (1 H, br s, C=CH2), 4.46 (1 H, d, J = 6.3 Hz, NCHC), 4.32-4.29 
(1 H, m, CHCH2CHOH), 4.16 (1 H, br s, NCHCH2CHOH), 4.01 (2 H, q, J = 7.0 Hz, 
OCH2CH3), 1.91-1.87 (3 H, m, CHCH2CHOH and CHCH2exoCH2exoCH), 1.76-1.67 
(1 H, m, CHCH2endoCH2endoCHCH2), 1.66-1.57 (1 H, m, CHCH2endoCH2endoCHCH2), 
1.55-1.40 (1 H, m, CHCH2CHOH), 1.16 (3 H, t, J = 7.1 Hz, OCH2CH3); 1H NMR δH 
(ppm) (CDCl3, 500 MHz): 5.08-4.79 (2 H, br m, C=CH2), 4.75-4.51 (1 H, br m, 
NCHC), 4.50-4.40 (1 H, br s, CHCH2CHOH), 4.39-4.28 (1 H, br s, 
NCHCH2CHOH), 4.15-4.02 (2 H, m, OCH2CH3), 2.65-1.97 (4 H, br m, OH, 
CHCH2CHOH and CHCH2exoCH2exoCH), 1.76-1.52 (3 H, br m, 
CHCH2endoCH2endoCH and CHCH2CHOH), 1.25-1.20 (3 H, t, m, OCH2CH3); 13C 
NMR δc (ppm) (CDCl3, 91 MHz): 154.5 (C, C=Ocarbamate), 150.4 (C, C=CH2), 106.3 
(CH2, C=CH2), 66.5 (CH, CHCH2CHOH), 61.4 (CH2, OCH2CH3), 60.3 (CH, 
NCHC), 53.9 (CH, NCHCH2CHOH), 43.1 (CH2, CHCH2CHOH), 29.4 (CH2, 
CHCH2CH2CHCH2), 28.1 (CH2, CHCH2CH2CHCH2), 15.1 (CH3, OCH2CH3); m/z 
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(ES+) 166 ([M+H (-OH and -C2H5)]+ 100%); m/z (ES+) found: [M+H]+, 212.1287. 
C11H18NO3 requires: [M+H]+, 212.1287. 
 
 
 
Synthesis of (1R*,2S*,3S*,5S*)-ethyl 3-hydroxy-8H-spiro[8-
azabicyclo[3.2.1]octane-2,2’-oxirane]-8-carboxylate (±)-152 
 
 
N
EtO2C
OH
N
EtO2C
OH
O
0 oC
151 152
m-CPBA,  DCM
 
 
 
Allylic alcohol (±)-151 (4.9 g, 0.02 mol) was dissolved in DCM (60 ml) and cooled 
to 0 oC. Then m-CPBA 75% w (6.2 g, 0.03 mol) was added portionwise and the 
mixture stirred at 0 oC for 3 h. A white solid formed during the reaction. The 
suspension was diluted with DCM (20 ml); it was washed with a 10% solution of 
sodium tiosulfate (40 ml), then with 1.0 M NaOH (40 ml) and finally with brine (40 
ml). The organic layer was dried over MgSO4 and then concentrated under vacuum. 
The residue was purified by flash chromatography on silica gel eluting with 50% 
EtOAc in n-hexane and then with 5% MeOH in DCM to yield (±)-152 as a colourless 
oil (3.7 g, 70%); νmax/cm-1 (CHCl3): 3525, 1707, 1487, 1123; 1H NMR δH (ppm) 
(DMSO-d6, 500 MHz): 4.33 (1 H, d, J = 9.0 Hz, OH), 4.26 (1 H, br s, 
NCHCH2CHOH), 4.08-4.00 (3 H, m, OCH2CH3 and CHCH2CHOH), 3.78 (1 H, br s, 
NCHC), 2.82 (1 H, d, J = 5.3 Hz, CCH2O), 2.66 (1 H, d, J = 5.3 Hz, CCH2O), 1.92-
1.86 (3 H, m, CHCH2CHOH and CHCH2exoCH2exoCH), 1.76-1.69 (2 H, m, 
CHCH2endoCH2endoCH), 1.59 (1 H, m, CHCH2CHOH), 1.17 (3 H, br t, OCH2CH3); 1H 
NMR δH (ppm) (CDCl3, 500 MHz): 4.44 (1 H, br s, NCHCH2CHOH), 4.17-4.10 (3 
H, m, OCH2CH3 and CHCH2CHOH), 4.09-3.90 (1 H, m, NCHC), 3.04 (1 H, d, J = 
5.3 Hz, CCH2O), 2.76 (1 H, br s, CCH2O), 2.16-2.12 (1 H, m, J = 13.0, 6.1 and 2.9 
Hz, CHCH2eqCHOH), 2.08-1.96 (2 H, m, CHCH2exoCH2exoCH), 1.84-1.76 (2 H, m, 
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CHCH2endoCH2endoCH and CHCH2CHOH), 1.74-1.70 (2 H, m, CHCH2axCHOH and 
CHCH2endoCH2endoCH), 1.26 (3 H, t, J = 7.1 Hz, OCH2CH3); 13C NMR δc (ppm) 
(CDCl3, 91 MHz): 154.3 (C, C=Ocarbamate), 61.9 (CH, CHCH2CHOH), 61.6 (CH2, 
OCH2CH3), 61.2 (C, CCH2O), 58.8 (CH, NCHC), 52.7 (CH, NCHCH2CHOH), 48.8 
(CH2, CCH2O), 40.2 (CH2, CHCH2CHOH), 26.6 (CH2, CHCH2CH2CH), 26.4 (CH2, 
CHCH2CH2CH), 14.7 (CH3, OCH2CH3); m/z (ES+) 250 ([M+Na]+, 100%); m/z 
(ES+) found: [M+H]+, 228.1247. C11H18NO4 requires: [M+H]+, 228.1236. 
 
 
 
Synthesis of (1R*,2R*,3S*,5S*)-ethyl 2-[(benzylamino)methyl]-2,3-dihydroxy-8-
azabicyclo[3.2.1]octane-8-carboxylate (±)-153 
 
 
N
EtO2C
OH
O N
EtO2C
OH
OHHN
Benzylamine,
EtOH, Reflux
152 153
 
 
 
Epoxide (±)-152 (0.5 g, 2.2 mmol) was dissolved in EtOH (5 ml) and benzylamine 
(0.24 ml, 2.2 mmol) was added. The solution was heated to reflux temperature 
overnight. The reaction mixture was cooled to RT and concentrated under reduced 
pressure. The residue was purified by SCX cartridge eluting first with MeOH and 
then with 2.0 M NH3 in MeOH to yield (±)-153 as a colourless oil (0.73 g, 
quantitative yield); νmax/cm-1 (CHCl3): 3405, 1690, 1113; 1H NMR δH (ppm) (CDCl3, 
500 MHz): 7.34-7.25 (5 H, m, CHAr), 4.31 (1 H, br s, NCHCH2CHOH), 4.19-4.09 (3 
H, m, OCH2CH3 and NCHC), 3.85-3.77 (3 H, m, NCH2Ar and CHCH2CHOH), 3.19 
(3 H, br s, OH, OH, NH), 2.82 (1 H, d, J = 12.1 Hz, CCH2NH), 2.78 (1 H, d, J = 12.1 
Hz, CCH2NH), 1.92-1.69 (4 H, m, CHCH2exoCH2exoCH and CHCH2CHOH), 1.57-
1.49 (2 H, m, CHCH2endoCH2endoCH), 1.26 (3 H, t, J = 7.1 Hz, OCH2CH3); 13C NMR 
δc (ppm) (CDCl3, 91 MHz): 155.6 (C, C=Ocarbamate), 139.6 (C, CAr), 129.0 (CH, 
CHAr), 128.5 (CH, CHAr), 127.8 (CH, CHAr), 74.6 (C, CCH2NH), 69.4 (CH, 
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CHCH2CHOH), 61.6 (CH2, OCH2CH3), 59.9 (CH, NCHC), 55.5 (CH2, CCH2NH), 
54.6 (CH2, NHCH2Ar), 52.5 (CH, NCHCH2CHOH), 36.5 (CH2, CHCH2CHOH), 
27.7 (CH2, CHCH2CH2CH), 25.0 (CH2, CHCH2CH2CH), 15.1 (CH3, OCH2CH3); m/z 
(ES+) 335 ([M+H]+, 100%); m/z (ES+) found: [M+H]+, 335.1974. C18H27N2O4 
requires: [M+H]+, 335. 1971. 
 
 
 
Synthesis of (5R*,8S*,9aS*,4aR*)-ethyl 3-benzyl-4a-hydroxy-2-oxodecahydro-5,8-
epiminocyclohepta[e ][1,3]oxazine-10-carboxylate (±)-155 
 
 
N
O
N
O
OHN
OH
HNHO Pyridine, Triphosgene,
DCM
EtO2C EtO2C
153 155
 
 
 
Intermediate (±)-153 (0.01 g, 0.03 mmol) was dissolved in DCM (1 ml); pyridine (30 
µl, 0.3 nmol) was added and cooled to 0 oC. Triphosgene (10 mg, 0.03 mmol) was 
subsequently added portionwise and the final mixture was stirred at RT for 1 h. It 
was then diluted with DCM (10 ml), washed with 0.1 M HCl (10 ml), H2O (10 ml), 
brine (10 ml), dried over MgSO4 and concentrated. The residue was purified by flash 
chromatography on silica gel eluting with 50% EtOAc in n-hexane followed by 3% 
MeOH in DCM to yield (±)-155 as a yellow oil (7 mg, 60%); νmax/cm-1 (CHCl3): 
3414, 2967, 1803, 1682, 1431, 1106; 1H NMR δH (ppm) (CDCl3, 500 MHz): 7.30-
7.16 (5 H, m, CHAr), 4.54 (1 H, d, J = 15.1 Hz, NCH2Ar), 4.46 (1 H, d, J = 15.1 Hz, 
NCH2Ar), 4.39 (1 H, br s, NCHCH2CHOCO), 4.20-4.19 (1 H, m, NCHC), 4.15 (1 H, 
dd, J = 5.8, 11.3 Hz, CH2CHOCO), 4.09-4.01 (2 H, m, OCH2CH3), 3.23 (1 H, d, J = 
11.8 Hz, CCH2N), 3.00 (1 H, d, J = 11.8 Hz, CCH2N), 1.98-1.82 (4 H, m, 
CHCH2exoCH2exoCH and CHCH2CHOCO), 1.57-1.47 (2 H, m, 
CHCH2endoCH2endoCH), 1.22-1.16 (3 H, m, OCH2CH3); 13C NMR δc (ppm) (CDCl3, 
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91 MHz): 154.5 (C, C=Ocarbamate), 152.5 (C, C=Ocyclic carbamate), 135.2 (C, CAr), 127.8 
(CH, CHAr), 126.9 (CH, CHAr), 126.7 (CH, CHAr), 71.1 (CH, CH2CHOCO), 67.3 (C, 
CCH2N), 60.8 (CH2, OCH2CH3), 57.9 (CH, NCHC), 51.9 (CH2, NCH2Ar), 51.7 
(CH2, CCH2N), 51.2 (CH, NCHCH2CHOCO), 31.4 (CH2, CHCH2CHOCO), 26.5 
(CH2, CHCH2CH2CH), 23.9 (CH2, CHCH2CH2CH), 13.6 (CH3, OCH2CH3); m/z 
(ES+) 361 ([M+H]+, 100%); m/z (ES+) found: [M+H]+, 361.1750. C19H25N2O5 
requires: [M+H]+, 361.1763. 
 
 
 
Synthesis of (1R*,2R*,5S*)-ethyl 2-[(benzylamino)methyl]-2-hydroxy-3-oxo-8-
azabicyclo[3.2.1]octane-8-carboxylate (±)-157 
 
 
N
EtO2C
OH
OHHN
N
EtO2C
OHHN
O
IBX, TFA, DMSO,
RT
153 157
 
 
 
Intermediate (±)-153 (0.73 g, 2.2 mmol) was dissolved in DMSO (20 ml) and TFA 
(0.18 ml, 2.3 mmol) was added followed by IBX (1.85 g, 6.6 mmol). The reaction 
mixture was stirred at RT overnight. Then 3 ml of water were added and after 10 
minutes of stirring a white solid was filtered. The filtrate was diluted with EtOAc (30 
ml), washed with water, dried over Na2SO4 and concentrated. It was then purified by 
SCX cartridge eluting first with MeOH and then with 2.0 M NH3 in MeOH. The 
amonia fractions were further purified by flash chromatography on silica gel eluting 
with 3% MeOH in DCM to yield (±)-157 as a yellow oil (0.44 g, 63%); νmax/cm-1 
(CHCl3): 3404, 2978, 1681, 1422, 1314, 1105, 747; 1H NMR δH (ppm) (CDCl3, 500 
MHz): 7.34-7.25 (5 H, m, CHAr), 4.56 (1 H, br s, NCHCH2CO), 4.45-4.18 (3 H, m, 
OCH2CH3 and NCHC), 3.84 (1 H, d, J = 13.4 Hz, NCH2Ar), 3.80 (1 H, d, J = 13.4 
Hz, NCH2Ar), 3.25 (1 H, d, J = 12.2 Hz, CCH2N), 3.17 (1 H, br d, CHCH2axCO), 
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2.28 (1 H, d, J = 12.2 Hz, CCH2NH), 2.16 (1 H, dd, J = 14.6 and 1.7 Hz, 
CHCH2eqCO), 1.97-1.89 (2 H, m, CHCH2exoCH2exoCH), 1.52-1.42 (2 H, m, 
CHCH2endoCH2endoCH), 1.30 (3 H, t, J = 7.1 Hz, OCH2CH3); 13C NMR δc (ppm) 
(CDCl3, 91 MHz): 209.5 (C, C=Oketone), 155.2 (C, C=Ocarbamate), 140.0 (C, CAr), 128.9 
(CH, CHAr), 128.4 (CH, CHAr), 127.6 (CH, CHAr), 77.7 (C, CCH2NH), 61.8 (CH2, 
OCH2CH3), 61.4 (CH, NCHC), 54.6 (CH2, NCH2Ar), 53.7 (CH, NCHCH2CO), 50.3 
(CH2, CCH2NH), 46.2 (CH2, CHCH2CO), 28.3 (CH2, CHCH2CH2CHCH2), 23.4 
(CH2, CHCH2CH2CHCH2), 15.1 (CH3, OCH2CH3); m/z (ES+) 333 ([M+H]+, 100%); 
m/z (ES+) found: [M+H]+, 333.1820. C18H25N2O4 requires: [M+H]+, 333.1814. 
 
 
 
Synthesis of (1R*,2R*,5S*)-ethyl 3’-benzyl-2’,3-dioxo-8H-spiro[8-
azabicyclo[3.2.1]octane-2,5’-[1,3]oxazolidine]-8-carboxylate (±)-156, (1R,2R,5S)-
(+)-ethyl 3’-benzyl-2’,3-dioxo-8H-spiro[8-azabicyclo[3.2.1]octane-2,5’-
[1,3]oxazolidine]-8-carboxylate 156 and (1S,2S,5R)-(-)-ethyl 3’-benzyl-2’,3-dioxo-
8H-spiro[8-azabicyclo[3.2.1]octane-2,5’-[1,3]oxazolidine]-8-carboxylate ent-156 
 
 
N
O
NO
OEtO2C
N
O
HNHO
EtO2C
Triphosgene, Pyridine,
DCM
157 (±)-156
 
 
Amino alcohol (±)-157 (0.44 g, 1.35 mmol) was dissolved in DCM (20 ml); pyridine 
(1.3 ml, 0.01 mol) was added and the mixture cooled to 0 oC. Triphosgene (432 mg, 
1.46 mmol) was subsequently added portionwise and the final mixture was stirred at 
RT for 7 h. It was then diluted with DCM (10 ml), washed with 0.1 M HCl (10 ml), 
H2O (20 ml), brine (20 ml), dried over MgSO4 and concentrated. The residue was 
purified by flash chromatography on silica gel eluting with 50% EtOAc in n-hexane 
to yield 330 mg (70%) of (±)-156 as a pale yellow solid; m.p.: 123.0-123.9 oC; νmax 
/cm-1 (CHCl3): 2968, 1760, 1698, 1418, 1332, 1106; 1H NMR δH (ppm) (CDCl3, 500 
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MHz): 7.40-7.26 (5 H, m, CHAr), 4.65 (1 H, br s, NCHCH2CO), 4.51-4.47 (2 H, m, 
NCH2Ar and NCHC), 4.39 (1 H, d, J = 15.0 Hz, NCH2Ar), 4.30-4.21 (2 H, m, 
OCH2CH3), 4.03 (1 H, d, J = 8.8 Hz, CCH2N), 3.21-3.07 (1 H, br d, J = 14.8 Hz, 
CHCH2axCO), 2.86 (1 H, br d, J = 8.8 Hz, CCH2N), 2.43 (1 H, d, J = 14.8 Hz, 
CHCH2eqCO), 2.08-1.98 (2 H, m, CHCH2exoCH2exoCH), 1.53 (1 H, m, 
CH2CHCH2endoCH2endoCH), 1.37-1.27 (3 H, m, OCH2CH3), 1.26-1.20 (1 H, m, 
CH2CHCH2endoCH2endoCH); 13C NMR δc (ppm) (91 MHz, CDCl3): 200.8 (C, 
C=Oketone), 155.7 (C, C=O), 154.7 (C, C=O), 135.8 (C, CAr), 129.4 (CH, CHAr), 
128.6 (CH, CHAr), 128.4 (CH, CHAr), 82.7 (C, CCH2N), 62.3 (CH2, OCH2CH3), 60.2 
(CH, NCHC), 54.0 (CH, NCHCH2CO), 48.8 (CH2, NCH2Ar), 46.8 (CH2, 
CHCH2CO), 45.3 (CH2, NCH2C), 27.9 (CH2, CH2CHCH2CH2CH), 23.9 (CH2, 
CH2CHCH2CH2CH), 15.0 (CH3, OCH2CH3); m/z (ES+) 359 ([M+H]+, 100%); m/z 
(ES+) found: [M+H]+, 359.1619. C19H23N2O5 requires: [M+H]+, 359.1607. 
 
The racemic compound was then separated into single enantiomers by SFC 
(Chiralpak AS-H column, 220 nm, 85/15 CO2/MeOH, 10 ml/min, 40 oC, Outlet 
P=100 bar): 
ent-156: enantiomer 1, Rt = 3.60 min, m.p. 82.5-88.3 oC; [α]D20 -5.0 (c 1, CHCl3); 
>99% enantiomeric excess, 80 mg, colourless solid. 
156: enantiomer 2, Rt = 4.19 min, m.p. 88.5-90.7 oC [α]D20 +4.6 (c 1, CHCl3); >99% 
enantiomeric excess, 80 mg, colourless solid. 
Absolute configuration of the catalyst assumed by correlation with optical rotation of 
E-stilbene oxide obtained from epoxidation reaction that is assumed to occur through 
a spiro transition state. 
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Synthesis of (1R*,2R*,5S*)-ethyl 2-hydroxy-3-oxo-2-({[(1S)-1-
phenylethyl]amino}methyl)-8-azabicyclo[3.2.1]octane-8-carboxylate (±)-159 
 
 
N
O
HNHO
EtO2C
N HNHO
OH
EtO2C
N O
OH
EtO2C
IBX, TFA, 
DMSO
EtOH,
(S)-(-)-α-methyl
benzylamine,
152
159
158
70 oC
Sealed tube
NNH OH
HO
CO2Et
N
O
NH OH
CO2Et
 
 
Epoxide (±)-152 (0.5 g, 2.2 mmol) was dissolved in EtOH (5 ml) and then (S)-(-)-α-
methyl benzylamine (0.24 ml, 2.2 mmol) was added. The solution was heated to 70 
oC overnight in a sealed tube. The reaction mixture was cooled to RT and 
concentrated under reduced pressure. The residue was purified by SCX cartridge 
eluting first with MeOH and then with 2.0 M NH3 in MeOH to yield 158 as a 
colourless oil. The crude reaction was used immediately in the following step. It was 
dissolved in DMSO (20 ml) and TFA (0.18 ml, 2.3 mmol) was added followed by 
IBX (1.85 g, 6.6 mmol). The reaction mixture was stirred at RT overnight. Then 5 ml 
of water were added; after 10 minutes of stirring a white solid was filtered. The 
filtrate was diluted with EtOAc (30 ml), washed with water, dried over MgSO4 and 
concentrated. The residue was purified by SCX cartridge eluting first with MeOH 
and then with 2.0 M NH3 in MeOH. The ammonia fractions were further purified by 
flash chromatography on silica gel eluting with 5% MeOH in DCM to yield 159 (0.4 
g, 53%) as a yellow oil and as a 0.8:1 mixture of diastereoisomers A:B; νmax/cm-1 
(CHCl3): 3328, 2977, 1699, 1432, 1186, 1112, 762; 1H NMR δH (ppm) (CDCl3, 500 
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MHz): 7.36-2.24 (10 H, m, CHAr A+B), 5.54 (2 H, br s, NCHCH2CO A+B), 4.38-
4.10 (6 H, m, NCHC and OCH2CH3 A+B), 3.88-3.77 (1 H, q, J = 6.6 Hz, NCHCH3 
B), 3.75-3.64 (1 H, q, J = 6.6 Hz, NCHCH3 A), 3.25-3.07 (3 H, m, CHCH2CO A+B 
and CCH2NH B), 3.02 (1 H, d, J = 12.2 Hz, CCH2NH A), 2.25-2.02 (4 H, m, 
CHCH2CO A+B and CCH2NH A+B), 2.00-1.77 (4 H, m, CHCH2exoCH2exoCH A+B), 
1.52-1.41 (2 H, m, CHCH2endoCH2endoCHCH2 A+B), 1.40-1.19 (14 H, m, NCHCH3 
A+B, OCH2CH3 A+B and CHCH2endoCH2endoCHCH2 A+B); 13C NMR δc (ppm) 
(CDCl3, 91 MHz): 209.5 (C, C=Oketone A+B), 155.3 (C, C=Ocarbamate A+B), 145.4 (C, 
CAr A/B), 145.0 (C, CAr A/B), 129.1 (CH, CHAr A/B), 129.0 (CH, CHAr A/B), 127.6 
(CH, CHAr A/B), 127.5 (CH, CHAr A/B), 127.2 (CH, CHAr A/B), 126.5 (CH, CHAr 
A/B), 78.5 (C, CCH2NH A+B), 61.8 (CH2, OCH2CH3 A+B), 61.2 (CH, NCHC 
A+B), 59.5 (CH, NCHCH3 A), 58.6 (CH, NCHCH3 B), 53.8 (CH, NCHCH2CO 
A/B), 53.6 (CH, NCHCH2CO A/B), 49.3 (CH2, CCH2NH A), 48.4 (CH2, CCH2NH 
B), 46.2 (CH2, CHCH2CO A+B), 28.2 (CH2, CHCH2CH2CHCH2 A+B), 24.9 (CH3, 
NCHCH3 A/B), 24.7 (CH3, NCHCH3 A/B), 23.4 (CH2, CHCH2CH2CHCH2 A+B), 
15.1 (CH3, OCH2CH3 A/B), 15.0 (CH3, OCH2CH3 A/B); m/z (ES+) 347 ([M+H]+, 
100%); m/z (ES+) found: [M+H]+, 347.1976. C19H27N2O4 requires: [M+H]+, 
347.1971. 
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Synthesis of (1R,2R,5S)-(-)-ethyl 2',3-dioxo-3'-[(1 S)-1-phenylethyl]-8H-spiro[8-
azabicyclo[3.2.1]octane-2,5'-[1,3]oxazolidine]-8-carboxylate 160 and (1S,2S,5R)-(-
)-ethyl 2',3-dioxo-3'-[(1 S)-1-phenylethyl]-8H-spiro[8-azabicyclo[3.2.1]octane-2,5'-
[1,3]oxazolidine]-8-carboxylate 161 
 
N
O
HNHO
N
O
N O
O
Triphosgene, 
Pyridine,
DCM
EtO2C
CO2Et
159
161
N
O
NO
EtO2C
160
O
+
N
O
NH OH
CO2Et
 
 
Amino alcohol 159 (0.4 g, 1.16 mmol) was dissolved in DCM (20 ml); pyridine (1.2 
ml, 0.016 mol) was added and the mixture cooled to 0 oC. Triphosgene (0.38 g, 1.27 
mmol) was subsequently added portionwise and the final mixture was stirred at RT 
for 4 hours. It was then diluted with DCM (10 ml), washed with 0.1 M HCl (10 ml), 
H2O (20 ml), brine (20 ml), dried over MgSO4 and concentrated. The residue was 
purified by flash chromatography on silica gel eluting with 40% EtOAc in n-hexane 
to yield the two single diastereoisomers 160 and 161 as pale yellow solids.  
First eluting diastereoisomer: diastereoisomer 160, pale yellow solid (100 mg, 23% 
of the overall yield); m.p. 91.8-92.4 oC; [α]D20 -120.0 (c 1, CHCl3); Rt = 5.47 min; 
νmax/cm-1 (CHCl3) 2981, 1769, 1731, 1713, 1417,1334, 1220, 1113, 1022, 702; 1H 
NMR δH (ppm) (CDCl3, 500 MHz): 7.41-7.32 (5 H, m, CHAr), 5.22-5.17 (1 H, q, J = 
7.1 Hz, NCHCH3), 4.63 (1 H, br s, NCHCH2CO), 4.58-4.19 (3 H, m, NCHC and 
OCH2CH3), 4.09 (1 H, br d, J = 8.5 Hz, CCH2N), 3.17-3.05 (1 H, m, CHCH2axCO), 
2.56 (1 H, br d, J = 8.5 Hz, CCH2N), 2.42 (1 H, d, J = 14.9 Hz, CHCH2eqCO), 2.04-
1.98 (2 H, m, CHCH2exoCH2exoCH), 1.66-1.53 (4 H, m, NCHCH3 and 
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CHCH2endoCH2endoCHCH2), 1.32-1.27 (3 H, m, OCH2CH3), 1.16-1.14 (1 H, m, 
CHCH2endoCH2endoCHCH2); 1H NMR δH (ppm) (CDCl3, 360 MHz, 55 ºC): 7.40-7.13 
(5 H, m, CHAr), 5.21-5.15 (1 H, q, J = 7.1 Hz, NCHCH3), 4.67 (1 H, br s, 
NCHCH2CO), 4.46-4.15 (3 H, m, NCHC and OCH2CH3), 4.09 (1 H, d, J = 9.0 Hz, 
CCH2N), 3.13 (1 H, br d, J = 15.0 Hz, CHCH2axCO), 2.56 (1 H, d, J = 9.0 Hz, 
CCH2N), 2.39 (1 H, d, J = 15.0 Hz, CHCH2eqCO), 2.14-1.88 (2 H, m, 
CHCH2exoCH2exoCH), 1.61-1.48 (4 H, m, NCHCH3 and CHCH2endoCH2endoCHCH2), 
1.32-1.27 (3 H, t, J = 7.1 Hz, OCH2CH3), 1.18-1.12 (1 H, m, 
CHCH2endoCH2endoCHCH2);13C NMR δc (ppm) (CDCl3, 91 MHz): 201.0 (C, 
C=Oketone), 155.0 (C, C=O), 154.8 (C, C=O), 139.7 (C, CAr), 129.3 (CH, CHAr), 
128.5 (CH, CHAr), 127.3 (CH, CHAr), 82.8 (C, CCH2N), 62.2 (CH2, OCH2CH3), 60.1 
(CH, NCHC), 54.0 (CH, NCHCH2CO), 52.0 (CH, NCHCH3), 46.7 (CH2, 
CHCH2CO), 41.4 (CH2, CCH2N), 27.9 (CH2, CHCH2CH2CHC), 23.8 (CH2, 
CHCH2CH2CHC), 16.5 (CH3, NCHCH3), 14.9 (CH3, OCH2CH3); m/z (ES+) 373 
([M+H]+, 100%); m/z (ES+) found: [M+H]+, 373.1772. C20H25N2O5 requires: 
[M+H]+, 373.1763. 
X-ray structure available confirming the absolute configuration; crystallisation from 
Et2O (See Appendix 8.1). 
 
Second eluting diastereoisomer: diastereoisomer 161, pale yellow solid (135 mg, 
31% of the overall yield); m.p 125.0-126.2 oC; [α]D20 -67.0 (c 1, CHCl3); Rt = 5.62 
min; νmax /cm-1 (CHCl3): 2980, 1728, 1752, 1700, 1420,1110, 1022, 752, 701; 1H 
NMR δΗ (ppm) (CDCl3, 500 MHz): 7.41-7.28 (5 H, m, CHAr), 5.21-5.13 (1 H, q, J = 
7.1 Hz, NCHCH3), 4.77-4.44 (2 H, m, NCHCH2CO and NCHC), 4.35-4.14 (2 H, m, 
OCH2CH3), 3.81 (1 H, br d, J = 9.1 Hz, CCH2N), 3.20-3.01 (1 H, m, CHCH2eqCO), 
3.00-2.85 (1 H, m, CCH2N), 2.39 (1 H, d, J = 15.7 Hz, CHCH2axCO), 2.17-1.94 (2 H, 
m, CHCH2exoCH2exoCH), 1.67-1.49 (4 H, m, NCHCH3 and 
CHCH2endoCH2endoCHCH2), 1.39-1.15 (4 H, m, OCH2CH3 and 
CHCH2endoCH2endoCHCH2); 1H NMR δΗ (ppm) (CDCl3, 360 MHz, 56 ºC): 7.38-7.27 
(5 H, m, CHAr), 5.17-5.11 (1 H, q, J = 7.1 Hz, NCHCH3), 4.62-4.50 (2 H, m, 
NCHCH2CO and NCHC), 4.26-4.16 (2 H, m, OCH2CH3), 3.81 (1 H, d, J = 8.9 Hz, 
CCH2N), 3.11 (1 H, br d, J = 14.7 Hz, CHCH2axCO), 2.90 (1 H, d, J = 8.9 Hz, 
CCH2N), 2.36 (1 H, d, J = 14.7 Hz, CHCH2eqCO), 2.10-1.96 (2 H, m, 
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CHCH2exoCH2exoCH), 1.61-1.52 (4 H, m, NCHCH3 and CHCH2endoCH2endoCHCH2), 
1.34-1.19 (4 H, m, OCH2CH3 and CHCH2endoCH2endoCHCH2); 13C NMR δc (ppm) 
(CDCl3, 91 MHz): 200.8 (C, C=Oketone), 155.1 (C, C=O), 154.7 (C, C=O), 139.3 (C, 
CAr), 129.1 (CH, CHAr), 128.4 (CH, CHAr), 127.3 (CH, CHAr), 82.8 (C, CCH2N), 
62.3 (CH2, OCH2CH3), 60.3 (CH, NCHC), 54.0 (CH, NCHCH2CO), 52.2 (CH, 
NCHCH3), 46.7 (CH2, CHCH2CO), 42.1 (CH2, CCH2N), 27.9 (CH2, 
CHCH2CH2CHCH2), 23.9 (CH2, CHCH2CH2CHCH2), 17.3 (CH3, NCHCH3), 15.0 
(CH3, OCH2CH3); m/z (ES+) 373 ([M+H]+, 100%); m/z (ES+) found: [M+H]+, 
373.1766. C20H25N2O5 requires: [M+H]+, 373.1763. 
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Synthesis of (1R*,2R*,3S*,5S*)-ethyl 2-(anilinomethyl)-2,3-dihydroxy-8-
azabicyclo[3.2.1]octane-8-carboxylate (±)-162 
 
 
N
EtO2C
HNHO
OH
N
EtO2C
OH
O Aniline, EtOH,70 oC
162152
Sealed tube
 
 
 
Epoxide (±)-152 (0.5 g, 2.2 mmol) was dissolved in EtOH (5 ml) and aniline (0.2 ml, 
2.2 mmol) was added. The solution was heated to 70 oC overnight in a sealed tube. 
The reaction mixture was then cooled to RT and and concentrated under reduced 
pressure. The residue was purified by SCX cartridge eluting first with MeOH and 
then with 2.0 M NH3 in MeOH to yield (±)-162 as a colourless oil (0.7 g, quantitative 
yield); νmax/cm-1 (CHCl3): 3370, 2978, 1670, 1603, 1438, 1314, 1115; 1H NMR δΗ 
(ppm) (CDCl3, 500 MHz): 7.19 (2 H, t, J = 7.9 Hz, CHAr-meta), 6.76 (1 H, t, J = 7.3 
Hz, CHAr-para), 6.71 (2 H, d, J = 7.9, CHAr-orto), 4.45 (1 H, br d, NCHC), 4.36 (1 H, br 
s, NCHCH2CHOH), 4.20-4.13 (2 H, m, OCH2CH3), 3.73-3.70 (1 H, dd, J = 11.4 and 
6.0 Hz, CHCH2CHaxOH), 3.49 (1 H, d, J = 12.8 Hz, CCH2NH), 3.20 (1 H, d, J = 12.8 
Hz, CCH2NH), 1.97-1.89 (3 H, m, CHCH2exoCH2exoCH and CHCH2CHOH), 1.83-
1.65 (2 H, m, CHCH2CHOH and CHCH2endoCH2endoCH), 1.65-1.49 (1 H, m, 
CHCH2endoCH2endoCH), 1.27 (3 H, t, J = 7.1 Hz, OCH2CH3); 13C NMR δc (ppm) 
(CDCl3, 91 MHz): 155.5 (C, C=Ocarbamate), 148.7 (C, CAr), 129.7 (CH, CHAr-meta), 
118.9 (CH, CHAr-para), 114.4 (CH, CHAr-orto), 75.3 (C, CCH2NH), 67.5 (CH, 
CHCH2CHOH), 61.5 (CH2, OCH2CH3), 58.8 (CH, NCHC), 52.7 (CH, 
NCHCH2CHOH), 48.0 (CH2, CCH2NH), 37.2 (CH2, CHCH2CHOH), 27.3 (CH2, 
CHCH2CH2CHCH2), 24.7 (CH2, CHCH2CH2CHCH2), 14.7 (CH3, OCH2CH3); m/z 
(ES+) 321 ([M+H]+, 100%); m/z (ES+) found: [M+H]+, 321.1824. C17H25N2O4 
requires: [M+H]+, 321.1814. 
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Synthesis of (1R*,2R*,5S*)-ethyl 2-(anilinomethyl)-2-hydroxy-3-oxo-8-
azabicyclo[3.2.1]octane-8-carboxylate (±)-163 
 
 
N
EtO2C
O
HNHO
N
EtO2C
HNHO
OH
(COCl)2, DMSO, 
Et3N,  DCM
162 163
 
 
 
COCl2 (0.21 ml, 2.42 mmol) in DCM (17 ml) was cooled to -60 oC; DMSO (0.34 ml, 
4.84 mmol) in DCM (1 ml) was added at -60 oC and the mixture stirred for 10 
minutes. Then intermediate (±)-162 (0.7 g, 2.2 mmol) in DCM (2 ml) was added 
over 5 minutes at -60 oC. After 15 minutes stirring at this temperature, Et3N (1.5 ml, 
0.011 mol) was added. The cooling bath was removed and slowly warmed to RT. 
Then H2O (3 ml) was added and the mixture stirred at RT for 10 minutes. The two 
phases were then separated; the organic layer was dried over Na2SO4 and 
concentrated. Purification by flash chromatography on silica gel eluting with 3% 
MeOH in DCM yielded a yellow oil that was further purified by SCX cartridge 
eluting first with MeOH and then with 2.0 M NH3 in MeOH. The title compound (±)-
163 was obtained as a pale yellow oil, (550 mg, 79%); νmax/cm-1 (CHCl3): 3381, 
2979, 1684, 1603, 1438, 1112, 748; 1H NMR δH (ppm) (CDCl3, 500 MHz): 7.20 (2 
H, t, J = 7.6 Hz, CHAr-meta), 6.78 (1 H, t, J = 7.3 Hz, CHAr-para), 6.73 (2 H, d, J = 7.9, 
CHAr-orto), 4.63-4.56 (2 H, br m, NCHCH2CO and NCHC), 4.26-4.20 (2 H, m, 
OCH2CH3), 4.01 (1 H, br s, NH), 3.70 (1 H, br s, OH), 3.58 (1 H, d, J = 13.4 Hz, 
CCH2NH), 3.24-3.17 (2 H, m, CCH2NH and CHCH2axCO), 2.25 (1 H, dd, J = 14.7 
and 2.0 Hz, CHCH2eqCO), 2.04-2.01 (2 H, m, CHCH2exoCH2exoCH), 1.63-1.59 (2 H, 
m, CHCH2endoCH2endoCH), 1.30 (3 H, t, J = 7.1 Hz, OCH2CH3); 13C NMR δc (ppm) 
(CDCl3, 91 MHz): 208.1 (C, C=Oketone), 155.8 (C, C=Ocarbamate), 148.8 (C, CAr), 
129.7 (CH, CHAr), 119.0 (CH, CHAr), 114.5 (CH, CHAr), 79.7 (C, CCH2NH), 62.2 
(CH2, OCH2CH3), 60.5 (CH, NCHC), 54.2 (CH, NCHCH2CO), 46.3 and 46.2 (CH2, 
CCH2NH and CH2, CHCH2CO), 28.4 (CH2, CHCH2CH2CH), 24.0 (CH2, 
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CHCH2CH2CH), 15.1 (CH3, OCH2CH3); m/z (ES+) 319 ([M+H]+, 100%); m/z (ES+) 
found: [M+H]+, 319.1650. C17H23N2O4 requires: [M+H]+, 319.1658. 
 
 
 
Synthesis of (1R*,2R*,5S*)-ethyl 2',3-dioxo-3'-phenyl-8H-spiro[8-
azabicyclo[3.2.1]octane-2,5'-[1,3]oxazolidine]-8-carboxylate (±)-164, (1R,2R,5S)-
(+)-ethyl 2',3-dioxo-3'-phenyl-8H-spiro[8-azabicyclo[3.2.1]octane-2,5'-
[1,3]oxazolidine]-8-carboxylate 164 and (1S,2S,5R)-(-)-ethyl 2',3-dioxo-3'-phenyl-
8H-spiro[8-azabicyclo[3.2.1]octane-2,5'-[1,3]oxazolidine]-8-carboxylate ent-164 
 
N
EtO2C
O
HNHO N
EtO2C
O
NO
O
Triphosgene, Pyridine,
 DCM
163 (±)-164
 
 
 
Amino alcohol (±)-163 (0.55 g, 1.73 mmol) was dissolved in DCM (10 ml); pyridine 
(1.76 ml, 0.02 mol) was added and the mixture cooled to 0 oC. Triphosgene (0.56 g, 
1.90 mmol) was subsequently added portionwise and the final mixture was stirred at 
RT for 4 hours. It was then diluted with DCM (20 ml), washed with 0.1 M HCl (10 
ml), H2O (20 ml), brine (20 ml), dried over MgSO4 and concentrated. The residue 
was purified by flash chromatography on silica gel eluting with 50% EtOAc in n-
hexane to yield (±)-164 a colourless solid (0.39 g, 66%); m.p.: 169.1-172.4 oC; 
νmax/cm-1 (CHCl3): 2981, 1759, 1729, 1699, 1403, 1316, 1111, 757; 1H NMR δH 
(ppm) (CDCl3, 500 MHz): 7.56 (2 H, d, J = 8.1 Hz, CHAr-orto), 7.39 (2 H, t, J = 8.1 
Hz, CHAr-meta), 7.17 (1 H, t, J = 7.4 Hz, CHAr-para), 4.90-4.60 (3 H, m, NCHCH2CO, 
NCHC and CCH2N), 4.31-4.20 (2 H, m, OCH2CH3), 3.48 (1 H, br d, J = 12.9 Hz, 
CCH2N), 3.24-3.20 (1 H, m, CHCH2axCO), 2.51 (1 H, d, J = 20.5 Hz, CHCH2eqCO), 
2.14-2.01 (2 H, m, CHCH2exoCH2exoCH), 1.68-1.56 (1 H, m, 
CHCH2endoCH2endoCHCH2), 1.45-1.33 (4 H, m, CHCH2endoCH2endoCHCH2 and 
OCH2CH3); 13C NMR δc (ppm) (CDCl3, 91 MHz): 200.4 (C, C=Oketone), 154.3 (C, 
C=Ocarbamate), 151.7 (C, C=Ocyclic carbamate), 137.7 (C, CAr), 129.2 (CH, CHAr-meta), 
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124.6 (CH, CHAr-para), 118.3 (CH, CHAr-orto), 81.6 (C, CCH2N), 62.0 (CH2, 
OCH2CH3), 60.0 (CH, NCHC), 53.8 (CH, NCHCH2CO), 46.4 (CH2, CHCH2CO), 
46.0 (CH2, CCH2N), 27.6 (CH2, CHCH2CH2CHCH2), 25.1 (CH2, 
CHCH2CH2CHCH2), 14.6 (CH3, OCH2CH3); m/z (ES+) 345 ([M+H]+, 100%); m/z 
(ES+) found: [M+H]+, 345.1442. C18H21N2O5 requires: [M+H]+, 345.1450. 
 
The racemic compound was then separated into single enantiomers by SFC 
(Chiralpak AS-H column, 220 nm, 85/15 CO2/MeOH, 10 ml/min, 35 oC, Outlet 
P=100 bar): 
ent-164: enantiomer 1, Rt = 3.32 min, m.p. 162.2-163.4 oC; [α]D20 -53.5 (c 1, 
CHCl3); 99% enantiomeric excess, colourless solid, 70 mg. 
164: enantiomer 2, Rt = 4.23 min, m.p. 163.8-164.2 oC [α]D20 +46.5 (c 1, CHCl3); 
98% enantiomeric excess, colourless solid, 70 mg. 
Absolute configuration of the catalyst assumed by correlation with optical rotation of 
E-stilbene oxide obtained from epoxidation reaction that is assumed to occur through 
a spiro transition state. 
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Synthesis of (1R*,2R*,3S*,5S*)-ethyl 2-[(tert-butylamino)methyl]-2,3-dihydroxy-8-
azabicyclo[3.2.1]octane-8-carboxylate (±)-165 
 
 
N
EtO2C
OH
O N
EtO2C
OH
HNHO
tBuNH2, EtOH,
70 oC,
Sealed tube
152 165
 
 
 
Epoxide (±)-152 (0.6 g, 2.64 mmol) was dissolved in EtOH (5 ml) and then 
tbutylamine (0.28 ml, 2.64 mmol) was added. The solution was heated to 70 oC 
overnight in a sealed tube. The reaction mixture was cooled to RT and concentrated 
under reduced pressure. The residue was purified by SCX cartridge eluting first with 
MeOH and then with 2.0 M NH3 in MeOH to yield (±)-165 as a colourless oil (0.79 
g, quantitative yield); νmax/cm-1 (CHCl3): 3374, 2964, 1688, 1434, 1314, 1109, 764; 
1H NMR δH (ppm) (CDCl3, 500 MHz): 4.38-4.26 (1 H, br s, NCHCH2CHOH), 4.24-
3.98 (3 H, m, NCHC and OCH2CH3), 3.88-3.75 (1 H, m, CHCH2CHaxOH), 2.78-2.68 
(2 H, m, CCH2NH), 1.99-1.84 (2 H, m, CHCH2exoCH2exoCH), 1.83-1.65 (2 H, m, 
CHCH2CHOH), 1.65-1.49 (2 H, m, CHCH2endoCH2endoCH), 1.31-1.16 (3 H, m, 
OCH2CH3), 1.13-0.95 (9 H, m, NHC(CH3)3); 13C NMR δc (ppm) (CDCl3, 91 MHz): 
155.6 (C, C=Ocarbamate), 73.8 (C, CCH2NH), 69.5 (CH, CHCH2CHOH), 61.5 (CH2, 
OCH2CH3), 59.9 (CH, NCHC), 52.4 (CH, NCHCH2CHOH), 50.8 (C, NHC(CH3)3), 
49.1 (CH2, CCH2NH), 36.4 (CH2, CHCH2CHOH), 29.3 (CH3, NHC(CH3)3), 27.8 
(CH2, CHCH2CH2CH), 25.1 (CH2, CHCH2CH2CH), 15.1 (CH3, OCH2CH3); m/z 
(ES+) 301 ([M+H]+, 100%); m/z (ES+) found: [M+H]+, 301.2125. C15H29N2O4 
requires: [M+H]+, 301.2127. 
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Synthesis of (1R*,2R*,5S*)-ethyl 2-[(tert-butylamino)methyl]-2-hydroxy-3-oxo-8-
azabicyclo[3.2.1]octane-8-carboxylate (±)-166 
 
 
N
EtO2C
OH
HNHO N
EtO2C
HNHO
O
IBX, TFA, DMSO
165 166
 
 
 
Intermediate (±)-165 (0.69 g, 2.3 mmol) was dissolved in DMSO (30 ml) and TFA 
(0.2 ml, 2.53 mmol) was added followed by IBX (1.9 g, 6.9 mmol). The reaction 
mixture was stirred at RT overnight. Then 5 ml of water were added and after 10 
minutes stirring a white solid was filtered. The solid was washed with further EtOAc 
and then volatiles were concentrated under reduced pressure. The residue was 
purified by SCX cartridge eluting first with MeOH and then with 2.0 M NH3 in 
MeOH to yield (±)-166 as a yellow oil (0.6 g, 88%); νmax/cm-1 (CHCl3): 3327, 2964, 
1694, 1425, 1313, 1108, 1022, 748; 1H NMR δH (ppm) (CDCl3, 500 MHz): 4.56 (1 
H, br s, NCHCH2CO), 4.37 (1 H, br s, NCHC), 4.24-4.20 (2 H, m, OCH2CH3), 3.27-
3.02 (2 H, m, CHCH2axCO and CCH2NH), 2.30-2.19 (1 H, br d, CCH2NH), 2.16 (1 
H, dd, J = 20.0 and 3.6 Hz, CHCH2eqCO), 1.98-1.96 (2 H, m, CHCH2exoCH2exoCH), 
1.51-1.49 (2 H, m, CHCH2endoCH2endoCH), 1.29 (3 H, m, J = 7.1 Hz, OCH2CH3), 1.1 
(9 H, s, NHC(CH3)3), 13C NMR δc (ppm) (CDCl3, 91 MHz): 210.0 (C, C=Oketone), 
155.1 (C, C=Ocarbamate), 77.4 (C, CCH2NH from HMBC), 61.7 (CH2, OCH2CH3 and 
CH, NCHC), 53.7 (CH, NCHCH2CO), 51.1 (C, NHC(CH3)3), 46.3 (CH2, 
CHCH2CO), 43.7 (CH2, CCH2NH), 29.4 (CH3, NHC(CH3)3), 28.3 (CH2, 
CHCH2CH2CHCH2), 23.0 (CH2, CHCH2CH2CHCH2), 15.1 (CH3, OCH2CH3); m/z 
(ES+) 299 ([M+H]+, 100%); m/z (ES+) found: [M+H]+, 299.1966. C15H27N2O4 
requires: [M+H]+, 299.1971. 
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Synthesis of (1S*,2S*,5R*)-ethyl 3'-tert-butyl-2',3-dioxo-8H-spiro[8-
azabicyclo[3.2.1]octane-2,5'-[1,3]oxazolidine]-8-carboxylate (±)-167 and 
(1S,2S,5R)-(-)-ethyl 3'-tert-butyl-2',3-dioxo-8H-spiro[8-azabicyclo[3.2.1]octane-
2,5'-[1,3]oxazolidine]-8-carboxylate ent-167 
 
 
N
EtO2C
O
NO
O
N
EtO2C
HNHO
O
Triphosgene, Pyridine,
DCM
166 (±)-167
 
 
 
Amino alcohol (±)-166 (0.6 g, 2.02 mmol) was dissolved in DCM (20 ml); pyridine 
(2 ml, 0.02 mol) was added and the mixture cooled to 0 oC. Triphosgene (660 mg, 
2.2 mmol) was susbequently added portionwise and the final mixture was stirred at 
RT for 2 h. It was then diluted with DCM (10 ml), washed with 0.1 M HCl, H2O (20 
ml), brine (20 ml), dried over MgSO4 and concentrated. The residue was purified by 
flash chromatography on silica gel eluting with 50% EtOAc in n-hexane to yield (±)-
167 as a colourless oil (250 mg, 38%); νmax/cm-1 (CHCl3): 2978, 1760, 1704, 1408, 
750; 1H NMR δH (ppm) (CDCl3, 360 MHz, 56 oC): 4.70-4.52 (2 H, br m, 
NCHCH2CO and NCHC), 4.26-4.17 (3 H, m, OCH2CH3 and CCH2N), 3.12 (1 H, br 
dd, J = 14.7 and 1.9 Hz, CHCH2axCO), 3.05 (1 H, d, J = 9.1 Hz, CCH2N), 2.41 (1 H, 
dd, J = 14.7 and 1.9 Hz, CHCH2eqCO), 2.10-2.00 (2 H, m, CHCH2exoCH2exoCH), 
1.68-1.52 (1 H, m, CHCH2endoCH2endoCHCH2), 1.40 (9 H, s, NC(CH3)3), 1.35-1.26 (4 
H, m, CHCH2endoCH2endoCHCH2 and OCH2CH3); 13C NMR δc (ppm) (CDCl3, 91 
MHz): 201.4 (C, C=Oketone), 154.8 (C, C=Ocarbamate), 154.0 (C, C=Ocarbamate), 81.3 (C, 
CCH2N), 62.1 (CH2, OCH2CH3), 60.1 (CH, NCHC), 54.3 (C, NC(CH3)3), 54.0 (CH, 
NCHCH2CO), 46.7 (CH2, CCH2N), 44.4 (CH2, CHCH2CO), 28.0 (CH2, 
CHCH2CH2CHCH2), 27.8 (CH3, NC(CH3)3), 23.8 (CH2, CHCH2CH2CHCH2), 14.9 
(CH3, OCH2CH3); m/z (ES+) 325 ([M+H]+, 100%); m/z (ES+) found: [M+H]+, 
325.1764. C16H25N2O5 requires: [M+H]+, 325.1763. 
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The racemic compound was then separated into single enantiomers by SFC 
(Chiralpak IA column, 220 nm, 87/13 CO2/iso-propanol, 10 ml/min, 35 oC, Outlet 
P=100 bar). 
ent-167: enantiomer 1, Rt = 3.45 min, [α]D20 -35.3 (c 1, CHCl3); >99% enantiomeric 
excess, colourless oil. 
Absolute configuration of the catalyst assumed by correlation with optical rotation of 
E-stilbene oxide obtained from epoxidation reaction that is assumed to occur through 
a spiro transition state. 
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Synthesis of (1R*,2R*,5S*)-ethyl 2-hydroxy-2-[(iso-propylamino)methyl]-3-oxo-8-
azabicyclo[3.2.1]octane-8-carboxylate (±)-169 
 
 
N
EtO2C
OH
O N
EtO2C
OH
OHHN N
EtO2C
OHHN
O
Iso-propylamine,
EtOH,
Reflux
IBX, TFA,
 DMSO
152 168 169
 
 
Epoxide (±)-152 (0.4 g, 1.76 mmol) was dissolved in EtOH (7 ml) and then iso-
propylamine (0.12 ml, 1.41 mmol) was added. The solution was heated to reflux 
temperature overnight. The reaction mixture was cooled to RT and concentrated 
under reduced pressure. The residue was purified by SCX cartridge eluting first with 
MeOH and then with 2.0 M NH3 in MeOH to yield (±)-168 as a colourless oil. It was 
then dissolved in DMSO (10 ml) and TFA (0.1 ml, 1.35 mmol) was added followed 
by IBX (1.03 g, 3.70 mmol). The reaction mixture was stirred at RT overnight. Then 
3 ml of water were added and after 10 minutes stirring a white solid was filtered. The 
solid was washed with further EtOAc and then volatiles were concentrated under 
reduced pressure. The residue was purified by SCX cartridge eluting first with 
MeOH and then with 2.0 M NH3 in MeOH. The amonia fractions were concentrated, 
diluted with EtOAc (20 ml), washed with water (20 ml), dried over Na2SO4 and 
concentrated. They were further purified by flash chromatography on silica gel 
eluting with 5% MeOH in DCM to yield (±)-169 as a colourless oil (210 mg, 60%); 
νmax/cm-1 (CHCl3): 3316, 2966, 1697, 1424, 1382, 1314, 1106, 1022, 765; 1H NMR 
δH (ppm) (CDCl3, 500 MHz): 4.56 (1 H, br s, NCHCH2CO), 4.42-4.18 (3 H, m, 
NCHC and OCH2CH3), 3.24-3.17 (2 H, m, CCH2NH and CHCH2axCO), 2.82-2.74 (1 
H, m, J = 6.3 Hz, NHCH(CH3)2), 2.21-2.14 (2 H, m, CCH2NH and CHCH2eqCO), 
1.97-1.91 (2 H, m, CHCH2exoCH2exoCH), 1.54-1.46 (2 H, m, CHCH2endoCH2endoCH), 
1.28 (3 H, t, J = 7.1 Hz, OCH2CH3), 1.09 (3 H, d, J = 6.3 Hz, NHCH(CH3)2), 1.05 (3 
H, d, J = 6.3 Hz, NHCH(CH3)2); 1H NMR δH (ppm) (CDCl3, 360 MHz, 56 oC): 4.55 
(1 H, br s, NCHCH2CO), 4.33 (1 H, br s, NCHC), 4.27-3.80 (4 H, m, OCH2CH3, NH 
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and OH), 3.27-3.17 (2 H, m, CCH2NH and CHCH2axCO), 2.82-2.74 (1 H, m, J = 6.3 
Hz, NHCH(CH3)2), 2.34 (1 H, d, J = 12.3 Hz, CCH2NH), 2.15 (1 H, dd, J = 11.6 and 
1.8 Hz, CHCH2eqCO), 2.06-1.87 (2 H, m, CHCH2exoCH2exoCH), 1.58-1.44 (2 H, m, 
CHCH2endoCH2endoCH), 1.28 (3 H, t, J = 7.1 Hz, OCH2CH3), 1.54-1.08 (6 H, m, 
NHCH(CH3)2); 13C NMR δc (ppm) (CDCl3, 91 MHz): 209.4 (C, C=Oketone), 154.7 
(C, C=Ocarbamate), 77.8 (C, CCH2NH), 61.4 (CH2, OCH2CH3), 61.1 (CH, NCHC), 
53.4 (CH, NCHCH2CO), 49.9 (CH, NHCH(CH3)2), 47.2 (CH2, CCH2NH), 45.9 
(CH2, CHCH2CO), 27.8 (CH2, CHCH2CH2CH), 23.3 (CH2, CHCH2CH2CH), 22.2 
(CH3, NHCH(CH3)2), 22.0 (CH3, NHCH(CH3)2), 14.7 (CH3, OCH2CH3); m/z (ES+) 
285 ([M+H]+, 100%); m/z (ES+) found: [M+H]+, 285.1822. C14H25N2O4 requires: 
[M+H]+, 285.1814. 
 
 
 
Synthesis of (1R*,2R*,5S*)-ethyl 3'-iso-propyl-2',3-dioxo-8H-spiro[8-
azabicyclo[3.2.1]octane-2,5'-[1,3]oxazolidine]-8-carboxylate (±)-170, (1R,2R,5S)-
(+)-ethyl 3'-iso-propyl-2',3-dioxo-8H-spiro[8-azabicyclo[3.2.1]octane-2,5'-
[1,3]oxazolidine]-8-carboxylate 170 and (1S,2S,5R)-(-)-ethyl 3'-iso-propyl-2',3-
dioxo-8H-spiro[8-azabicyclo[3.2.1]octane-2,5'-[1,3]oxazolidine]-8-carboxylate ent-
170 
 
 
N
EtO2C
O
NO
O
N
EtO2C
OHHN
O
Triphosgene, Pyridine,
DCM
169 (±)-170
 
 
 
Amino alcohol (±)-169 (0.21 g, 0.74 mmol) was dissolved in DCM (10 ml); pyridine 
(0.75 ml, 7.4 mmol) was added and the mixture cooled to 0 oC. Triphosgene (241 
mg, 0.81 mmol) was slowly added portionwise and the final mixture was stirred at 
RT for 7 h. It was then diluted with DCM (10 ml), washed with 0.1 M HCl (10 ml), 
H2O (20 ml), brine (20 ml), dried over MgSO4 and concentrated. The residue was 
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purified by flash chromatography on silica gel eluting with 3% MeOH in DCM and, 
after evaporation of the volatiles, was triturated with Et2O to yield (±)-170 as a 
colourless solid (180 mg, 78%); m.p.: 148.5-150.0 oC; νmax /cm-1 (CHCl3): 2974, 
2364, 1750, 1695, 1412, 1332, 1275, 1101, 1034, 930, 755; 1H NMR δH (ppm) 
(DMSO-d6, 360 MHz): 4.70-4.41 (2 H, br m, NCHCH2CO and NCHC), 4.19-4.01 (2 
H, m, OCH2CH3), 3.96-3.81 (2 H, m, CCH2N and NCH(CH3)2), 3.23 (1 H, d, J = 9.3 
Hz, CCH2N), 2.90 (1 H, dd, J = 15.3 Hz and 4.0, CHCH2axCO), 2.44 (1 H, dd, J = 
15.3 Hz and 1.8, CHCH2eqCO), 2.15-1.95 (2 H, m, CHCH2exoCH2exoCH), 1.57-1.45 
(1 H, m, CHCH2endoCH2endoCHCH2), 1.40-1.28 (1 H, m, CHCH2endoCH2endoCHCH2), 
1.22 (3 H, t, J = 7.3 Hz, OCH2CH3), 1.16 (3 H, d, J = 6.7 Hz, NCH(CH3)2), 1.13 (3 
H, d, J = 6.7 Hz, NCH(CH3)2); 13C NMR δc (ppm) (DMSO-d6, 91 MHz): 201.9 (C, 
C=Oketone), 154.1 (C, C=Ocarbamate and C=Ocyclic carbamate), 82.1 (C, CCH2N), 61.2 
(CH2, OCH2CH3), 59.5 (CH, NCHC), 53.6 (CH, NCHCH2CO), 45.8 (CH2, 
CHCH2CO), 45.0 (CH, NCH(CH3)2), 40.8 (CH2, CCH2N), 27.6 (CH2, 
CHCH2CH2CHCH2), 23.2 (CH2, CHCH2CH2CHCH2), 19.8 (CH3, NCH(CH3)2), 19.7 
(CH3, NCH(CH3)2), 14.8 (CH3, OCH2CH3); m/z (ES+) 311 ([M+H]+, 100%); m/z 
(ES+) found: [M+H]+, 311.1600. C15H23N2O5 requires: [M+H]+, 311.1607. 
X-ray structure available; crystallisation from EtOAc/n-hexane (See Appendix 8.2). 
 
The racemic compound was then separated into single enantiomers by SFC 
(Chiralpak AD-H column, 220 nm, 80/20 CO2/MeOH, 10 ml/min, 35 oC, Outlet 
P=100 bar): 
170: enantiomer 1, Rt = 2.38 min, m.p. 147.4-148.1 oC; [α]D20 +125.5 (c 1, CHCl3); 
>99% enantiomeric excess, 50 mg, colourless solid. 
ent-170: enantiomer 2, Rt = 3.16 min, m.p. 147.4-148.1 oC; [α]D20 -125.6 (c 1, 
CHCl3); >99% enantiomeric excess, 50 mg, colourless solid. 
Absolute configuration of the catalyst assumed by correlation with optical rotation of 
E-stilbene oxide obtained from epoxidation reaction that is assumed to occur through 
a spiro transition state. 
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Synthesis of (1R*,2R*,5S*)-ethyl 2-hydroxy-2-[(methylamino)methyl]-3-oxo-8-
azabicyclo[3.2.1]octane-8-carboxylate (±)-172 
 
 
N
EtO2C
OH
O N
EtO2C
OH
N
EtO2C
O
Methylamine,
EtOH,
IBX, TFA,
DMSO
152 171 172
HNHO HN
OH
70 oC,
Sealed tube
 
 
Epoxide (±)-152 (500 mg, 2.2 mmol) was dissolved in EtOH (5 ml) and then 
methylamine 33% wt in EtOH (0.27 ml, 2.2 mmol) was added. The solution was 
heated to 70 oC overnight in a sealed tube. The reaction mixture was cooled to RT 
and concentrated under reduced pressure. The residue was purified by SCX cartridge 
eluting first with MeOH and then with 2.0 M NH3 in MeOH to yield (±)-171 as a 
colourless oil. It was dissolved in DMSO (20 ml) and TFA (180 µl, 2.39 mmol) was 
added followed by IBX (1.82 g, 6.5 mmol). The reaction mixture was stirred at RT 
overnight. Then 3 ml of water were added and after 20 minutes stirring a white solid 
was filtered. The filtrate was diluted with EtOAc (15 ml) and purified by SCX 
cartridge eluting first with MeOH and then with 2.0 M NH3 in MeOH. The amonia 
fractions were further purified by flash chromatography on silica gel eluting with 5% 
MeOH in DCM to yield (±)-172 a as a colourless oil (0.4 g, 72% slightly impure). 
A small portion was further purified by chromatography on silica gel eluting with 5% 
MeOH in DCM to get the full characterization while all the rest of the material was 
taken through the next step. 
(±)-172: νmax/cm-1 (CHCl3): 2981, 1697, 1430, 1332, 1108, 1034, 765; 1H NMR δH 
(ppm) (CDCl3, 500 MHz): 4.57 (1 H, br s, NCHCH2CO), 4.48-4.26 (1 H, br s, 
NCHC), 4.25-4.18 (2 H, m, OCH2CH3), 3.24 (1 H, d, J = 12.2 Hz, CCH2NH), 3.18 (1 
H, br d, J = 14.6, CHCH2axCO), 3.00 (2 H, br s, OH and NH), 2.49 (3 H, s, NHCH3), 
2.30-2.24 (1 H, br s, CCH2NH), 2.17 (1 H, dd, J = 14.6 Hz and 1.9, CHCH2eqCO), 
1.99-1.96 (2 H, m, CHCH2exoCH2exoCH), 1.55-1.49 (2 H, m, CHCH2endoCH2endoCH), 
1.30 (3 H, t, J = 7.1 Hz, OCH2CH3); 13C NMR δc (ppm) (CDCl3, 91 MHz): 209.3 (C, 
C=Oketone), 155.2 (C, C=Ocarbamate), 78.3 (C, CCH2NH), 61.8 (CH2, OCH2CH3), 61.4 
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(CH, NCHC), 53.7 (CH, NCHCH2CO), 52.8 (CH2, CCH2NH), 46.2 (CH2, 
CHCH2CO), 37.3 (CH3, NHCH3), 28.2 (CH2, CHCH2CH2CH), 23.5 (CH2, 
CHCH2CH2CH), 15.0 (CH3, OCH2CH3); m/z (ES+) 257 ([M+H]+, 100%); m/z (ES+) 
found: [M+H]+, 257.1494. C12H21N2O4 requires: [M+H]+, 257.1501. 
 
 
 
Synthesis of (1R*,2R*,5S*)-ethyl 3'-methyl-2',3-dioxo-8H-spiro[8-
azabicyclo[3.2.1]octane-2,5'-[1,3]oxazolidine]-8-carboxylate (±)-173, (1R,2R,5S)-
(+)-ethyl 3'-methyl-2',3-dioxo-8H-spiro[8-azabicyclo[3.2.1]octane-2,5'-
[1,3]oxazolidine]-8-carboxylate 173 and (1S,2S,5R)-(-)-ethyl 3'-methyl-2',3-dioxo-
8H-spiro[8-azabicyclo[3.2.1]octane-2,5'-[1,3]oxazolidine]-8-carboxylate ent-173 
 
 
N
EtO2C
OHHN
O
N
EtO2C
O
NO
O
Triphosgene, Pyridine,
DCM
172 (±)-173
 
 
Amino alcohol (±)-172 (0.4 g, 1.56 mmol) was dissolved in DCM (20 ml); pyridine 
(1.6 ml, 0.02 mol) was added and the mixture cooled to 0 oC. Triphosgene (0.51 g, 
1.72 mmol) was subsequently added portionwise and the final mixture was stirred at 
RT for 6 h. It was then diluted with DCM (20 ml), washed with 0.1 M HCl (20 ml), 
H2O (20 ml), brine (20 ml), dried over MgSO4 and concentrated. The residue was 
purified by flash chromatography on silica gel eluting with EtOAc to yield (±)-173 as 
a pale yellow oil that solidified at room temperature (210 mg, 48%); m.p.: 110.3-
113.2 ºC; νmax /cm-1 (CHCl3): 2981, 1784, 1716, 1695, 1441, 1337, 1122, 1037, 934, 
755; 1H NMR δH (ppm) (CDCl3, 500 MHz): 4.76-4.48 (2 H, m, NCHCH2CO and 
NCHC), 4.33-4.14 (3 H, m, OCH2CH3 and CCH2N), 3.17-3.02 (2 H, m, CHCH2axCO 
and CCH2N), 2.91 (3 H, s, NCH3), 2.45 (1 H, dd, J = 14.8 and 1.6 Hz, CHCH2eqCO), 
2.18-2.00 (2 H, m, CHCH2exoCH2exoCH), 1.63-1.55 (1 H, m, 
CHCH2endoCH2endoCHCH2), 1.36-1.25 (4 H, m, CHCH2endoCH2endoCHCH2 and 
OCH2CH3); 1H NMR δH (ppm) (CDCl3, 360 MHz, 56 oC): 4.75-4.55 (2 H, m, 
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NCHCH2CO and NCHC), 4.34-4.20 (2 H, m, OCH2CH3), 4.17 (1 H, d, J = 8.9 Hz, 
CCH2N), 3.16 (1 H, br d, J = 14.8 Hz, CHCH2axCO), 3.04 (1 H, d, J = 8.9 Hz, 
CCH2N), 2.92 (3 H, s, NCH3), 2.46 (1 H, dd, J = 14.8 and 1.9 Hz, CHCH2eqCO), 
2.19-2.03 (2 H, m, CHCH2exoCH2exoCH), 1.68-1.60 (1 H, m, 
CHCH2endoCH2endoCHCH2), 1.36-1.27 (4 H, m, CHCH2endoCH2endoCHCH2 and 
OCH2CH3); 13C NMR δc (ppm) (CDCl3, 91 MHz): 201.0 (C, C=Oketone), 155.8 (C, 
C=Ocyclic carbamate), 154.6 (C, C=Ocarbamate), 82.3 (C, CCH2N), 62.3 (CH2, OCH2CH3), 
60.2 (CH, NCHC), 54.0 (CH, NCHCH2CO), 47.9 (CH2, CCH2N), 46.8 (CH2, 
CHCH2CO), 31.5 (CH3, NCH3), 27.9 (CH2, CHCH2CH2CHCH2), 23.8 (CH2, 
CHCH2CH2CHCH2), 15.0 (CH3, OCH2CH3); m/z (ES+) 283 ([M+H]+, 100%); m/z 
(ES+) found: [M+H]+, 283.1292. C13H19N2O5 requires: [M+H]+, 283.1294. 
 
The racemic compound was then separated into single enantiomers by SFC 
(Chiralpak AD-H column, 220 nm, 85/15 CO2/MeOH, 10 ml/min, 35 oC, Outlet 
P=100 bar): 
173: enantiomer 1, Rt = 3.74 min, m.p. 119.1-120.0 ºC; [α]D20 -49.3 (c 1, CHCl3); 
>99% enantiomeric excess, 70 mg, colourless solid. 
ent-173: enantiomer 2, Rt = 4.31 min, m.p. 119.1-120.0 ºC; [α]D20 +49.2 (c 1, 
CHCl3); >99% enantiomeric excess, 70 mg, colourless solid. 
For alternative chiral HPLC conditions see Table 7.1. 
Absolute configuration of the catalyst assumed by correlation with optical rotation of 
E-stilbene oxide obtained from epoxidation reaction that is assumed to occur through 
a spiro transition state. 
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Synthesis of (1R*,2R*,3S*,5S*)-ethyl 2-{[{[(1,1-dimethylethyl)oxy] 
carbonyl}(methyl)amino]methyl}-2,3-dihydroxy-8-azabicyclo[3.2.1]octane-8-
carboxylate (±)-174 
 
N
EtO2C
OH
O
N
EtO2C
OH
HNHO
N
EtO2C
OH
NHO
O
O
NH2CH3, EtOH
Boc2O, DCM, 
Et3N
174171152
 
 
Epoxide (±)-152 (2.0 g, 8.81 mmol) was dissolved in EtOH (10 ml) and methylamine 
33% wt in EtOH (1.08 ml, 8.81 mmol) was added. The solution was heated to 70 oC 
overnight in a sealed tube. The reaction mixture was cooled to RT and purified by 
SCX cartridge eluting first with MeOH and then with 2.0 M NH3 in MeOH to yield 
(±)-171 as a colourless oil (2.27 g, 8.81 mmol). It was dissolved in DCM (20 ml) and 
cooled to 0 oC. Et3N (1.35 ml, 9.7 mmol) was added followed by Boc2O (2.1 g, 9.7 
mmol). The reaction mixture was stirred for 2 hours between 0 oC and RT. The 
organic layer was then washed with brine (20 ml), dried over Na2SO4 and 
concentrated in vacuo. Purification by chromatography on silica gel eluting with 
100% ethyl acetate yielded the title compound (±)-174 as a colourless oil (2.1 g, 
67%); νmax/cm-1  (film): 3444, 1695, 1152, 1113, 1058, 962, 874, 768; 1H NMR δH 
(ppm) (CDCl3, 400 MHz): 4.37-4.20 (2 H, br m, NCHCH2CHOH and NCHC), 4.18-
4.10 (2 H, m, OCH2CH3), 3.71-3.17 (3 H, m, CHCH2CHOH and CCH2N), 2.96 (3 H, 
s, NCH3), 2.91-2.86 (1 H, m, CHCH2CHOH), 2.02-1.87 (2 H, m, 
CHCH2exoCH2exoCH), 1.84-1.66 (3 H, m, CHCH2endoCH2endoCH and CHCH2CHOH), 
1.62-1.54 (1 H, m, CHCH2endoCH2endoCH), 1.47 (9 H, s, OC(CH3)3), 1.25 (3 H, t, J = 
7.1 Hz, OCH2CH3); 13C NMR δc (ppm) (CDCl3, 91 MHz): 158.0 (C, C=Oboc carbamate), 
155.4 (C, C=Ocarbamate), 80.5 (C, C(CH3)3), 76.2 (C, CCH2N), 67.2 (CH, 
CHCH2CHOH), 61.1 (CH2, OCH2CH3), 59.0 (CH, NCHC), 54.6 (CH2, CCH2N), 
52.6 (CH, NCHCH2CHOH), 38.0 (CH3, NCH3), 36.7 (CH2, CHCH2CHOH), 28.3 
(CH3, OC(CH3)3), 27.2 (CH2, CHCH2CH2CH), 24.9 (CH2, CHCH2CH2CH), 14.6 
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(CH3, OCH2CH3); m/z (ES+) 259 ([M+H (-C5H9O2)]+, 100%), 381 ([M+Na]+, 
80%); m/z (ES+) found: [M+H]+, 359.2189 C17H31N2O6 requires: [M+H]+, 
359.2182. 
 
 
 
Synthesis of (1R*,2R*,5S*)-ethyl 2-{[{[(1,1-dimethylethyl)oxy] carbonyl} 
(methyl)amino]methyl}-2-hydroxy-3-oxo-8-azabicyclo[3.2.1]octane-8-carboxylate 
(±)-175 
 
 
N
EtO2C
OH
NHO
O
O
N
EtO2C
NHO
O
O
O174 175
(COCl)2, DMSO, 
Et3N,  DCM
 
 
 
DMSO (0.91 ml, 5.58 mmol) was added to a stirred solution of oxalyl chloride (0.85 
g, 6.7 mmol) previously cooled to -78 oC. After 10 min, intermediate (±)-174 (2.0 g, 
5.58 mmol) in DCM (3 ml) was added dropwise. After stirring for 30 min, Et3N 
(4.67 ml, 0.034 mol) was added and the reaction mixture allowed warming to RT and 
stirred at RT for 2 h. After quenching with a saturated solution of NH4Cl (5 ml), the 
organic layer was extracted with DCM (20 ml), washed with brine (3 x 20 ml), dried 
over Na2SO4 and concentrated in vacuo. Purification by chromatography on silica gel 
eluting with a gradient from 50% ethyl acetate in cyclohexane to 100% ethyl acetate 
yielded the title compound (±)-175 as a colourless solid (1.6 g, 80%); m.p.: 104.7-
105.2 oC; νmax/cm-1  (nujol): 3264, 1719, 1694, 1655, 1320, 1158, 1118, 1080, 942, 
767; 1H NMR δH (ppm) (CDCl3, 400 MHz): 5.04 (1 H, br s, OH), 4.63-4.32 (2 H, m, 
NCHCH2CO and NCHC), 4.29-4.11 (2 H, m, OCH2CH3), 3.81-3.35 (2 H, m, 
CCH2N), 3.29-3.11 (1 H, m, CHCH2axCO), 2.96 (3 H, s, NCH3), 2.19 (1 H, d, J = 
13.6 Hz, CHCH2eqCO), 2.11-1.92 (2 H, m, CHCH2exoCH2exoCH), 1.64-1.49 (2 H, m, 
CHCH2endoCH2endoCH), 1.49-1.46 (9 H, s, OC(CH3)3), 1.34-1.25 (3 H, m, 
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OCH2CH3); 13C NMR δc (ppm) (CDCl3, 91 MHz): 206.6 (C, C=Oketone), 158.9 (C, 
C=Oboc carbamate), 155.4 (C, C=Ocarbamate), 80.7 (C, OC(CH3)3 and CCH2N), 61.1 (CH2, 
OCH2CH3), 59.8 (CH, NCHC), 54.0 (CH, NCHCH2CO), 51.4 (CH2, CCH2N), 45.5 
(CH2, CHCH2CO), 37.8 (CH3, NCH3), 28.3 (CH3, OC(CH3)3), 27.7 (CH2, 
CHCH2CH2CH), 24.1 (CH2, CHCH2CH2CH), 14.6 (CH3, OCH2CH3); m/z (ES+) 257 
([M+H (-C5H9O2)]+, 100%), 379 ([M+Na]+, 80%); m/z (ES+) found: [M+H]+, 
357.2040 C17H29N2O6 requires: [M+H]+, 357.2026. 
 
 
 
Synthesis of (1R*,2R*,5S*)-ethyl 3'-methyl-2',3-dioxo-8H-spiro[8-azabicyclo 
[3.2.1]octane-2,5'-[1,3]oxazolidine]-8-carboxylate (±)-173 
 
N
EtO2C
NHO
O
O
O
N
EtO2C
N+HO
O
H
H
HCl 4.0M in 
Dioxane
Et3N, CDI, 
THF N
EtO2C
O
N
O
O
Cl-
175 176 (±)-173
 
 
Amino alcohol (±)-175 (1.6 g, 4.5 mmol) and anisole (0.97 ml, 9.0 mmol) were 
dissolved in 4.0 M HCl in dioxane (30 ml) and stirred at RT for 2 h. The solvent was 
evaporated under reduced pressure and the residue triturated with Et2O to deliver (±)-
176 as a colourless solid. The crude material was dissolved in THF (30 ml); Et3N (1 
ml, 7.2 mmol) was added followed by carbonyldiimidazole (0.875 g, 5.4 mmol). The 
reaction mixture was stirred at RT overnight and then diluted with ethyl acetate (50 
ml), washed with 20 ml of a 10% citric acid solution, then with a saturated solution 
of NaHCO3 (20 ml) and finally with brine (20 ml). The organic layer was dried and 
concentrated in vacuo. Purification by chromatography on silica gel eluting with 
100% ethyl acetate yielded the title compound (±)-173 as a colourless oil that then 
solidified (900 mg, 71%). The analytical data of the racemic mixture were in 
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agreement with the data obtained for batches prepared according to the procedure 
previously described. 
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Synthesis of (1R*,2S*,5S*)-ethyl 3-oxo-8H-spiro[8-azabicyclo[3.2.1]octane-2,4'-
[1,3,2]dioxathiolane]-8-carboxylate 2'-oxide (±)-184 
 
N
EtO2C
OHHO
O
N
O
SOCl2, Pyridine,
DCM
O
SO
OEtO2C
142 184
 
 
 
Diol (±)-142 (0.5 g, 2.1 mmol) was dissolved in DCM (20 ml) and cooled to 0 oC. 
Pyridine (1.7 ml, 21 mmol) was added followed by thionyl chloride (0.17 ml, 2.3 
mmol) in DCM (1 ml). The reaction mixture was stirred at 0 oC for 30 min and then 
slowly warmed to RT. It was stirred at RT for further 3 hours and then quenched by 
addition of 0.1 M HCl. The organic phase was diluted with DCM (20 ml), washed 
with brine (20 ml), dried over MgSO4 and concentrated. Purification by 
chromatography on silica gel eluting with 2% MeOH in DCM delivered the title 
compound (±)-184 as a colourless oil (470 mg, 79%) as a 2:1 mixture of 
diastereoisomers; νmax/cm-1 (film): 1701, 1220, 1120, 1112, 1035, 961, 765, 675; 
NMR δH (ppm) (CDCl3, 360 MHz): 5.31 (1 HA, d, J = 8.3 Hz, CCH2AO), 5.14 (1 HB, 
d, J = 8.6 Hz, CCH2BO), 4.84-4.49 (1 HB and 2 HA, m, NCHBCH2CO, NCHACH2CO 
and NCHAC), 4.49-4.40 (1 HA and 1 HB, m, CCH2AO and NCHBC), 4.28-4.07 (2 HA 
and 3 HB, m, OCH2ACH3, OCH2BCH3 and CCH2BO), 3.23-3.05 (1 HA and 1 HB, m, 
CHCH2ACO and CHCH2BCO), 2.52-2.44 (1 HA and 1 HB, m, CHCH2ACO and 
CHCH2BCO), 2.31-2.02 (2 HA and 2 HB, m, CHCH2exoACH2exoACH, 
CHCH2exoBCH2exoBCH), 1.69-1.56 (1 HA and 2 HB, m, CHCH2endoACH2endoACH, 
CHCH2endoBCH2endoBCH), 1.40-1.29 (4 HA and 3 HB, m, OCH2CH3A, 
CHCH2endoACH2endoACH and OCH2CH3B); 13C NMR δc (ppm) (CDCl3, 91 MHz): 
199.3 (C, C=Oketone A and B), 154.2 (C, C=Ocarbamate A and B), 91.4 (C, CCH2O 
A/B), 91.1 (C, CCH2O A/B), 67.9 (CH2, CCH2O A and B), 61.8 (CH2, OCH2CH3 A 
and B), 61.5 (CH, NCHC A/B), 59.1 (CH, NCHC A/B), 53.9 (CH, NCHCH2CO 
A/B), 53.4 (CH, NCHCH2CO A/B), 46.9 (CH2, CHCH2CO A/B), 46.2 (CH2, 
CHCH2CO A/B), 27.8 (CH2, CHCH2CH2CHCH2 A and B), 25.4 (CH2, 
CHCH2CH2CHCH2 A/B), and 24.2 (CH2, CHCH2CH2CHCH2 A/B), 14.6 (CH3, 
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OCH2CH3 A/B) 14.4 (CH3, OCH2CH3 A/B); m/z (ES+) 290 ([M+H]+ 100%), m/z 
(ES+) found: [M+H]+, 290.0698. C11H16NO6S requires: [M+H]+, 290.0698. 
 
 
(1R*,2S*,5S*)-Ethyl 3-oxo-8H-spiro[8-azabicyclo[3.2.1]octane-2,4'-[1,3,2] 
dioxathiolane]-8-carboxylate 2',2'-dioxide (±)-185 
 
 
N
EtO2C
O
O
SO
O
N
EtO2C
O
O
SO
OO
184 (±)-185
RuCl3·XH2O, NaIO4,
CH3CN/H2O
 
 
 
Intermediate (±)-184 (200 mg, 0.69 mmol) was dissolved in CH3CN (5 ml) and 
cooled to 0 oC. RuCl3xH2O (catalytic amount) was added followed by NaIO4 (222 
mg, 1.0 mmol) dissolved in H2O (1 ml). The mixture was stirred at room temperature 
for 1 hour and then partitioned between EtOAc (20 ml) and H2O (20 ml). The 
organic layer was washed with a saturated solution of NaHCO3 (20 ml), brine (20 
ml), dried over MgSO4 and concentrated. Purification by chromatography on silica 
gel eluting with 50% ethyl acetate in n-hexane delivered (±)-185 as a colorless oil 
(130 mg, 62%) which then decomposed; 1H NMR δH (ppm) (CDCl3, 400 MHz): 5.21 
(1 H, d, J = 9.1 Hz, CCH2O), 4.92-4.68 (1 H, br s, NCHC), 4.68-4.62 (1 H, m, 
NCHCH2CO), 4.23-4.13 (3 H, m, OCH2CH3 and CCH2O), 3.04 (1 H, br d, 
CHCH2axCO), 2.49 (1 H, dd, J = 15.0, 1.8 Hz, CHCH2eqCO), 2.19-2.01 (2 H, m, 
CHCH2exoCH2exoCH), 1.58-1.52 (1 H, m, CHCH2endoCH2endoCH), 1.27-1.18 (4 H, m, 
OCH2CH3 and CHCH2endoCH2endoCH); m/z (ES+) 306 ([M+H]+, 15%), 328 
([M+Na]+, 100%). 
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Synthesis of (1R*,2R*,5S*)-ethyl 3'-methyl-3-oxo-8H-spiro[8-
azabicyclo[3.2.1]octane-2,5'-[1,2,3]oxathiazolidine]-8-carboxylate 2'-oxide (±)-186 
 
N
EtO2C
HNHO
O
N
EtO2C
O
SOCl2, Pyridine,
DCM
N
SO
O
172 186
 
 
 
Amino alcohol (±)-172 (0.7 g, 2.7 mmol) was dissolved in DCM (20 ml) and cooled 
to 0 oC. Pyridine (2.21 ml, 27 mmol) was added followed by thionyl chloride (0.22 
ml, 3 mmol) in DCM (1 ml). The reaction mixture was stirred at 0 oC for 30 min and 
then slowly warmed to RT. It was stirred at RT for further 48 h and then quenched 
by addition of a saturated solution of NH4Cl. The organic phase was diluted with 
DCM (20 ml), washed with a 0.1 M HCl solution (20 ml), brine (20 ml), dried over 
MgSO4 and concentrated. Purification by chromatography on silica gel eluting with a 
gradient from 50% to 100% EtOAc in cyclohexane delivered the title compound (±)-
186 as a colorless solid (400 mg, 48%); m.p. 127.2-129.2 oC; νmax/cm-1 (nujol): 1723, 
1697, 1161, 1118; NMR δH (ppm) (CDCl3, 360 MHz):10:7 mixture of 
diastereoisomers A:B: 4.79-4.52 (2 HA and 2 HB, m, NCHAC, NCHBC, 
NCHACH2CO and NCHBCH2CO), 4.29-4.03 (3 HA and 3 HB, m, OCH2ACH3, 
OCH2BCH3, CCH2AN and CCH2BN), 3.20-3.01 (2 HA and 2 HB, m, CHCH2AaxCO, 
CHCH2BaxCO, CCH2AN and CCH2BN), 2.73 (3 HA, s, NCH3A), 2.70 (3 HB, s, 
NCH3B), 2.46-2.39 (1 HA and 1 HB, m, CHCH2AeqCO and CHCH2BeqCO), 2.15-2.01 
(2 HA and 2 HB, m, CHCH2AexoCH2AexoCH and CHCH2BexoCH2BexoCH), 1.68-1.54 (1 
HA and 1 HB, m, CHCH2AendoCH2endoCH and CHCH2BendoCH2endoCH), 1.48-1.19 (4 
HA and 4 HB, m, OCH2CH3A, OCH2CH3A, CHCH2AendoCH2endoCHC and 
CHCH2BendoCH2endoCHC); 13C NMR δc (ppm) (CDCl3, 91 MHz): 200.7 (C, C=Oketone 
A and B), 155.2 (C, C=Ocarbamate A and B), 95.6 (C, CCH2N A/B), 94.5 (C, CCH2N 
A/B), 63.1 (CH, NCHC A/B), 62.1 (CH2, OCH2CH3 A/B), 61.9 (CH2, OCH2CH3 
A/B), 60.1 (CH, NCHC A/B), 54.2 (CH, NCHCH2CO A/B), 53.9 (CH, NCHCH2CO 
A/B), 51.5 (CH2, CCH2N A/B), 50.3 (CH2, CCH2N A/B), 47.1 (CH2, CHCH2CO 
A/B), 46.5 (CH2, CHCH2CO A/B), 33.1 (CH3, NCH3 A/B), 32.5 (CH3, NCH3 A/B), 
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27.8 (CH2, CHCH2CH2CH A and B), 25.7 (CH2, CHCH2CH2CH A and B), 15.0 
(CH3, OCH2CH3 A/B), 14.8 (CH3, OCH2CH3 A/B); m/z (ES+) 303 ([M+H]+ 100%); 
m/z (ES+) found: [M+H]+, 303.1003. C12H19N2O5S requires: [M+H]+, 303.1015. 
 
 
 
Synthesis of (1R*,2R*,5S*)-ethyl 3'-methyl-3-oxo-8H-spiro[8-
azabicyclo[3.2.1]octane-2,5'-[1,2,3]oxathiazolidine]-8-carboxylate 2',2'-dioxide (±)-
187, (1R,2R,5S)-(-)-ethyl 3'-methyl-3-oxo-8H-spiro[8-azabicyclo[3.2.1]octane-2,5'-
[1,2,3]oxathiazolidine]-8-carboxylate 2',2'-dioxide 187 and (1S,2S,5R)-(+)-ethyl 3'-
methyl-3-oxo-8H-spiro[8-azabicyclo[3.2.1]octane-2,5'-[1,2,3]oxathiazolidine]-8-
carboxylate 2',2'-dioxide ent-187 
 
 
N
EtO2C
O
N
SO
O
N
EtO2C
O
N
SO
O ORuCl3·XH2O, NaIO4,
CH3CN/H2O
186 (±)-187
 
 
 
Intermediate (±)-186 (400 mg, 1.32 mmol) was dissolved in CH3CN (10 ml) and 
cooled to 0 oC. RuCl3xH2O (catalytic amount) was added followed by NaIO4 (420 
mg, 1.98 mmol) dissolved in H2O (2 ml). The mixture was stirred at RT for 30 min 
and then partitioned between DCM (20 ml) and H2O (20 ml). The organic layer was 
washed with a saturated solution of NaHCO3 (20 ml), brine (20 ml), dried over 
MgSO4 and concentrated. Purification by chromatography on silica gel eluting with a 
gradient from 50% to 100% ethyl acetate in cyclohexane delivered a solid that was 
triturated with diethyl ether to afford the title compound (±)-187 as a colorless solid 
(230 mg, 55%); m.p.: 127.1-128.2 oC; νmax/cm-1 (nujol): 1731, 1689, 1348, 1214, 
1178; 1H NMR δH (ppm) (CDCl3, 360 MHz): 4.79-4.77 (1 H, m, NCHC), 4.68-4.66 
(1 H, m, NCHCH2CO), 4.27-4.19 (2 H, m, OCH2CH3), 4.10 (1 H, d, J = 10.4 Hz, 
CCH2N), 3.18-3.09 (2 H, m, CCH2N and CHCH2axCO), 2.82 (3 H, s, NCH3), 2.50 (1 
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H, dd, J = 14.7, 2.1 Hz, CHCH2eqCO), 2.21-1.98 (2 H, m, CHCH2exoCH2exoCH), 
1.62-1.54 (1 H, m, CHCH2endoCH2endoCHCH2), 1.35-1.27 (4 H, m, OCH2CH3 and 
CHCH2endoCH2endoCHCH2); 13C NMR δc (ppm) (CDCl3, 91 MHz): 199.2 (C, 
C=Oketone), 154.2 (C, C=Ocarbamate), 86.9 (C, CCH2N), 62.4 (CH2, OCH2CH3), 60.2 
(CH, NCHC), 54.1 (CH, NCHCH2CO), 50.7 (CH2, CCH2N), 46.9 (CH2, 
CHCH2CO), 35.6 (CH3, NCH3), 27.7 (CH2, CHCH2CH2CHCH2), 23.6 (CH2, 
CHCH2CH2CHCH2), 14.8 (CH3, OCH2CH3); m/z (ES+) 319 ([M+H]+, 100%); m/z 
(ES+) found: [M+H]+, 319.0970. C12H19N2O6S requires: [M+H]+, 319.0964. 
 
The racemic mixture (110mg) was separated into single enantiomers by semi 
preparative chiral chromatography, column: Chiralpak AD-H (25 x 0.46 cm); mobile 
phase: n-hexane/iso-propanol 85/15 % v/v; flow rate: 14.0 ml/min; DAD: 225 nm. 
ent-187: enantiomer 1: Rt = 15.23 min; m.p.: 108.3-110.1 oC; [α]D20 +40.0 (c 0.1, 
CH3OH); 100% ee, 40 mg, colourless solid; 
187: enantiomer 2: Rt = 18.53 min; m.p.: 113.5-114.8 oC; [α]D20 -40.0 (c 0.1, 
CH3OH); 100% ee, 40 mg, colourless solid. 
Absolute configuration of the catalyst assumed by correlation with optical rotation of 
E-stilbene oxide obtained from epoxidation reaction that is assumed to occur through 
a spiro transition state. 
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(1R*,2S*,3S*,5S*)-Ethyl 2-(ethoxymethyl)-2,3-dihydroxy-8-azabicyclo[3.2.1]octane-
8-carboxylate (±)-191 
 
 
N
CO2Et
OH
OOH
191
 
 
 
To an EtOH solution (1 ml) of EtONa in EtOH 21% w/w (0.29 ml, 0.88 mmol), 
diethyl malonate (0.15 ml, 0.97 mmol) was added followed by epoxide (±)-152 (100 
mg, 0.44 mmol) in EtOH (2 ml). The reaction mixture was stirred at room 
temperature for 30 min and then it was heated to reflux temperature for 5 hours. 
After this period of time, the solvent was evaporated under reduced pressure and the 
residue was purified by chromatography on silica gel eluting with a gradient from 
50% to 100% EtOAc in cyclohexane. Two sets of fractions were isolated none of 
which contained materials of suitable purity to be characterized. 30 mg of material 
containing products with m/z 274 and m/z 342 were dissolved in DMSO (0.5 ml), 
water (20 µl) was added followed by NaCl (8.1 mg) and the mixture was heated to 
150° C for 5 h. After cooling to room temperature, the residue was partitioned 
between Et2O and water. The organic layer was washed with brine, dried and 
concentrated. Purification by chromatography on silica gel eluting with a gradient 
from 50% to 100% ethyl acetate in cyclohexane afforded the title compound (±)-191 
as a colourless oil (12 mg, 10% over two steps); νmax/cm-1 (film): 3442, 2975, 2928, 
2880, 1665, 1440, 1385, 1330, 1110, 1069, 964; 1H NMR δΗ (ppm) (CDCl3, 400 
MHz): 4.45-4.26 (2 H, br s, NCHC and NCHCH2CHOH), 4.24-4.10 (2 H, m, 
OCH2CH3carbamate), 3.77-3.66 (2 H, m, CHCH2CHOH and CCH2O), 3.57 (2 H, q, J = 
7.1 Hz, OCH2CH3ether), 3.50 (1 H, d, J = 9.7 Hz, CCH2O), 2.95 (1 H, br s, CHCOH), 
2.58 (1 H, d, J = 8.3 Hz, CHCH2CHOH), 2.00-1.77 (4 H, m, CHCH2exoCH2exoCH and 
CHCH2CHOH), 1.74-1.67 (1 H, m, CHCH2endoCH2endoCH), 1.62-1.54 (1 H, m, 
CHCH2endoCH2endoCH), 1.31-1.26 (3 H, t, J = 7.1 Hz, OCH2CH3carbamate), 1.25-1.21 (3 
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H, t, J = 7.1 Hz, OCH2CH3ether); 13C NMR δc (ppm) (CDCl3, 101 MHz): 155.2 (C, 
C=O), 74.8 (C, CCH2O), 73.1 (CH2, CCH2O), 67.4 (CH2, OCH2CH3ether), 66.3 (CH, 
CHCH2CHOH), 61.1 (CH2, OCH2CH3carbamate), 58.1 (CH, NCHC), 52.3 (CH, 
NCHCH2CHOH), 36.7 (CH2, CHCH2CHOH), 27.3 (CH2, CHCH2CH2CH), 24.6 
(CH2, CHCH2CH2CH), 15.1 (CH3, OCH2CH3ether), 14.7 (CH3, OCH2CH3carbamate); m/z 
(ES+) 274 ([M+H]+, 100%); m/z (ES+) found: [M+H]+, 274.1655. C13H24NO5 
requires: [M+H]+, 274.1654. 
 
 
Synthesis of (1R*,2S*,3S*,5S*)-ethyl 3-({[4-(methyloxy)phenyl]methyl}oxy)-8H-
spiro[8-azabicyclo[3.2.1]octane-2,2'-oxirane]-8-carboxylate (±)-193 
 
 
N
EtO2C
OH
O
N
O
O
O
NaH, PMB-Cl,
THF
EtO2C
152 193
 
 
 
Epoxide (±)-152 (0.1 g, 0.44 mmol) was dissolved in THF (5 ml) and cooled to 0 oC. 
NaH (60% dispersed in mineral oil, 19 mg, 0.49 mmol) was added followed by 
PMB-Cl (66 µl, 0.49 mmol). The reaction mixture was slowly warmed to room 
temperature and then stirred for 48 hours. After this period of time, it was quenched 
with a saturated solution of NH4Cl (10 ml). The organic layer was diluted with ethyl 
acetate (30 ml), washed with H2O (20 ml), brine (20 ml), dried over Na2SO4 and 
concentrated under vacuum. The crude material was purified by chromatography on 
silica gel eluting with 50% ethyl acetate in cyclohexane to deliver (±)-193 as a 
colourless oil (10 mg, 6.5%); νmax/cm-1 (film): 1694, 1612, 1514, 1101, 1030, 821, 
768; 1H NMR δH (ppm) (Acetone-d6, 400 MHz): 7.11 (2 H, d, J = 8.7 Hz, 
OCH2CCHAr), 6.75 (2 H, d, J = 8.7 Hz, CHArCOCH3), 4.39 (1 H, d, J = 11.4 Hz, 
OCH2CAr), 4.31-4.21 (2 H, m, OCH2CAr and NCHCH2CHO), 4.00 (1 H, dd, J = 11.4 
and 6.1 Hz, CHCH2CHaxO), 3.95-3.87 (2 H, br q, J = 7.1 Hz, OCH2CH3), 3.74-3.63 
(4 H, m, OCH3 and NCHC), 2.76-2.73 (1 H, m, CCH2O), 2.48 (1 H, d, J = 5.4 Hz, 
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CCH2O), 2.05-1.99 (1 H, ddd, J = 12.5, 5.95 and 3.1 Hz, CHCH2eqCHO), 1.88-1.53 
(5 H, m, CHCH2exoCH2exoCH, CHCH2endoCH2endoCH and CHCH2axCHO), 1.10-1.02 
(3 H, m, OCH2CH3); 1H NMR δH (ppm) (CDCl3, 400 MHz): 7.22 (2 H, d, J = 8.7 Hz, 
OCH2CCHAr), 6.88 (2 H, d, J = 8.7 Hz, CHArCOCH3), 4.55-4.38 (3 H, m, OCH2CAr 
and NCHCH2CHO), 4.09-4.21 (2 H, m, OCH2CH3), 4.00-3.93 (1 H, dd, J = 11.2 and 
6.1 Hz, CHCH2CHaxO), 3.90-3.83 (4 H, m, NCHC and OCH3), 3.01 (1 H, d, J = 5.1 
Hz, CCH2O), 2.68 (1 H, br s, CCH2O), 2.09-1.86 (4 H, m, CHCH2exoCH2exoCH, 
CHCH2CHO), 1.78-1.57 (2 H, m, CHCH2endoCH2endoCH), 1.29-1.23 (3 H, m, 
OCH2CH3);13C NMR δc (ppm) (Acetone-d6, 101 MHz): 160.2 (C, CArOCH3), 154.8 
(C, C=O), 131.7 (C, OCH2CAr), 130.1 (CH, OCH2CCHAr), 114.4 (CH, 
CHArCOCH3), 71.5 (CH2, OCH2CAr), 69.1 (CH, CHCH2CHO), 61.7 (C, CCH2O), 
61.2 (CH2, OCH2CH3), 61.0 (CH, NCHC), 55.5 (CH3, OCH3), 53.6 (CH, 
NCHCH2CHO), 48.2 (CH2, CCH2O), 36.5 (CH2, CHCH2CHO), 27.1 (CH2, 
CHCH2CH2CH and CHCH2CH2CH), 15.1 (CH3, OCH2CH3); m/z (ES+) 370 
([M+Na]+, 20%), 121 ([C8H9O]+, 100%); m/z (ES+) found: [M+H]+, 348.1823. 
C19H26NO5 requires: [M+H]+, 348.1811. 
 
 
 
Synthesis of (1R*,2S*,3S*,5S*)-ethyl 3-[(trimethylsilyl)oxy]-8H-spiro[8-azabicyclo 
[3.2.1]octane-2,2'-oxirane]-8-carboxylate (±)-194 
 
 
N
EtO2C
OH
O
N
EtO2C
O
O
Si
TMSOTf, Et3N,
DCM
152 194
 
 
 
Epoxide (±)-152 (0.8 g, 3.5 mmol) was dissolved in DCM (30 ml) and cooled to -78 
oC. Et3N (2.45 ml, 18 mmol) was added followed by TMSOTf (1.6 ml, 8.8 mmol). 
After stirring at this temperature for 30 min, the reaction mixture was slowly warmed 
 Chapter 7 
 
 236
to -30 oC and stirred at this temperature for further 30 min. It was then quenched with 
a saturated solution of NH4Cl (10 ml). The organic layer was washed with brine, 
dried and concentrated under vacuum. The crude reaction mixture, as a colourless 
oil, was used in the following step without further purification (the yield was 
assumed to be quantitative). 
An aliquot of the crude material was purified by chromatography on silica gel eluting 
with a gradient from 20 to 50% ethyl acetate in cyclohexane to deliver the title 
compound (±)-194 as colourless oil; νmax/cm-1 (film): 1701, 1467, 1328, 1252, 1108, 
911, 886, 764, 842, 764; 1H NMR δH (ppm) (CDCl3, 400 MHz): 5.53-4.36 (1 H, br 
m, NCHCH2CHO), 4.26 (1 H, dd, J = 10.7 and 6.6 Hz, CHCH2CHO), 4.19-4.06 (2 
H, m, OCH2CH3), 4.05-3.83 (1 H, br d, NCHC), 2.88 (1 H, d, J = 5.1 Hz, CCH2O), 
2.80-2.60 (1 H, br s, CCH2O), 2.12-1.85 (4 H, m, CHCH2CHO and 
CHCH2exoCH2exoCH), 1.85-1.70 (2 H, m, CHCH2endoCH2endoCH), 1.26 (3 H, t, J = 7.1 
Hz, OCH2CH3), 0.12 (9 H, s, Si(CH3)3); 13C NMR δc (ppm) (CDCl3, 91 MHz): 154.2 
(C, C=O), 62.8 (CH, CHCH2CHO), 61.6 (C, CCH2O), 61.1 (CH2 OCH2CH3), 59.5 
(CH, NCHC), 52.5 (CH, NCHCH2CHO), 47.9 (CH2, CCH2O), 39.5 (CH2, 
CHCH2CHO), 27.8 (CH2, CHCH2CH2CH), 26.9 (CH2, CHCH2CH2CH) 14.7 (CH3, 
OCH2CH3), 0.17 (CH3, Si(CH3)3); m/z (ES+) 300 ([M+H]+ 100%); m/z (ES+) found: 
[M+Na]+, 322.1462 C14H25NO4Si23Na requires: [M+Na]+, 322.1451 
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Synthesis of (1R*,2R*,3S*,5S*)-ethyl 3-hydroxy-5'-oxodihydro-3'H,8-
azaspiro[bicyclo[3.2.1]octane-2,2'-furan]-8-carboxylate (±)-189 
 
 
N
EtO2C
O
O
Si
N
EtO2C
O
O
COOEt
N
EtO2C
O
O
COOEt
NaCl, DMSO,
H2O
N
EtO2C
O
O
Diethyl malonate
NaH, THF
and
OH O
Si
OH
194 188 195
189
 
NaH (60% dispersed in mineral oil, 87 mg, 2.2 mmol) was suspended in THF (10 
ml) and cooled to 0 oC. Diethyl malonate (0.33 ml, 2.2 mmol) in THF (1 ml) was 
added dropwise and the reaction mixture was stirred at 0 oC for 30 minutes. 
Intermediate (±)-194 (540 mg, 1.8 mmol) in THF (2 ml) was added dropwise and 
then the mixture heated to reflux for 3 hours. The volatiles were evaporated under 
reduced pressure and a mixture of two compounds was obtained: 
(1R*,2R*,3S*,5S*)-diethyl 3-hydroxy-5'-oxodihydro-3'H-8-azaspiro[bicycle[3.2.1] 
octane-2,2'-furan]-4',8-dicarboxylate (m/z 342) (±)-188 and (1R*,2R*,3S*,5S*)-
diethyl 5'-oxo-3-[(trimethylsilyl)oxy]dihydro-3'H,8-azaspiro [bicycle [3.2.1] octane-
2,2'-furan]-4',8-dicarboxylate (m/z 414) (±)-195. 
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N
EtO2C
O
O
COOEt
OH
188
 
 
Purification by column chromatography on silica gel of an aliquot of the intermediate 
mixture (gradient from 10% to 100% EtOAc in cyclohexane) allowed the 
characterization of a pure sample of (1R*,2R*,3S*,5S*)-diethyl 3-hydroxy-5'-
oxodihydro-3'H-8-azaspiro[bicyclo[3.2.1]octane-2,2'-furan]-4',8-dicarboxylate (±)-
188 as a 2:1 mixture of diastereoisomers, colourless oil: νmax/cm-1 (nujol): 3441, 
1778, 1737, 1674, 1158, 1112, 1075, 970, 763, 722; 1H NMR δH (ppm) (CDCl3, 400 
MHz): 4.63-4.35 (2 HA and 2 HB, br m, NCHACH2CHOH, NCHBCH2CHOH, 
NCHAC and NCHBC), 4.33-4.24 (2 HA and 2 HB, m, OCH2AesterCH3, and 
OCH2BesterCH3), 4.22-4.11 (2 HA and 2 HB, br m, OCH2AcarbamateCH3, and 
OCH2BcarbamateCH3), 3.90-3.69 (2 HA and 2 HB, m, CHCH2CHAOH, CHCH2CHBOH, 
CHACOOCH2CH3 and CHBCOOCH2CH3), 3.01-2.86 (1 HA, m, CHCH2CHOHA), 
2.67-2.28 (2 HA and 2 HB, m, CCH2ACH and CCH2BCH), 2.23-2.12 (1 HB, m, 
CHCH2CHOHB), 2.10-1.73 (4 HA and 4 HB, m, CHCH2AexoCH2AexoCH, 
CHCH2BexoCH2BexoCH, CHCH2ACHOH and CHCH2BCHOH), 1.71-1.56 (2 HA and 2 
HB, m, CHCH2AendoCH2AendoCH, CHCH2BendoCH2BendoCH), 1.38-1.19 (6 HA and 6 HB, 
m, OCH2CH3Acarbamate, OCH2CH3Bcarbamate, OCH2CH3Aester and OCH2CH3Bester); 13C 
NMR δc (ppm) (CDCl3, 91 MHz): 170.8 (C, C=O A/B), 170.3 (C, C=O A/B), 168.1 
(C, C=O A/B), 167.4 (C, C=O A/B), 154.2 (C, C=O A/B), 154.0 (C, C=O A/B), 87.1 
(C, CCH2CH A/B), 86.7 (C, CCH2CH A/B), 68.7 (CH, CHCH2CHOH A/B), 67.1 
(CH, CHCH2CHOH A/B), 62.5 (CH2, OCH2CH3 A/B), 62.4 (CH2, OCH2CH3 A/B), 
61.3 (CH2, OCH2CH3 A and B), 60.0 (CH, NCHC A/B), 58.9 (CH, NCHC A/B), 
52.4 (CH, NCHCH2CHOH A/B), 52.2 (CH, NCHCH2CHOH A/B), 47.7 (CH, 
CHCOOCH2CH3 A/B), 46.4 (CH, CHCOOCH2CH3 A/B), 37.6 (CH2, CHCH2CHOH 
A/B), 37.5 (CH2, CHCH2CHOH A/B), 31.2 (CH2, CCH2CH A/B), 30.2 (CH2, 
CCH2CH A/B), 27.1 (CH2, CHCH2CH2CH A and B), 24.3 (CH2, CHCH2CH2CH 
A/B), 24.1 (CH2, CHCH2CH2CH A/B), 14.6 (CH3, OCH2CH3 A/B), 14.5 (CH3, 
OCH2CH3 A/B), 14.1 (CH3, OCH2CH3 A/B), 14.0 (CH3, OCH2CH3 A/B); m/z (ES+) 
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342 ([M+H]+ 90%), 359 ([M+NH4+] 100%); m/z (ES+) found: (M+H)+, 342.1554. 
C16H24NO7 requires: (M+H)+, 342.1553. 
 
The previously obtained mixture containing (±)-188 and (±)-195 (250 mg) was 
dissolved in DMSO (5 ml) and water added (0.5 ml) followed by NaCl (56 mg). The 
mixture was heated to 160 oC for 7 h. After this period of time the mixture was 
cooled to room temperature and partitioned between DCM and water. The organic 
layer was washed with brine, dried and concentrated. Purification by 
chromatography on silica gel eluting with a gradient from 50% to 100% ethyl acetate 
in cyclohexane afforded the title compound (±)-189 as a colourless oil (170 mg, 35% 
over two steps); νmax/cm-1 (film): 3440, 1772, 1684, 1437, 1336, 1385, 1217, 1111, 
964, 772; 1H NMR δH (ppm) (CDCl3, 400 MHz): 4.46-4.32 (1 H, br s, 
NCHCH2CHOH), 4.27-4.02 (3 H, m, NCHC and OCH2CH3), 3.73 (1 H, dd, J=11.24 
and 6.06 Hz, CHOH), 2.79-2.53 (2 H, m, CCH2CH2), 2.51-2.09 (2 H, m, CCH2CH2 
and CHOH), 2.08-1.75 (5 H, m, CHCH2exoCH2exoCH, CCH2CH2, and 
CHCH2CHOH), 1.70-1.53 (2 H, m, CHCH2endoCH2endoCH), 1.32-1.16 (3 H, m, 
OCH2CH3); 13C NMR δc (ppm) (CDCl3, 91 MHz): 176.4 (C, C=Olactone), 154.2 (C, 
C=Ocarbamate), 87.9 (C, CCH2CH2), 68.1 (CH, CHCH2CHOH), 61.3 (CH2, 
OCH2CH3), 59.3 (CH, NCHC), 52.3 (CH, NCHCH2CHOH), 37.6 (CH2, 
CHCH2CHOH), 28.8 (CH2, CCH2CH2), 27.1 (CH2, CHCH2CH2CH), 26.5 (CH2, 
CCH2CH2), 24.9 (CH2, CHCH2CH2CH), 14.6 (CH3, OCH2CH3); m/z (ES+) 270 
([M+H]+ 100%), m/z (ES+) found: [M+H]+, 270.1337. C13H20NO5 requires: 
[M+H]+, 270.1341. 
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Synthesis of (1R*,2R*,5S*)-ethyl 3,5'-dioxodihydro-3'H,8H-spiro[8-
azabicyclo[3.2.1]octane-2,2'-3furan]-8-carboxylate (±)-190, (1R,2R,5S)-(-)-ethyl 
3,5'-dioxodihydro-3'H,8H-spiro[8-azabicyclo[3.2.1]octane-2,2'-3furan]-8-
carboxylate 190 and (1S,2S,5R)-(+)-ethyl 3,5'-dioxodihydro-3'H,8H-spiro[8-
azabicyclo[3.2.1]octane-2,2'-3furan]-8-carboxylate ent-190 
 
 
N
EtO2C
O
O
N
EtO2C
O
O
O
TPAP, NMO,
DCM
OH
189 (±)-190
 
 
 
Lactone (±)-189 (170 mg, 0.63 mmol) was dissolved in DCM (5 ml). NMO (111 mg, 
0.95 mmol) was added followed by TPAP (10 mg). The reaction mixture was stirred 
at RT for 3 h and then was filtered through a pad of Celite™. The solvent was 
removed under reduced pressure and the residue was purified by chromatography on 
silica gel eluting with a gradient from 30 to 80% ethyl acetate in cyclohexane to yield 
(±)-190 as a colorless solid (90 mg, 53%);m.p.: 111.5-112.5 oC; νmax/cm-1 (nujol): 
1795, 1724, 1694, 1113, 1016, 956, 932, 769; 1H NMR δΗ (ppm) (CDCl3, 400 MHz): 
4.74-4.40 (2 H, m, NCHCH2CO and NCHC), 4.35-4.14 (2 H, m, OCH2CH3), 3.23-
2.98 (1 H, m, CHCH2axCO), 2.92-2.80 (1 H, m, CCH2CH2), 2.78-2.59 (2 H, m, 
CCH2CH2), 2.46 (1 H, d, J = 16.0 Hz, CHCH2eqCO), 2.23-1.99 (2 H, m, 
CHCH2exoCH2exoCH), 1.86-1.71 (1 H, m, CCH2CH2), 1.67-1.57 (1 H, m, 
CHCH2endoCH2endoCHCH2), 1.54-1.42 (1 H, m, CHCH2endoCH2endoCHCH2), 1.31 (3 
H, t, J = 7.1 Hz, OCH2CH3); 13C NMR δc (ppm) (CDCl3, 100 MHz): 202.3 (C, 
C=Oketone), 174.4 (C, C=Olactone), 154.2 (C, C=Ocarbamate), 88.8 (C, CCH2CH2), 61.8 
(CH2, OCH2CH3), 60.4 (CH, NCHC), 53.5 (CH, NCHCH2CO), 46.4 (CH2, 
CHCH2CO), 28.5 (CH2, CCH2CH2), 27.6 (CH2, CHCH2CH2CH), 23.6 and 23.4 
(CH2, CCH2CH2 and CHCH2CH2CH), 14.6 (CH3, OCH2CH3); m/z (ES+) 268 
([M+H]+, 100%); m/z (ES+) found: [M+H]+, 268.1172. C13H18NO5 requires: 
[M+H]+, 268.1185. 
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The racemic mixture was separated into single enantiomers by semi preparative 
chiral chromatography (column: Chiralpak AD-H (25 x 2.0 cm); mobile phase: n-
hexane/ethanol 70/30 % v/v; flow rate: 14.0 ml/min; DAD: 225 nm). 
ent-190: enantiomer 1: Rt: 18.75 min; m.p.145.9-146.7 oC; [α]D20 +25.0 (c 0.16, 
CH3OH); 100% ee, 32 mg, colourless solid;  
190: enantiomer 2: Rt: 22.15 min; m.p.: 145.9-146.7 oC; [α]D20 -33.3 (c 0.18, 
CH3OH); 100% ee, 32 mg, colourless solid. 
Absolute configuration of the catalyst assumed by correlation with optical rotation of 
E-stilbene oxide obtained from epoxidation reaction that is assumed to occur through 
a spiro transition state. 
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Synthesis of (1S*,2S*,5R*)-ethyl-2-fluoro-3-oxo-8-azabicyclo[3.2.1]octane-8-
carboxylate (±)-124, (1R,2R,5S)-(-)-ethyl-2-fluoro-3-oxo-8-azabicyclo[3.2.1]octane-
8-carboxylate 124 and of (1S,2S,5R)- (+)-ethyl-2-fluoro-3-oxo-8-
azabicyclo[3.2.1]octane-8-carboxylate ent-124145 
 
 
N
EtO2C
O
N
EtO2C
O
LiHMDS, THF, 
TMSOTf, -78 oC
Si
N
EtO2C
O
FSelectluor,CH3CN
120 (±)-124(±)-121
 
 
Ethyl 3-oxo-8-azabicyclo[3.2.1]octane-8-carboxylate (1.5g, 7.6 mmol) 120 was 
dissolved in THF (50 ml) and cooled to -78 oC. LiHMDS 1.0 M in THF (8.4 ml, 8.3 
mmol) was added dropwise keeping the internal temperature below -70 oC. The 
mixture was stirred at -78 oC for 30 min. Then TMSOTf (1.1 ml, 9.9 mmol) was 
added and stirred for 20 min before slowly warming the reaction mixture to RT. It 
was then quenched with a saturated solution of NH4Cl (5 ml) and diluted with ethyl 
acetate (30 ml). The organic layer was washed with water (20 ml), followed by a 
saturated solution of NaHCO3 (20 ml) and brine (20 ml). It was dried and 
concentrated in vacuo. The residue was taken through the following step without 
further purification. (±)-121 was dissolved in dry CH3CN (100 ml) and SelectfluorTM 
(5.4 g, 15 mmol) was added in a single portion. The reaction mixture was stirred at 
RT for 2 h before pouring it into EtOAc (50 ml). The organic phase was washed with 
water (3 x 20 ml), dried and concentrated in vacuo. The residue was purified by 
chromatography on silica gel eluting with a gradient from 10 to 50% ethyl acetate in 
cyclohexane to yield the title compound (±)-124 (1.0 g, 61%) as a colourless solid.  
The racemic compound (530 mg) was separated into single enantiomers by chiral 
chromatography (column: Chiralpak AD-H (25 x 2.0 cm); mobile phase: n-
hexane/iso-propanol 75/25 % v/v; flow rate: 14.0 ml/min; DAD: 225 nm). 
124: enantiomer 1: Rt 9.76 min; [α]D20 -13.3 (c 0.15, CH3OH); >99% enantiomeric 
excess, 130 mg, colourless oil; 
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ent-124: enantiomer 2: Rt 10.43 min; [α]D20 +22.2 (c 0.18, CH3OH); >95.5% 
enantiomeric excess, 140 mg, colourless solid. 
Analytical data of the racemic mixture and of the single enantiomers are in 
agreement with the literature ones.145 
 
 
 
Synthesis of (1R*,2R*,4S*,5S*)-ethyl 2-bromo-4-fluoro-3-oxo-8-azabicyclo[3.2.1] 
octane-8-carboxylate (±)-198 
 
N
EtO2C
O
N
EtO2C
O
N
EtO2C
O
Br
FNBS, THF
Et3N, TMSOTf,
DCM, 0 oC
Si
(±)-198(±)-197(±)-124
F F
 
 
 
Ketone (±)-124 (750 mg, 3.47 mmol) was dissolved in DCM (30 ml) and Et3N (2.4 
ml, 17 mmol) was added. The solution was cooled to 0 oC and then TMSOTf (3.08 
ml, 17 mmol) was added. After stirring at 0 oC for 2 h, the reaction mixture was 
quenched with a saturated solution of NH4Cl (10 ml). The organic layer was washed 
with 0.1 M HCl (10 ml), brine (10 ml), dried over MgSO4 and concentrated. The 
crude ethyl 4-fluoro-3-[(trimethylsilyl)oxy]-8-azabicyclo[3.2.1]oct-2-ene-8-
carboxylate (±)-197 was obtained (400 mg, 1.39 mmol): 1H NMR δΗ (ppm) (CDCl3, 
400 MHz): 5.41 (1 H, br s, CHCH=COSi(CH3)3), 4.83-4.54 (2 H, m, NCHCHF and 
NCHCH=COSi(CH3)3), 4.34 (1 H, d, J = 49.8 Hz, CHCHFCOSi(CH3)3), 4.06-4.22 
(2 H, m, OCH2CH3), 2.04-2.20 (1 H, m, CHCH2CH2CH), 1.75-1.89 (1 H, m, 
CHCH2CH2CH), 1.57-1.71 (1 H, m, CHCH2CH2CH), 1.37-1.50 (1 H, m, 
CHCH2CH2CH), 1.27 (3 H, t, J = 7.1 Hz, OCH2CH3), 0.19-0.23 (9 H, m, Si(CH3)3). 
It was dissolved in THF (20 ml) and then NBS (320 mg, 1.8 mmol) was added. The 
reaction mixture was stirred at room temperature for 5 h. The crude material, 
obtained after evaporation of the solvent, was dissolved in DCM (10 ml), washed 
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with water (3 x 20 ml) and dried. Evaporation of the volatiles delivered a residue that 
was purified by chromatography on silica gel eluting with a gradient from 10 to 50% 
ethyl acetate in cyclohexane. 320 mg (31% yield over two steps) of the title 
compound (±)-198 were obtained as a colourless solid. An aliquot of this material 
was crystallized from a mixture ethyl acetate/cyclohexane to yield platy needles 
suitable for X-ray analysis (See Appendix 8.3). 
M.p: 84.0-85.6 oC; νmax/cm-1 (film): 1728, 1701, 1430, 1337, 1286, 1260, 1219, 
1170, 1110, 1040, 789; 1H NMR δΗ (ppm) (CDCl3, 400 MHz): 5.07-4.76 (2 H, m, 
NCHCHF and NCHCHBr), 4.51 (1 H, d, J = 48.1 Hz, CHCHFCO), 4.35-4.05 (3 H, 
m, OCH2CH3 and CHCHBrCO), 2.27-2.04 (2 H, m, CHCH2exoCH2exoCH), 1.76-1.62 
(1 H, m, CHCH2endoCH2endoCH), 1.57-1.43 (1 H, m, CHCH2endoCH2endoCH), 1.37-
1.28 (3 H, m, , J = 7.2 Hz, OCH2CH3); 1H NMR δΗ (ppm) (DMSO-d6, 400 MHz): 
4.82-4.54 (4 H, m, NCHCHFCO, NCHCHBrCO, CHCHBrCO and CHCHFCO), 
4.19-4.04 (2 H, m, OCH2CH3), 2.11-1.97 (2 H, m, CHCH2exoCH2exoCH), 1.75-1.63 (1 
H, m, CHCH2endoCH2endoCH), 1.54-1.42 (1 H, m, CHCH2endoCH2endoCH), 1.28-1.17 
(3 H, t, J = 6.8 Hz, OCH2CH3); 13C NMR δC (ppm) (CDCl3, 101 MHz): 195.3 (C, 
C=Oketone), 154.3 (C, C=Ocarbamate), 92.0 (CHCHFCO, d, 1JC-F = 183.8 Hz), 62.0 
(CH2, OCH2CH3), 58.2 (CH, NCHCH), 56.0 (CH, NCHCH), 48.7 (CH, 
CHCHBrCO), 27.4 (CH2, CHCH2CH2CH), 22.5 (CH2, CHCH2CH2CH), 14.6 (CH3, 
OCH2CH3); 19F NMR (CDCl3, 282 MHz): -169.4 (d, J = 42.3 Hz), -169.9 (d, J = 48.5 
Hz) rotamers at 29 oC; 19F NMR (DMSO-d6, 282 MHz, 25 ºC): -169.4 (d, J = 46.5 
Hz), -169.9 (d, J = 46.5 Hz) rotamers at 25 oC; 19F NMR (DMSO-d6, 282 MHz, 80 
ºC): -169.4 (dd, J = 46.5 and 9.6 Hz); m/z (ES+) 294 ([M+H]+ 100%); m/z (ES+) 
found: [M+H]+, 294.0151 C10H14NO3FBr requires: [M+H]+, 294.0141. 
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Synthesis of (1S,2S,4R,5R)-(+)-Ethyl 2-bromo-4-fluoro-3-oxo-8-azabicyclo[3.2.1] 
octane-8-carboxylate 198 
 
 
N
EtO2C
O
N
EtO2C
O
N
EtO2C
O
Br
FNBS, THF
Et3N, TMSOTf,
DCM, 0 oC
Si
F F
124 197 198
 
 
 
(-)-Ethyl (1SR2R,5S)-2-fluoro-3-oxo-8-azabicyclo[3.2.1]octane-8-carboxylate 124 
(>99% ee, 90 mg, 0.42 mmol) was dissolved in DCM (10 ml) and Et3N (0.29 ml, 2.1 
mmol) was added. The solution was cooled to 0 oC and then TMSOTf (0.38 ml, 2.1 
mmol) was added. After stirring at 0 oC for 2 h, the reaction mixture was quenched 
with a saturated solution of NH4Cl (5 ml). The organic layer was washed with 0.1 M 
HCl (10 ml), brine (10 ml), dried over MgSO4 and concentrated. The crude silyl enol 
ether intermediate 197 was obtained in quantitative yield. It was dissolved in THF 
(10 ml) and then NBS (96 mg, 0.54 mmol) was added. The reaction mixture was 
stirred at room temperature for 18 h. The crude material, obtained after evaporation 
of the solvent, was dissolved in DCM (10 ml), washed with water (3 x 20 ml) and 
dried. Evaporation of the volatiles delivered a residue that was purified by 
chromatography on silica gel eluting with a gradient from 10 to 30% ethyl acetate in 
cyclohexane. The title compound 198 was obtained as a pale yellow oil (40 mg, 32% 
yield over two steps). 
The analytical data correspond to the ones previously reported for the racemic 
compound (±)-198. 
[α]D20 +40.0 (c 0.1, CH3OH) (partially epimerised).  
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Synthesis of (1R*,2S*,5S*)-ethyl 2'-oxo-3-(trimethylsilyloxy)-8-
azaspiro[bicyclo[3.2.1]oct[3]ene-2,4'-[1,3]dioxolane]-8-carboxylate (±)-200 
 
 
N
EtO2C
O
OO
O
N
EtO2C
O
OO
O
Si
Et3N, TMSOTf
DCM, 0 °C
(±)-143 (±)-200
 
 
 
Ketone (±)-143 (150 mg, 0.56 mmol) was dissolved in DCM (10 ml) and Et3N (0.23 
ml, 1.67 mmol) was added. The solution was cooled to 0 oC and then TMSOTf (0.38 
ml, 2.1 mmol) was added. After stirring at 0 oC for 2 h, the reaction mixture was 
quenched with a saturated solution of NH4Cl (5 ml). The organic layer was washed 
with 0.1 M HCl (10 ml), brine (10 ml), dried over MgSO4 and concentrated, 
affording (±)-200 as a colourless oil in quantitative yield; νmax/cm-1 (film): 1804, 
1701, 1652, 1430, 1385, 1325, 1237, 1112, 1067, 882, 851, 767; 1H NMR δΗ (ppm) 
(CDCl3, 400 MHz): 5.46-5.28 (1 H, br s, CHCH=COSi(CH3)3), 4.77-4.57 (2 H, m, 
NCHCH= COSi(CH3)3 and NCHC), 4.54 (1 H, d, J = 8.5 Hz, CCH2O), 4.29-4.05 (3 
H, m, CCH2O and OCH2CH3), 2.29-2.11 (1 H, br m, CHCH2CH2CH), 1.99-1.78 (1 
H, br m, CHCH2CH2CH), 1.70-1.67 (1 H, br m, CHCH2CH2CH), 1.47-1.33 (1 H, br 
m, CHCH2CH2CH), 1.29 (3 H, t, J = 7.14 Hz, OCH2CH3), 0.22-0.26 (9 H, s, 
OSi(CH3)3); 13C NMR δc (ppm) (CDCl3, 100 MHz,): (quaternary carbon COSi(CH3)3 
not visible), 154.0 (C, C=O), 153.5 (C, C=O), 112.5 (CH, CHCH=COSi(CH3)3), 
84.1 (C, CCH2O), 67.2 (CH2, CCH2O), 61.6 (CH2 ,OCH2CH3), 58.3 (CH, NCH), 
51.8 (CH, NCH), 29.9 (CH2, CHCH2CH2CH), 22.8 (CH2, CHCH2CH2CH), 14.6 
(CH3, OCH2CH3), 0.0 (CH3, OSi(CH3)3); m/z (ES+) 342 ([M+H]+, 100%), 359 
([M+Na]+, 60%); m/z (ES+) found: [M+H]+, 342.1386 C15H24NO6Si requires: 
[M+H]+, 342.1373. 
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Synthesis of (1R*,2S*,4S*,5S*)-ethyl 4-fluoro-3,3-dihydroxy-2'-oxo-8-
azaspiro[bicyclo[3.2.1]octane-2,4'-[1,3]dioxolane]-8-carboxylate (±)-201 
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EtO2C
O
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O
N
EtO2C
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O
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DCM, 0 °C
F
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CH3CN
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O
OO
O
(±)-143
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Ketone (±)-143 (150 mg, 0.58 mmol) was dissolved in DCM (10 ml) and cooled to 0 
oC. Et3N (0.23 ml, 1.67 mmol) was added followed by TMSOTf (0.3 ml, 1.67 
mmol). The reaction mixture was stirred at 0 oC for 2 h and then quenched with a 
saturated solution of NH4Cl (10 ml). The organic layer was washed with 0.1 M HCl 
(20 ml), with brine (20 ml) and finally dried over Na2SO4 and concentrated in vacuo. 
The crude silyl enol ether (±)-200 (whose analytical data were consistent with the 
ones previously reported) was reacted in the following step without further 
purification. It was dissolved in CH3CN (5 ml) and SelectfluorTM (0.39 g, 1.12 
mmol) was added in one single portion. The reaction mixture was stirred at RT for 2 
h then the solvent was evaporated under reduced pressure. Purification by 
chromatography on silica gel eluting first with a gradient from 30 to 100% ethyl 
acetate in cyclohexane and then with 5% MeOH in DCM afforded the title 
compound (±)-201 as a colourless solid (100 mg, 59%); νmax/cm-1 (nujol): 3370, 
1808, 1771, 1671, 1332, 1236, 1066, 1018, 763, 722; 1H NMR δΗ (ppm) (DMSO-d6, 
400 MHz, 25 °C): 6.94 (1 H, s, OH), 6.60 (1 H, s, OH), 4.68-4.21 (5 H, m, NCHC, 
NCHCHFC(OH)2, CHCHFC(OH)2 and CCH2O), 4.12-3.90 (2 H, m, OCH2CH3), 
1.91-1.60 (4 H, m, CHCH2CH2CH), 1.17 (3 H, t, J = 7.0 Hz, OCH2CH3); 13C NMR 
δC (ppm) (DMSO-d6, 101 MHz): 154.5 (C, C=O), 154.0 (C, C=O), 91.8 (CH, d, J = 
187 Hz, CHCHFC(OH)2), 90.3 (C, d, J = 22 Hz, CHCHFC(OH)2), 84.6 (C, CCH2O), 
66.5 (C, CCH2O), 60.5 (CH2, OCH2CH3), 57.9 (CH, NCHC), 55.6 (CH, 
NCHCHFC(OH)2), 24.5 (CH2, CHCH2CH2CH), 24.0 (CH2, CHCH2CH2CH), 14.5 
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(CH3, OCH2CH3); 19F NMR δF (ppm) (DMSO-d6, 282 MHz, 25 °C): -176.8 (d, J = 
47.4 Hz), 177.2 (d, J = 49.1 Hz); m/z (ES+) 306 ([M+H]+ 30%), 323 ([M+NH4+] 
100%); m/z (ES+) found: [M+H]+, 306.0989. C12H17NO7F requires: [M+H]+, 
306.0984. Absence of a defined melting point, suggesting thermal decomposition. 
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Synthesis of (1S,2S,4R,5R)-(-)-ethyl 4-fluoro-3,3-dihydroxy-3'-methyl-2'-oxo-8-
azaspiro[bicyclo[3.2.1]octane-2,5'-oxazolidine]-8-carboxylate ent-203 
 
 Et3N, TMSOTf,
 DCM, 0 °C
N
CO2Et
O
N O
O
ent-173
N
CO2Et
O
N O
O
Si
ent-203
 
 
Ketone ent-173 (ee > 99%) (100 mg, 0.35 mmol) was dissolved in DCM (10 ml) and 
cooled to 0 oC. Et3N (0.25 ml, 1.77 mmol) was added followed by TMSOTf (0.32 
ml, 1.77 mmol). The reaction mixture was stirred at 0 oC for 2 h and then quenched 
with a saturated solution of NH4Cl (10 ml). The organic layer was washed with 0.1 
M HCl (20 ml), with brine (20 ml) and finally dried over Na2SO4 and concentrated in 
vacuo. The title compound ent-203 was obtained in quantitative yield as a colourless 
oil (120 mg), [α]D20 -33.9 (c 0.59, CH3OH); νmax/cm-1 (film): 1742, 1699, 1651, 
1435, 1106, 1023, 883, 846, 757; 1H NMR δΗ (ppm) (CDCl3, 400 MHz): 5.35-5.18 
(1 H, br m, CHCH=COSi(CH3)3), 4.70-4.45 (2 H, m, NCHC and 
NCHCHC=COSi(CH3)3), 4.26-4.03 (2 H, m, OCH2CH3), 3.63 (1 H, d, J = 8.5 Hz, 
CCH2N), 3.31 (1 H, d, J = 8.5 Hz, CCH2N), 2.89 (3 H, m, NCH3), 2.23-2.02 (1 H, m, 
CHCH2exoCH2exoCH), 1.93-1.78 (1 H, m, CHCH2exoCH2exoCH), 1.73-1.62 (1 H, m, 
CHCH2endoCH2endoCH), 1.54-1.41 (1 H, m, CHCH2endoCH2endoCH), 1.27 (3 H, t, J = 
7.2 Hz, OCH2CH3), 0.24 (9 H, s, OSi(CH3)3); 13C NMR δC (ppm) (CDCl3, 101 
MHz): 157.1 (C, C=O), 153.7 (C, C=O), 146.4 (C, COSi(CH3)3), 111.6 (CH, 
CHCH=COSi(CH3)3), 80.4 (C, CCH2N), 61.5 (CH2, OCH2CH3), 59.1 (CH, 
NCHCH), 51.9 (CH, NCHC), 49.9 (CH2, CCH2N), 30.8 (CH3, NCH3), 29.2 (CH2, 
CHCH2CH2CH), 22.9 (CH2, CHCH2CH2CH), 14.6 (CH3, OCH2CH3), 0.12 (CH3, 
OSi(CH3)3); m/z (ES+) 355 ([M+H]+ 100%), 372 ([M+H2O]+ 90%); m/z (ES+) 
found: [M+H]+, 355.1697. C16H27N2O5Si requires: [M+H]+, 355.1689. 
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Synthesis of (1S,2S,4R,5R)-(-)-ethyl 4-fluoro-3,3-dihydroxy-3'-methyl-2'-oxo-8-
azaspiro[bicyclo[3.2.1]octane-2,5'-oxazolidine]-8-carboxylate ent-202 
 
 Et3N, TMSOTf
 DCM, 0°C N
CO2Et
OH
N O
O
F
N
CO2Et
O
N O
O
HO
ent-173
SelectfluorTM
CH3CN
N
CO2Et
O
N O
O
Si
ent-203 ent-202
 
Ketone ent-173 (ee > 99%) (100 mg, 0.35 mmol) was dissolved in DCM (10 ml) and 
cooled to 0 oC. Et3N (0.25 ml, 1.77 mmol) was added followed by TMSOTf (0.32 
ml, 1.77 mmol). The reaction mixture was stirred at 0 oC for 2 h and then quenched 
with a saturated solution of NH4Cl (10 ml). The organic layer was washed at first 
with 0.1 M HCl (20 ml), then with brine (20 ml) and finally dried over Na2SO4 and 
concentrated in vacuo. The crude silyl enol ether ent-203 was reacted in the 
following step without further purification. It was dissolved in CH3CN (10 ml) and 
SelectfluorTM (0.25 g, 0.71 mmol) was added in a single portion. The reaction 
mixture was stirred at RT for 1.5 h and then the solvent was evaporated under 
reduced pressure. The residue was partitioned between DCM (20 ml) and water (20 
ml). The organic layer was washed with 0.1 M HCl (20 ml), brine (20 ml), dried and 
concentrated under reduced pressure. Purification by chromatography on silica gel 
with a gradient starting from 50% to 100% ethyl acetate in cyclohexane afforded the 
title compound ent-202 as a colourless solid (35 mg, 31%); [α]D20 -9.5 (c 0.21, 
CH3OH); νmax/cm-1 (nujol): 3363, 3288, 1762, 1733, 1665, 1339, 1110, 1046, 1029; 
1H NMR δH (ppm) (DMSO-d6, 300 MHz): 6.65 (1 H, s, OH), 6.14 (1 H, s, OH), 
4.55-4.43 (1 H, m, NCHCHFC(OH)2), 4.37-4.21 (2 H, m, CHCHFC(OH)2 and 
NCHC), 4.06-3.98 (2 H, br q, OCH2CH3), 3.68 (1 H, br d, J = 8.7 Hz, CCH2N), 3.18-
3.15 (1 H, m, CCH2N), 2.77 (3 H, s, NCH3), 2.02-1.75 (4 H, m, CHCH2CH2CH), 
1.25-1.16 (3 H, m, OCH2CH3); 1H NMR δH (ppm) (DMSO-d6, 300 MHz, 90 ºC): 
6.38 (1 H, s, OH), 5.70 (1 H, s, OH), 4.56-4.49 (1 H, m, NCHCHFC(OH)2), 4.27 (1 
H, d, J = 6.9 Hz, NCHC), 4.23 (1 H, dd, J = 47 and 3.0 Hz, CHCHFC(OH)2), 4.07-
4.01 (2 H, m, OCH2CH3), 3.74 (1 H, d, J = 9.6 Hz, CCH2N), 3.16 (1 H, d, J = 9.6 Hz, 
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CCH2N), 2.77 (3 H, s, NCH3), 1.92-1.74 (4 H, m, CHCH2CH2CH), 1.25-1.20 (3 H, 
m, OCH2CH3); 13C NMR δc (ppm) (CDCl3, 91 MHz): 156.6 (C, C=Ooxazolidinone), 
153.5 (C, C=Ocarbamate), 91.4 (C, CCH2N from HMBC), 92.5 (CH, d, J = 155 Hz, 
CHCHFC(OH)2 from HSQC), 80.7 (C, C(OH)2 from HMBC), 60.3 (CH2, 
OCH2CH3), 58.4 (CH, NCHC), 55.2 (CH, NCHCHFC(OH)2), 48.2 (CH2, CCH2N), 
30.4 (CH3, NCH3), 24.1 and 23.2 (CH2, CHCH2CH2CH), 14.5 (CH3, OCH2CH3); 19F 
NMR (DMSO-d6, 282 MHz, 25 oC): -180.8 (dd, J = 46.2 and 9.6 Hz), -181.3 (dd, J = 
47.4 and 9.6 Hz) rotamers at 25 oC; 19F NMR (DMSO-d6, 282 MHz, 90 oC): -181.1 
(d, J=45.7 Hz); m/z (ES+) 319 ([M+H]+ 100%), 336 ([M+NH4+] 90%); m/z (ES+) 
found: [M+H]+, 319.1309. C13H20N2O6F requires: [M+H]+, 319.1305. Absence of a 
defined melting point, suggesting thermal decomposition. 
 
Compound ent-202 crystallized from a mixture ethyl acetate/pentane in colourless 
blocks suitable for X-ray analysis (See Appendix 8.4). 
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Synthesis of (1S,2S,4S,5R)-(-)-ethyl 4-chloro-3'-methyl-2',3-dioxo-8H-spiro[8-
azabicyclo[3.2.1]octane-2,5'-[1,3]oxazolidine]-8-carboxylate ent-204 
 
 
N
CO2Et
O
ON
O
N
CO2Et
TMSO
ON
O
Et3N, TMSOTf
DCM, 0 oC
N
CO2Et
O
ON
O
Cl
Sulfuryl
Chloride, DCM
ent-173 ent-203 ent-204
 
 
Ketone ent-173 (>99.5% ee) (150 mg, 0.53 mmol) was dissolved in DCM (10 ml) 
and Et3N (0.37 ml, 2.66 mmol) added. The solution was cooled to 0 oC and then 
TMSOTf (0.48 ml, 2.66 mmol) was added. After stirring at 0 oC for 1 h, the reaction 
mixture was quenched with a saturated solution of NH4Cl (5 ml). The organic layer 
was washed with 0.1 M HCl (10 ml), brine (10 ml), dried over MgSO4 and 
concentrated. To a -78 oC cooled solution of sulfuryl chloride (47µl, 0.6 mmol) in 
DCM (5 ml) a solution of (-)-(1S,2S,5R)-ethyl 3'-methyl-2'-oxo-3-
[(trimethylsilyl)oxy]-8H-spiro[8-azabicyclo[3.2.1]oct-3-ene-2,5'-[1,3]oxazolidine]-8-
carboxylate ent-203 (0.53 mmol) was added over 2 minutes, under nitrogen 
atmosphere. The reaction mixture was allowed to slowly reach room temperature and 
stirred at this temperature for 30 min. The mixture was then quenched with a 
saturated solution of NH4Cl (10 ml). The organic layer was washed with brine (20 
ml), dried over Na2SO4 and concentrated in vacuo. Purification by chromatography 
on silica gel eluting with a gradient from 25 to 100% ethyl acetate in cyclohexane 
yielded the title compound ent-204 (30 mg, 39%) as a colourless solid; m p: 155.8-
157.7 ºC; [α]D20 -12.5 (c 0.16, CH3OH); νmax/cm-1 (nujol): 1779, 1747, 1697, 1319, 
1299, 1118, 1022, 768; 1H NMR δH (ppm) (CDCl3, 400 MHz): 5.11-4.93 (1 H, m, 
CHCHClCO), 4.81-4.49 (2 H, m, NCHCHClCO and NCHC), 4.37-4.15 (3 H, m, 
OCH2CH3 and CCH2N), 3.21-3.06 (1 H, br d, J = 9.1 Hz, CCH2N), 2.92 (3 H, s, 
NCH3), 2.28-1.94 (2 H, m, CHCH2exoCH2exoCH), 1.93-1.81 (1 H, m, 
CHCH2endoCH2endoCHCHBr), 1.39-1.21 (4 H, m, OCH2CH3 and 
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CHCH2endoCH2endoCHCHBr); 13C NMR δC (ppm) (CDCl3, 101 MHz): 193.6 (C, 
C=Oketone), 154.7 (C, C=O), 154.1 (C, C=O), 83.7 (C, CCH2N), 63.5 (CH, 
CHCHClCO), 62.4 (CH2, OCH2CH3), 60.4 (CH, NCHCHClCO), 60.3 (CH, NCHC), 
47.6 (CH2, CCH2N), 31.1 (CH3, NCH3), 23.7 (CH2, CHCH2CH2CH), 23.1 (CH2, 
CHCH2CH2CH), 14.6 (CH3, OCH2CH3); m/z (ES+) 317 ([M+H]+, 100%); m/z (ES+) 
found: [M+H]+, 317.0894 C13H18N2O5Cl requires: [M+H]+, 317.0904. 
Compound ent-204 crystallized from a mixture ethyl acetate/cyclohexane in 
colourless platy needles suitable for X-ray analysis. Absolute stereochemistry 
assigned (See Appendix 8.5). 
 
 
 Chapter 7 
 
 254
Synthesis of (1R*,2R*,4R*,5S*)-ethyl-4-bromo-1,3',5-trimethyl-2',3-dioxo-8H-
spiro[8-azabicyclo[3.2.1]octane-2,5'-[1,3]oxazolidine]-8-carboxylate (±)-205 and 
(1S*,2S*,4R*,5R*)-ethyl-4-bromo-3'-methyl-2',3-dioxo-8H-spiro[8-
azabicyclo[3.2.1]octane-2,5'-[1,3]oxazolidine]-8-carboxylate (±)-206 
 
 
N
EtO2C
NO
O
O
N
EtO2C
NO
O
O
Et3N, TMSOTf
DCM, 0 oC
Si
N
EtO2C
NO
O
O
Br
NBS, THF
N
NO
O
O
Br
and
Major product
Minor product
(±)-173 (±)-203
(±)-205
(±)-206
EtO2C
 
 
Ketone (±)-173 (0.4 g, 1.42 mmol) was dissolved in DCM (20 ml) and cooled to 0 
oC. Et3N (0.99 ml, 7.1 mmol) was added followed by TMSOTf (1.3 ml, 7.1 mmol). 
The reaction mixture was stirred at 0 oC for 1 h and then quenched with a saturated 
solution of NH4Cl (10 ml). The organic layer was washed at first with 0.1 M HCl (20 
ml), then with brine (20 ml) and finally dried over Na2SO4 and concentrated in 
vacuo. The intermediate silyl enol ether was reacted in the following step without 
further purification. It was dissolved in THF (30 ml) and cooled to 0 oC before 
portionwise addition of NBS (280 mg, 1.56 mmol). The reaction mixture was stirred 
at 0 oC for 1 h and then at RT for a further hour before quenching with a saturated 
solution of NaHCO3 (10 ml). The organic layer was diluted with ethyl acetate (30 
ml), washed with brine (20 ml), dried over Na2SO4 and concentrated in vacuo. 
Purification by chromatography on silica gel eluting with a gradient from 10 to 50% 
ethyl acetate in cyclohexane yielded (±)-205 (higher running spot, 200 mg, 39%) as a 
colourless solid and (±)-206 (lower running spot, 130 mg, 25%) as a colourless solid. 
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(1R,2R,4R,5S)-(+)-ethyl-4-bromo-1,3',5-trimethyl-2',3-dioxo-8H-spiro[8-
azabicyclo[3.2.1]octane-2,5'-[1,3]oxazolidine]-8-carboxylate 205 and of 
(1S,2S,4S,5R)-(-)-ethyl 4-bromo-3'-methyl-2',3-dioxo-8H-spiro[8-
azabicyclo[3.2.1]octane-2,5'-[1,3]oxazolidine]-8-carboxylate ent- 205 
 
 
N
EtO2C
NO
O
O
Br
N
CO2Et
N O
O
O
Br
205 ent-205
 
 
 
The racemic ketone (±)-205 was characterized and then separated into single 
enantiomers by preparative chiral chromatography (column: Chiralpak AD-H (25 x 
2.0 cm); mobile phase: n-hexane/iso-propanol 83/17 % v/v; flow rate: 16.0 ml/min; 
DAD: 230 nm): m.p. 127.9-130.0 oC; νmax/cm-1 (nujol): 1780, 1744, 1698, 1120, 
1020, 751, 666; 1H NMR δH (ppm) (CDCl3, 400 MHz): 5.26-5.10 (1 H, m, 
CHCHBrCO), 4.82-4.54 (2 H, m, NCHC and NCHCHBrCO), 4.37-4.15 (3 H, m, 
OCH2CH3 and CCH2N), 3.14 (1 H, br d, J=9.1 Hz, CCH2N), 2.93 (3 H, s, NCH3), 
2.23-1.99 (2 H, m, CHCH2exoCH2exoCH), 1.99-1.88 (1 H, m, CHCH2endoCH2endoCH), 
1.24-1.37 (4 H, m, OCH2CH3 and CHCH2endoCH2endoCH); 1H NMR δH (ppm) 
(DMSO-d6, 300 MHz, 90 ºC): 5.32 (1 H, d, J = 3.3 Hz, CHCHBrCO), 4.17-4.63 (2 
H, m, NCHC and NCHCHBrCO), 4.20-4.15 (2 H, m, OCH2CH3), 4.05 (1 H, d, J = 
9.3 Hz, CCH2N), 3.39 (1 H, d, J = 9.3 Hz, CCH2N), 2.82 (3 H, s, NCH3), 2.21-1.96 
(2 H, m, CHCH2exoCH2exoCH), 1.83-1.69 (1 H, m, CHCH2endoCH2endoCH), 1.41-1.24 
(4 H, m, OCH2CH3 and CHCH2endoCH2endoCH); 13C NMR δc (ppm) (CDCl3, 101 
MHz): 192.9 (C, C=Oketone), 154.7 (C, C=O), 154.1 (C, C=O), 83.8 (C, CCH2N), 62.4 
(CH2, OCH2CH3), 60.6 (CH, NCHC), 60.4 (CH, NCHCHBrCO), 55.6 (CH, 
CHCHBrCO), 47.9 (CH2, CCH2N), 31.1 (CH3, NCH3), 23.9 (CH2, 
CHCH2CH2CHBr), 23.5 (CH2, CHCH2CH2CHBr), 14.6 (CH3, OCH2CH3); m/z 
(ES+) 361 ([M+H]+ 100%); m/z (ES+) found: [M+H]+, 361.0383 C13H18N2O5Br 
requires: [M+H]+, 361.0399. 
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ent-205: enantiomer 1, Rt 14.86 min; m.p. 148.0-152.4 oC; [α]D20 -13.3 (c 0.3, 
CH3OH); >99% enantiomeric excess, 65 mg, colourless solid. 
205: enantiomer 2, Rt 17.95 min; m.p. 135.7-148.5 oC; [α]D20 +13.3 (c 0.3, CH3OH); 
>99.5% enantiomeric excess, 65 mg, colourless solid. 
 
 
 
(1S,2S,4R,5R)-(+)-ethyl-4-bromo-3'-methyl-2',3-dioxo-8H-spiro[8-
azabicyclo[3.2.1]octane-2,5'-[1,3]oxazolidine]-8-carboxylate 206 and 
(1S,2R,4S,5S)-(-)-ethyl-4-bromo-3'-methyl-2',3-dioxo-8H-spiro[8-
azabicyclo[3.2.1]octane-2,5'-[1,3]oxazolidine]-8-carboxylate ent-206 
 
 
 
N
EtO2C
NO
O
O
Br
N
CO2Et
N O
O
O
Br
206 ent-206
 
 
 
The racemic ketone (±)-206 was characterized and then separated into single 
enantiomers by preparative chiral chromatography (column: Chiralpak OJ-H (25 x 
2.0 cm); mobile phase: n-hexane/iso-propanol 70/30 % v/v; flow rate: 14.0 ml/min; 
DAD: 225 nm): m.p. 107.4-109.4 ºC, νmax/cm-1 (nujol): 1761, 1697, 1108, 1017, 756, 
666; 1H NMR δH (ppm) (CDCl3, 400 MHz): 5.02-4.64 (2 H, m, NCHC and 
NCHCHBrCO), 4.47-4.11 (4 H, m, OCH2CH3, CHCHBrCO and CCH2N), 3.12 (1 H, 
d, J = 9.1 Hz, CCH2N), 2.94 (3 H, s, NCH3), 2.30-2.07 (2 H, m, 
CHCH2exoCH2exoCH), 1.75-1.65 (1 H, m, CHCH2endoCH2endoCH), 1.39-1.24 (4 H, m, 
OCH2CH3 and CHCH2endoCH2endoCH); 1H NMR δH (ppm) (DMSO-d6, 400 MHz): 
4.80-4.65 (2 H, m, NCHC and NCHCHBrCO), 4.61 (1 H, br s, CHCHBrCO), 4.21-
4.03 (2 H, br m, OCH2CH3), 3.86 (1 H, d, J = 9.2 Hz, CCH2N), 3.34 (1 H, d, J = 9.2 
Hz, CCH2N), 2.7 (3 H, s, NCH3), 2.16-1.93 (2 H, m, CHCH2exoCH2exoCH), 1.74-1.63 
(1 H, m, CHCH2endoCH2endoCHCHBr), 1.45-1.33 (1 H, m, 
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CHCH2endoCH2endoCHCHBr), 1.22 (3 H, t, J = 7.1 Hz, OCH2CH3); 13C NMR δC 
(ppm) (DMSO-d6, 101 MHz): 195.6 (C, C=Oketone), 155.4 (C, C=O), 154.0 (C, 
C=O), 81.3 (C, CCH2N), 61.5 (CH2, OCH2CH3), 59.3 (CH, NCH), 58.8 (CH, NCH), 
48.5 (CH2, CCH2N), 47.6 (CH, CHCHBrCO), 31.1 (CH3, NCH3), 27.7 (CH2, 
CHCH2CH2CH), 23.3 (CH2, CHCH2CH2CH), 15.7 (CH3, OCH2CH3); m/z (ES+) 361 
([M+H]+ 100%); m/z (ES+) found: [M+H]+, 361.0385 C13H18N2O5Br requires: 
[M+H]+, 361.0399. 
ent-206: enantiomer 1, Rt 14.14 min; m.p. 185.0-188.8 oC; [α]D20 -164.3 (c 0.28, 
CH3OH); >94% enantiomeric excess, 40 mg, colourless solid. 
206: enantiomer 2, Rt 17.17 min; m.p. 185.0-188.8 oC; [α]D20 +162.5 (c 0.3, 
CH3OH); >93% enantiomeric excess, 40 mg, colourless solid. 
Compound ent-206 crystallized from a mixture ethyl acetate/cyclohexane in 
colourless needles suitable for X-ray analysis. Absolute configuration assigned (See 
Appendix 8.6). 
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Synthesis of (1R,2R,3R,4R,5S)-(+)-ethyl 3,4-dihydroxy-3-methoxy-3'-methyl-2'-oxo-
8-azaspiro[bicyclo[3.2.1]octane-2,5'-oxazolidine]-8-carboxylate 209 
 
N
EtO2C
NO
O
O
N
EtO2C
NO
O
O
HO
MeOH, KOH,
PhI(OAc)2
OH
H
173 209
 
 
To a stirred solution of KOH (47 mg, 0.84 mmol) in dry MeOH (1 ml) at 0 oC under 
nitrogen atmosphere, (+)-ethyl (1R,2R,5S)-3'-methyl-2',3-dioxo-8H-spiro[8-
azabicyclo[3.2.1]octane-2,5'-[1,3]oxazolidine]-8-carboxylate 173 (99.5% ee, 55 mg, 
0.2 mmol) in dry MeOH (1 ml) was added dropwise over 1 minute. The reaction 
mixture was stirred at 0 oC for 10 minutes before portionwise addition of PhI(OAc)2 
(94 mg, 0.29 mmol). After 5 h stirring at room temperature, the solvent was 
evaporated under reduced pressure and the residue was partitioned between DCM 
(20 ml) and water (20 ml). The organic phase was washed with brine (20 ml), dried 
and concentrated under reduced pressure. Purification by chromatography on silica 
gel eluting with a gradient from 50 to 100% ethyl acetate in cyclohexane afforded 
209 as a colourless solid (18 mg, 30%); m.p. 150.6-154.0 oC; [α]D20 +18.2 (c 0.55, 
CH3OH); νmax/cm-1 (nujol): 3391, 1742, 1711, 1315, 1277, 1213, 1103, 723; 1H 
NMR δH (ppm) (CDCl3, 400 MHz): 4.61-4.76 (1 H, br s, NCHCHOH), 4.31-4.51 (1 
H, br s, NCHC), 4.04-4.26 (3 H, m, CHCH(OH)C(OH)OCH3 and OCH2CH3), 3.68 
(1 H, d, J = 9.3 Hz, CCH2N), 3.33 (1 H, d, J = 9.3 Hz, CCH2N), 3.29 (3 H, s, OCH3), 
2.94 (3 H, s, NCH3), 1.84-1.99 (2 H, m, CHCH2exoCH2exoCH), 1.55-1.59 (1 H, m, 
CHCH2endoCH2endoCH), 1.28 (4 H, m, CHCH2endoCH2endoCH and OCH2CH3); 13C 
NMR δc (ppm) (CDCl3, 101 MHz): 157.0 (C, C=O), 153.8 (C, C=O), 84.7 (C, 
CHCH(OH)C(OH)OCH3), 78.2 (C, CCH2N), 61.8 (CH2, OCH2CH3), 61.5 (CH, 
CHCH(OH)C(OH)OCH3), 58.9 (CH, NCHC), 52.3 (CH3, OCH3), 52.2 (CH, 
NCHCHOH) 50.7 (CH2, CCH2N), 30.9 (CH3, NCH3), 26.4 (CH2, CHCH2CH2CH), 
24.9 (CH2, CHCH2CH2CH), 14.6 (CH3, OCH2CH3); m/z (ES+) found: [M+H]+, 
313.1398. C14H21N2O6 requires: [M+H]+, 313.1400; m/z (ES+) 313 ([M+H]+, 100%) 
and 330 ([M+18]+, 100%). 
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Table 7.1: Summary of HPLC/SFC conditions for preparative or analytical chiral 
separations and measurement of the enantiomeric purity of the different catalysts. 
Ketone Technique Column Conditions 
Retention 
Timesa 
(±)-124 HPLC Chiralpak AD-H 
225 nm 
75/25% v/v n-
nHexane/EtOH 
14 ml/min 
9.76 min 124 
10.43 min ent-
124 
(±)-143 SFC Chiralpak AD-H 
220 nm 
90/10 CO2/iPOH 
10 ml/min 
35 oC 
Outlet P=100 bar 
5.20 min ent-
143 
6.35 min 143 
(±)-156 SFC Chiralpak AS-H 
220 nm 
85/15 CO2/MeOH 
10 ml/min 
40 oC 
Outlet P=100 bar 
3.60 min ent-
156 
4.19 min 156 
160 HPLC ACE 3 C8 
254 nm 
50% CH3CN/0.1% 
TFA-H2O 
1.0 ml/min 
5.47 min 
161 HPLC ACE 3 C8 
254 nm 
50% CH3CN/0.1% 
TFA-H2O 
1.0 ml/min 
5.62 min 
(±)-164 SFC Chiralpak AS-H 
220 nm 
85/15 CO2/MeOH 
10 ml/min 
35 oC 
Outlet P=100 bar 
3.32 min ent-
164 
4.23 min 164 
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(±)-167 SFC Chiralpak IA 
220 nm 
87/13 CO2/iPOH 
10 ml/min 
35 oC 
Outlet P=100 bar 
3.45 min ent-
167 
4.22 min 167 
(±)-170 SFC Chiralpak AD-H 
220 nm 
80/20 CO2/MeOH 
10 ml/min 
35 oC 
Outlet P=100 bar 
2.38 min 170 
3.16 min ent-
170 
 
(±)-173 
 
SFC Chiralpak AD-H 
220 nm 
87/15 CO2/MeOH 
10 ml/min 
35 oC 
Outlet P=100 bar 
3.74 min 173 
4.32 min ent-
173 
 
(±)-173 
 
HPLC Chiralpak AS-H 
225 nm 
70/30% v/v 
nHexane/EtOH 
14 ml/min 
11.46 min ent-
173 
16.45 min 173 
 
(±)-187 
 
HPLC Chiralpak AD-H 
225 nm 
85/15% v/v 
nHexane/iPOH 
14 ml/min 
15.23 min ent-
187 
18.53 min 187 
 
(±)-190 
 
HPLC Chiralpak AD-H 
225 nm 
70/30% v/v 
nHexane/EtOH 
14 ml/min 
18.75 min ent-
190 
22.15 min 190 
(±)-205 HPLC Chiralpak AD-H 
230 nm 
85/15% v/v n-
nHexane/iPOH 
1 ml/min 
14.86 min ent-
205 
17.95 min 205 
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(±)-206 HPLC Chiralpak OJ-H 
225 nm 
70/30% v/v n-
nHexane/iPOH 
0.8 ml/min 
11.09 min ent-
206 
15.97 min 206 
a The ent-series gives the (S,S) stilbene oxide. Absolute configuration of the catalyst 
is assumed by correlation with optical rotation of E-stilbene oxide obtained from 
epoxidation reaction that is assumed to occur through a spiro transition state. 
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7.4 General procedure for alkene epoxidation: one-phase epoxidation system – 
Yang pH 7.5 
 
To a solution of ketone and alkene (0.1 mmol) in acetonitrile (1.5 ml) was added 
aqueous Na2EDTA solution (1.0 ml of a 0.4 mM aqueous solution). Oxone® (307 
mg, 1.0 mmol KHSO5) and NaHCO3 (130 mg, 1.55 mmol) were added in portions 
simultaneously over 30 minutes. The reaction was stirred vigorously until completion 
(by TLC analysis) or for 24 hours, then diluted with water (10 ml). 
Work-up A: 
the reaction mixture was extracted into diethyl ether (3 × 25 ml). The combined 
organic extracts were dried (Na2SO4), filtered and evaporated to dryness under 
reduced pressure. Flash column chromatography (gradient from 5 to 10% diethyl 
ether in cyclohexane) on silica or purification by preparative thin layer 
chromatography afforded the relevant epoxide. 
Work-up B: 
the reaction mixture was extracted into DCM (25 ml). The organic phase was 
separated using a phase separation cartridge and evaporated to dryness under reduced 
pressure or under a steam of nitrogen. Flash column chromatography (gradient from 
5 to 10% diethyl ether in cyclohexane) on silica or purification by preparative thin 
layer chromatography afforded the relevant epoxide. 
 
Work-up B is highly efficient when epoxidation reactions are run in parallel. No 
difference in the enantioselectivity has been observed between work-up A and work-
up B. 
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7.5 Determination of epoxide enantiomeric purity 
 
The epoxide products are all literature compounds (E-stilbene oxide186, styrene 
oxide187, E-methyl styrene oxide188, phenyl cyclohexene oxide189, α-methyl styrene 
oxide190,191, α-ethyl styrene oxide192, α-i-propyl styrene oxide117, E-ethyl-cinnamate 
oxide193) and the 1H NMR data are in agreement with the literature data. Substrates 
but-1-en-2-ylbenzene194 and (3-methylbut-1-en-2-yl)benzene195 were not 
commercially available and were prepared according to literature methods. 
 
 
Table 7.2: HPLC condition for measuring the enantiomeric excesses and 
configurations of the different epoxides 
Alkene Technique Column Conditions 
Retention 
Times 
E-Stilbene HPLC Chiralpak AS 
220 nm 
5% EtOH/nHexane 
1.0 ml/min 
5.25 min 
(R)a 
5.95 min (S)a 
E-Stilbene HPLC Chiralpak AS 
220 nm 
5% iPOH/nHexane 
1.0 ml/min 
5.63 min 
(R)a 
6.36 min (S)a 
Styrene HPLC Chiralpak AS 
220 nm 
1% 
iPrOH/nHexane 
0.8 ml/min 
6.09 min 
(R)a 
6.82 min (S)a 
α-Methyl 
styrene 
HPLC Chiralcel OD 
220 nm 
0.7% 
iPrOH/nHexane 
0.8 ml/min 
6.60 min 
(R)b 
7.15 min (S)b 
But-1-en-2-
ylbenzene 
HPLC Chiralcel OD 
220 nm 
0.7% 
iPrOH/nHexane 
0.8 ml/min 
12.30 min 
(R)d 
14.07 min 
(S)d 
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(3-Methylbut-1-
en-2-yl)benzene 
HPLC Chiralcel OD 
220 nm 
0.7% 
iPrOH/nHexane 
0.8 ml/min 
7.12 min 
(ND)c 
9.53 min 
(ND)c 
E-β-Methyl 
styrene 
HPLC Chiralpak AS 
220 nm 
1% 
iPrOH/nHexane 
1.0 ml/min 
6.54 min 
(R,R)e 
7.25 min 
(S,S)e 
Phenyl 
cyclohexene 
HPLC Chiralcel OJ-H 
220 nm 
1% EtOH/nHexane 
1.5 ml/min 
6.15 min 
(S,S)f 
7.46 min 
(R,R)f 
Phenyl 
cyclohexene 
HPLC Chiralcel OJ 
220 nm 
1% EtOH/nHexane 
1.5 ml/min 
7.80 min 
(S,S)f 
9.36 min 
(R,R)f 
E-Ethyl 
cinnamate 
HPLC Chiralpak AS 
220 nm 
10% 
EtOH/nHexane 
1.0 ml/min 
6.60 min 
(2S,3R)g 
8.32 min 
(2R,3S)g 
E-Ethyl-
cinnamate 
HPLC Chiralpak AS 
220 nm 
10% 
iPOH/nHexane 
1.0 ml/min 
4.87 min 
(2S,3R)g 
5.63 min 
(2R,3S)g 
a Absolute configuration assigned by comparison with a pure enantiomerically 
enriched sample.196 b Absolute configuration assigned by comparison with the 
literature data.101 c Absolute configuration of the major peak not determined. d 
Absolute configuration determined by comparing the measured optical rotation of the 
product with the reported enantiomerically pure product.194 e Absolute configuration 
determined by comparing the measured optical rotation of the product with the 
reported enantiomerically pure product.197 f Absolute configuration assigned by 
comparing the measured optical rotation of the product with the reported literature 
data.100 g Absolute configuration assigned by comparing the measured optical 
rotation of the product with the reported literature data.93 
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Appendix 8.1: Crystal data and structure refinement for ketone 160. 
 
Empirical formula C20 H24 N2 O5 
Formula weight 372.41 
Temperature 173(2) K 
Diffractometer, wavelength OD Xcalibur 3, 0.71073 Å 
Crystal system, space group Orthorhombic, P2(1)2(1)2(1) 
Unit cell dimensions a = 6.3682(3) Å α = 90° 
 b = 20.4804(7) Å β = 90° 
 c = 28.9173(10) Å γ = 90° 
Volume, Z 3771.5(3) Å3, 8 
Density (calculated) 1.368 Mg/m3 
Absorption coefficient 0.102 mm-1 
F(000) 1648 
Crystal colour / morphology Colourless blocky needles 
Crystal size 0.38 x 0.32 x 0.24 mm3 
θ range for data collection 4.04 to 32.63° 
Index ranges -8<=h<=9, -30<=k<=24, -42<=l<=41 
Reflns collected / unique 36296 / 12976 [R(int) = 0.0387] 
Reflns observed [F>4σ(F)] 12640 
Absorption correction Numeric analytical 
Max. and min. transmission 0.97935 and 0.96728 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 12976 / 0 / 487 
Goodness-of-fit on F2 1.237 
Final R indices [F>4σ(F)] R1 = 0.0810, wR2 = 0.1933 
 R1+ = 0.0810, wR2+ = 0.1933 
 R1- = 0.0810, wR2- = 0.1933 
R indices (all data) R1 = 0.0883, wR2 = 0.1959 
Absolute structure parameter x+ = 0.6(10), x- = 0.4(10) 
 Absolute structure assigned by internal 
 reference on C(17) 
 Appendix 
 280
Largest diff. peak, hole 0.762, -0.422 eÅ-3 
Mean and maximum shift/error 0.000 and 0.001 
Bond lengths [Å] and angles [°] for ketone 160. 
 
N(1)-C(9) 1.369(3) 
N(1)-C(6) 1.461(3) 
N(1)-C(2) 1.463(3) 
C(2)-C(3) 1.535(3) 
C(2)-C(7) 1.545(3) 
C(3)-O(13) 1.455(3) 
C(3)-C(16) 1.532(3) 
C(3)-C(4) 1.547(3) 
C(4)-O(4) 1.207(3) 
C(4)-C(5) 1.507(3) 
C(5)-C(6) 1.547(4) 
C(6)-C(8) 1.542(3) 
C(7)-C(8) 1.556(3) 
C(9)-O(9) 1.210(3) 
C(9)-O(10) 1.338(3) 
O(10)-C(11) 1.456(4) 
C(11)-C(12) 1.487(6) 
O(13)-C(14) 1.374(3) 
C(14)-O(14) 1.212(3) 
C(14)-N(15) 1.351(3) 
N(15)-C(16) 1.457(3) 
N(15)-C(17) 1.474(3) 
C(17)-C(18) 1.520(3) 
C(17)-C(24) 1.529(3) 
C(18)-C(23) 1.393(3) 
C(18)-C(19) 1.399(3) 
C(19)-C(20) 1.388(4) 
C(20)-C(21) 1.386(5) 
C(21)-C(22) 1.377(5) 
C(22)-C(23) 1.395(4) 
N(1')-C(9') 1.332(4) 
N(1')-C(2') 1.457(4) 
N(1')-C(6') 1.462(4) 
C(2')-C(3') 1.530(4) 
C(2')-C(7') 1.553(5) 
C(3')-O(13') 1.453(3) 
C(3')-C(16') 1.527(3) 
C(3')-C(4') 1.556(4) 
C(4')-O(4') 1.202(3) 
C(4')-C(5') 1.504(4) 
C(5')-C(6') 1.524(5) 
C(6')-C(8') 1.529(6) 
C(7')-C(8') 1.545(5) 
C(9')-O(9') 1.208(3) 
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C(9')-O(10') 1.349(3) 
O(10')-C(11') 1.469(5) 
C(11')-C(12') 1.435(6) 
O(13')-C(14') 1.375(4) 
C(14')-O(14') 1.203(3) 
C(14')-N(15') 1.343(3) 
N(15')-C(16') 1.448(3) 
N(15')-C(17') 1.468(3) 
C(17')-C(18') 1.520(4) 
C(17')-C(24') 1.526(4) 
C(18')-C(19') 1.383(4) 
C(18')-C(23') 1.403(4) 
C(19')-C(20') 1.380(5) 
C(20')-C(21') 1.395(7) 
C(21')-C(22') 1.388(6) 
C(22')-C(23') 1.392(4) 
 
C(9)-N(1)-C(6) 121.14(19) 
C(9)-N(1)-C(2) 126.10(19) 
C(6)-N(1)-C(2) 106.37(17) 
N(1)-C(2)-C(3) 108.70(17) 
N(1)-C(2)-C(7) 101.42(17) 
C(3)-C(2)-C(7) 110.02(18) 
O(13)-C(3)-C(16) 104.57(16) 
O(13)-C(3)-C(2) 108.81(17) 
C(16)-C(3)-C(2) 115.92(18) 
O(13)-C(3)-C(4) 105.57(17) 
C(16)-C(3)-C(4) 112.90(19) 
C(2)-C(3)-C(4) 108.45(17) 
O(4)-C(4)-C(5) 123.3(2) 
O(4)-C(4)-C(3) 122.0(2) 
C(5)-C(4)-C(3) 114.54(19) 
C(4)-C(5)-C(6) 107.87(19) 
N(1)-C(6)-C(8) 101.22(19) 
N(1)-C(6)-C(5) 108.89(18) 
C(8)-C(6)-C(5) 111.3(2) 
C(2)-C(7)-C(8) 104.65(18) 
C(6)-C(8)-C(7) 104.81(18) 
O(9)-C(9)-O(10) 125.7(2) 
O(9)-C(9)-N(1) 122.9(2) 
O(10)-C(9)-N(1) 111.2(2) 
C(9)-O(10)-C(11) 116.7(2) 
O(10)-C(11)-C(12) 111.4(3) 
C(14)-O(13)-C(3) 108.81(17) 
O(14)-C(14)-N(15) 129.1(2) 
O(14)-C(14)-O(13) 121.2(2) 
N(15)-C(14)-O(13) 109.69(18) 
C(14)-N(15)-C(16) 111.77(18) 
C(14)-N(15)-C(17) 121.48(18) 
C(16)-N(15)-C(17) 123.81(18) 
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N(15)-C(16)-C(3) 100.84(17) 
N(15)-C(17)-C(18) 110.33(17) 
N(15)-C(17)-C(24) 109.86(18) 
C(18)-C(17)-C(24) 115.4(2) 
C(23)-C(18)-C(19) 118.5(2) 
C(23)-C(18)-C(17) 122.7(2) 
C(19)-C(18)-C(17) 118.8(2) 
C(20)-C(19)-C(18) 120.5(3) 
C(21)-C(20)-C(19) 120.3(3) 
C(22)-C(21)-C(20) 119.8(3) 
C(21)-C(22)-C(23) 120.3(3) 
C(18)-C(23)-C(22) 120.6(2) 
C(9')-N(1')-C(2') 130.1(2) 
C(9')-N(1')-C(6') 123.0(2) 
C(2')-N(1')-C(6') 105.3(2) 
N(1')-C(2')-C(3') 108.6(2) 
N(1')-C(2')-C(7') 103.8(3) 
C(3')-C(2')-C(7') 108.7(3) 
O(13')-C(3')-C(16') 104.6(2) 
O(13')-C(3')-C(2') 110.0(2) 
C(16')-C(3')-C(2') 112.9(2) 
O(13')-C(3')-C(4') 105.5(2) 
C(16')-C(3')-C(4') 112.8(2) 
C(2')-C(3')-C(4') 110.6(2) 
O(4')-C(4')-C(5') 123.8(3) 
O(4')-C(4')-C(3') 120.2(3) 
C(5')-C(4')-C(3') 116.0(2) 
C(4')-C(5')-C(6') 112.1(2) 
N(1')-C(6')-C(5') 107.2(3) 
N(1')-C(6')-C(8') 102.8(3) 
C(5')-C(6')-C(8') 112.1(3) 
C(8')-C(7')-C(2') 103.7(3) 
C(6')-C(8')-C(7') 105.4(3) 
O(9')-C(9')-N(1') 124.2(3) 
O(9')-C(9')-O(10') 125.2(3) 
N(1')-C(9')-O(10') 110.5(2) 
C(9')-O(10')-C(11') 115.6(3) 
C(12')-C(11')-O(10') 109.4(4) 
C(14')-O(13')-C(3') 109.25(18) 
O(14')-C(14')-N(15') 129.2(3) 
O(14')-C(14')-O(13') 121.5(2) 
N(15')-C(14')-O(13') 109.3(2) 
C(14')-N(15')-C(16') 112.6(2) 
C(14')-N(15')-C(17') 122.1(2) 
C(16')-N(15')-C(17') 125.16(19) 
N(15')-C(16')-C(3') 101.52(19) 
N(15')-C(17')-C(18') 112.3(2) 
N(15')-C(17')-C(24') 110.2(2) 
C(18')-C(17')-C(24') 112.6(2) 
C(19')-C(18')-C(23') 119.0(3) 
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C(19')-C(18')-C(17') 119.5(2) 
C(23')-C(18')-C(17') 121.5(2) 
C(20')-C(19')-C(18') 121.4(3) 
C(19')-C(20')-C(21') 119.8(4) 
C(22')-C(21')-C(20') 119.6(3) 
C(21')-C(22')-C(23') 120.3(3) 
C(22')-C(23')-C(18') 119.9(3) 
 
CRYST1    6.368   20.480   28.917  90.00  90.00  90.00 
SCALE1      0.157030  0.000000  0.000000       0.000000 
SCALE2      0.000000  0.048827  0.000000       0.000000 
SCALE3      0.000000  0.000000  0.034581       0.000000 
ATOM      1  N1          0       1.122  14.527   4.932 1.000  1.75 
ATOM      2  C2          0       1.782  15.740   5.417 1.000  1.66 
ATOM      3  H2A         0       2.015  16.364   4.672 1.000  1.99 
ATOM      4  C3          0       0.879  16.405   6.465 1.000  1.55 
ATOM      5  C4          0       0.620  15.390   7.604 1.000  1.87 
ATOM      6  O4          0       0.825  15.661   8.762 1.000  3.00 
ATOM      7  C5          0       0.187  14.023   7.137 1.000  2.22 
ATOM      8  H5A         0      -0.736  14.062   6.780 1.000  2.66 
ATOM      9  H5B         0       0.203  13.384   7.893 1.000  2.66 
ATOM     10  C6          0       1.167  13.566   6.032 1.000  1.89 
ATOM     11  H6A         0       0.964  12.638   5.720 1.000  2.26 
ATOM     12  C7          0       3.039  15.153   6.097 1.000  2.05 
ATOM     13  H7A         0       3.283  15.680   6.899 1.000  2.46 
ATOM     14  H7B         0       3.806  15.146   5.472 1.000  2.46 
ATOM     15  C8          0       2.633  13.704   6.491 1.000  2.28 
ATOM     16  H8A         0       3.209  13.041   6.033 1.000  2.74 
ATOM     17  H8B         0       2.709  13.572   7.469 1.000  2.74 
ATOM     18  C9          0       0.140  14.469   3.981 1.000  2.06 
ATOM     19  O9          0      -0.659  13.562   3.917 1.000  3.08 
ATOM     20  O10         0       0.260  15.468   3.099 1.000  2.87 
ATOM     21  C11         0      -0.704  15.498   2.008 1.000  3.57 
ATOM     22  H11         0      -0.903  14.572   1.721 1.000  4.28 
ATOM     23  H11         0      -0.312  15.979   1.237 1.000  4.28 
ATOM     24  C12         0      -1.966  16.169   2.417 1.000  6.11 
ATOM     25  H12         0      -2.591  16.179   1.662 1.000  9.17 
ATOM     26  H12         0      -1.773  17.090   2.692 1.000  9.17 
ATOM     27  H12         0      -2.367  15.682   3.167 1.000  9.17 
ATOM     28  O13         0      -0.422  16.662   5.868 1.000  1.97 
ATOM     29  C14         0      -0.880  17.879   6.312 1.000  1.83 
ATOM     30  O14         0      -1.997  18.265   6.043 1.000  2.65 
ATOM     31  N15         0       0.076  18.484   7.050 1.000  1.73 
ATOM     32  C16         0       1.345  17.771   6.979 1.000  1.99 
ATOM     33  H16         0       1.773  17.700   7.869 1.000  2.39 
ATOM     34  H16         0       1.971  18.205   6.347 1.000  2.39 
ATOM     35  C17         0      -0.052  19.890   7.473 1.000  1.75 
ATOM     36  H17         0      -1.017  20.043   7.687 1.000  2.10 
ATOM     37  C18         0       0.301  20.821   6.325 1.000  1.77 
ATOM     38  C19         0      -0.699  21.173   5.412 1.000  2.31 
ATOM     39  H19         0      -1.583  20.847   5.533 1.000  2.77 
ATOM     40  C20         0      -0.410  21.994   4.332 1.000  3.02 
ATOM     41  H20         0      -1.095  22.221   3.713 1.000  3.62 
ATOM     42  C21         0       0.873  22.486   4.151 1.000  3.19 
ATOM     43  H21         0       1.067  23.053   3.414 1.000  3.83 
ATOM     44  C22         0       1.867  22.149   5.043 1.000  2.84 
ATOM     45  H22         0       2.746  22.489   4.922 1.000  3.41 
ATOM     46  C23         0       1.588  21.312   6.124 1.000  2.20 
ATOM     47  H23         0       2.282  21.076   6.727 1.000  2.64 
ATOM     48  C24         0       0.733  20.118   8.765 1.000  2.55 
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ATOM     49  H24         0       0.434  19.479   9.446 1.000  3.82 
ATOM     50  H24         0       0.578  21.031   9.085 1.000  3.82 
ATOM     51  H24         0       1.689  19.989   8.594 1.000  3.82 
ATOM     52  N1'         0       3.273  11.477   0.623 1.000  3.54 
ATOM     53  C2'         0       2.556  10.219   0.791 1.000  2.81 
ATOM     54  H2'         0       2.732   9.588   0.036 1.000  3.37 
ATOM     55  C3'         0       2.942   9.612   2.141 1.000  2.22 
ATOM     56  C4'         0       2.738  10.648   3.285 1.000  2.63 
ATOM     57  O4'         0       2.363  10.286   4.368 1.000  3.96 
ATOM     58  C5'         0       3.031  12.081   2.937 1.000  3.16 
ATOM     59  H5'         0       4.001  12.249   3.035 1.000  3.79 
ATOM     60  H5'         0       2.554  12.674   3.570 1.000  3.79 
ATOM     61  C6'         0       2.605  12.423   1.514 1.000  3.53 
ATOM     62  H6'         0       2.835  13.368   1.281 1.000  4.24 
ATOM     63  C7'         0       1.064  10.648   0.847 1.000  3.94 
ATOM     64  H7'         0       0.632  10.548  -0.038 1.000  4.73 
ATOM     65  H7'         0       0.565  10.110   1.512 1.000  4.73 
ATOM     66  C8'         0       1.125  12.133   1.270 1.000  4.12 
ATOM     67  H8'         0       0.768  12.715   0.553 1.000  4.94 
ATOM     68  H8'         0       0.598  12.283   2.095 1.000  4.94 
ATOM     69  C9'         0       4.133  11.854  -0.322 1.000  2.54 
ATOM     70  O9'         0       4.624  12.956  -0.394 1.000  3.51 
ATOM     71  O10         0       4.430  10.816  -1.131 1.000  3.72 
ATOM     72  C11         0       5.420  11.093  -2.181 1.000  4.73 
ATOM     73  H11         0       6.150  11.652  -1.814 1.000  5.68 
ATOM     74  H11         0       5.812  10.244  -2.505 1.000  5.68 
ATOM     75  C12         0       4.782  11.779  -3.268 1.000  5.50 
ATOM     76  H12         0       5.440  11.961  -3.970 1.000  8.25 
ATOM     77  H12         0       4.406  12.625  -2.945 1.000  8.25 
ATOM     78  H12         0       4.064  11.220  -3.630 1.000  8.25 
ATOM     79  O13         0       4.360   9.293   2.154 1.000  2.61 
ATOM     80  C14         0       4.538   8.044   2.699 1.000  2.23 
ATOM     81  O14         0       5.636   7.595   2.896 1.000  3.15 
ATOM     82  N15         0       3.339   7.481   2.924 1.000  2.25 
ATOM     83  C16         0       2.245   8.282   2.416 1.000  2.44 
ATOM     84  H16         0       1.526   8.382   3.089 1.000  2.93 
ATOM     85  H16         0       1.866   7.894   1.588 1.000  2.93 
ATOM     86  C17         0       3.203   6.153   3.533 1.000  2.27 
ATOM     87  H17         0       4.078   5.936   3.965 1.000  2.72 
ATOM     88  C18         0       2.931   5.071   2.500 1.000  2.23 
ATOM     89  C19         0       3.900   4.120   2.239 1.000  3.22 
ATOM     90  H19         0       4.733   4.167   2.695 1.000  3.86 
ATOM     91  C20         0       3.684   3.105   1.330 1.000  4.51 
ATOM     92  H20         0       4.353   2.448   1.181 1.000  5.41 
ATOM     93  C21         0       2.479   3.048   0.631 1.000  4.55 
ATOM     94  H21         0       2.326   2.354  -0.001 1.000  5.45 
ATOM     95  C22         0       1.504   4.009   0.862 1.000  3.90 
ATOM     96  H22         0       0.688   3.980   0.376 1.000  4.68 
ATOM     97  C23         0       1.716   5.013   1.801 1.000  2.79 
ATOM     98  H23         0       1.040   5.658   1.969 1.000  3.35 
ATOM     99  C24         0       2.151   6.185   4.638 1.000  2.99 
ATOM    100  H24         0       2.369   6.896   5.276 1.000  4.49 
ATOM    101  H24         0       2.139   5.322   5.103 1.000  4.49 
ATOM    102  H24         0       1.270   6.357   4.245 1.000  4.49 
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Appendix 8.2: Crystal data and structure refinement for ketone (±)-170. 
 
Empirical formula C15 H22 N2 O5 
Formula weight 310.35 
Temperature 173(2) K 
Diffractometer, wavelength OD Xcalibur PX Ultra, 1.54248 Å 
Crystal system, space group Orthorhombic, P2(1)2(1)2(1) 
Unit cell dimensions a = 6.1801(7) Å α = 90° 
 b = 15.6334(11) Å β = 90° 
 c = 16.1019(17) Å γ = 90° 
Volume, Z 1555.7(3) Å3, 4 
Density (calculated) 1.325 Mg/m3 
Absorption coefficient 0.830 mm-1 
F(000) 664 
Crystal colour / morphology Colourless needles 
Crystal size 0.25 x 0.08 x 0.05 mm3 
θ range for data collection 3.94 to 71.01° 
Index ranges -5<=h<=7, -18<=k<=19, -19<=l<=18 
Reflns collected / unique 14495 / 2945 [R(int) = 0.1168] 
Reflns observed [F>4σ(F)] 2681 
Absorption correction Numeric analytical 
Max. and min. transmission 0.96051 and 0.82686 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2945 / 0 / 200 
Goodness-of-fit on F2 1.134 
Final R indices [F>4σ(F)] R1 = 0.0478, wR2 = 0.1137 
 R1+ = 0.0478, wR2+ = 0.1137 
 R1- = 0.0480, wR2- = 0.1141 
R indices (all data) R1 = 0.0539, wR2 = 0.1236 
Absolute structure parameter x+ = 0.0(3), x- = 1.2(3) 
Extinction coefficient 0.0031(4) 
Largest diff. peak, hole 0.196, -0.191 eÅ-3 
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Mean and maximum shift/error 0.000 and 0.000 
Bond lengths [Å] and angles [°] 
 
N(1)-C(9) 1.360(3) 
N(1)-C(2) 1.456(3) 
N(1)-C(6) 1.466(3) 
C(2)-C(3) 1.539(3) 
C(2)-C(7) 1.543(3) 
C(3)-O(13) 1.454(3) 
C(3)-C(16) 1.528(3) 
C(3)-C(4) 1.535(4) 
C(4)-O(4) 1.212(3) 
C(4)-C(5) 1.510(4) 
C(5)-C(6) 1.538(4) 
C(6)-C(8) 1.530(4) 
C(7)-C(8) 1.547(4) 
C(9)-O(9) 1.220(3) 
C(9)-O(10) 1.336(3) 
O(10)-C(11) 1.445(3) 
C(11)-C(12) 1.481(5) 
O(13)-C(14) 1.379(3) 
C(14)-O(14) 1.209(3) 
C(14)-N(15) 1.341(3) 
N(15)-C(16) 1.449(3) 
N(15)-C(17) 1.474(3) 
C(17)-C(19) 1.514(4) 
C(17)-C(18) 1.515(4) 
 
C(9)-N(1)-C(2) 124.32(19) 
C(9)-N(1)-C(6) 122.3(2) 
C(2)-N(1)-C(6) 105.18(19) 
N(1)-C(2)-C(3) 108.6(2) 
N(1)-C(2)-C(7) 102.26(18) 
C(3)-C(2)-C(7) 110.5(2) 
O(13)-C(3)-C(16) 104.12(17) 
O(13)-C(3)-C(4) 106.3(2) 
C(16)-C(3)-C(4) 116.5(2) 
O(13)-C(3)-C(2) 108.86(19) 
C(16)-C(3)-C(2) 113.0(2) 
C(4)-C(3)-C(2) 107.62(18) 
O(4)-C(4)-C(5) 124.5(3) 
O(4)-C(4)-C(3) 121.9(2) 
C(5)-C(4)-C(3) 113.5(2) 
C(4)-C(5)-C(6) 109.7(2) 
N(1)-C(6)-C(8) 100.3(2) 
N(1)-C(6)-C(5) 109.85(19) 
C(8)-C(6)-C(5) 111.9(2) 
C(2)-C(7)-C(8) 104.2(2) 
C(6)-C(8)-C(7) 104.7(2) 
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O(9)-C(9)-O(10) 124.8(2) 
O(9)-C(9)-N(1) 124.4(2) 
O(10)-C(9)-N(1) 110.8(2) 
C(9)-O(10)-C(11) 117.1(2) 
O(10)-C(11)-C(12) 107.0(3) 
C(14)-O(13)-C(3) 108.49(18) 
O(14)-C(14)-N(15) 129.9(2) 
O(14)-C(14)-O(13) 121.1(2) 
N(15)-C(14)-O(13) 109.0(2) 
C(14)-N(15)-C(16) 112.8(2) 
C(14)-N(15)-C(17) 122.5(2) 
C(16)-N(15)-C(17) 124.7(2) 
N(15)-C(16)-C(3) 100.86(19) 
N(15)-C(17)-C(19) 110.7(2) 
N(15)-C(17)-C(18) 110.0(2) 
C(19)-C(17)-C(18) 112.7(3) 
 
CRYST1    6.180   15.633   16.102  90.00  90.00  90.00 
SCALE1      0.161810  0.000000  0.000000       0.000000 
SCALE2      0.000000  0.063966  0.000000       0.000000 
SCALE3      0.000000  0.000000  0.062104       0.000000 
ATOM      1  N1          0       4.477   2.663  12.144 1.000  2.59 
ATOM      2  C2          0       4.166   3.427  10.944 1.000  2.51 
ATOM      3  H2A         0       3.266   3.858  11.004 1.000  3.01 
ATOM      4  C3          0       5.280   4.466  10.720 1.000  2.51 
ATOM      5  C4          0       6.591   3.700  10.497 1.000  2.96 
ATOM      6  O4          0       7.295   3.903   9.532 1.000  3.72 
ATOM      7  C5          0       6.863   2.652  11.549 1.000  3.14 
ATOM      8  H5A         0       7.123   3.090  12.398 1.000  3.77 
ATOM      9  H5B         0       7.612   2.073  11.258 1.000  3.77 
ATOM     10  C6          0       5.602   1.800  11.769 1.000  2.88 
ATOM     11  H6A         0       5.758   1.086  12.451 1.000  3.45 
ATOM     12  C7          0       4.208   2.344   9.846 1.000  3.06 
ATOM     13  H7A         0       4.621   2.696   9.018 1.000  3.67 
ATOM     14  H7B         0       3.297   2.018   9.637 1.000  3.67 
ATOM     15  C8          0       5.072   1.215  10.458 1.000  3.61 
ATOM     16  H8A         0       4.526   0.407  10.628 1.000  4.33 
ATOM     17  H8B         0       5.818   0.976   9.852 1.000  4.33 
ATOM     18  C9          0       4.307   3.124  13.412 1.000  2.69 
ATOM     19  O9          0       4.969   2.763  14.371 1.000  3.68 
ATOM     20  O10         0       3.268   3.962  13.476 1.000  3.05 
ATOM     21  C11         0       3.031   4.624  14.739 1.000  3.90 
ATOM     22  H11         0       3.803   5.197  14.977 1.000  4.68 
ATOM     23  H11         0       2.901   3.956  15.458 1.000  4.68 
ATOM     24  C12         0       1.811   5.447  14.573 1.000  5.92 
ATOM     25  H12         0       1.613   5.911  15.413 1.000  8.89 
ATOM     26  H12         0       1.057   4.869  14.334 1.000  8.89 
ATOM     27  H12         0       1.955   6.106  13.862 1.000  8.89 
ATOM     28  O13         0       5.459   5.233  11.942 1.000  2.75 
ATOM     29  C14         0       4.804   6.438  11.801 1.000  2.85 
ATOM     30  O14         0       4.636   7.172  12.747 1.000  3.68 
ATOM     31  N15         0       4.455   6.598  10.517 1.000  3.02 
ATOM     32  C16         0       4.916   5.515   9.671 1.000  2.99 
ATOM     33  H16         0       5.703   5.781   9.134 1.000  3.59 
ATOM     34  H16         0       4.199   5.194   9.068 1.000  3.59 
ATOM     35  C17         0       3.647   7.740  10.052 1.000  3.19 
ATOM     36  H17         0       3.576   8.391  10.807 1.000  3.82 
ATOM     37  C18         0       2.246   7.277   9.707 1.000  3.92 
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ATOM     38  H18         0       1.851   6.826  10.482 1.000  5.88 
ATOM     39  H18         0       2.285   6.654   8.951 1.000  5.88 
ATOM     40  H18         0       1.697   8.051   9.464 1.000  5.88 
ATOM     41  C19         0       4.331   8.444   8.899 1.000  4.54 
ATOM     42  H19         0       5.225   8.733   9.176 1.000  6.81 
ATOM     43  H19         0       3.802   9.226   8.634 1.000  6.81 
ATOM     44  H19         0       4.407   7.829   8.139 1.000  6.81 
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Appendix 8.3: Crystal data and structure refinement for ketone (±)-198. 
 
Empirical formula C10 H13 Br F N O3 
Formula weight 294.12 
Temperature 173(2) K 
Diffractometer, wavelength OD Xcalibur PX Ultra, 1.54184 Å 
Crystal system, space group Monoclinic, P2(1)/n 
Unit cell dimensions a = 7.03686(16) Å α = 90° 
b = 17.7252(4) Å  β =  
95.608(2)° 
 c = 8.91974(19) Å γ = 90° 
Volume, Z 1107.23(8) Å3, 4 
Density (calculated) 1.764 Mg/m3 
Absorption coefficient 5.163 mm-1 
F(000) 592 
Crystal colour / morphology Colourless platy needles 
Crystal size 0.20 x 0.15 x 0.03 mm3 
θ range for data collection 4.99 to 71.41° 
Index ranges -7<=h<=8, -21<=k<=21, -10<=l<=10 
Reflns collected / unique 15312 / 2138 [R(int) = 0.0560] 
Reflns observed [F>4σ(F)] 1756 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.43493 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2138 / 0 / 145 
Goodness-of-fit on F2 1.007 
Final R indices [F>4σ(F)] R1 = 0.0358, wR2 = 0.0929 
R indices (all data) R1 = 0.0445, wR2 = 0.0965 
Largest diff. peak, hole 0.518, -0.466 eÅ-3 
Mean and maximum shift/error 0.000 and 0.001 
Bond lengths [Å] and angles [°] 
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N(1)-C(7) 1.347(4) 
N(1)-C(6) 1.460(3) 
N(1)-C(2) 1.467(4) 
C(2)-C(3) 1.521(4) 
C(2)-C(11) 1.552(4) 
C(3)-F 1.409(3) 
C(3)-C(4) 1.544(4) 
C(4)-O(4) 1.201(4) 
C(4)-C(5) 1.518(4) 
C(5)-C(6) 1.525(4) 
C(5)-Br 1.958(3) 
C(6)-C(12) 1.546(4) 
C(7)-O(7) 1.216(3) 
C(7)-O(8) 1.347(4) 
O(8)-C(9) 1.449(3) 
C(9)-C(10) 1.487(4) 
C(11)-C(12) 1.541(4) 
 
C(7)-N(1)-C(6) 120.9(2) 
C(7)-N(1)-C(2) 126.5(2) 
C(6)-N(1)-C(2) 105.3(2) 
N(1)-C(2)-C(3) 108.9(2) 
N(1)-C(2)-C(11) 103.2(2) 
C(3)-C(2)-C(11) 109.4(2) 
F-C(3)-C(2) 110.5(2) 
F-C(3)-C(4) 107.5(2) 
C(2)-C(3)-C(4) 110.5(2) 
O(4)-C(4)-C(5) 121.9(3) 
O(4)-C(4)-C(3) 121.2(3) 
C(5)-C(4)-C(3) 116.8(2) 
C(4)-C(5)-C(6) 111.6(2) 
C(4)-C(5)-Br 106.7(2) 
C(6)-C(5)-Br 111.4(2) 
N(1)-C(6)-C(5) 108.1(2) 
N(1)-C(6)-C(12) 103.5(2) 
C(5)-C(6)-C(12) 109.4(2) 
O(7)-C(7)-O(8) 124.2(3) 
O(7)-C(7)-N(1) 124.8(3) 
O(8)-C(7)-N(1) 111.0(2) 
C(7)-O(8)-C(9) 117.5(2) 
O(8)-C(9)-C(10) 110.3(3) 
C(12)-C(11)-C(2) 104.7(2) 
C(11)-C(12)-C(6) 104.7(2) 
 
CRYST1    7.037   17.725    8.920  90.00  95.61  90.00 
SCALE1      0.142108  0.000000  0.013954       0.000000 
SCALE2      0.000000  0.056417  0.000000       0.000000 
SCALE3      0.000000  0.000000  0.112651       0.000000 
ATOM      1  N1          0       5.117  13.545   8.736 1.000  2.37 
ATOM      2  C2          0       4.254  14.110   9.780 1.000  2.44 
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ATOM      3  H2A         0       3.641  13.421  10.165 1.000  2.93 
ATOM      4  C3          0       3.483  15.286   9.198 1.000  2.54 
ATOM      5  H3A         0       2.968  15.739   9.926 1.000  3.05 
ATOM      6  F           0       2.594  14.846   8.198 1.000  3.14 
ATOM      7  C4          0       4.450  16.298   8.545 1.000  2.60 
ATOM      8  O4          0       4.280  17.482   8.655 1.000  3.85 
ATOM      9  C5          0       5.672  15.725   7.850 1.000  2.58 
ATOM     10  H5A         0       6.385  16.425   7.817 1.000  3.09 
ATOM     11 BR           0       5.126  15.284   6.023 1.000  3.19 
ATOM     12  C6          0       6.211  14.500   8.582 1.000  2.41 
ATOM     13  H6A         0       6.992  14.096   8.105 1.000  2.89 
ATOM     14  C7          0       5.297  12.237   8.468 1.000  2.37 
ATOM     15  O7          0       6.237  11.780   7.846 1.000  2.79 
ATOM     16  O8          0       4.267  11.504   8.930 1.000  2.94 
ATOM     17  C9          0       4.313  10.073   8.712 1.000  2.99 
ATOM     18  H9A         0       4.943   9.869   7.976 1.000  3.59 
ATOM     19  H9B         0       3.416   9.748   8.448 1.000  3.59 
ATOM     20  C10         0       4.751   9.375   9.950 1.000  3.40 
ATOM     21  H10         0       4.775   8.409   9.789 1.000  5.11 
ATOM     22  H10         0       4.121   9.570  10.675 1.000  5.11 
ATOM     23  H10         0       5.645   9.686  10.201 1.000  5.11 
ATOM     24  C11         0       5.267  14.630  10.833 1.000  3.15 
ATOM     25  H11         0       4.942  15.466  11.252 1.000  3.78 
ATOM     26  H11         0       5.417  13.954  11.541 1.000  3.78 
ATOM     27  C12         0       6.562  14.884  10.038 1.000  2.95 
ATOM     28  H12         0       7.302  14.323  10.381 1.000  3.54 
ATOM     29  H12         0       6.829  15.836  10.095 1.000  3.54 
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Appendix 8.4: Crystal data and structure refinement for ketone ent-202. 
 
Empirical formula C13 H19 F N2 O6 
Formula weight 318.30 
Temperature 173(2) K 
Diffractometer, wavelength OD Xcalibur PX Ultra, 1.54184 Å 
Crystal system, space group Orthorhombic, P2(1)2(1)2(1) 
Unit cell dimensions a = 7.10039(3) Å α = 90° 
 b = 11.38790(5) Å β = 90° 
 c = 17.67104(8) Å γ = 90° 
Volume, Z 1428.85(6) Å3, 4 
Density (calculated) 1.480 Mg/m3 
Absorption coefficient 1.078 mm-1 
F(000) 672 
Crystal colour / morphology Colourless blocks 
Crystal size 0.17 x 0.15 x 0.10 mm3 
θ range for data collection 4.62 to 71.35° 
Index ranges -8<=h<=8, -13<=k<=13, -21<=l<=18 
Reflns collected / unique 23172 / 2764 [R(int) = 0.0236] 
Reflns observed [F>4σ(F)] 2628 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.85014 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2764 / 2 / 209 
Goodness-of-fit on F2 1.074 
Final R indices [F>4σ(F)] R1 = 0.0240, wR2 = 0.0632 
 R1+ = 0.0240, wR2+ = 0.0632 
 R1- = 0.0243, wR2- = 0.0641 
R indices (all data) R1 = 0.0254, wR2 = 0.0639 
Absolute structure parameter x+ = 0.00(11), x- = 1.01(11) 
Extinction coefficient 0.0058(4) 
Largest diff. peak, hole 0.139, -0.124 eÅ-3 
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Mean and maximum shift/error 0.000 and 0.001 
Bond lengths [Å] and angles [°]. 
 
N(1)-C(7) 1.3454(16) 
N(1)-C(6) 1.4623(16) 
N(1)-C(2) 1.4625(16) 
C(2)-C(3) 1.5203(18) 
C(2)-C(11) 1.5405(18) 
C(3)-F 1.4034(14) 
C(3)-C(4) 1.5449(17) 
C(4)-O(13) 1.3982(14) 
C(4)-O(14) 1.4028(15) 
C(4)-C(5) 1.5608(16) 
C(5)-O(15) 1.4494(14) 
C(5)-C(6) 1.5396(17) 
C(5)-C(18) 1.5398(17) 
C(6)-C(12) 1.5411(18) 
C(7)-O(7) 1.2217(17) 
C(7)-O(8) 1.3461(16) 
O(8)-C(9) 1.4499(16) 
C(9)-C(10) 1.481(2) 
C(11)-C(12) 1.5497(19) 
O(15)-C(16) 1.3596(15) 
C(16)-O(16) 1.2166(15) 
C(16)-N(17) 1.3355(17) 
N(17)-C(18) 1.4431(16) 
N(17)-C(19) 1.4478(16) 
 
C(7)-N(1)-C(6) 128.67(11) 
C(7)-N(1)-C(2) 124.45(11) 
C(6)-N(1)-C(2) 105.89(10) 
N(1)-C(2)-C(3) 107.63(10) 
N(1)-C(2)-C(11) 102.05(10) 
C(3)-C(2)-C(11) 112.45(10) 
F-C(3)-C(2) 107.46(10) 
F-C(3)-C(4) 108.72(9) 
C(2)-C(3)-C(4) 113.70(10) 
O(13)-C(4)-O(14) 107.74(10) 
O(13)-C(4)-C(3) 108.58(9) 
O(14)-C(4)-C(3) 111.07(10) 
O(13)-C(4)-C(5) 106.06(9) 
O(14)-C(4)-C(5) 110.51(10) 
C(3)-C(4)-C(5) 112.62(10) 
O(15)-C(5)-C(6) 106.08(9) 
O(15)-C(5)-C(18) 104.61(9) 
C(6)-C(5)-C(18) 113.03(10) 
O(15)-C(5)-C(4) 107.02(10) 
C(6)-C(5)-C(4) 113.22(10) 
C(18)-C(5)-C(4) 112.11(10) 
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N(1)-C(6)-C(5) 107.47(10) 
N(1)-C(6)-C(12) 101.71(10) 
C(5)-C(6)-C(12) 112.88(11) 
O(7)-C(7)-N(1) 125.19(12) 
O(7)-C(7)-O(8) 122.73(12) 
N(1)-C(7)-O(8) 112.05(11) 
C(7)-O(8)-C(9) 115.23(10) 
O(8)-C(9)-C(10) 107.25(12) 
C(2)-C(11)-C(12) 104.86(10) 
C(6)-C(12)-C(11) 104.62(11) 
C(16)-O(15)-C(5) 110.20(9) 
O(16)-C(16)-N(17) 128.91(12) 
O(16)-C(16)-O(15) 121.12(11) 
N(17)-C(16)-O(15) 109.96(10) 
C(16)-N(17)-C(18) 112.96(10) 
C(16)-N(17)-C(19) 123.95(11) 
C(18)-N(17)-C(19) 121.85(11) 
N(17)-C(18)-C(5) 102.01(10) 
 
CRYST1    7.100   11.388   17.671  90.00  90.00  90.00 
SCALE1      0.140837  0.000000  0.000000       0.000000 
SCALE2      0.000000  0.087812  0.000000       0.000000 
SCALE3      0.000000  0.000000  0.056590       0.000000 
ATOM      1  N1          0       2.128 -10.682  -3.478 1.000  2.06 
ATOM      2  C2          0       1.289 -10.358  -4.632 1.000  2.02 
ATOM      3  H2A         0       0.878 -11.180  -5.027 1.000  2.42 
ATOM      4  C3          0       0.226  -9.375  -4.167 1.000  1.89 
ATOM      5  H3A         0      -0.328  -9.100  -4.952 1.000  2.27 
ATOM      6  F           0      -0.591 -10.043  -3.243 1.000  2.29 
ATOM      7  C4          0       0.804  -8.110  -3.493 1.000  1.88 
ATOM      8  C5          0       2.078  -8.410  -2.643 1.000  1.86 
ATOM      9  C6          0       2.969  -9.508  -3.253 1.000  2.10 
ATOM     10  H6A         0       3.744  -9.722  -2.658 1.000  2.52 
ATOM     11  C7          0       1.948 -11.753  -2.684 1.000  2.05 
ATOM     12  O7          0       1.100 -12.616  -2.846 1.000  2.50 
ATOM     13  O8          0       2.849 -11.797  -1.684 1.000  2.50 
ATOM     14  C9          0       2.742 -12.945  -0.806 1.000  2.75 
ATOM     15  H9A         0       2.989 -13.772  -1.291 1.000  3.30 
ATOM     16  H9B         0       1.813 -13.040  -0.476 1.000  3.30 
ATOM     17  C10         0       3.669 -12.720   0.328 1.000  4.92 
ATOM     18  H10         0       3.623 -13.481   0.943 1.000  7.37 
ATOM     19  H10         0       3.412 -11.901   0.801 1.000  7.37 
ATOM     20  H10         0       4.584 -12.628  -0.011 1.000  7.37 
ATOM     21  C11         0       2.303  -9.716  -5.597 1.000  2.39 
ATOM     22  H11         0       1.883  -8.980  -6.109 1.000  2.87 
ATOM     23  H11         0       2.656 -10.387  -6.233 1.000  2.87 
ATOM     24  C12         0       3.433  -9.176  -4.685 1.000  2.60 
ATOM     25  H12         0       4.293  -9.622  -4.888 1.000  3.12 
ATOM     26  H12         0       3.543  -8.199  -4.801 1.000  3.12 
ATOM     27  O13         0       1.207  -7.218  -4.492 1.000  2.22 
ATOM     28  H13         0       0.471  -6.997  -4.961 1.000  4.55 
ATOM     29  O14         0      -0.168  -7.466  -2.712 1.000  2.30 
ATOM     30  H14         0      -0.609  -8.011  -2.148 1.000  5.21 
ATOM     31  O15         0       1.624  -8.925  -1.366 1.000  2.03 
ATOM     32  C16         0       2.023  -8.103  -0.360 1.000  2.00 
ATOM     33  O16         0       1.774  -8.364   0.802 1.000  2.55 
ATOM     34  N17         0       2.666  -7.046  -0.863 1.000  2.13 
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ATOM     35  C18         0       2.855  -7.129  -2.291 1.000  2.28 
ATOM     36  H18         0       3.814  -7.213  -2.524 1.000  2.74 
ATOM     37  H18         0       2.476  -6.339  -2.752 1.000  2.74 
ATOM     38  C19         0       3.355  -6.060  -0.057 1.000  2.67 
ATOM     39  H19         0       3.075  -6.148   0.878 1.000  4.00 
ATOM     40  H19         0       3.135  -5.161  -0.381 1.000  4.00 
ATOM     41  H19         0       4.323  -6.203  -0.123 1.000  4.00 
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Appendix 8.5: Crystal data and structure refinement for ketone ent-204. 
 
Empirical formula C13 H17 Cl N2 O5 
Formula weight 316.74 
Temperature 173(2) K 
Diffractometer, wavelength OD Xcalibur PX Ultra, 1.54184 Å 
Crystal system, space group Monoclinic, P2(1) 
Unit cell dimensions a = 9.4726(4) Å α = 90° 
 b = 7.7442(2) Å β = 
112.692(5)° 
 c = 10.8359(5) Å γ = 90° 
Volume, Z 733.37(4) Å3, 2 
Density (calculated) 1.434 Mg/m3 
Absorption coefficient 2.532 mm-1 
F(000) 332 
Crystal colour / morphology Colourless platy needles 
Crystal size 0.24 x 0.19 x 0.03 mm3 
θ range for data collection 5.06 to 71.67° 
Index ranges -11<=h<=11, -9<=k<=9, -13<=l<=13 
Reflns collected / unique 21539 / 2837 [R(int) = 0.0582] 
Reflns observed [F>4σ(F)] 2418 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.51100 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2837 / 1 / 191 
Goodness-of-fit on F2 1.036 
Final R indices [F>4σ(F)] R1 = 0.0544, wR2 = 0.1457 
 R1+ = 0.0544, wR2+ = 0.1457 
 R1- = 0.0680, wR2- = 0.1858 
R indices (all data) R1 = 0.0604, wR2 = 0.1497 
Absolute structure parameter x+ = 0.00(2), x- = 1.01(2) 
Largest diff. peak, hole 0.604, -0.219 eÅ-3 
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Mean and maximum shift/error 0.000 and 0.000 
Bond lengths [Å] and angles [°] 
 
N(1)-C(7) 1.353(4) 
N(1)-C(2) 1.450(4) 
N(1)-C(6) 1.469(4) 
C(2)-C(11) 1.537(5) 
C(2)-C(3) 1.545(4) 
C(3)-C(4) 1.522(5) 
C(3)-Cl 1.776(3) 
C(4)-O(4) 1.190(4) 
C(4)-C(5) 1.555(5) 
C(5)-O(13) 1.454(3) 
C(5)-C(16) 1.520(5) 
C(5)-C(6) 1.528(4) 
C(6)-C(12) 1.552(4) 
C(7)-O(7) 1.221(4) 
C(7)-O(8) 1.323(4) 
O(8)-C(9) 1.438(4) 
C(9)-C(10) 1.481(7) 
C(11)-C(12) 1.544(6) 
O(13)-C(14) 1.376(4) 
C(14)-O(14) 1.217(4) 
C(14)-N(15) 1.321(5) 
N(15)-C(16) 1.438(4) 
N(15)-C(17) 1.455(4) 
 
C(7)-N(1)-C(2) 123.9(3) 
C(7)-N(1)-C(6) 125.4(3) 
C(2)-N(1)-C(6) 106.0(3) 
N(1)-C(2)-C(11) 102.2(3) 
N(1)-C(2)-C(3) 107.5(2) 
C(11)-C(2)-C(3) 111.6(3) 
C(4)-C(3)-C(2) 110.6(3) 
C(4)-C(3)-Cl 110.9(2) 
C(2)-C(3)-Cl 110.6(2) 
O(4)-C(4)-C(3) 125.1(3) 
O(4)-C(4)-C(5) 121.5(3) 
C(3)-C(4)-C(5) 113.4(3) 
O(13)-C(5)-C(16) 105.4(2) 
O(13)-C(5)-C(6) 109.1(3) 
C(16)-C(5)-C(6) 113.5(3) 
O(13)-C(5)-C(4) 105.2(2) 
C(16)-C(5)-C(4) 113.8(3) 
C(6)-C(5)-C(4) 109.4(3) 
N(1)-C(6)-C(5) 108.9(3) 
N(1)-C(6)-C(12) 102.0(3) 
C(5)-C(6)-C(12) 109.6(3) 
O(7)-C(7)-O(8) 125.3(3) 
O(7)-C(7)-N(1) 123.4(3) 
 Appendix 
 298
O(8)-C(7)-N(1) 111.3(3) 
C(7)-O(8)-C(9) 118.6(3) 
O(8)-C(9)-C(10) 107.0(3) 
C(2)-C(11)-C(12) 104.6(3) 
C(11)-C(12)-C(6) 104.9(3) 
C(14)-O(13)-C(5) 108.7(2) 
O(14)-C(14)-N(15) 130.2(3) 
O(14)-C(14)-O(13) 120.3(3) 
N(15)-C(14)-O(13) 109.5(3) 
C(14)-N(15)-C(16) 113.9(3) 
C(14)-N(15)-C(17) 123.7(3) 
C(16)-N(15)-C(17) 120.6(3) 
N(15)-C(16)-C(5) 101.1(3) 
 
CRYST1    9.473    7.744   10.836  90.00 112.69  90.00 
SCALE1      0.105568  0.000000  0.044143       0.000000 
SCALE2      0.000000  0.129129  0.000000       0.000000 
SCALE3      0.000000  0.000000  0.100029       0.000000 
ATOM      1  N1          0       5.358   2.019   1.376 1.000  3.80 
ATOM      2  C2          0       4.447   0.893   1.286 1.000  4.03 
ATOM      3  H2A         0       4.601   0.359   0.455 1.000  4.83 
ATOM      4  C3          0       4.640   0.038   2.558 1.000  3.96 
ATOM      5  H3A         0       5.592  -0.264   2.591 1.000  4.75 
ATOM      6 CL           0       3.604  -1.404   2.506 1.000  5.22 
ATOM      7  C4          0       4.361   0.863   3.806 1.000  3.86 
ATOM      8  O4          0       3.695   0.508   4.727 1.000  5.31 
ATOM      9  C5          0       5.021   2.270   3.778 1.000  3.78 
ATOM     10  C6          0       4.803   2.907   2.407 1.000  3.88 
ATOM     11  H6A         0       5.190   3.827   2.355 1.000  4.65 
ATOM     12  C7          0       6.657   1.970   1.000 1.000  3.88 
ATOM     13  O7          0       7.165   0.997   0.465 1.000  4.61 
ATOM     14  O8          0       7.269   3.117   1.239 1.000  4.45 
ATOM     15  C9          0       8.678   3.215   0.970 1.000  4.72 
ATOM     16  H9A         0       8.831   3.475   0.027 1.000  5.67 
ATOM     17  H9B         0       9.121   2.345   1.133 1.000  5.67 
ATOM     18  C10         0       9.222   4.248   1.882 1.000  7.92 
ATOM     19  H10         0      10.187   4.337   1.735 1.000 11.87 
ATOM     20  H10         0       9.056   3.984   2.811 1.000 11.87 
ATOM     21  H10         0       8.784   5.106   1.703 1.000 11.87 
ATOM     22  C11         0       3.075   1.585   1.270 1.000  4.80 
ATOM     23  H11         0       2.390   1.018   1.707 1.000  5.75 
ATOM     24  H11         0       2.788   1.778   0.343 1.000  5.75 
ATOM     25  C12         0       3.289   2.893   2.061 1.000  4.39 
ATOM     26  H12         0       2.741   2.899   2.885 1.000  5.27 
ATOM     27  H12         0       3.048   3.680   1.511 1.000  5.27 
ATOM     28  O13         0       6.442   2.028   3.968 1.000  4.03 
ATOM     29  C14         0       6.813   2.524   5.196 1.000  4.22 
ATOM     30  O14         0       7.951   2.375   5.601 1.000  5.74 
ATOM     31  N15         0       5.768   3.086   5.778 1.000  4.48 
ATOM     32  C16         0       4.606   3.165   4.934 1.000  4.21 
ATOM     33  H16         0       4.438   4.093   4.634 1.000  5.05 
ATOM     34  H16         0       3.800   2.818   5.392 1.000  5.05 
ATOM     35  C17         0       5.849   3.866   7.003 1.000  5.61 
ATOM     36  H17         0       5.777   4.819   6.789 1.000  8.41 
ATOM     37  H17         0       6.706   3.693   7.444 1.000  8.41 
ATOM     38  H17         0       5.116   3.610   7.602 1.000  8.41 
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Appendix 8.6: Crystal data and structure refinement for ketone ent-206. 
 
Empirical formula C13 H17 Br N2 O5 
Formula weight 361.20 
Temperature 173(2) K 
Diffractometer, wavelength OD Xcalibur PX Ultra, 1.54184 Å 
Crystal system, space group Orthorhombic, P2(1)2(1)2(1) 
Unit cell dimensions a = 6.06554(12) Å α = 90° 
 b = 13.7896(3) Å β = 90° 
 c = 17.3403(3) Å γ = 90° 
Volume, Z 1450.36(12) Å3, 4 
Density (calculated) 1.654 Mg/m3 
Absorption coefficient 4.094 mm-1 
F(000) 736 
Crystal colour / morphology Colourless needles 
Crystal size 0.19 x 0.02 x 0.02 mm3 
 range for data collection 4.10 to 71.46° 
Index ranges -6<=h<=7, -14<=k<=16, -21<=l<=19 
Reflns collected / unique 9540 / 2774 [R(int) = 0.0444] 
Reflns observed [F>4σ(F)] 2116 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.82647 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2774 / 0 / 191 
Goodness-of-fit on F2 0.930 
Final R indices [F>4σ(F)] R1 = 0.0304, wR2 = 0.0597 
 R1+ = 0.0304, wR2+ = 0.0597 
 R1- = 0.0397, wR2- = 0.0856 
R indices (all data) R1 = 0.0466, wR2 = 0.0635 
Absolute structure parameter x+ = 0.00(2), x- = **** 
Largest diff. peak, hole 0.431, -0.366 eÅ-3 
Mean and maximum shift/error 0.000 and 0.000 
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Bond lengths [Å] and angles [°] 
 
Br-C(3) 1.961(3) 
C(14)-O(14) 1.203(4) 
C(14)-N(15) 1.336(4) 
C(14)-O(13) 1.384(3) 
O(13)-C(5) 1.449(4) 
O(8)-C(7) 1.342(4) 
O(8)-C(9) 1.451(4) 
C(9)-C(10) 1.485(5) 
C(7)-O(7) 1.214(4) 
C(7)-N(1) 1.375(4) 
C(6)-N(1) 1.476(4) 
C(6)-C(5) 1.536(4) 
C(6)-C(12) 1.548(4) 
N(1)-C(2) 1.477(4) 
C(5)-C(16) 1.530(4) 
C(5)-C(4) 1.537(5) 
C(16)-N(15) 1.445(4) 
N(15)-C(17) 1.452(4) 
C(12)-C(11) 1.542(4) 
C(3)-C(4) 1.514(5) 
C(3)-C(2) 1.541(5) 
C(4)-O(4) 1.207(4) 
C(11)-C(2) 1.517(5) 
 
O(14)-C(14)-N(15) 130.0(3) 
O(14)-C(14)-O(13) 120.9(3) 
N(15)-C(14)-O(13) 109.1(3) 
C(14)-O(13)-C(5) 109.5(3) 
C(7)-O(8)-C(9) 117.0(3) 
O(8)-C(9)-C(10) 109.7(3) 
O(7)-C(7)-O(8) 125.2(3) 
O(7)-C(7)-N(1) 124.5(3) 
O(8)-C(7)-N(1) 110.3(3) 
N(1)-C(6)-C(5) 107.8(3) 
N(1)-C(6)-C(12) 104.2(3) 
C(5)-C(6)-C(12) 109.3(3) 
C(7)-N(1)-C(6) 117.6(3) 
C(7)-N(1)-C(2) 121.2(3) 
C(6)-N(1)-C(2) 104.7(3) 
O(13)-C(5)-C(16) 105.0(3) 
O(13)-C(5)-C(6) 110.1(3) 
C(16)-C(5)-C(6) 112.0(3) 
O(13)-C(5)-C(4) 107.0(3) 
C(16)-C(5)-C(4) 112.2(3) 
C(6)-C(5)-C(4) 110.2(3) 
N(15)-C(16)-C(5) 101.8(3) 
C(14)-N(15)-C(16) 113.2(3) 
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C(14)-N(15)-C(17) 122.8(3) 
C(16)-N(15)-C(17) 122.5(3) 
C(11)-C(12)-C(6) 104.7(3) 
C(4)-C(3)-C(2) 113.9(3) 
C(4)-C(3)-Br 107.1(2) 
C(2)-C(3)-Br 109.9(2) 
O(4)-C(4)-C(3) 120.1(3) 
O(4)-C(4)-C(5) 121.6(3) 
C(3)-C(4)-C(5) 118.3(3) 
C(2)-C(11)-C(12) 105.1(3) 
N(1)-C(2)-C(11) 103.3(3) 
N(1)-C(2)-C(3) 107.2(3) 
C(11)-C(2)-C(3) 110.1(3) 
 
CRYST1    6.066   13.790   17.340  90.00  90.00  90.00 
SCALE1      0.164867  0.000000  0.000000       0.000000 
SCALE2      0.000000  0.072518  0.000000       0.000000 
SCALE3      0.000000  0.000000  0.057669       0.000000 
ATOM      1 BR           0       4.823   5.118   5.646 1.000  3.72 
ATOM      2  C14         0       4.202   8.425   8.936 1.000  2.56 
ATOM      3  O14         0       5.204   8.540   9.591 1.000  3.24 
ATOM      4  O13         0       4.262   8.035   7.609 1.000  2.53 
ATOM      5  O8          0       4.768   8.201   2.815 1.000  2.80 
ATOM      6  C9          0       5.179   8.956   1.646 1.000  3.60 
ATOM      7  H9A         0       5.855   8.443   1.137 1.000  4.32 
ATOM      8  H9B         0       5.589   9.812   1.928 1.000  4.32 
ATOM      9  C7          0       4.364   8.904   3.883 1.000  2.42 
ATOM     10  O7          0       4.570  10.088   4.061 1.000  2.72 
ATOM     11  C6          0       2.815   8.722   5.758 1.000  2.40 
ATOM     12  H6A         0       3.033   9.689   5.888 1.000  2.88 
ATOM     13  N1          0       3.714   8.085   4.776 1.000  2.21 
ATOM     14  C5          0       2.919   7.934   7.072 1.000  2.25 
ATOM     15  C16         0       2.013   8.512   8.161 1.000  2.54 
ATOM     16  H16         0       1.655   9.397   7.901 1.000  3.05 
ATOM     17  H16         0       1.260   7.903   8.366 1.000  3.05 
ATOM     18  N15         0       2.925   8.619   9.278 1.000  2.60 
ATOM     19  C12         0       1.401   8.528   5.158 1.000  2.76 
ATOM     20  H12         0       0.752   8.270   5.860 1.000  3.31 
ATOM     21  H12         0       1.087   9.360   4.722 1.000  3.31 
ATOM     22  C3          0       3.018   5.863   5.472 1.000  2.98 
ATOM     23  H3A         0       2.385   5.120   5.258 1.000  3.57 
ATOM     24  C4          0       2.646   6.443   6.820 1.000  2.63 
ATOM     25  O4          0       2.112   5.749   7.651 1.000  3.42 
ATOM     26  C11         0       1.567   7.397   4.122 1.000  2.99 
ATOM     27  H11         0       0.909   6.675   4.283 1.000  3.59 
ATOM     28  H11         0       1.445   7.743   3.203 1.000  3.59 
ATOM     29  C2          0       2.982   6.887   4.320 1.000  2.48 
ATOM     30  H2A         0       3.366   6.513   3.476 1.000  2.97 
ATOM     31  C10         0       4.001   9.226   0.783 1.000  4.61 
ATOM     32  H10         0       4.280   9.752   0.004 1.000  6.92 
ATOM     33  H10         0       3.331   9.727   1.293 1.000  6.92 
ATOM     34  H10         0       3.615   8.377   0.482 1.000  6.92 
ATOM     35  C17         0       2.531   9.191  10.553 1.000  3.18 
ATOM     36  H17         0       3.221   9.002  11.223 1.000  4.77 
ATOM     37  H17         0       1.681   8.797  10.839 1.000  4.77 
ATOM     38  H17         0       2.426  10.161  10.457 1.000  4.77 
 
